FeatureID,Name,Formula,MW,KEGG.Pathways,name4plot,C,H,N,O,Cl,S,P,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,gap_status,Study.File.ID,SampleID1,SampleID2,Batch,RT.Range..min.,Instrument.Name,Software.Revision,Ref..File.ID,Sample.Type,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.566127384301268,1.1008123504674148,0.1385685614336606,0.0019632835139276436,0.01088937650052313,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.594004731145233,1.085059072289574,0.11777358735117073,0.026485509647572594,0.05754292274621426,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.103801103179432,0.9576333821932541,-0.06245465074583852,0.12418370271958887,0.19707413692456494,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,25.865814408569634,1.0265314904938285,0.03777788510110572,0.08505398531370713,0.14574978703992067,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4092114122264,1.0532658116518734,0.07486957383562665,0.02624835755969652,0.05736916472628281,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.807259567111366,1.0003147408655144,4.5400364284028277e-4,0.9714962443290832,0.9795473181771144,Upregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,23.4205611952757,0.9537463244870903,-0.06832250273517732,0.0699602677557655,0.12519045880967647,Downregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,24.170614998523433,1.0548579660598723,0.07704875679420652,0.0019988718507809584,0.01088937650052313,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.307573026424432,1.015061224119682,0.02156674718387041,0.5050737035097985,0.6104367608644916,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,24.8086255276989,1.0270701580207056,0.03853473391655019,0.5521159185033222,0.6479817049958605,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,23.041615449195902,0.9207567852253831,-0.11910797123919635,0.3988442900213529,0.5054797425617841,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,19.773865904456468,0.7892315115387577,-0.34147953538808523,0.009406355227105284,0.026913727483742825,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,22.453952408312833,0.9802539583470489,-0.028772532411116224,0.2423444885428845,0.33505961484148805,Downregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,23.853567090450035,1.1165145292601892,0.15900202514626824,5.4150580298791877e-5,0.0014117829863613597,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.219694200619735,1.2267728630574928,0.29486815880153566,2.066199539534021e-4,0.0023567588497809926,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,24.8158824974359,1.0249965913013328,0.03561911195429194,0.05234192130528202,0.09950417331472884,Upregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,22.049019786161434,0.8735632169127127,-0.19501598484622076,0.002313759194775498,0.011729473695736901,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,23.939439294293933,1.0409253745124962,0.05786664339249682,0.054976077362542584,0.1039703017478137,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,19.6695044806278,0.9964379020473756,-0.005148195693390129,0.7139713578517997,0.7821407552300275,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,24.318654783177898,1.2494047070342678,0.32124087026674736,0.041439243003192065,0.08310617415475331,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,21.784813540310235,0.8667151961815712,-0.20637009516318233,0.00654843812478187,0.021152034650844094,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,22.928283771934336,0.9388260761790735,-0.09107018117734773,0.002576878285587238,0.012540807656524558,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,20.475389434119734,0.816868262813282,-0.29182466267364443,0.0013122360050663799,0.007921788149874274,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.497973241322267,0.9898901128056645,-0.014659713643976079,0.8219107565918614,0.8620615694138777,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.485788575419033,1.037503200145043,0.053115786412587455,0.006322760483348946,0.020605424789485405,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,22.165337714170267,0.8724043800065735,-0.19693108167405884,0.0024559615009637787,0.012279807504818894,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,25.28688897484737,1.0038833972791867,0.005591707599108244,0.7720505162001491,0.8228508080872459,Upregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.122502056196932,0.9339384303965501,-0.0986006510438823,0.009129819911104982,0.026659074140426547,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,24.9743973785335,1.25510904616313,0.32781271359791014,4.227441532177798e-5,0.0012858467993707469,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,23.497595787553568,1.060598468239976,0.08487856999315756,0.6395315214122348,0.718243093278356,Upregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.958095537650166,0.9452162443479122,-0.08128367141691287,0.01552025041803678,0.0377659426838895,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,24.6671449735766,1.2256242944410356,0.29351679989690455,8.006099144280871e-5,0.0017189565809779517,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,23.38991073964,1.0676908970314392,0.09449403853764649,0.01425466957295203,0.03515509725761819,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,22.7348999953628,0.8854599622251635,-0.17550102066579315,0.003092160136033529,0.013014118638113149,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.587601625183932,1.0380965069346357,0.053940570481948065,0.012019850356753074,0.03156291640442354,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.803554025363766,1.3212815246994458,0.401937893545508,1.509789670316696e-5,6.888415370819925e-4,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,24.758022372246,1.2126132216549146,0.2781194579753137,0.004814019712443241,0.01706989735222466,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,24.5485426565242,1.2124363544970778,0.2779090166099337,0.07129836300601956,0.1257193357352519,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.029476746366534,0.9120615438043759,-0.1327969174867457,0.2627615457902587,0.36055625644152034,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,22.8985088550048,0.8322586537401743,-0.26489612844867644,0.016861134600730052,0.0402242753546828,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,20.433706575370067,0.972514773773269,-0.040207928194666,0.045482005264313445,0.08925232215846456,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,25.037299940457633,1.1741300907182688,0.23159226435632896,0.13030354043908704,0.2030328301116583,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,22.2772711304372,0.828881368545762,-0.2707624603047723,0.01240097293419107,0.03186686451875605,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,27.253349088264866,1.3536824122121383,0.4368893075469344,0.05136073029360713,0.09815008668673614,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,20.845667219626765,0.738862443882277,-0.43662229614635395,1.239999528177793e-6,1.2481230131084379e-4,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,23.7733798686438,1.0670436322419505,0.0936191702879899,0.005562213121158063,0.019237557051234692,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,22.158699269424634,0.9028007533440173,-0.14752047249715208,4.129683333541318e-4,0.003864960042929695,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.956049228421765,1.036393541881255,0.051571930737827815,0.017916688421358146,0.04192045688330592,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.471649933646468,1.143912585004738,0.19397680911047102,0.041262139530914274,0.08310617415475331,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,22.6033729887552,1.0266778458829466,0.037983559399098435,0.16000846480487446,0.23935692481057042,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,27.011193972771935,1.2875361838946837,0.3646129772215935,6.166433611776803e-4,0.004593363812854149,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.6825608717218,1.0187403530862338,0.026786397875694583,0.06182299738632972,0.11512956145923647,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,20.116460474973,0.791272009710014,-0.3377543703522401,0.004766616531558956,0.01706989735222466,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,23.0578247972753,0.954418975819366,-0.06730536781362476,0.059836565784238294,0.11200177698075373,Downregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.6625817729804,1.095569162667878,0.13168056373329118,0.22979909191692194,0.32136654616734295,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.4972793866126,1.0646502017221846,0.0903795007467462,0.10089732745941114,0.16664038245558854,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,19.20433686231887,0.8568157517860523,-0.22294309190618236,0.13448570943975952,0.2079969658708145,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,19.1185912418606,0.8344271030297887,-0.26114207608572887,0.16925995005006544,0.2481119749729875,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,19.8210213802509,0.9668329331903567,-0.04866147848515967,0.31326621275101557,0.4157897005604389,Downregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,25.294523030630334,0.9708705834659184,-0.04264909691071546,0.18214742282573243,0.26278185506479185,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.954562846351568,1.0386167468289214,0.05466339298033458,0.5157404871547384,0.6175788524387482,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,24.0000434184496,1.0590533250410104,0.08277523317856765,0.021328372645806698,0.04896135858943047,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.90240466157117,1.1407957965926234,0.1900405711106473,0.0027626202152236487,0.012604454731957898,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.80357991509757,0.9612374961764159,-0.05703516833732357,0.1256695369146301,0.1984714044045506,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,24.353790988481233,0.9715002930411335,-0.04171366390543388,0.14918759412556387,0.22688946606596172,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,21.4310757834881,0.9942753502400181,-0.00828265415124471,0.6645014367014744,0.7394604402318237,Downregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,24.506970139269633,0.8965933344097364,-0.15747432096135716,0.004296318518125518,0.016334961032456397,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,25.564708055042733,1.4235886151608501,0.5095323003678524,1.2268032307555972e-4,0.0019717592282331494,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.883969398243533,0.8643730203059706,-0.21027405285911624,0.0012056566932494928,0.00785829808992973,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,24.728874746064367,0.9023172125770756,-0.148293388058783,0.017423628080856835,0.041296261360472375,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,25.401351878297167,1.0941339813378448,0.12978941306314776,0.03805468172094693,0.07716643793414238,Upregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,22.836745093079035,1.12864003370781,0.17458542907677482,0.1913070791534775,0.2749097790985011,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,22.316963510961,0.9809368661915505,-0.027767808354548847,0.8750077173514672,0.9021972226928969,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,23.205046164106534,0.9581068376066978,-0.061741556367066186,0.5687965881656921,0.6632931459440179,Downregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.530187616676667,1.0474402280975175,0.0668679192585931,0.10569024726329265,0.17145306778267475,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,22.297625001318668,0.8658283705217891,-0.2078470209015324,0.1263378412546433,0.1984714044045506,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,24.4118505594793,1.2501497997725701,0.32210097683970895,0.03745934472186559,0.07638358001944659,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,21.86909840411323,0.9327772139556153,-0.1003955483244563,0.1654880255884727,0.2445470823473382,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,21.515747310562766,1.0512714340138714,0.07213521539626236,0.027492859128946025,0.058683588199212273,Upregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,21.438924294262634,0.8315691923991928,-0.2660917840169612,0.1119847571537858,0.18006359630454544,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,22.2136008498238,0.8457907302437145,-0.24162734618381695,0.03328412086809078,0.06902672793666553,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,23.201213878412467,1.0232434116671354,0.033149377764871625,0.0828885752619503,0.14338545009768655,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,20.350438889289368,0.9974072037516245,-0.003745472013457423,0.9526835694795937,0.9686058575488905,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.798457259929968,0.928594705528652,-0.10687903962281915,0.09556403962594869,0.15927339937658114,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.88502210316277,1.0581802055874074,0.08158533592916119,0.00288039954983736,0.012821290679154104,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,23.529627941271798,1.21752495051444,0.2839513374941623,0.013796394014012534,0.03458680342813893,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,24.073843143713866,0.9388005894068011,-0.09110934725934038,0.009506122698445972,0.026913727483742825,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.524769667096166,1.0975478154595244,0.13428379317627095,0.011407600973253496,0.030613094488419333,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.928779198312665,1.017394241977161,0.024878834290079126,0.23942584109661474,0.3322830114078494,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,19.994562376860568,0.9888455230503527,-0.016182933393435642,0.5883716533940531,0.6774626293023008,Downregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,23.733448392661234,1.1268152589364018,0.17225100542720526,4.4671633847964145e-4,0.0038821777034540265,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,22.482879336333102,0.9174117784266164,-0.12435866493796377,0.26556213324007477,0.3630343769012258,Downregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,21.041565646723765,0.9252111277988314,-0.11214547707187719,0.3120535891186412,0.4157897005604389,Downregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,24.165255710774368,1.0502310841696536,0.07070680151555805,0.1371363236029223,0.21120151103403645,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,23.538084352090902,0.9140657231513852,-0.12963019321925273,7.920636249595093e-5,0.0017189565809779517,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.769442735972667,1.1610241018778447,0.21539792164251906,0.005586797390221583,0.019237557051234692,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,26.2140919862775,1.0135226168441689,0.01937828302766191,0.39337586422302606,0.500286377844615,Upregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,22.623372687072166,1.0061415527947322,0.008833290380773191,0.7745230287996839,0.8228508080872459,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,23.090265279797098,0.9880679692859407,-0.017317806540020856,0.39080493326647986,0.4987545477002278,Downregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,22.400349997975766,0.9250125234523003,-0.11245519693384746,0.043393023649074165,0.08654892695033918,Downregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,22.947201351414336,0.9836464299770277,-0.023788260404069977,0.8203479325969751,0.8620615694138777,Downregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,22.8669909716679,1.0968439971240365,0.13335834745478156,0.28381591081291796,0.38367706461746315,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,24.1363509991147,1.1398705608688389,0.18887000702597098,0.31601341806051403,0.4179162956235059,Upregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,22.25772333764183,0.9088915956948013,-0.13781986172188196,0.37636588940851906,0.48541890330074017,Downregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,22.2100602386838,1.0132332634743486,0.018966345232297215,0.8990839617497629,0.9244102705314463,Upregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,21.398619490928034,0.8669182314918743,-0.2060321713184259,0.15141547065667202,0.22932218584931655,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,24.0627635221294,1.1710677571012247,0.2278245515060064,0.20071182428886672,0.28617115572436075,Upregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,24.420362419832866,0.9859790309458648,-0.02037113010171959,0.8426868765085652,0.8788020283589324,Downregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.830237271205835,1.0092162261480149,0.013235307220633333,0.41046106672589244,0.5148394823194183,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,25.442634343612866,0.9665418804914853,-0.0490958487743552,0.7698363038503511,0.8228508080872459,Downregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,26.180160431799134,1.0249815170395529,0.0355978945933583,0.09111592345146534,0.15396903731381875,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,26.225865677845633,1.055844720336738,0.07839767780965463,0.024110372543629292,0.05396837625205425,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,28.553976095025767,1.3200075194112997,0.40054614790683024,0.0017211368948160314,0.00981585885324768,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.070044113405768,0.8143330432405694,-0.2963091510522944,1.49136020714306e-4,0.0020086410725133775,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.593573848828566,0.9961884766223881,-0.005509372108028135,0.45820195255971413,0.5688561655928424,Downregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,25.973922461483767,1.0577166727420504,0.08095322899159452,0.002728114931460129,0.012604454731957898,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.796021753680765,1.222179413779465,0.2894560857870766,2.2639591246222027e-5,8.26345080487104e-4,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.9894823673106,1.0793301690838228,0.110136255406875,0.003101995401413271,0.013014118638113149,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.368795927286868,1.2666739956183566,0.34104526526533196,5.367742328620263e-4,0.004215465393083545,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,29.1315440805228,1.0060926215691894,0.008763126741423075,0.5120981841532508,0.6168839512077114,Upregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,24.662792247739535,1.1008826110604595,0.138660640137533,0.07860938159588965,0.13709867640368661,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0680353065692,1.2414526246321842,0.3120292075378568,5.625995736624361e-4,0.004278100924724775,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.623408826406866,1.029024265318292,0.041277002680480575,0.017696635765925613,0.041672722932663546,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,30.160000249908702,1.0203480844121264,0.029061401204569137,0.023449917060230474,0.0528346896727415,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.107123291704035,1.0653336126287118,0.09130528577189692,0.012362557013876986,0.03186686451875605,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,22.409622164550132,1.0537980056021201,0.0755983544096671,0.41628482159844155,0.520356026998052,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,26.490919508027833,0.9705131066164241,-0.04318039846275937,0.5622791361327739,0.6577945022066105,Downregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,21.180552498331465,0.9369643044298769,-0.09393400837210326,0.046116249029117456,0.08991319898235071,Downregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,18.658165294612566,0.6392226464651175,-0.6456095737238523,5.405488699761809e-7,1.2481230131084379e-4,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.132218324769134,0.8907611021619639,-0.1668895351263824,0.02685563461974847,0.05766062727181289,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,26.007661329102834,1.2289722858648864,0.2974523823532845,0.0012663858854927452,0.007921788149874274,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,25.890722771367333,1.221859175737032,0.28907801823908635,1.3922801069935127e-4,0.0020086410725133775,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,21.7600087803012,0.8158134214207139,-0.2936888529471339,0.010425757037517155,0.028612039990178657,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,18.398550731601034,0.6581669577413136,-0.6034744948901924,0.0012581628838253243,0.007921788149874274,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,25.008631001851434,1.1938482650781936,0.2556194855726581,0.10043367066363716,0.16662858996467075,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,23.863685102265467,1.1097064465321054,0.15017808725711984,0.002806393250531055,0.01264609304251648,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.18245599682387,1.1214647304696461,0.16538424906738325,7.257057696436573e-4,0.0051937765866653905,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,24.423802064708966,0.9532931985012423,-0.0690080916987022,0.3104135124409979,0.4157897005604389,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,23.4468422600727,0.9548614785234014,-0.06663663790894235,0.6176926234948701,0.7001795266323838,Downregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.769556190813802,1.1799165902755795,0.23868487734221067,0.016262286430878826,0.03930950031305147,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,25.961904728350966,1.150391023242263,0.20212432326258914,0.00814013180538269,0.02475956757470568,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,22.2084141088284,0.9041837672936336,-0.14531207753481748,4.950686937930464e-4,0.004106819846237771,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,24.948216780476233,1.165907328626915,0.22145312143409426,9.214961828527798e-4,0.006346152957382351,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.9973175426306,1.0880229115958135,0.12170893719268822,0.008099844499790392,0.02475956757470568,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,22.1980290328719,1.1015493471862121,0.13953412631083983,0.010381770881338338,0.028612039990178657,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.291061494286634,1.016382794159351,0.023443858041209978,0.21097755986152017,0.29732358822183347,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,26.896290643774165,1.2938519307876533,0.37167252386734195,0.0020687752284324437,0.010943521135910754,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.754665037825333,1.303814819547479,0.3827389785476127,1.5105144869035893e-4,0.0020086410725133775,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.951153853234366,1.0773953119156143,0.10754769268540493,8.729929282668327e-6,4.5520345545341993e-4,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.372221168289766,1.0273325935015847,0.038903322177636306,0.024248804672155882,0.05396837625205425,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.2475055098148,1.082955341612016,0.11497375101337327,0.06892786606267459,0.12454787679641696,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1117199147677,1.009050474649864,0.012998342636274746,0.494125402108136,0.6052207106358042,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.3008751858887,1.2640103448392248,0.3380082707833516,0.013834721371255573,0.03458680342813893,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,22.190746064366,0.8875827377325877,-0.17204648552026683,0.08555108674216647,0.1459165731817325,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,21.1782160796956,0.9840932057449244,-0.023133131865610036,0.5395948190564397,0.6353293837277435,Downregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,23.872074329576865,1.029964890945904,0.0425951602031325,0.3199757037434022,0.4216286348965408,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,22.740743807338802,0.9001272492751825,-0.1517991279768952,0.20847743754291015,0.2960866330862343,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.382455560123066,0.9413164941721939,-0.08724822017675382,1.483246670081398e-4,0.0020086410725133775,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,22.367876646803502,0.900428311713467,-0.15131667544927616,0.00205956103336835,0.010943521135910754,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,23.06729450881,0.9263361327236171,-0.11039230634780095,0.007018326356901053,0.022083526898869693,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.384079335290934,1.0514427164692657,0.07237025290668997,0.06697643121398135,0.12223198696551596,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,21.877988208980234,0.9396253142077188,-0.0898425137318159,0.38420452422289975,0.49266029477048623,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,22.942307806516734,0.8955863314178911,-0.1590955851717352,0.0059862242401707315,0.01994508816846971,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.316701044452202,1.0277528035116819,0.03949330730139702,0.02568404851317831,0.056473962092229414,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.813348170484634,1.025650834996793,0.0365396740703279,0.016593023858331987,0.03984509018612615,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.901086034777933,0.9607495518690677,-0.05776769652816738,0.003236555130672252,0.01327351261455474,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,27.909488039612032,1.0669988698502126,0.09355864808140334,0.05740562406468731,0.10800542671964365,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.50742501049143,0.9878244336418988,-0.017673440953309225,0.1558391864555886,0.2340794364456372,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,24.1455385493278,1.1630081553244698,0.2178612134103724,0.3129111278449974,0.4157897005604389,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,24.939526478210265,1.2045803747008574,0.2685306595072348,0.07005648456455801,0.12519045880967647,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,28.173696116950566,1.386380839954424,0.47132362143000445,0.0022216644475437047,0.011584393190763603,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,24.9235035664126,1.2440544144863752,0.3150495898035344,0.1982255713171534,0.2837346412971019,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.781975247267432,1.3869508461509321,0.4719166591316813,1.1990734792780877e-4,0.0019717592282331494,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,19.705480221759068,1.0040119231053555,0.005776402060428594,0.517175008740252,0.6175788524387482,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,23.6548731976333,0.8020987488239184,-0.31814823268524034,0.0038216808886408606,0.014999070154343163,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.099573067452233,0.8570770948150795,-0.22250311306430962,9.33194785681232e-5,0.0018923116487424983,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,21.695794727274965,0.9826820037562316,-0.025203459425501333,0.1818061573447661,0.26278185506479185,Downregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,29.744880444626066,0.9714242947947421,-0.04182652705403723,0.10403447059438159,0.17028063572622995,Downregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.623232217938032,0.8712324524915745,-0.19887040096033393,4.765131676723138e-5,0.0013379023553876503,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.616801933017666,1.009853555634826,0.014146095078357627,0.38467995619065365,0.49266029477048623,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,22.208054932019035,1.0426986143403185,0.06032221593073452,0.07042246767851136,0.12519045880967647,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,19.6245483141361,0.9973028341348247,-0.0038964448624972206,0.8582671099819785,0.8899644748392674,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,22.5906632251769,0.8990854964067552,-0.1534697829549348,0.0048169847322716165,0.01706989735222466,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,24.428730592725632,1.1319160537765611,0.17876696763000904,0.002312968237659415,0.011729473695736901,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,21.926386648387865,1.004767863883691,0.006862227466135879,0.9678047536526572,0.9785283520310799,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,22.966200792567435,1.0014423432936639,0.0020793623001184387,0.9799212366159809,0.9826133279253654,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,25.796916021192267,0.9875707638368896,-0.018043967491177447,0.8504051004053235,0.884324392159382,Downregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,21.665846514552968,0.942040279890762,-0.08613934677301911,0.4992215843800703,0.6094176531729956,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,20.591065114808067,0.8090109867234606,-0.3057687996686689,0.006192265977615745,0.020361955692159883,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,26.8691542025348,1.0041773220880736,0.006014049277438921,0.9666973436200184,0.9785283520310799,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.9170538346994,0.876209981550381,-0.19065144533582043,4.448157642309398e-4,0.0038821777034540265,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.7173040578018,0.9596508062411847,-0.05941855545955328,0.08969253559601217,0.15226872322113694,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,21.039713919288733,0.7917423079005055,-0.336897148936647,0.009469229097633146,0.026913727483742825,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,22.379361040085033,0.8513287512022888,-0.23221174071833253,0.30040729998977966,0.4046076180674154,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,26.269378315050066,0.8821451786802249,-0.18091198862145738,0.2801536008822923,0.38013406811166056,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.773482146853834,1.1636772008184855,0.21869091618079728,0.15470548949064766,0.233336792000357,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,21.0121770164514,0.8067763346358181,-0.3097593292362989,1.5840649888208315e-4,0.0020086410725133775,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,27.695660187399035,1.4322197639846412,0.5182528809295713,0.00840778399453988,0.025362323619893025,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,22.3372806432835,0.8019299607795531,-0.3184518552750456,0.027853155173505055,0.05910698626935666,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,21.93527962217363,0.8726646991919892,-0.1965006560764593,0.11440805658121543,0.1823534526294482,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.285136866672833,0.9598359958064161,-0.05914017681383645,2.6469038718810025e-4,0.0027603426092473312,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.140693160787634,0.9910891591982214,-0.01291324560159214,0.504028565325876,0.6104367608644916,Downregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.291514034102,1.0228694036727615,0.03262195866979506,0.14846361702375627,0.22673313896933486,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.438707093650066,0.8676295539809953,-0.20484889865952247,0.015338811880569476,0.0375749418550863,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,21.733237079986733,0.8015867666083135,-0.3190694036024348,0.004404320567316057,0.016403847010922047,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,22.252768619880968,0.8509398636468836,-0.2328709153662264,0.004349848215717159,0.01636798555398725,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,20.92999464096337,0.9870020166236282,-0.018875062515785093,0.5288586649131611,0.6247036009492033,Downregulated
Feature0158,[Similar to: NP-016129; ΔMass: -205.0627 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,20.005141981386267,1.0010466106384572,0.001509150369115668,0.937757575318346,0.9587717506756198,Upregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.5456550326866,1.4724840278049784,0.558251985069981,6.619883439885149e-4,0.004832514911116159,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,24.25762104421,0.9603577768470356,-0.05835611954942881,0.001989279411050226,0.01088937650052313,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.965383720255165,1.1406822675293915,0.18989699066669533,0.2374475831502146,0.3307952971367494,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,22.25895033704043,0.9477027018490967,-0.0774935440300995,0.09540864912241748,0.15927339937658114,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,24.923316596574733,0.9270276274580581,-0.10931575991703202,0.018121949856287095,0.04213064775506236,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,24.222725506233168,0.8797609206112229,-0.18481657739992566,0.27598121150056687,0.3758699335735332,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,26.316278898461267,1.2824605897461887,0.3589144922250486,1.2424784177907517e-4,0.0019717592282331494,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,21.738216075565102,1.0212952472304766,0.03039999661719758,0.6347268124949577,0.7172609491042091,Upregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,26.162434114821632,1.3427891176895903,0.4252327502216194,0.0037539621313901917,0.014893436716928478,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.8337936011975,1.0034793482117053,0.005010926078565344,0.6697607978795947,0.7430476936962068,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,26.937916665808466,0.9964815513220846,-0.005084999368957957,0.5206635132659071,0.6190299099089775,Downregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,23.217544671826833,1.0468989933361064,0.06612225521750936,0.7744867306084532,0.8228508080872459,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,24.108635256202835,1.2155081633653666,0.2815595825539583,0.008981759595220054,0.026438243969800965,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,21.3107007310268,0.9269158962071873,-0.10948965315561368,0.25110489405010555,0.3458614578425982,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.917033442832967,0.9606937808994696,-0.05785144659241886,2.474690025272079e-4,0.0026566525271303197,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.0349272644887,0.705144884269071,-0.5040083801543239,0.004635488137063159,0.01706989735222466,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.197596559426202,0.7178719033054582,-0.478201661637359,0.0073867947200479634,0.022848983667944973,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.938223191140768,0.8303431209937723,-0.26822047329019444,0.0016300371174004147,0.009443865838907163,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.125362054021366,0.7801166176953956,-0.3582382898932086,0.06654375702696083,0.12223198696551596,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,20.317969427304867,0.7908718899755154,-0.33848407738981623,1.0435085940069187e-6,1.2481230131084379e-4,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,18.85588198535987,0.7060879660683211,-0.5020801659164786,0.0011689691727038553,0.0077577045097619495,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,21.5637946093456,0.873056472942814,-0.1958531184673886,0.0041558985240438264,0.016137265545489325,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,22.801633119129335,0.8879286282639947,-0.17148437753242637,0.026683778720702187,0.057630646349445556,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,21.14245989898127,0.7823577845478202,-0.35409956926317593,1.596250030768819e-4,0.0020086410725133775,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.202955578550668,0.8689247652245848,-0.2026968264048736,0.06675032524037698,0.12223198696551596,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,21.8974773807363,0.8602024227044587,-0.217251900341854,0.0013239152798420017,0.007921788149874274,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.65159511419827,1.0235922742449224,0.03364116351910951,0.7755087068000344,0.8228508080872459,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,21.1559492989488,0.8109139486561008,-0.3023792660598981,0.011394757310157603,0.030613094488419333,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,25.603971130468235,0.9698127942973577,-0.04422180821066402,0.014164101169295047,0.03515509725761819,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,25.451702419370932,0.8961609419030477,-0.1581702451551585,0.006010848489127857,0.01994508816846971,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,21.714504669852033,0.9468731175986884,-0.07875697951604749,0.008485393057504637,0.02538662677040322,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,23.261406152512667,0.9491403195233016,-0.07530670593857591,0.07887869053362792,0.13709867640368661,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,25.304712550202268,1.0715347378379236,0.09967862117091744,0.005025435769326288,0.017637346690423994,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.90328229717007,1.0568372005636186,0.07975315531212736,0.009876790448213229,0.02773098856613714,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.6732501470252,1.0613463869906998,0.08589557919081023,0.0034712032141385523,0.014077657479561906,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.746410490872265,1.0308275646471583,0.043803020936536645,0.011015501285689384,0.030004910218482277,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,25.095807339854865,1.0718697799232804,0.1001296452822923,1.971289281320676e-4,0.002321034153813054,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,22.884681882553068,0.9200955959546891,-0.12014433301669786,0.46333509926756133,0.5732790211276606,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,19.8498585260969,0.9949258959821654,-0.0073390199651008695,0.6565843452431543,0.7328846667087197,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,26.1004603730291,1.0719665577780395,0.10025989863117754,0.013754883120142307,0.03458680342813893,Upregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,21.256871713120866,0.7912881233276158,-0.3377249913280623,0.02975933141745994,0.06242618372053379,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,21.044622882169833,0.7507311832349055,-0.41363168520336807,2.0517090626440074e-6,1.2481230131084379e-4,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.927081129806467,0.7404433949303256,-0.43353864563215744,1.4753649344840621e-6,1.2481230131084379e-4,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,27.7706753526044,1.4158638203875868,0.5016825118196704,1.0797641565670061e-4,0.0019717592282331494,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,27.247732720547802,1.3581123318514652,0.44160281235341026,0.0031491811872838265,0.013061944697256779,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,20.504811434739832,1.0060132990414692,0.008649377046379851,0.7633659489727341,0.8228508080872459,Upregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.235425305062833,1.0239356378590543,0.03412503383418071,0.7734138524861198,0.8228508080872459,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.910134891071465,1.0588187095043624,0.08245559283476873,0.025276591032715734,0.05591488319358329,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,20.105743560235066,1.0140462551719223,0.02012346159682552,0.6058826639712285,0.6910849135921825,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.1410153720616,1.103851668970004,0.1425463217368063,0.13071976733216356,0.2030328301116583,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.389617741496433,1.009629121270818,0.013825428455172019,0.16439102585852694,0.24391351397708264,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,20.726216876243168,0.8039428154374657,-0.31483520892946204,0.04631145591419708,0.08991319898235071,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,20.424621107540467,1.0003719243647804,5.364736790212588e-4,0.9904286672760223,0.9904286672760223,Upregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.2922994852546,1.0381096126165414,0.05395878399371363,0.01177636628207781,0.031147635456220298,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,20.1144961385284,0.9941368795898476,-0.00848358926684661,0.5009710291887962,0.609514752179702,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,26.575013147248068,1.3566391906975577,0.4400370752108212,2.163879560309127e-5,8.26345080487104e-4,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,24.762378508808798,1.224137478101973,0.2917655905781073,4.705204483760791e-4,0.0039939526431923,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.151375727031734,0.8975839953910886,-0.15588114306694975,6.937179186141658e-5,0.00168804693529447,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,24.286457409492034,1.0872778271554415,0.12072063277109155,0.4720456810379627,0.5801234800634896,Upregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.4579521373332,1.1702582104346702,0.22682688691428046,4.2481642015588264e-4,0.003876449833922429,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.307620936458832,0.8699827846500533,-0.20094124190959162,5.428133519861003e-4,0.004215465393083545,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,21.810838272032534,1.045158204780373,0.06372133845627032,0.14659311020614968,0.22481716481195224,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,24.335794363931768,1.0525665570827076,0.07391146230565886,0.3468951625787929,0.45277003040870456,Upregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.815439668341533,1.029078015047878,0.04135235799112797,0.06616281190233159,0.12223198696551596,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,28.003605830377733,1.3437479557436953,0.4262625599183387,3.622033934443944e-5,0.001201856714610945,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,24.610537720242032,0.9881940015805585,-0.017133796353756156,0.8644098048791117,0.8937948407390247,Downregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,27.195462672482165,1.303488336935851,0.3823776743041665,0.002691764218950255,0.012604454731957898,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.668780909383567,1.0336822574312479,0.04779278519305363,0.08463231673549729,0.1457113000398892,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,20.0408390846854,0.9948018862889152,-0.007518851770536778,0.6499881470918395,0.7277474653022129,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,22.33873100038783,1.0039778758261586,0.005727477667601568,0.6117623754592962,0.6956176543384521,Upregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,20.3130816158032,0.8109433312072752,-0.30232699258133866,0.0027281217633199277,0.012604454731957898,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,22.1150163502614,0.8660437369607734,-0.20748820907731536,0.003025449083321851,0.013014118638113149,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,22.704067665479734,0.9385050997640288,-0.09156351031679154,0.34733043428612953,0.45277003040870456,Downregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,21.708426848423198,0.9355113064821359,-0.09617300506947442,0.5938478471200341,0.681296633564225,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,20.046508995598366,0.987799790720677,-0.017709431826272853,0.7697805121026053,0.8228508080872459,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,20.4002106878276,1.0012387712457378,0.0017860630994759308,0.9524683153371287,0.9686058575488905,Upregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,26.9410955864788,1.1635896780097208,0.21858240372493956,0.009511974918911847,0.026913727483742825,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,22.699728880447566,1.0107426948801692,0.015415776601704324,0.6779904095205164,0.7498984832575407,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,23.033311777728667,1.0494277263277914,0.06960281221474789,0.012484826373101684,0.03186686451875605,Upregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,20.837510858465734,0.8085142350342422,-0.3066549202824052,0.11288519802765357,0.18071533894777872,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.71201812109503,1.084981848959617,0.11767090752230105,2.2705252288012542e-4,0.0025113385106438116,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,20.970954117482567,0.7868356332982661,-0.3458658006941157,0.007298019841093407,0.02276732685469311,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,19.680713163433968,0.9893343187652106,-0.015469971757411863,0.3592207530852452,0.4649488470784202,Downregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,25.064584704857968,0.9769459547655731,-0.03364934123858102,0.7173824685145112,0.7821407552300275,Downregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,21.0187264198941,1.0348000712502363,0.04935205847077582,0.12669544445550765,0.1984714044045506,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.448736412949035,1.0573378051992708,0.08043637201540908,0.4087739950674999,0.5146672781144574,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.814102171301332,1.4681535344598293,0.5540028481684313,0.0030015085449933815,0.013014118638113149,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,24.511445401693567,0.8348066827323231,-0.26048594538842523,0.008860072266565837,0.026292084368264475,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,19.741058022810833,0.9680168837629345,-0.046895884258738814,0.10518581263139533,0.17139652504669328,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,24.84631810044243,1.0292475384104929,0.04158999825624675,0.1117252145762355,0.18006359630454544,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.4157355648094,1.0411712451898414,0.05820737340972859,0.011490394369625886,0.030613094488419333,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.990452279342367,1.045735443595088,0.06451791612745156,0.010179374455560266,0.02836237920824044,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,24.684339618769567,1.1661956485793947,0.22180984476219476,0.2250715858963642,0.3159658802006651,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,24.825079770936966,0.9348665206255441,-0.09716770184261689,0.595434592073939,0.681296633564225,Downregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,30.5610379393236,1.7180164042296857,0.7807438119058466,1.6509378678192143e-4,0.0020086410725133775,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,20.5573156123154,1.0071043052956328,0.010213110295910365,0.6368702880225134,0.7174618985438809,Upregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,21.0330889006201,0.9177822767129084,-0.12377614774196889,0.037329572595408846,0.07638358001944659,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.110363772102936,1.0673099628212257,0.09397921729129842,0.004242769243023444,0.01630116603898481,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,25.8361317883481,1.008666911259558,0.012449836674447724,0.7075063634724976,0.777830791167053,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,23.141694182978632,0.9184541548967816,-0.12272038460544965,0.5874393157138682,0.6774626293023008,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,24.9347004994001,1.2329700789834153,0.3021377896628803,0.18146403281742096,0.26278185506479185,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.911257123432666,0.9346005474613334,-0.09757821259635596,5.066482591107361e-4,0.0041094803238981925,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,25.94410557089917,1.4078230170522539,0.4934659785279216,0.0030589685478346848,0.013014118638113149,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,26.828544468971135,1.2160784940369804,0.2822363532083687,0.029112010834567558,0.06142129453535929,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.805674903946368,1.1350473636611857,0.18275250006545404,3.157211264994852e-4,0.003201061421453114,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.069283230913967,1.0501020695846848,0.07052956420266959,0.05012278790288056,0.09628851360290212,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,20.2000386933588,0.9929028617289777,-0.010275512840496106,0.5177510379349506,0.6175788524387482,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,26.21209259559477,1.0252029455140594,0.0359095287600971,0.7178552137042717,0.7821407552300275,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,25.413674365881267,1.2799958174322952,0.35613909602250604,0.0706554370268311,0.12519045880967647,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,22.287667406137032,0.936228775426809,-0.09506698725303496,0.005709392366683118,0.019475964615320914,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.116208624241732,1.0072758459099345,0.010458824387179799,0.8305499197016353,0.8686267068512804,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,26.138573810870266,1.1520263988752009,0.20417377675415407,0.09204004164322391,0.15481389492984665,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,18.55128408291017,0.9793173009021046,-0.03015172303495142,0.3540039914431268,0.4598272486716771,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,21.380353481004168,0.9967170068846124,-0.004744149660242255,0.9192683529458326,0.942508283216935,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.416481051520467,1.0285771339052994,0.040649986891564946,0.10217302750857267,0.1679871848676983,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,25.302410447073868,0.8908483684133927,-0.16674820382976188,0.07882149455662066,0.13709867640368661,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,22.7885861540737,1.1566384229884656,0.20993793368586516,0.048890251710323365,0.09441768187443401,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,21.600860611240467,0.9947545721360621,-0.007587469972758506,0.741097754158892,0.8050615484166534,Downregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.914901047264333,1.00961966875452,0.013811921354457746,0.5775894129272423,0.6714017061096925,Upregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.973615210334966,1.317951099718866,0.39829684265108006,1.8489320679624176e-6,1.2481230131084379e-4,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,20.0216272513046,0.76607930567508975,-0.38443434505852325,0.01838094816546537,0.04246231696452443,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,22.051379250204068,0.9942872970890568,-0.008265319359317728,0.8206893172505106,0.8620615694138777,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,24.5682518657356,0.8742391793979374,-0.1939000603275891,0.06816155965794236,0.12377596654302966,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,24.7846464920801,1.1134670061399936,0.15505880933051777,0.2108093371399271,0.29732358822183347,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.823328827164534,0.9810224110021198,-0.0276420003670998,0.16433678474636487,0.24391351397708264,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,23.991709384314934,0.922395784568335,-0.1165421751286564,0.02235364563741897,0.05067751961278214,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,23.661974831278002,0.8065852710065963,-0.310101033849446,0.004690141751407014,0.01706989735222466,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.206665230593835,0.9469108670075782,-0.0786994641019858,0.030932103922091392,0.0645155310375049,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,25.221915194440665,0.9994278270957835,-8.257072576372654e-4,0.9780748862279489,0.9826133279253654,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,24.282027306939934,0.9911398683077012,-0.012839431950621236,0.18107219339108846,0.26278185506479185,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,21.939800873107835,1.0395326420186033,0.055935060494491824,0.43017400807464634,0.5358822967482796,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,21.429909145334232,1.0457323331734223,0.06451362498803057,0.04519640104594972,0.0891712777393062,Upregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.884867714479768,1.0137133090926387,0.01964969767505932,0.0438691898356109,0.08702312114129337,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,18.2901738334145,1.007982395288537,0.011470441961126506,0.5832062341440808,0.6757786522621889,Upregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.577985861204034,1.0365592337556166,0.05180256102403164,0.0014226507847491532,0.00837528284570066,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,24.229165913917132,0.9392958910736398,-0.0903483967091581,0.002510112797135349,0.012380961769654086,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,24.418750614290865,0.954698265597568,-0.06688325651305485,0.006628625816840799,0.021223231781990277,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,22.959582771927433,1.0327554030558757,0.0464986079466617,0.8003107488632761,0.8467055748843356,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,21.729665789563366,1.0167642435378985,0.023985201213183222,0.3246550445148799,0.4262557239134215,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,20.1780974681236,0.988994803163278,-0.015965154762698528,0.5287838781289972,0.6247036009492033,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.5037403069425,0.8813059105746041,-0.18228521414809729,0.002662181875139105,0.012604454731957898,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,25.0391865595278,1.1104538205969323,0.1511493981248147,0.4714483617321614,0.5801234800634896,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,24.223592088894932,1.0726785974925146,0.10121787174874368,0.6962629149358588,0.767782368433802,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,22.269461871508234,0.8702769745470772,-0.20045346839495853,1.1750240735218273e-4,0.0019717592282331494,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.614798177812,1.033735386611513,0.04786693489873394,0.00600087231519557,0.01994508816846971,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.320172208313167,1.0380235725741753,0.05383920636411263,0.007008249982765871,0.022083526898869693,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,20.294767812924498,0.7361831519650492,-0.44186336181114483,0.0035177318079837954,0.014109583625429509,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,23.078877850794434,0.9252319390270396,-0.11211302618887485,3.3569390860161184e-4,0.003311575044313198,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.803669004105068,0.7778957469246137,-0.3623512757594722,0.0012877950490283922,0.007921788149874274,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,23.200819436435832,1.1078595157173767,0.14777494923215428,0.4089137278169662,0.5146672781144574,Upregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,21.236094019068332,0.9808595226449581,-0.02788156445258876,0.1674051776518843,0.24638262033442648,Downregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.583660968513033,1.0284181189887491,0.040426933355910334,0.02188348163509594,0.04992169248006262,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.9127932214179,1.0495424567011409,0.06976052854838032,7.514835978300933e-4,0.005274836792461232,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,25.067859196871233,1.0520053158687788,0.07314199470450107,0.0011125337800604468,0.007519904254112279,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.618789530451767,1.0348214007079213,0.04938179521562986,3.639214494617603e-4,0.0034955612908826976,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,24.420577158328534,1.06279798053827,0.08786739162548396,0.03503464891754127,0.07224659240057944,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F59,F1246_3,Area: 60,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.291037384054867,1.0333212626805808,0.04728886215973314,0.01227945949149159,0.03186686451875605,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.566127384301268,1.1008123504674148,0.1385685614336606,0.0019632835139276436,0.01088937650052313,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.594004731145233,1.085059072289574,0.11777358735117073,0.026485509647572594,0.05754292274621426,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.103801103179432,0.9576333821932541,-0.06245465074583852,0.12418370271958887,0.19707413692456494,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,25.865814408569634,1.0265314904938285,0.03777788510110572,0.08505398531370713,0.14574978703992067,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4092114122264,1.0532658116518734,0.07486957383562665,0.02624835755969652,0.05736916472628281,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.807259567111366,1.0003147408655144,4.5400364284028277e-4,0.9714962443290832,0.9795473181771144,Upregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,23.4205611952757,0.9537463244870903,-0.06832250273517732,0.0699602677557655,0.12519045880967647,Downregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,24.170614998523433,1.0548579660598723,0.07704875679420652,0.0019988718507809584,0.01088937650052313,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.307573026424432,1.015061224119682,0.02156674718387041,0.5050737035097985,0.6104367608644916,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,24.8086255276989,1.0270701580207056,0.03853473391655019,0.5521159185033222,0.6479817049958605,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,23.041615449195902,0.9207567852253831,-0.11910797123919635,0.3988442900213529,0.5054797425617841,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,19.773865904456468,0.7892315115387577,-0.34147953538808523,0.009406355227105284,0.026913727483742825,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,22.453952408312833,0.9802539583470489,-0.028772532411116224,0.2423444885428845,0.33505961484148805,Downregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,23.853567090450035,1.1165145292601892,0.15900202514626824,5.4150580298791877e-5,0.0014117829863613597,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.219694200619735,1.2267728630574928,0.29486815880153566,2.066199539534021e-4,0.0023567588497809926,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,24.8158824974359,1.0249965913013328,0.03561911195429194,0.05234192130528202,0.09950417331472884,Upregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,22.049019786161434,0.8735632169127127,-0.19501598484622076,0.002313759194775498,0.011729473695736901,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,23.939439294293933,1.0409253745124962,0.05786664339249682,0.054976077362542584,0.1039703017478137,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,19.6695044806278,0.9964379020473756,-0.005148195693390129,0.7139713578517997,0.7821407552300275,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,24.318654783177898,1.2494047070342678,0.32124087026674736,0.041439243003192065,0.08310617415475331,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,21.784813540310235,0.8667151961815712,-0.20637009516318233,0.00654843812478187,0.021152034650844094,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,22.928283771934336,0.9388260761790735,-0.09107018117734773,0.002576878285587238,0.012540807656524558,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,20.475389434119734,0.816868262813282,-0.29182466267364443,0.0013122360050663799,0.007921788149874274,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.497973241322267,0.9898901128056645,-0.014659713643976079,0.8219107565918614,0.8620615694138777,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.485788575419033,1.037503200145043,0.053115786412587455,0.006322760483348946,0.020605424789485405,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,22.165337714170267,0.8724043800065735,-0.19693108167405884,0.0024559615009637787,0.012279807504818894,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,25.28688897484737,1.0038833972791867,0.005591707599108244,0.7720505162001491,0.8228508080872459,Upregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.122502056196932,0.9339384303965501,-0.0986006510438823,0.009129819911104982,0.026659074140426547,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,24.9743973785335,1.25510904616313,0.32781271359791014,4.227441532177798e-5,0.0012858467993707469,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,23.497595787553568,1.060598468239976,0.08487856999315756,0.6395315214122348,0.718243093278356,Upregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.958095537650166,0.9452162443479122,-0.08128367141691287,0.01552025041803678,0.0377659426838895,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,24.6671449735766,1.2256242944410356,0.29351679989690455,8.006099144280871e-5,0.0017189565809779517,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,23.38991073964,1.0676908970314392,0.09449403853764649,0.01425466957295203,0.03515509725761819,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,22.7348999953628,0.8854599622251635,-0.17550102066579315,0.003092160136033529,0.013014118638113149,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.587601625183932,1.0380965069346357,0.053940570481948065,0.012019850356753074,0.03156291640442354,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.803554025363766,1.3212815246994458,0.401937893545508,1.509789670316696e-5,6.888415370819925e-4,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,24.758022372246,1.2126132216549146,0.2781194579753137,0.004814019712443241,0.01706989735222466,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,24.5485426565242,1.2124363544970778,0.2779090166099337,0.07129836300601956,0.1257193357352519,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.029476746366534,0.9120615438043759,-0.1327969174867457,0.2627615457902587,0.36055625644152034,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,22.8985088550048,0.8322586537401743,-0.26489612844867644,0.016861134600730052,0.0402242753546828,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,20.433706575370067,0.972514773773269,-0.040207928194666,0.045482005264313445,0.08925232215846456,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,25.037299940457633,1.1741300907182688,0.23159226435632896,0.13030354043908704,0.2030328301116583,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,22.2772711304372,0.828881368545762,-0.2707624603047723,0.01240097293419107,0.03186686451875605,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,27.253349088264866,1.3536824122121383,0.4368893075469344,0.05136073029360713,0.09815008668673614,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,20.845667219626765,0.738862443882277,-0.43662229614635395,1.239999528177793e-6,1.2481230131084379e-4,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,23.7733798686438,1.0670436322419505,0.0936191702879899,0.005562213121158063,0.019237557051234692,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,22.158699269424634,0.9028007533440173,-0.14752047249715208,4.129683333541318e-4,0.003864960042929695,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.956049228421765,1.036393541881255,0.051571930737827815,0.017916688421358146,0.04192045688330592,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.471649933646468,1.143912585004738,0.19397680911047102,0.041262139530914274,0.08310617415475331,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,22.6033729887552,1.0266778458829466,0.037983559399098435,0.16000846480487446,0.23935692481057042,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,27.011193972771935,1.2875361838946837,0.3646129772215935,6.166433611776803e-4,0.004593363812854149,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.6825608717218,1.0187403530862338,0.026786397875694583,0.06182299738632972,0.11512956145923647,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,20.116460474973,0.791272009710014,-0.3377543703522401,0.004766616531558956,0.01706989735222466,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,23.0578247972753,0.954418975819366,-0.06730536781362476,0.059836565784238294,0.11200177698075373,Downregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.6625817729804,1.095569162667878,0.13168056373329118,0.22979909191692194,0.32136654616734295,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.4972793866126,1.0646502017221846,0.0903795007467462,0.10089732745941114,0.16664038245558854,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,19.20433686231887,0.8568157517860523,-0.22294309190618236,0.13448570943975952,0.2079969658708145,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,19.1185912418606,0.8344271030297887,-0.26114207608572887,0.16925995005006544,0.2481119749729875,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,19.8210213802509,0.9668329331903567,-0.04866147848515967,0.31326621275101557,0.4157897005604389,Downregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,25.294523030630334,0.9708705834659184,-0.04264909691071546,0.18214742282573243,0.26278185506479185,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.954562846351568,1.0386167468289214,0.05466339298033458,0.5157404871547384,0.6175788524387482,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,24.0000434184496,1.0590533250410104,0.08277523317856765,0.021328372645806698,0.04896135858943047,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.90240466157117,1.1407957965926234,0.1900405711106473,0.0027626202152236487,0.012604454731957898,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.80357991509757,0.9612374961764159,-0.05703516833732357,0.1256695369146301,0.1984714044045506,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,24.353790988481233,0.9715002930411335,-0.04171366390543388,0.14918759412556387,0.22688946606596172,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,21.4310757834881,0.9942753502400181,-0.00828265415124471,0.6645014367014744,0.7394604402318237,Downregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,24.506970139269633,0.8965933344097364,-0.15747432096135716,0.004296318518125518,0.016334961032456397,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,25.564708055042733,1.4235886151608501,0.5095323003678524,1.2268032307555972e-4,0.0019717592282331494,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.883969398243533,0.8643730203059706,-0.21027405285911624,0.0012056566932494928,0.00785829808992973,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,24.728874746064367,0.9023172125770756,-0.148293388058783,0.017423628080856835,0.041296261360472375,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,25.401351878297167,1.0941339813378448,0.12978941306314776,0.03805468172094693,0.07716643793414238,Upregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,22.836745093079035,1.12864003370781,0.17458542907677482,0.1913070791534775,0.2749097790985011,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,22.316963510961,0.9809368661915505,-0.027767808354548847,0.8750077173514672,0.9021972226928969,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,23.205046164106534,0.9581068376066978,-0.061741556367066186,0.5687965881656921,0.6632931459440179,Downregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.530187616676667,1.0474402280975175,0.0668679192585931,0.10569024726329265,0.17145306778267475,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,22.297625001318668,0.8658283705217891,-0.2078470209015324,0.1263378412546433,0.1984714044045506,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,24.4118505594793,1.2501497997725701,0.32210097683970895,0.03745934472186559,0.07638358001944659,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,21.86909840411323,0.9327772139556153,-0.1003955483244563,0.1654880255884727,0.2445470823473382,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,21.515747310562766,1.0512714340138714,0.07213521539626236,0.027492859128946025,0.058683588199212273,Upregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,21.438924294262634,0.8315691923991928,-0.2660917840169612,0.1119847571537858,0.18006359630454544,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,22.2136008498238,0.8457907302437145,-0.24162734618381695,0.03328412086809078,0.06902672793666553,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,23.201213878412467,1.0232434116671354,0.033149377764871625,0.0828885752619503,0.14338545009768655,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,20.350438889289368,0.9974072037516245,-0.003745472013457423,0.9526835694795937,0.9686058575488905,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.798457259929968,0.928594705528652,-0.10687903962281915,0.09556403962594869,0.15927339937658114,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.88502210316277,1.0581802055874074,0.08158533592916119,0.00288039954983736,0.012821290679154104,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,23.529627941271798,1.21752495051444,0.2839513374941623,0.013796394014012534,0.03458680342813893,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,24.073843143713866,0.9388005894068011,-0.09110934725934038,0.009506122698445972,0.026913727483742825,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.524769667096166,1.0975478154595244,0.13428379317627095,0.011407600973253496,0.030613094488419333,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.928779198312665,1.017394241977161,0.024878834290079126,0.23942584109661474,0.3322830114078494,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,19.994562376860568,0.9888455230503527,-0.016182933393435642,0.5883716533940531,0.6774626293023008,Downregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,23.733448392661234,1.1268152589364018,0.17225100542720526,4.4671633847964145e-4,0.0038821777034540265,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,22.482879336333102,0.9174117784266164,-0.12435866493796377,0.26556213324007477,0.3630343769012258,Downregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,21.041565646723765,0.9252111277988314,-0.11214547707187719,0.3120535891186412,0.4157897005604389,Downregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,24.165255710774368,1.0502310841696536,0.07070680151555805,0.1371363236029223,0.21120151103403645,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,23.538084352090902,0.9140657231513852,-0.12963019321925273,7.920636249595093e-5,0.0017189565809779517,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.769442735972667,1.1610241018778447,0.21539792164251906,0.005586797390221583,0.019237557051234692,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,26.2140919862775,1.0135226168441689,0.01937828302766191,0.39337586422302606,0.500286377844615,Upregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,22.623372687072166,1.0061415527947322,0.008833290380773191,0.7745230287996839,0.8228508080872459,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,23.090265279797098,0.9880679692859407,-0.017317806540020856,0.39080493326647986,0.4987545477002278,Downregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,22.400349997975766,0.9250125234523003,-0.11245519693384746,0.043393023649074165,0.08654892695033918,Downregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,22.947201351414336,0.9836464299770277,-0.023788260404069977,0.8203479325969751,0.8620615694138777,Downregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,22.8669909716679,1.0968439971240365,0.13335834745478156,0.28381591081291796,0.38367706461746315,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,24.1363509991147,1.1398705608688389,0.18887000702597098,0.31601341806051403,0.4179162956235059,Upregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,22.25772333764183,0.9088915956948013,-0.13781986172188196,0.37636588940851906,0.48541890330074017,Downregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,22.2100602386838,1.0132332634743486,0.018966345232297215,0.8990839617497629,0.9244102705314463,Upregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,21.398619490928034,0.8669182314918743,-0.2060321713184259,0.15141547065667202,0.22932218584931655,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,24.0627635221294,1.1710677571012247,0.2278245515060064,0.20071182428886672,0.28617115572436075,Upregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,24.420362419832866,0.9859790309458648,-0.02037113010171959,0.8426868765085652,0.8788020283589324,Downregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.830237271205835,1.0092162261480149,0.013235307220633333,0.41046106672589244,0.5148394823194183,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,25.442634343612866,0.9665418804914853,-0.0490958487743552,0.7698363038503511,0.8228508080872459,Downregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,26.180160431799134,1.0249815170395529,0.0355978945933583,0.09111592345146534,0.15396903731381875,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,26.225865677845633,1.055844720336738,0.07839767780965463,0.024110372543629292,0.05396837625205425,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,28.553976095025767,1.3200075194112997,0.40054614790683024,0.0017211368948160314,0.00981585885324768,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.070044113405768,0.8143330432405694,-0.2963091510522944,1.49136020714306e-4,0.0020086410725133775,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.593573848828566,0.9961884766223881,-0.005509372108028135,0.45820195255971413,0.5688561655928424,Downregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,25.973922461483767,1.0577166727420504,0.08095322899159452,0.002728114931460129,0.012604454731957898,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.796021753680765,1.222179413779465,0.2894560857870766,2.2639591246222027e-5,8.26345080487104e-4,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.9894823673106,1.0793301690838228,0.110136255406875,0.003101995401413271,0.013014118638113149,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.368795927286868,1.2666739956183566,0.34104526526533196,5.367742328620263e-4,0.004215465393083545,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,29.1315440805228,1.0060926215691894,0.008763126741423075,0.5120981841532508,0.6168839512077114,Upregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,24.662792247739535,1.1008826110604595,0.138660640137533,0.07860938159588965,0.13709867640368661,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0680353065692,1.2414526246321842,0.3120292075378568,5.625995736624361e-4,0.004278100924724775,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.623408826406866,1.029024265318292,0.041277002680480575,0.017696635765925613,0.041672722932663546,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,30.160000249908702,1.0203480844121264,0.029061401204569137,0.023449917060230474,0.0528346896727415,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.107123291704035,1.0653336126287118,0.09130528577189692,0.012362557013876986,0.03186686451875605,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,22.409622164550132,1.0537980056021201,0.0755983544096671,0.41628482159844155,0.520356026998052,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,26.490919508027833,0.9705131066164241,-0.04318039846275937,0.5622791361327739,0.6577945022066105,Downregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,21.180552498331465,0.9369643044298769,-0.09393400837210326,0.046116249029117456,0.08991319898235071,Downregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,18.658165294612566,0.6392226464651175,-0.6456095737238523,5.405488699761809e-7,1.2481230131084379e-4,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.132218324769134,0.8907611021619639,-0.1668895351263824,0.02685563461974847,0.05766062727181289,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,26.007661329102834,1.2289722858648864,0.2974523823532845,0.0012663858854927452,0.007921788149874274,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,25.890722771367333,1.221859175737032,0.28907801823908635,1.3922801069935127e-4,0.0020086410725133775,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,21.7600087803012,0.8158134214207139,-0.2936888529471339,0.010425757037517155,0.028612039990178657,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,18.398550731601034,0.6581669577413136,-0.6034744948901924,0.0012581628838253243,0.007921788149874274,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,25.008631001851434,1.1938482650781936,0.2556194855726581,0.10043367066363716,0.16662858996467075,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,23.863685102265467,1.1097064465321054,0.15017808725711984,0.002806393250531055,0.01264609304251648,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.18245599682387,1.1214647304696461,0.16538424906738325,7.257057696436573e-4,0.0051937765866653905,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,24.423802064708966,0.9532931985012423,-0.0690080916987022,0.3104135124409979,0.4157897005604389,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,23.4468422600727,0.9548614785234014,-0.06663663790894235,0.6176926234948701,0.7001795266323838,Downregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.769556190813802,1.1799165902755795,0.23868487734221067,0.016262286430878826,0.03930950031305147,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,25.961904728350966,1.150391023242263,0.20212432326258914,0.00814013180538269,0.02475956757470568,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,22.2084141088284,0.9041837672936336,-0.14531207753481748,4.950686937930464e-4,0.004106819846237771,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,24.948216780476233,1.165907328626915,0.22145312143409426,9.214961828527798e-4,0.006346152957382351,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.9973175426306,1.0880229115958135,0.12170893719268822,0.008099844499790392,0.02475956757470568,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,22.1980290328719,1.1015493471862121,0.13953412631083983,0.010381770881338338,0.028612039990178657,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.291061494286634,1.016382794159351,0.023443858041209978,0.21097755986152017,0.29732358822183347,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,26.896290643774165,1.2938519307876533,0.37167252386734195,0.0020687752284324437,0.010943521135910754,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.754665037825333,1.303814819547479,0.3827389785476127,1.5105144869035893e-4,0.0020086410725133775,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.951153853234366,1.0773953119156143,0.10754769268540493,8.729929282668327e-6,4.5520345545341993e-4,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.372221168289766,1.0273325935015847,0.038903322177636306,0.024248804672155882,0.05396837625205425,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.2475055098148,1.082955341612016,0.11497375101337327,0.06892786606267459,0.12454787679641696,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1117199147677,1.009050474649864,0.012998342636274746,0.494125402108136,0.6052207106358042,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.3008751858887,1.2640103448392248,0.3380082707833516,0.013834721371255573,0.03458680342813893,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,22.190746064366,0.8875827377325877,-0.17204648552026683,0.08555108674216647,0.1459165731817325,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,21.1782160796956,0.9840932057449244,-0.023133131865610036,0.5395948190564397,0.6353293837277435,Downregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,23.872074329576865,1.029964890945904,0.0425951602031325,0.3199757037434022,0.4216286348965408,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,22.740743807338802,0.9001272492751825,-0.1517991279768952,0.20847743754291015,0.2960866330862343,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.382455560123066,0.9413164941721939,-0.08724822017675382,1.483246670081398e-4,0.0020086410725133775,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,22.367876646803502,0.900428311713467,-0.15131667544927616,0.00205956103336835,0.010943521135910754,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,23.06729450881,0.9263361327236171,-0.11039230634780095,0.007018326356901053,0.022083526898869693,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.384079335290934,1.0514427164692657,0.07237025290668997,0.06697643121398135,0.12223198696551596,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,21.877988208980234,0.9396253142077188,-0.0898425137318159,0.38420452422289975,0.49266029477048623,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,22.942307806516734,0.8955863314178911,-0.1590955851717352,0.0059862242401707315,0.01994508816846971,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.316701044452202,1.0277528035116819,0.03949330730139702,0.02568404851317831,0.056473962092229414,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.813348170484634,1.025650834996793,0.0365396740703279,0.016593023858331987,0.03984509018612615,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.901086034777933,0.9607495518690677,-0.05776769652816738,0.003236555130672252,0.01327351261455474,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,27.909488039612032,1.0669988698502126,0.09355864808140334,0.05740562406468731,0.10800542671964365,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.50742501049143,0.9878244336418988,-0.017673440953309225,0.1558391864555886,0.2340794364456372,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,24.1455385493278,1.1630081553244698,0.2178612134103724,0.3129111278449974,0.4157897005604389,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,24.939526478210265,1.2045803747008574,0.2685306595072348,0.07005648456455801,0.12519045880967647,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,28.173696116950566,1.386380839954424,0.47132362143000445,0.0022216644475437047,0.011584393190763603,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,24.9235035664126,1.2440544144863752,0.3150495898035344,0.1982255713171534,0.2837346412971019,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.781975247267432,1.3869508461509321,0.4719166591316813,1.1990734792780877e-4,0.0019717592282331494,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,19.705480221759068,1.0040119231053555,0.005776402060428594,0.517175008740252,0.6175788524387482,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,23.6548731976333,0.8020987488239184,-0.31814823268524034,0.0038216808886408606,0.014999070154343163,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.099573067452233,0.8570770948150795,-0.22250311306430962,9.33194785681232e-5,0.0018923116487424983,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,21.695794727274965,0.9826820037562316,-0.025203459425501333,0.1818061573447661,0.26278185506479185,Downregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,29.744880444626066,0.9714242947947421,-0.04182652705403723,0.10403447059438159,0.17028063572622995,Downregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.623232217938032,0.8712324524915745,-0.19887040096033393,4.765131676723138e-5,0.0013379023553876503,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.616801933017666,1.009853555634826,0.014146095078357627,0.38467995619065365,0.49266029477048623,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,22.208054932019035,1.0426986143403185,0.06032221593073452,0.07042246767851136,0.12519045880967647,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,19.6245483141361,0.9973028341348247,-0.0038964448624972206,0.8582671099819785,0.8899644748392674,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,22.5906632251769,0.8990854964067552,-0.1534697829549348,0.0048169847322716165,0.01706989735222466,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,24.428730592725632,1.1319160537765611,0.17876696763000904,0.002312968237659415,0.011729473695736901,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,21.926386648387865,1.004767863883691,0.006862227466135879,0.9678047536526572,0.9785283520310799,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,22.966200792567435,1.0014423432936639,0.0020793623001184387,0.9799212366159809,0.9826133279253654,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,25.796916021192267,0.9875707638368896,-0.018043967491177447,0.8504051004053235,0.884324392159382,Downregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,21.665846514552968,0.942040279890762,-0.08613934677301911,0.4992215843800703,0.6094176531729956,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,20.591065114808067,0.8090109867234606,-0.3057687996686689,0.006192265977615745,0.020361955692159883,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,26.8691542025348,1.0041773220880736,0.006014049277438921,0.9666973436200184,0.9785283520310799,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.9170538346994,0.876209981550381,-0.19065144533582043,4.448157642309398e-4,0.0038821777034540265,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.7173040578018,0.9596508062411847,-0.05941855545955328,0.08969253559601217,0.15226872322113694,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,21.039713919288733,0.7917423079005055,-0.336897148936647,0.009469229097633146,0.026913727483742825,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,22.379361040085033,0.8513287512022888,-0.23221174071833253,0.30040729998977966,0.4046076180674154,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,26.269378315050066,0.8821451786802249,-0.18091198862145738,0.2801536008822923,0.38013406811166056,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.773482146853834,1.1636772008184855,0.21869091618079728,0.15470548949064766,0.233336792000357,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,21.0121770164514,0.8067763346358181,-0.3097593292362989,1.5840649888208315e-4,0.0020086410725133775,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,27.695660187399035,1.4322197639846412,0.5182528809295713,0.00840778399453988,0.025362323619893025,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,22.3372806432835,0.8019299607795531,-0.3184518552750456,0.027853155173505055,0.05910698626935666,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,21.93527962217363,0.8726646991919892,-0.1965006560764593,0.11440805658121543,0.1823534526294482,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.285136866672833,0.9598359958064161,-0.05914017681383645,2.6469038718810025e-4,0.0027603426092473312,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.140693160787634,0.9910891591982214,-0.01291324560159214,0.504028565325876,0.6104367608644916,Downregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.291514034102,1.0228694036727615,0.03262195866979506,0.14846361702375627,0.22673313896933486,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.438707093650066,0.8676295539809953,-0.20484889865952247,0.015338811880569476,0.0375749418550863,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,21.733237079986733,0.8015867666083135,-0.3190694036024348,0.004404320567316057,0.016403847010922047,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,22.252768619880968,0.8509398636468836,-0.2328709153662264,0.004349848215717159,0.01636798555398725,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,20.92999464096337,0.9870020166236282,-0.018875062515785093,0.5288586649131611,0.6247036009492033,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,20.005141981386267,1.0010466106384572,0.001509150369115668,0.937757575318346,0.9587717506756198,Upregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.5456550326866,1.4724840278049784,0.558251985069981,6.619883439885149e-4,0.004832514911116159,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,24.25762104421,0.9603577768470356,-0.05835611954942881,0.001989279411050226,0.01088937650052313,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.965383720255165,1.1406822675293915,0.18989699066669533,0.2374475831502146,0.3307952971367494,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,22.25895033704043,0.9477027018490967,-0.0774935440300995,0.09540864912241748,0.15927339937658114,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,24.923316596574733,0.9270276274580581,-0.10931575991703202,0.018121949856287095,0.04213064775506236,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,24.222725506233168,0.8797609206112229,-0.18481657739992566,0.27598121150056687,0.3758699335735332,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,26.316278898461267,1.2824605897461887,0.3589144922250486,1.2424784177907517e-4,0.0019717592282331494,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,21.738216075565102,1.0212952472304766,0.03039999661719758,0.6347268124949577,0.7172609491042091,Upregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,26.162434114821632,1.3427891176895903,0.4252327502216194,0.0037539621313901917,0.014893436716928478,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.8337936011975,1.0034793482117053,0.005010926078565344,0.6697607978795947,0.7430476936962068,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,26.937916665808466,0.9964815513220846,-0.005084999368957957,0.5206635132659071,0.6190299099089775,Downregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,23.217544671826833,1.0468989933361064,0.06612225521750936,0.7744867306084532,0.8228508080872459,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,24.108635256202835,1.2155081633653666,0.2815595825539583,0.008981759595220054,0.026438243969800965,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,21.3107007310268,0.9269158962071873,-0.10948965315561368,0.25110489405010555,0.3458614578425982,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.917033442832967,0.9606937808994696,-0.05785144659241886,2.474690025272079e-4,0.0026566525271303197,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.0349272644887,0.705144884269071,-0.5040083801543239,0.004635488137063159,0.01706989735222466,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.197596559426202,0.7178719033054582,-0.478201661637359,0.0073867947200479634,0.022848983667944973,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.938223191140768,0.8303431209937723,-0.26822047329019444,0.0016300371174004147,0.009443865838907163,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.125362054021366,0.7801166176953956,-0.3582382898932086,0.06654375702696083,0.12223198696551596,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,20.317969427304867,0.7908718899755154,-0.33848407738981623,1.0435085940069187e-6,1.2481230131084379e-4,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,18.85588198535987,0.7060879660683211,-0.5020801659164786,0.0011689691727038553,0.0077577045097619495,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,21.5637946093456,0.873056472942814,-0.1958531184673886,0.0041558985240438264,0.016137265545489325,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,22.801633119129335,0.8879286282639947,-0.17148437753242637,0.026683778720702187,0.057630646349445556,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,21.14245989898127,0.7823577845478202,-0.35409956926317593,1.596250030768819e-4,0.0020086410725133775,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.202955578550668,0.8689247652245848,-0.2026968264048736,0.06675032524037698,0.12223198696551596,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,21.8974773807363,0.8602024227044587,-0.217251900341854,0.0013239152798420017,0.007921788149874274,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.65159511419827,1.0235922742449224,0.03364116351910951,0.7755087068000344,0.8228508080872459,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,21.1559492989488,0.8109139486561008,-0.3023792660598981,0.011394757310157603,0.030613094488419333,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,25.603971130468235,0.9698127942973577,-0.04422180821066402,0.014164101169295047,0.03515509725761819,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,25.451702419370932,0.8961609419030477,-0.1581702451551585,0.006010848489127857,0.01994508816846971,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,21.714504669852033,0.9468731175986884,-0.07875697951604749,0.008485393057504637,0.02538662677040322,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,23.261406152512667,0.9491403195233016,-0.07530670593857591,0.07887869053362792,0.13709867640368661,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,25.304712550202268,1.0715347378379236,0.09967862117091744,0.005025435769326288,0.017637346690423994,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.90328229717007,1.0568372005636186,0.07975315531212736,0.009876790448213229,0.02773098856613714,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.6732501470252,1.0613463869906998,0.08589557919081023,0.0034712032141385523,0.014077657479561906,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.746410490872265,1.0308275646471583,0.043803020936536645,0.011015501285689384,0.030004910218482277,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,25.095807339854865,1.0718697799232804,0.1001296452822923,1.971289281320676e-4,0.002321034153813054,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,22.884681882553068,0.9200955959546891,-0.12014433301669786,0.46333509926756133,0.5732790211276606,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,19.8498585260969,0.9949258959821654,-0.0073390199651008695,0.6565843452431543,0.7328846667087197,Downregulated
Feature0118,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da]  83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,26.1004603730291,1.0719665577780395,0.10025989863117754,0.013754883120142307,0.03458680342813893,Upregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,21.256871713120866,0.7912881233276158,-0.3377249913280623,0.02975933141745994,0.06242618372053379,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,21.044622882169833,0.7507311832349055,-0.41363168520336807,2.0517090626440074e-6,1.2481230131084379e-4,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.927081129806467,0.7404433949303256,-0.43353864563215744,1.4753649344840621e-6,1.2481230131084379e-4,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,27.7706753526044,1.4158638203875868,0.5016825118196704,1.0797641565670061e-4,0.0019717592282331494,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,27.247732720547802,1.3581123318514652,0.44160281235341026,0.0031491811872838265,0.013061944697256779,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,20.504811434739832,1.0060132990414692,0.008649377046379851,0.7633659489727341,0.8228508080872459,Upregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.235425305062833,1.0239356378590543,0.03412503383418071,0.7734138524861198,0.8228508080872459,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.910134891071465,1.0588187095043624,0.08245559283476873,0.025276591032715734,0.05591488319358329,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,20.105743560235066,1.0140462551719223,0.02012346159682552,0.6058826639712285,0.6910849135921825,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.1410153720616,1.103851668970004,0.1425463217368063,0.13071976733216356,0.2030328301116583,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.389617741496433,1.009629121270818,0.013825428455172019,0.16439102585852694,0.24391351397708264,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,20.726216876243168,0.8039428154374657,-0.31483520892946204,0.04631145591419708,0.08991319898235071,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,20.424621107540467,1.0003719243647804,5.364736790212588e-4,0.9904286672760223,0.9904286672760223,Upregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.2922994852546,1.0381096126165414,0.05395878399371363,0.01177636628207781,0.031147635456220298,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,20.1144961385284,0.9941368795898476,-0.00848358926684661,0.5009710291887962,0.609514752179702,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,26.575013147248068,1.3566391906975577,0.4400370752108212,2.163879560309127e-5,8.26345080487104e-4,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,24.762378508808798,1.224137478101973,0.2917655905781073,4.705204483760791e-4,0.0039939526431923,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.151375727031734,0.8975839953910886,-0.15588114306694975,6.937179186141658e-5,0.00168804693529447,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,24.286457409492034,1.0872778271554415,0.12072063277109155,0.4720456810379627,0.5801234800634896,Upregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.4579521373332,1.1702582104346702,0.22682688691428046,4.2481642015588264e-4,0.003876449833922429,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.307620936458832,0.8699827846500533,-0.20094124190959162,5.428133519861003e-4,0.004215465393083545,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,21.810838272032534,1.045158204780373,0.06372133845627032,0.14659311020614968,0.22481716481195224,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,24.335794363931768,1.0525665570827076,0.07391146230565886,0.3468951625787929,0.45277003040870456,Upregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.815439668341533,1.029078015047878,0.04135235799112797,0.06616281190233159,0.12223198696551596,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,28.003605830377733,1.3437479557436953,0.4262625599183387,3.622033934443944e-5,0.001201856714610945,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,24.610537720242032,0.9881940015805585,-0.017133796353756156,0.8644098048791117,0.8937948407390247,Downregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,27.195462672482165,1.303488336935851,0.3823776743041665,0.002691764218950255,0.012604454731957898,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.668780909383567,1.0336822574312479,0.04779278519305363,0.08463231673549729,0.1457113000398892,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,20.0408390846854,0.9948018862889152,-0.007518851770536778,0.6499881470918395,0.7277474653022129,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,22.33873100038783,1.0039778758261586,0.005727477667601568,0.6117623754592962,0.6956176543384521,Upregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,20.3130816158032,0.8109433312072752,-0.30232699258133866,0.0027281217633199277,0.012604454731957898,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,22.1150163502614,0.8660437369607734,-0.20748820907731536,0.003025449083321851,0.013014118638113149,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,22.704067665479734,0.9385050997640288,-0.09156351031679154,0.34733043428612953,0.45277003040870456,Downregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,21.708426848423198,0.9355113064821359,-0.09617300506947442,0.5938478471200341,0.681296633564225,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,20.046508995598366,0.987799790720677,-0.017709431826272853,0.7697805121026053,0.8228508080872459,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,20.4002106878276,1.0012387712457378,0.0017860630994759308,0.9524683153371287,0.9686058575488905,Upregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,26.9410955864788,1.1635896780097208,0.21858240372493956,0.009511974918911847,0.026913727483742825,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,22.699728880447566,1.0107426948801692,0.015415776601704324,0.6779904095205164,0.7498984832575407,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,23.033311777728667,1.0494277263277914,0.06960281221474789,0.012484826373101684,0.03186686451875605,Upregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,20.837510858465734,0.8085142350342422,-0.3066549202824052,0.11288519802765357,0.18071533894777872,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.71201812109503,1.084981848959617,0.11767090752230105,2.2705252288012542e-4,0.0025113385106438116,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,20.970954117482567,0.7868356332982661,-0.3458658006941157,0.007298019841093407,0.02276732685469311,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,19.680713163433968,0.9893343187652106,-0.015469971757411863,0.3592207530852452,0.4649488470784202,Downregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,25.064584704857968,0.9769459547655731,-0.03364934123858102,0.7173824685145112,0.7821407552300275,Downregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,21.0187264198941,1.0348000712502363,0.04935205847077582,0.12669544445550765,0.1984714044045506,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.448736412949035,1.0573378051992708,0.08043637201540908,0.4087739950674999,0.5146672781144574,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.814102171301332,1.4681535344598293,0.5540028481684313,0.0030015085449933815,0.013014118638113149,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,24.511445401693567,0.8348066827323231,-0.26048594538842523,0.008860072266565837,0.026292084368264475,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,19.741058022810833,0.9680168837629345,-0.046895884258738814,0.10518581263139533,0.17139652504669328,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,24.84631810044243,1.0292475384104929,0.04158999825624675,0.1117252145762355,0.18006359630454544,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.4157355648094,1.0411712451898414,0.05820737340972859,0.011490394369625886,0.030613094488419333,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.990452279342367,1.045735443595088,0.06451791612745156,0.010179374455560266,0.02836237920824044,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,24.684339618769567,1.1661956485793947,0.22180984476219476,0.2250715858963642,0.3159658802006651,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,24.825079770936966,0.9348665206255441,-0.09716770184261689,0.595434592073939,0.681296633564225,Downregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,30.5610379393236,1.7180164042296857,0.7807438119058466,1.6509378678192143e-4,0.0020086410725133775,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,20.5573156123154,1.0071043052956328,0.010213110295910365,0.6368702880225134,0.7174618985438809,Upregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,21.0330889006201,0.9177822767129084,-0.12377614774196889,0.037329572595408846,0.07638358001944659,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.110363772102936,1.0673099628212257,0.09397921729129842,0.004242769243023444,0.01630116603898481,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,25.8361317883481,1.008666911259558,0.012449836674447724,0.7075063634724976,0.777830791167053,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,23.141694182978632,0.9184541548967816,-0.12272038460544965,0.5874393157138682,0.6774626293023008,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,24.9347004994001,1.2329700789834153,0.3021377896628803,0.18146403281742096,0.26278185506479185,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.911257123432666,0.9346005474613334,-0.09757821259635596,5.066482591107361e-4,0.0041094803238981925,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,25.94410557089917,1.4078230170522539,0.4934659785279216,0.0030589685478346848,0.013014118638113149,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,26.828544468971135,1.2160784940369804,0.2822363532083687,0.029112010834567558,0.06142129453535929,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.805674903946368,1.1350473636611857,0.18275250006545404,3.157211264994852e-4,0.003201061421453114,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.069283230913967,1.0501020695846848,0.07052956420266959,0.05012278790288056,0.09628851360290212,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,20.2000386933588,0.9929028617289777,-0.010275512840496106,0.5177510379349506,0.6175788524387482,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,26.21209259559477,1.0252029455140594,0.0359095287600971,0.7178552137042717,0.7821407552300275,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,25.413674365881267,1.2799958174322952,0.35613909602250604,0.0706554370268311,0.12519045880967647,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,22.287667406137032,0.936228775426809,-0.09506698725303496,0.005709392366683118,0.019475964615320914,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.116208624241732,1.0072758459099345,0.010458824387179799,0.8305499197016353,0.8686267068512804,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,26.138573810870266,1.1520263988752009,0.20417377675415407,0.09204004164322391,0.15481389492984665,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,18.55128408291017,0.9793173009021046,-0.03015172303495142,0.3540039914431268,0.4598272486716771,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,21.380353481004168,0.9967170068846124,-0.004744149660242255,0.9192683529458326,0.942508283216935,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.416481051520467,1.0285771339052994,0.040649986891564946,0.10217302750857267,0.1679871848676983,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,25.302410447073868,0.8908483684133927,-0.16674820382976188,0.07882149455662066,0.13709867640368661,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Missing ions,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,22.7885861540737,1.1566384229884656,0.20993793368586516,0.048890251710323365,0.09441768187443401,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,21.600860611240467,0.9947545721360621,-0.007587469972758506,0.741097754158892,0.8050615484166534,Downregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.914901047264333,1.00961966875452,0.013811921354457746,0.5775894129272423,0.6714017061096925,Upregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.973615210334966,1.317951099718866,0.39829684265108006,1.8489320679624176e-6,1.2481230131084379e-4,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,20.0216272513046,0.76607930567508975,-0.38443434505852325,0.01838094816546537,0.04246231696452443,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,22.051379250204068,0.9942872970890568,-0.008265319359317728,0.8206893172505106,0.8620615694138777,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,24.5682518657356,0.8742391793979374,-0.1939000603275891,0.06816155965794236,0.12377596654302966,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,24.7846464920801,1.1134670061399936,0.15505880933051777,0.2108093371399271,0.29732358822183347,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.823328827164534,0.9810224110021198,-0.0276420003670998,0.16433678474636487,0.24391351397708264,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,23.991709384314934,0.922395784568335,-0.1165421751286564,0.02235364563741897,0.05067751961278214,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,23.661974831278002,0.8065852710065963,-0.310101033849446,0.004690141751407014,0.01706989735222466,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.206665230593835,0.9469108670075782,-0.0786994641019858,0.030932103922091392,0.0645155310375049,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,25.221915194440665,0.9994278270957835,-8.257072576372654e-4,0.9780748862279489,0.9826133279253654,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,24.282027306939934,0.9911398683077012,-0.012839431950621236,0.18107219339108846,0.26278185506479185,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,21.939800873107835,1.0395326420186033,0.055935060494491824,0.43017400807464634,0.5358822967482796,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,21.429909145334232,1.0457323331734223,0.06451362498803057,0.04519640104594972,0.0891712777393062,Upregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.884867714479768,1.0137133090926387,0.01964969767505932,0.0438691898356109,0.08702312114129337,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,18.2901738334145,1.007982395288537,0.011470441961126506,0.5832062341440808,0.6757786522621889,Upregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.577985861204034,1.0365592337556166,0.05180256102403164,0.0014226507847491532,0.00837528284570066,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,24.229165913917132,0.9392958910736398,-0.0903483967091581,0.002510112797135349,0.012380961769654086,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,24.418750614290865,0.954698265597568,-0.06688325651305485,0.006628625816840799,0.021223231781990277,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,22.959582771927433,1.0327554030558757,0.0464986079466617,0.8003107488632761,0.8467055748843356,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,21.729665789563366,1.0167642435378985,0.023985201213183222,0.3246550445148799,0.4262557239134215,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,20.1780974681236,0.988994803163278,-0.015965154762698528,0.5287838781289972,0.6247036009492033,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.5037403069425,0.8813059105746041,-0.18228521414809729,0.002662181875139105,0.012604454731957898,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,25.0391865595278,1.1104538205969323,0.1511493981248147,0.4714483617321614,0.5801234800634896,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,24.223592088894932,1.0726785974925146,0.10121787174874368,0.6962629149358588,0.767782368433802,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,22.269461871508234,0.8702769745470772,-0.20045346839495853,1.1750240735218273e-4,0.0019717592282331494,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.614798177812,1.033735386611513,0.04786693489873394,0.00600087231519557,0.01994508816846971,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.320172208313167,1.0380235725741753,0.05383920636411263,0.007008249982765871,0.022083526898869693,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,20.294767812924498,0.7361831519650492,-0.44186336181114483,0.0035177318079837954,0.014109583625429509,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,23.078877850794434,0.9252319390270396,-0.11211302618887485,3.3569390860161184e-4,0.003311575044313198,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.803669004105068,0.7778957469246137,-0.3623512757594722,0.0012877950490283922,0.007921788149874274,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,23.200819436435832,1.1078595157173767,0.14777494923215428,0.4089137278169662,0.5146672781144574,Upregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,21.236094019068332,0.9808595226449581,-0.02788156445258876,0.1674051776518843,0.24638262033442648,Downregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.583660968513033,1.0284181189887491,0.040426933355910334,0.02188348163509594,0.04992169248006262,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.9127932214179,1.0495424567011409,0.06976052854838032,7.514835978300933e-4,0.005274836792461232,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,No gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,25.067859196871233,1.0520053158687788,0.07314199470450107,0.0011125337800604468,0.007519904254112279,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.618789530451767,1.0348214007079213,0.04938179521562986,3.639214494617603e-4,0.0034955612908826976,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,24.420577158328534,1.06279798053827,0.08786739162548396,0.03503464891754127,0.07224659240057944,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F58,F1154_3,Area: 59,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.291037384054867,1.0333212626805808,0.04728886215973314,0.01227945949149159,0.03186686451875605,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.566127384301268,1.1008123504674148,0.1385685614336606,0.0019632835139276436,0.01088937650052313,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.594004731145233,1.085059072289574,0.11777358735117073,0.026485509647572594,0.05754292274621426,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.103801103179432,0.9576333821932541,-0.06245465074583852,0.12418370271958887,0.19707413692456494,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,25.865814408569634,1.0265314904938285,0.03777788510110572,0.08505398531370713,0.14574978703992067,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4092114122264,1.0532658116518734,0.07486957383562665,0.02624835755969652,0.05736916472628281,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.807259567111366,1.0003147408655144,4.5400364284028277e-4,0.9714962443290832,0.9795473181771144,Upregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,23.4205611952757,0.9537463244870903,-0.06832250273517732,0.0699602677557655,0.12519045880967647,Downregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,24.170614998523433,1.0548579660598723,0.07704875679420652,0.0019988718507809584,0.01088937650052313,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.307573026424432,1.015061224119682,0.02156674718387041,0.5050737035097985,0.6104367608644916,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,24.8086255276989,1.0270701580207056,0.03853473391655019,0.5521159185033222,0.6479817049958605,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,23.041615449195902,0.9207567852253831,-0.11910797123919635,0.3988442900213529,0.5054797425617841,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,19.773865904456468,0.7892315115387577,-0.34147953538808523,0.009406355227105284,0.026913727483742825,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,22.453952408312833,0.9802539583470489,-0.028772532411116224,0.2423444885428845,0.33505961484148805,Downregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,23.853567090450035,1.1165145292601892,0.15900202514626824,5.4150580298791877e-5,0.0014117829863613597,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.219694200619735,1.2267728630574928,0.29486815880153566,2.066199539534021e-4,0.0023567588497809926,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,24.8158824974359,1.0249965913013328,0.03561911195429194,0.05234192130528202,0.09950417331472884,Upregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,22.049019786161434,0.8735632169127127,-0.19501598484622076,0.002313759194775498,0.011729473695736901,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,23.939439294293933,1.0409253745124962,0.05786664339249682,0.054976077362542584,0.1039703017478137,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,19.6695044806278,0.9964379020473756,-0.005148195693390129,0.7139713578517997,0.7821407552300275,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,24.318654783177898,1.2494047070342678,0.32124087026674736,0.041439243003192065,0.08310617415475331,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,21.784813540310235,0.8667151961815712,-0.20637009516318233,0.00654843812478187,0.021152034650844094,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,22.928283771934336,0.9388260761790735,-0.09107018117734773,0.002576878285587238,0.012540807656524558,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,20.475389434119734,0.816868262813282,-0.29182466267364443,0.0013122360050663799,0.007921788149874274,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.497973241322267,0.9898901128056645,-0.014659713643976079,0.8219107565918614,0.8620615694138777,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.485788575419033,1.037503200145043,0.053115786412587455,0.006322760483348946,0.020605424789485405,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,22.165337714170267,0.8724043800065735,-0.19693108167405884,0.0024559615009637787,0.012279807504818894,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,25.28688897484737,1.0038833972791867,0.005591707599108244,0.7720505162001491,0.8228508080872459,Upregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.122502056196932,0.9339384303965501,-0.0986006510438823,0.009129819911104982,0.026659074140426547,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,24.9743973785335,1.25510904616313,0.32781271359791014,4.227441532177798e-5,0.0012858467993707469,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,23.497595787553568,1.060598468239976,0.08487856999315756,0.6395315214122348,0.718243093278356,Upregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.958095537650166,0.9452162443479122,-0.08128367141691287,0.01552025041803678,0.0377659426838895,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,24.6671449735766,1.2256242944410356,0.29351679989690455,8.006099144280871e-5,0.0017189565809779517,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,23.38991073964,1.0676908970314392,0.09449403853764649,0.01425466957295203,0.03515509725761819,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,22.7348999953628,0.8854599622251635,-0.17550102066579315,0.003092160136033529,0.013014118638113149,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.587601625183932,1.0380965069346357,0.053940570481948065,0.012019850356753074,0.03156291640442354,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.803554025363766,1.3212815246994458,0.401937893545508,1.509789670316696e-5,6.888415370819925e-4,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,24.758022372246,1.2126132216549146,0.2781194579753137,0.004814019712443241,0.01706989735222466,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,24.5485426565242,1.2124363544970778,0.2779090166099337,0.07129836300601956,0.1257193357352519,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.029476746366534,0.9120615438043759,-0.1327969174867457,0.2627615457902587,0.36055625644152034,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,22.8985088550048,0.8322586537401743,-0.26489612844867644,0.016861134600730052,0.0402242753546828,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,20.433706575370067,0.972514773773269,-0.040207928194666,0.045482005264313445,0.08925232215846456,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,25.037299940457633,1.1741300907182688,0.23159226435632896,0.13030354043908704,0.2030328301116583,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,22.2772711304372,0.828881368545762,-0.2707624603047723,0.01240097293419107,0.03186686451875605,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,27.253349088264866,1.3536824122121383,0.4368893075469344,0.05136073029360713,0.09815008668673614,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,20.845667219626765,0.738862443882277,-0.43662229614635395,1.239999528177793e-6,1.2481230131084379e-4,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,23.7733798686438,1.0670436322419505,0.0936191702879899,0.005562213121158063,0.019237557051234692,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,22.158699269424634,0.9028007533440173,-0.14752047249715208,4.129683333541318e-4,0.003864960042929695,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.956049228421765,1.036393541881255,0.051571930737827815,0.017916688421358146,0.04192045688330592,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.471649933646468,1.143912585004738,0.19397680911047102,0.041262139530914274,0.08310617415475331,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,22.6033729887552,1.0266778458829466,0.037983559399098435,0.16000846480487446,0.23935692481057042,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,27.011193972771935,1.2875361838946837,0.3646129772215935,6.166433611776803e-4,0.004593363812854149,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.6825608717218,1.0187403530862338,0.026786397875694583,0.06182299738632972,0.11512956145923647,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,20.116460474973,0.791272009710014,-0.3377543703522401,0.004766616531558956,0.01706989735222466,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,23.0578247972753,0.954418975819366,-0.06730536781362476,0.059836565784238294,0.11200177698075373,Downregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.6625817729804,1.095569162667878,0.13168056373329118,0.22979909191692194,0.32136654616734295,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.4972793866126,1.0646502017221846,0.0903795007467462,0.10089732745941114,0.16664038245558854,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,19.20433686231887,0.8568157517860523,-0.22294309190618236,0.13448570943975952,0.2079969658708145,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,19.1185912418606,0.8344271030297887,-0.26114207608572887,0.16925995005006544,0.2481119749729875,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,19.8210213802509,0.9668329331903567,-0.04866147848515967,0.31326621275101557,0.4157897005604389,Downregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,25.294523030630334,0.9708705834659184,-0.04264909691071546,0.18214742282573243,0.26278185506479185,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.954562846351568,1.0386167468289214,0.05466339298033458,0.5157404871547384,0.6175788524387482,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,24.0000434184496,1.0590533250410104,0.08277523317856765,0.021328372645806698,0.04896135858943047,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.90240466157117,1.1407957965926234,0.1900405711106473,0.0027626202152236487,0.012604454731957898,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.80357991509757,0.9612374961764159,-0.05703516833732357,0.1256695369146301,0.1984714044045506,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,24.353790988481233,0.9715002930411335,-0.04171366390543388,0.14918759412556387,0.22688946606596172,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,21.4310757834881,0.9942753502400181,-0.00828265415124471,0.6645014367014744,0.7394604402318237,Downregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,24.506970139269633,0.8965933344097364,-0.15747432096135716,0.004296318518125518,0.016334961032456397,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,25.564708055042733,1.4235886151608501,0.5095323003678524,1.2268032307555972e-4,0.0019717592282331494,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.883969398243533,0.8643730203059706,-0.21027405285911624,0.0012056566932494928,0.00785829808992973,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,24.728874746064367,0.9023172125770756,-0.148293388058783,0.017423628080856835,0.041296261360472375,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,25.401351878297167,1.0941339813378448,0.12978941306314776,0.03805468172094693,0.07716643793414238,Upregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,22.836745093079035,1.12864003370781,0.17458542907677482,0.1913070791534775,0.2749097790985011,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,22.316963510961,0.9809368661915505,-0.027767808354548847,0.8750077173514672,0.9021972226928969,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,23.205046164106534,0.9581068376066978,-0.061741556367066186,0.5687965881656921,0.6632931459440179,Downregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.530187616676667,1.0474402280975175,0.0668679192585931,0.10569024726329265,0.17145306778267475,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,22.297625001318668,0.8658283705217891,-0.2078470209015324,0.1263378412546433,0.1984714044045506,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,24.4118505594793,1.2501497997725701,0.32210097683970895,0.03745934472186559,0.07638358001944659,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,21.86909840411323,0.9327772139556153,-0.1003955483244563,0.1654880255884727,0.2445470823473382,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,21.515747310562766,1.0512714340138714,0.07213521539626236,0.027492859128946025,0.058683588199212273,Upregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,21.438924294262634,0.8315691923991928,-0.2660917840169612,0.1119847571537858,0.18006359630454544,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,22.2136008498238,0.8457907302437145,-0.24162734618381695,0.03328412086809078,0.06902672793666553,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,23.201213878412467,1.0232434116671354,0.033149377764871625,0.0828885752619503,0.14338545009768655,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,20.350438889289368,0.9974072037516245,-0.003745472013457423,0.9526835694795937,0.9686058575488905,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.798457259929968,0.928594705528652,-0.10687903962281915,0.09556403962594869,0.15927339937658114,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.88502210316277,1.0581802055874074,0.08158533592916119,0.00288039954983736,0.012821290679154104,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,23.529627941271798,1.21752495051444,0.2839513374941623,0.013796394014012534,0.03458680342813893,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,24.073843143713866,0.9388005894068011,-0.09110934725934038,0.009506122698445972,0.026913727483742825,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.524769667096166,1.0975478154595244,0.13428379317627095,0.011407600973253496,0.030613094488419333,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.928779198312665,1.017394241977161,0.024878834290079126,0.23942584109661474,0.3322830114078494,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,19.994562376860568,0.9888455230503527,-0.016182933393435642,0.5883716533940531,0.6774626293023008,Downregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,23.733448392661234,1.1268152589364018,0.17225100542720526,4.4671633847964145e-4,0.0038821777034540265,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,22.482879336333102,0.9174117784266164,-0.12435866493796377,0.26556213324007477,0.3630343769012258,Downregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,21.041565646723765,0.9252111277988314,-0.11214547707187719,0.3120535891186412,0.4157897005604389,Downregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,24.165255710774368,1.0502310841696536,0.07070680151555805,0.1371363236029223,0.21120151103403645,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,23.538084352090902,0.9140657231513852,-0.12963019321925273,7.920636249595093e-5,0.0017189565809779517,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.769442735972667,1.1610241018778447,0.21539792164251906,0.005586797390221583,0.019237557051234692,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,26.2140919862775,1.0135226168441689,0.01937828302766191,0.39337586422302606,0.500286377844615,Upregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,22.623372687072166,1.0061415527947322,0.008833290380773191,0.7745230287996839,0.8228508080872459,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,23.090265279797098,0.9880679692859407,-0.017317806540020856,0.39080493326647986,0.4987545477002278,Downregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,22.400349997975766,0.9250125234523003,-0.11245519693384746,0.043393023649074165,0.08654892695033918,Downregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,22.947201351414336,0.9836464299770277,-0.023788260404069977,0.8203479325969751,0.8620615694138777,Downregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,22.8669909716679,1.0968439971240365,0.13335834745478156,0.28381591081291796,0.38367706461746315,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,24.1363509991147,1.1398705608688389,0.18887000702597098,0.31601341806051403,0.4179162956235059,Upregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,22.25772333764183,0.9088915956948013,-0.13781986172188196,0.37636588940851906,0.48541890330074017,Downregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,22.2100602386838,1.0132332634743486,0.018966345232297215,0.8990839617497629,0.9244102705314463,Upregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,21.398619490928034,0.8669182314918743,-0.2060321713184259,0.15141547065667202,0.22932218584931655,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,24.0627635221294,1.1710677571012247,0.2278245515060064,0.20071182428886672,0.28617115572436075,Upregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,24.420362419832866,0.9859790309458648,-0.02037113010171959,0.8426868765085652,0.8788020283589324,Downregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.830237271205835,1.0092162261480149,0.013235307220633333,0.41046106672589244,0.5148394823194183,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,25.442634343612866,0.9665418804914853,-0.0490958487743552,0.7698363038503511,0.8228508080872459,Downregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,26.180160431799134,1.0249815170395529,0.0355978945933583,0.09111592345146534,0.15396903731381875,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,26.225865677845633,1.055844720336738,0.07839767780965463,0.024110372543629292,0.05396837625205425,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,28.553976095025767,1.3200075194112997,0.40054614790683024,0.0017211368948160314,0.00981585885324768,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.070044113405768,0.8143330432405694,-0.2963091510522944,1.49136020714306e-4,0.0020086410725133775,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.593573848828566,0.9961884766223881,-0.005509372108028135,0.45820195255971413,0.5688561655928424,Downregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,25.973922461483767,1.0577166727420504,0.08095322899159452,0.002728114931460129,0.012604454731957898,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.796021753680765,1.222179413779465,0.2894560857870766,2.2639591246222027e-5,8.26345080487104e-4,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.9894823673106,1.0793301690838228,0.110136255406875,0.003101995401413271,0.013014118638113149,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.368795927286868,1.2666739956183566,0.34104526526533196,5.367742328620263e-4,0.004215465393083545,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,29.1315440805228,1.0060926215691894,0.008763126741423075,0.5120981841532508,0.6168839512077114,Upregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,24.662792247739535,1.1008826110604595,0.138660640137533,0.07860938159588965,0.13709867640368661,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0680353065692,1.2414526246321842,0.3120292075378568,5.625995736624361e-4,0.004278100924724775,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.623408826406866,1.029024265318292,0.041277002680480575,0.017696635765925613,0.041672722932663546,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,30.160000249908702,1.0203480844121264,0.029061401204569137,0.023449917060230474,0.0528346896727415,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.107123291704035,1.0653336126287118,0.09130528577189692,0.012362557013876986,0.03186686451875605,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,22.409622164550132,1.0537980056021201,0.0755983544096671,0.41628482159844155,0.520356026998052,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,26.490919508027833,0.9705131066164241,-0.04318039846275937,0.5622791361327739,0.6577945022066105,Downregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,21.180552498331465,0.9369643044298769,-0.09393400837210326,0.046116249029117456,0.08991319898235071,Downregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,18.658165294612566,0.6392226464651175,-0.6456095737238523,5.405488699761809e-7,1.2481230131084379e-4,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.132218324769134,0.8907611021619639,-0.1668895351263824,0.02685563461974847,0.05766062727181289,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,26.007661329102834,1.2289722858648864,0.2974523823532845,0.0012663858854927452,0.007921788149874274,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,25.890722771367333,1.221859175737032,0.28907801823908635,1.3922801069935127e-4,0.0020086410725133775,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,21.7600087803012,0.8158134214207139,-0.2936888529471339,0.010425757037517155,0.028612039990178657,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,18.398550731601034,0.6581669577413136,-0.6034744948901924,0.0012581628838253243,0.007921788149874274,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,25.008631001851434,1.1938482650781936,0.2556194855726581,0.10043367066363716,0.16662858996467075,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,23.863685102265467,1.1097064465321054,0.15017808725711984,0.002806393250531055,0.01264609304251648,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.18245599682387,1.1214647304696461,0.16538424906738325,7.257057696436573e-4,0.0051937765866653905,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,24.423802064708966,0.9532931985012423,-0.0690080916987022,0.3104135124409979,0.4157897005604389,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,23.4468422600727,0.9548614785234014,-0.06663663790894235,0.6176926234948701,0.7001795266323838,Downregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.769556190813802,1.1799165902755795,0.23868487734221067,0.016262286430878826,0.03930950031305147,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,25.961904728350966,1.150391023242263,0.20212432326258914,0.00814013180538269,0.02475956757470568,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,22.2084141088284,0.9041837672936336,-0.14531207753481748,4.950686937930464e-4,0.004106819846237771,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,24.948216780476233,1.165907328626915,0.22145312143409426,9.214961828527798e-4,0.006346152957382351,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.9973175426306,1.0880229115958135,0.12170893719268822,0.008099844499790392,0.02475956757470568,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,22.1980290328719,1.1015493471862121,0.13953412631083983,0.010381770881338338,0.028612039990178657,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.291061494286634,1.016382794159351,0.023443858041209978,0.21097755986152017,0.29732358822183347,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,26.896290643774165,1.2938519307876533,0.37167252386734195,0.0020687752284324437,0.010943521135910754,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.754665037825333,1.303814819547479,0.3827389785476127,1.5105144869035893e-4,0.0020086410725133775,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.951153853234366,1.0773953119156143,0.10754769268540493,8.729929282668327e-6,4.5520345545341993e-4,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.372221168289766,1.0273325935015847,0.038903322177636306,0.024248804672155882,0.05396837625205425,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.2475055098148,1.082955341612016,0.11497375101337327,0.06892786606267459,0.12454787679641696,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1117199147677,1.009050474649864,0.012998342636274746,0.494125402108136,0.6052207106358042,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.3008751858887,1.2640103448392248,0.3380082707833516,0.013834721371255573,0.03458680342813893,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,22.190746064366,0.8875827377325877,-0.17204648552026683,0.08555108674216647,0.1459165731817325,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,21.1782160796956,0.9840932057449244,-0.023133131865610036,0.5395948190564397,0.6353293837277435,Downregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,23.872074329576865,1.029964890945904,0.0425951602031325,0.3199757037434022,0.4216286348965408,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,22.740743807338802,0.9001272492751825,-0.1517991279768952,0.20847743754291015,0.2960866330862343,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.382455560123066,0.9413164941721939,-0.08724822017675382,1.483246670081398e-4,0.0020086410725133775,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,22.367876646803502,0.900428311713467,-0.15131667544927616,0.00205956103336835,0.010943521135910754,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,23.06729450881,0.9263361327236171,-0.11039230634780095,0.007018326356901053,0.022083526898869693,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.384079335290934,1.0514427164692657,0.07237025290668997,0.06697643121398135,0.12223198696551596,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,21.877988208980234,0.9396253142077188,-0.0898425137318159,0.38420452422289975,0.49266029477048623,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,22.942307806516734,0.8955863314178911,-0.1590955851717352,0.0059862242401707315,0.01994508816846971,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.316701044452202,1.0277528035116819,0.03949330730139702,0.02568404851317831,0.056473962092229414,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.813348170484634,1.025650834996793,0.0365396740703279,0.016593023858331987,0.03984509018612615,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.901086034777933,0.9607495518690677,-0.05776769652816738,0.003236555130672252,0.01327351261455474,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,27.909488039612032,1.0669988698502126,0.09355864808140334,0.05740562406468731,0.10800542671964365,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.50742501049143,0.9878244336418988,-0.017673440953309225,0.1558391864555886,0.2340794364456372,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,24.1455385493278,1.1630081553244698,0.2178612134103724,0.3129111278449974,0.4157897005604389,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,24.939526478210265,1.2045803747008574,0.2685306595072348,0.07005648456455801,0.12519045880967647,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,28.173696116950566,1.386380839954424,0.47132362143000445,0.0022216644475437047,0.011584393190763603,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,24.9235035664126,1.2440544144863752,0.3150495898035344,0.1982255713171534,0.2837346412971019,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.781975247267432,1.3869508461509321,0.4719166591316813,1.1990734792780877e-4,0.0019717592282331494,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,19.705480221759068,1.0040119231053555,0.005776402060428594,0.517175008740252,0.6175788524387482,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,23.6548731976333,0.8020987488239184,-0.31814823268524034,0.0038216808886408606,0.014999070154343163,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.099573067452233,0.8570770948150795,-0.22250311306430962,9.33194785681232e-5,0.0018923116487424983,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,21.695794727274965,0.9826820037562316,-0.025203459425501333,0.1818061573447661,0.26278185506479185,Downregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,29.744880444626066,0.9714242947947421,-0.04182652705403723,0.10403447059438159,0.17028063572622995,Downregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.623232217938032,0.8712324524915745,-0.19887040096033393,4.765131676723138e-5,0.0013379023553876503,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.616801933017666,1.009853555634826,0.014146095078357627,0.38467995619065365,0.49266029477048623,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,22.208054932019035,1.0426986143403185,0.06032221593073452,0.07042246767851136,0.12519045880967647,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,19.6245483141361,0.9973028341348247,-0.0038964448624972206,0.8582671099819785,0.8899644748392674,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,22.5906632251769,0.8990854964067552,-0.1534697829549348,0.0048169847322716165,0.01706989735222466,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,24.428730592725632,1.1319160537765611,0.17876696763000904,0.002312968237659415,0.011729473695736901,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,21.926386648387865,1.004767863883691,0.006862227466135879,0.9678047536526572,0.9785283520310799,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,22.966200792567435,1.0014423432936639,0.0020793623001184387,0.9799212366159809,0.9826133279253654,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,25.796916021192267,0.9875707638368896,-0.018043967491177447,0.8504051004053235,0.884324392159382,Downregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,21.665846514552968,0.942040279890762,-0.08613934677301911,0.4992215843800703,0.6094176531729956,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,20.591065114808067,0.8090109867234606,-0.3057687996686689,0.006192265977615745,0.020361955692159883,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,26.8691542025348,1.0041773220880736,0.006014049277438921,0.9666973436200184,0.9785283520310799,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.9170538346994,0.876209981550381,-0.19065144533582043,4.448157642309398e-4,0.0038821777034540265,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.7173040578018,0.9596508062411847,-0.05941855545955328,0.08969253559601217,0.15226872322113694,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,21.039713919288733,0.7917423079005055,-0.336897148936647,0.009469229097633146,0.026913727483742825,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,22.379361040085033,0.8513287512022888,-0.23221174071833253,0.30040729998977966,0.4046076180674154,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,26.269378315050066,0.8821451786802249,-0.18091198862145738,0.2801536008822923,0.38013406811166056,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.773482146853834,1.1636772008184855,0.21869091618079728,0.15470548949064766,0.233336792000357,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,21.0121770164514,0.8067763346358181,-0.3097593292362989,1.5840649888208315e-4,0.0020086410725133775,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,27.695660187399035,1.4322197639846412,0.5182528809295713,0.00840778399453988,0.025362323619893025,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,22.3372806432835,0.8019299607795531,-0.3184518552750456,0.027853155173505055,0.05910698626935666,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,21.93527962217363,0.8726646991919892,-0.1965006560764593,0.11440805658121543,0.1823534526294482,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.285136866672833,0.9598359958064161,-0.05914017681383645,2.6469038718810025e-4,0.0027603426092473312,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.140693160787634,0.9910891591982214,-0.01291324560159214,0.504028565325876,0.6104367608644916,Downregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.291514034102,1.0228694036727615,0.03262195866979506,0.14846361702375627,0.22673313896933486,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.438707093650066,0.8676295539809953,-0.20484889865952247,0.015338811880569476,0.0375749418550863,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,21.733237079986733,0.8015867666083135,-0.3190694036024348,0.004404320567316057,0.016403847010922047,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,22.252768619880968,0.8509398636468836,-0.2328709153662264,0.004349848215717159,0.01636798555398725,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,20.92999464096337,0.9870020166236282,-0.018875062515785093,0.5288586649131611,0.6247036009492033,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,20.005141981386267,1.0010466106384572,0.001509150369115668,0.937757575318346,0.9587717506756198,Upregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.5456550326866,1.4724840278049784,0.558251985069981,6.619883439885149e-4,0.004832514911116159,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,24.25762104421,0.9603577768470356,-0.05835611954942881,0.001989279411050226,0.01088937650052313,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.965383720255165,1.1406822675293915,0.18989699066669533,0.2374475831502146,0.3307952971367494,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,22.25895033704043,0.9477027018490967,-0.0774935440300995,0.09540864912241748,0.15927339937658114,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,24.923316596574733,0.9270276274580581,-0.10931575991703202,0.018121949856287095,0.04213064775506236,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,24.222725506233168,0.8797609206112229,-0.18481657739992566,0.27598121150056687,0.3758699335735332,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,26.316278898461267,1.2824605897461887,0.3589144922250486,1.2424784177907517e-4,0.0019717592282331494,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,21.738216075565102,1.0212952472304766,0.03039999661719758,0.6347268124949577,0.7172609491042091,Upregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,26.162434114821632,1.3427891176895903,0.4252327502216194,0.0037539621313901917,0.014893436716928478,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.8337936011975,1.0034793482117053,0.005010926078565344,0.6697607978795947,0.7430476936962068,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,26.937916665808466,0.9964815513220846,-0.005084999368957957,0.5206635132659071,0.6190299099089775,Downregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,23.217544671826833,1.0468989933361064,0.06612225521750936,0.7744867306084532,0.8228508080872459,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,24.108635256202835,1.2155081633653666,0.2815595825539583,0.008981759595220054,0.026438243969800965,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,21.3107007310268,0.9269158962071873,-0.10948965315561368,0.25110489405010555,0.3458614578425982,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.917033442832967,0.9606937808994696,-0.05785144659241886,2.474690025272079e-4,0.0026566525271303197,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.0349272644887,0.705144884269071,-0.5040083801543239,0.004635488137063159,0.01706989735222466,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.197596559426202,0.7178719033054582,-0.478201661637359,0.0073867947200479634,0.022848983667944973,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.938223191140768,0.8303431209937723,-0.26822047329019444,0.0016300371174004147,0.009443865838907163,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.125362054021366,0.7801166176953956,-0.3582382898932086,0.06654375702696083,0.12223198696551596,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,20.317969427304867,0.7908718899755154,-0.33848407738981623,1.0435085940069187e-6,1.2481230131084379e-4,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,18.85588198535987,0.7060879660683211,-0.5020801659164786,0.0011689691727038553,0.0077577045097619495,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,21.5637946093456,0.873056472942814,-0.1958531184673886,0.0041558985240438264,0.016137265545489325,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,22.801633119129335,0.8879286282639947,-0.17148437753242637,0.026683778720702187,0.057630646349445556,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,21.14245989898127,0.7823577845478202,-0.35409956926317593,1.596250030768819e-4,0.0020086410725133775,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.202955578550668,0.8689247652245848,-0.2026968264048736,0.06675032524037698,0.12223198696551596,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,21.8974773807363,0.8602024227044587,-0.217251900341854,0.0013239152798420017,0.007921788149874274,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.65159511419827,1.0235922742449224,0.03364116351910951,0.7755087068000344,0.8228508080872459,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,21.1559492989488,0.8109139486561008,-0.3023792660598981,0.011394757310157603,0.030613094488419333,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,25.603971130468235,0.9698127942973577,-0.04422180821066402,0.014164101169295047,0.03515509725761819,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,25.451702419370932,0.8961609419030477,-0.1581702451551585,0.006010848489127857,0.01994508816846971,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,21.714504669852033,0.9468731175986884,-0.07875697951604749,0.008485393057504637,0.02538662677040322,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,23.261406152512667,0.9491403195233016,-0.07530670593857591,0.07887869053362792,0.13709867640368661,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,25.304712550202268,1.0715347378379236,0.09967862117091744,0.005025435769326288,0.017637346690423994,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.90328229717007,1.0568372005636186,0.07975315531212736,0.009876790448213229,0.02773098856613714,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.6732501470252,1.0613463869906998,0.08589557919081023,0.0034712032141385523,0.014077657479561906,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.746410490872265,1.0308275646471583,0.043803020936536645,0.011015501285689384,0.030004910218482277,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,25.095807339854865,1.0718697799232804,0.1001296452822923,1.971289281320676e-4,0.002321034153813054,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,22.884681882553068,0.9200955959546891,-0.12014433301669786,0.46333509926756133,0.5732790211276606,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,19.8498585260969,0.9949258959821654,-0.0073390199651008695,0.6565843452431543,0.7328846667087197,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,26.1004603730291,1.0719665577780395,0.10025989863117754,0.013754883120142307,0.03458680342813893,Upregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,21.256871713120866,0.7912881233276158,-0.3377249913280623,0.02975933141745994,0.06242618372053379,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,21.044622882169833,0.7507311832349055,-0.41363168520336807,2.0517090626440074e-6,1.2481230131084379e-4,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.927081129806467,0.7404433949303256,-0.43353864563215744,1.4753649344840621e-6,1.2481230131084379e-4,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,27.7706753526044,1.4158638203875868,0.5016825118196704,1.0797641565670061e-4,0.0019717592282331494,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,27.247732720547802,1.3581123318514652,0.44160281235341026,0.0031491811872838265,0.013061944697256779,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,20.504811434739832,1.0060132990414692,0.008649377046379851,0.7633659489727341,0.8228508080872459,Upregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.235425305062833,1.0239356378590543,0.03412503383418071,0.7734138524861198,0.8228508080872459,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.910134891071465,1.0588187095043624,0.08245559283476873,0.025276591032715734,0.05591488319358329,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,20.105743560235066,1.0140462551719223,0.02012346159682552,0.6058826639712285,0.6910849135921825,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.1410153720616,1.103851668970004,0.1425463217368063,0.13071976733216356,0.2030328301116583,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.389617741496433,1.009629121270818,0.013825428455172019,0.16439102585852694,0.24391351397708264,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,20.726216876243168,0.8039428154374657,-0.31483520892946204,0.04631145591419708,0.08991319898235071,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,20.424621107540467,1.0003719243647804,5.364736790212588e-4,0.9904286672760223,0.9904286672760223,Upregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.2922994852546,1.0381096126165414,0.05395878399371363,0.01177636628207781,0.031147635456220298,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,20.1144961385284,0.9941368795898476,-0.00848358926684661,0.5009710291887962,0.609514752179702,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,26.575013147248068,1.3566391906975577,0.4400370752108212,2.163879560309127e-5,8.26345080487104e-4,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,24.762378508808798,1.224137478101973,0.2917655905781073,4.705204483760791e-4,0.0039939526431923,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.151375727031734,0.8975839953910886,-0.15588114306694975,6.937179186141658e-5,0.00168804693529447,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,24.286457409492034,1.0872778271554415,0.12072063277109155,0.4720456810379627,0.5801234800634896,Upregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.4579521373332,1.1702582104346702,0.22682688691428046,4.2481642015588264e-4,0.003876449833922429,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.307620936458832,0.8699827846500533,-0.20094124190959162,5.428133519861003e-4,0.004215465393083545,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,21.810838272032534,1.045158204780373,0.06372133845627032,0.14659311020614968,0.22481716481195224,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,24.335794363931768,1.0525665570827076,0.07391146230565886,0.3468951625787929,0.45277003040870456,Upregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.815439668341533,1.029078015047878,0.04135235799112797,0.06616281190233159,0.12223198696551596,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,28.003605830377733,1.3437479557436953,0.4262625599183387,3.622033934443944e-5,0.001201856714610945,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,24.610537720242032,0.9881940015805585,-0.017133796353756156,0.8644098048791117,0.8937948407390247,Downregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,27.195462672482165,1.303488336935851,0.3823776743041665,0.002691764218950255,0.012604454731957898,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.668780909383567,1.0336822574312479,0.04779278519305363,0.08463231673549729,0.1457113000398892,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,20.0408390846854,0.9948018862889152,-0.007518851770536778,0.6499881470918395,0.7277474653022129,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,22.33873100038783,1.0039778758261586,0.005727477667601568,0.6117623754592962,0.6956176543384521,Upregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,20.3130816158032,0.8109433312072752,-0.30232699258133866,0.0027281217633199277,0.012604454731957898,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,22.1150163502614,0.8660437369607734,-0.20748820907731536,0.003025449083321851,0.013014118638113149,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,22.704067665479734,0.9385050997640288,-0.09156351031679154,0.34733043428612953,0.45277003040870456,Downregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,21.708426848423198,0.9355113064821359,-0.09617300506947442,0.5938478471200341,0.681296633564225,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,20.046508995598366,0.987799790720677,-0.017709431826272853,0.7697805121026053,0.8228508080872459,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,20.4002106878276,1.0012387712457378,0.0017860630994759308,0.9524683153371287,0.9686058575488905,Upregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,26.9410955864788,1.1635896780097208,0.21858240372493956,0.009511974918911847,0.026913727483742825,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,22.699728880447566,1.0107426948801692,0.015415776601704324,0.6779904095205164,0.7498984832575407,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,23.033311777728667,1.0494277263277914,0.06960281221474789,0.012484826373101684,0.03186686451875605,Upregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,20.837510858465734,0.8085142350342422,-0.3066549202824052,0.11288519802765357,0.18071533894777872,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.71201812109503,1.084981848959617,0.11767090752230105,2.2705252288012542e-4,0.0025113385106438116,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,20.970954117482567,0.7868356332982661,-0.3458658006941157,0.007298019841093407,0.02276732685469311,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,19.680713163433968,0.9893343187652106,-0.015469971757411863,0.3592207530852452,0.4649488470784202,Downregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,25.064584704857968,0.9769459547655731,-0.03364934123858102,0.7173824685145112,0.7821407552300275,Downregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,21.0187264198941,1.0348000712502363,0.04935205847077582,0.12669544445550765,0.1984714044045506,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.448736412949035,1.0573378051992708,0.08043637201540908,0.4087739950674999,0.5146672781144574,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.814102171301332,1.4681535344598293,0.5540028481684313,0.0030015085449933815,0.013014118638113149,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,24.511445401693567,0.8348066827323231,-0.26048594538842523,0.008860072266565837,0.026292084368264475,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,19.741058022810833,0.9680168837629345,-0.046895884258738814,0.10518581263139533,0.17139652504669328,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,24.84631810044243,1.0292475384104929,0.04158999825624675,0.1117252145762355,0.18006359630454544,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.4157355648094,1.0411712451898414,0.05820737340972859,0.011490394369625886,0.030613094488419333,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.990452279342367,1.045735443595088,0.06451791612745156,0.010179374455560266,0.02836237920824044,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,24.684339618769567,1.1661956485793947,0.22180984476219476,0.2250715858963642,0.3159658802006651,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,24.825079770936966,0.9348665206255441,-0.09716770184261689,0.595434592073939,0.681296633564225,Downregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,30.5610379393236,1.7180164042296857,0.7807438119058466,1.6509378678192143e-4,0.0020086410725133775,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,20.5573156123154,1.0071043052956328,0.010213110295910365,0.6368702880225134,0.7174618985438809,Upregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,21.0330889006201,0.9177822767129084,-0.12377614774196889,0.037329572595408846,0.07638358001944659,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.110363772102936,1.0673099628212257,0.09397921729129842,0.004242769243023444,0.01630116603898481,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,25.8361317883481,1.008666911259558,0.012449836674447724,0.7075063634724976,0.777830791167053,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,23.141694182978632,0.9184541548967816,-0.12272038460544965,0.5874393157138682,0.6774626293023008,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,24.9347004994001,1.2329700789834153,0.3021377896628803,0.18146403281742096,0.26278185506479185,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.911257123432666,0.9346005474613334,-0.09757821259635596,5.066482591107361e-4,0.0041094803238981925,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,25.94410557089917,1.4078230170522539,0.4934659785279216,0.0030589685478346848,0.013014118638113149,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,26.828544468971135,1.2160784940369804,0.2822363532083687,0.029112010834567558,0.06142129453535929,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.805674903946368,1.1350473636611857,0.18275250006545404,3.157211264994852e-4,0.003201061421453114,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.069283230913967,1.0501020695846848,0.07052956420266959,0.05012278790288056,0.09628851360290212,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,20.2000386933588,0.9929028617289777,-0.010275512840496106,0.5177510379349506,0.6175788524387482,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,26.21209259559477,1.0252029455140594,0.0359095287600971,0.7178552137042717,0.7821407552300275,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,25.413674365881267,1.2799958174322952,0.35613909602250604,0.0706554370268311,0.12519045880967647,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,22.287667406137032,0.936228775426809,-0.09506698725303496,0.005709392366683118,0.019475964615320914,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.116208624241732,1.0072758459099345,0.010458824387179799,0.8305499197016353,0.8686267068512804,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,26.138573810870266,1.1520263988752009,0.20417377675415407,0.09204004164322391,0.15481389492984665,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,18.55128408291017,0.9793173009021046,-0.03015172303495142,0.3540039914431268,0.4598272486716771,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,21.380353481004168,0.9967170068846124,-0.004744149660242255,0.9192683529458326,0.942508283216935,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.416481051520467,1.0285771339052994,0.040649986891564946,0.10217302750857267,0.1679871848676983,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,25.302410447073868,0.8908483684133927,-0.16674820382976188,0.07882149455662066,0.13709867640368661,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,22.7885861540737,1.1566384229884656,0.20993793368586516,0.048890251710323365,0.09441768187443401,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,21.600860611240467,0.9947545721360621,-0.007587469972758506,0.741097754158892,0.8050615484166534,Downregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.914901047264333,1.00961966875452,0.013811921354457746,0.5775894129272423,0.6714017061096925,Upregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.973615210334966,1.317951099718866,0.39829684265108006,1.8489320679624176e-6,1.2481230131084379e-4,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,20.0216272513046,0.76607930567508975,-0.38443434505852325,0.01838094816546537,0.04246231696452443,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,22.051379250204068,0.9942872970890568,-0.008265319359317728,0.8206893172505106,0.8620615694138777,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,24.5682518657356,0.8742391793979374,-0.1939000603275891,0.06816155965794236,0.12377596654302966,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,24.7846464920801,1.1134670061399936,0.15505880933051777,0.2108093371399271,0.29732358822183347,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.823328827164534,0.9810224110021198,-0.0276420003670998,0.16433678474636487,0.24391351397708264,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,23.991709384314934,0.922395784568335,-0.1165421751286564,0.02235364563741897,0.05067751961278214,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,23.661974831278002,0.8065852710065963,-0.310101033849446,0.004690141751407014,0.01706989735222466,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.206665230593835,0.9469108670075782,-0.0786994641019858,0.030932103922091392,0.0645155310375049,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,25.221915194440665,0.9994278270957835,-8.257072576372654e-4,0.9780748862279489,0.9826133279253654,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,24.282027306939934,0.9911398683077012,-0.012839431950621236,0.18107219339108846,0.26278185506479185,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,21.939800873107835,1.0395326420186033,0.055935060494491824,0.43017400807464634,0.5358822967482796,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,21.429909145334232,1.0457323331734223,0.06451362498803057,0.04519640104594972,0.0891712777393062,Upregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.884867714479768,1.0137133090926387,0.01964969767505932,0.0438691898356109,0.08702312114129337,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,18.2901738334145,1.007982395288537,0.011470441961126506,0.5832062341440808,0.6757786522621889,Upregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.577985861204034,1.0365592337556166,0.05180256102403164,0.0014226507847491532,0.00837528284570066,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,24.229165913917132,0.9392958910736398,-0.0903483967091581,0.002510112797135349,0.012380961769654086,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,24.418750614290865,0.954698265597568,-0.06688325651305485,0.006628625816840799,0.021223231781990277,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,22.959582771927433,1.0327554030558757,0.0464986079466617,0.8003107488632761,0.8467055748843356,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,21.729665789563366,1.0167642435378985,0.023985201213183222,0.3246550445148799,0.4262557239134215,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,20.1780974681236,0.988994803163278,-0.015965154762698528,0.5287838781289972,0.6247036009492033,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.5037403069425,0.8813059105746041,-0.18228521414809729,0.002662181875139105,0.012604454731957898,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,No gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,25.0391865595278,1.1104538205969323,0.1511493981248147,0.4714483617321614,0.5801234800634896,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,24.223592088894932,1.0726785974925146,0.10121787174874368,0.6962629149358588,0.767782368433802,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,22.269461871508234,0.8702769745470772,-0.20045346839495853,1.1750240735218273e-4,0.0019717592282331494,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.614798177812,1.033735386611513,0.04786693489873394,0.00600087231519557,0.01994508816846971,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.320172208313167,1.0380235725741753,0.05383920636411263,0.007008249982765871,0.022083526898869693,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,20.294767812924498,0.7361831519650492,-0.44186336181114483,0.0035177318079837954,0.014109583625429509,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,23.078877850794434,0.9252319390270396,-0.11211302618887485,3.3569390860161184e-4,0.003311575044313198,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.803669004105068,0.7778957469246137,-0.3623512757594722,0.0012877950490283922,0.007921788149874274,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,23.200819436435832,1.1078595157173767,0.14777494923215428,0.4089137278169662,0.5146672781144574,Upregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,21.236094019068332,0.9808595226449581,-0.02788156445258876,0.1674051776518843,0.24638262033442648,Downregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.583660968513033,1.0284181189887491,0.040426933355910334,0.02188348163509594,0.04992169248006262,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.9127932214179,1.0495424567011409,0.06976052854838032,7.514835978300933e-4,0.005274836792461232,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,25.067859196871233,1.0520053158687788,0.07314199470450107,0.0011125337800604468,0.007519904254112279,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.618789530451767,1.0348214007079213,0.04938179521562986,3.639214494617603e-4,0.0034955612908826976,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,24.420577158328534,1.06279798053827,0.08786739162548396,0.03503464891754127,0.07224659240057944,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F56,F1246_2,Area: 57,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.291037384054867,1.0333212626805808,0.04728886215973314,0.01227945949149159,0.03186686451875605,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.566127384301268,1.1008123504674148,0.1385685614336606,0.0019632835139276436,0.01088937650052313,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.594004731145233,1.085059072289574,0.11777358735117073,0.026485509647572594,0.05754292274621426,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.103801103179432,0.9576333821932541,-0.06245465074583852,0.12418370271958887,0.19707413692456494,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,25.865814408569634,1.0265314904938285,0.03777788510110572,0.08505398531370713,0.14574978703992067,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4092114122264,1.0532658116518734,0.07486957383562665,0.02624835755969652,0.05736916472628281,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.807259567111366,1.0003147408655144,4.5400364284028277e-4,0.9714962443290832,0.9795473181771144,Upregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,23.4205611952757,0.9537463244870903,-0.06832250273517732,0.0699602677557655,0.12519045880967647,Downregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,24.170614998523433,1.0548579660598723,0.07704875679420652,0.0019988718507809584,0.01088937650052313,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.307573026424432,1.015061224119682,0.02156674718387041,0.5050737035097985,0.6104367608644916,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,24.8086255276989,1.0270701580207056,0.03853473391655019,0.5521159185033222,0.6479817049958605,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,23.041615449195902,0.9207567852253831,-0.11910797123919635,0.3988442900213529,0.5054797425617841,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,19.773865904456468,0.7892315115387577,-0.34147953538808523,0.009406355227105284,0.026913727483742825,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,22.453952408312833,0.9802539583470489,-0.028772532411116224,0.2423444885428845,0.33505961484148805,Downregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,23.853567090450035,1.1165145292601892,0.15900202514626824,5.4150580298791877e-5,0.0014117829863613597,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.219694200619735,1.2267728630574928,0.29486815880153566,2.066199539534021e-4,0.0023567588497809926,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,24.8158824974359,1.0249965913013328,0.03561911195429194,0.05234192130528202,0.09950417331472884,Upregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,22.049019786161434,0.8735632169127127,-0.19501598484622076,0.002313759194775498,0.011729473695736901,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,23.939439294293933,1.0409253745124962,0.05786664339249682,0.054976077362542584,0.1039703017478137,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,19.6695044806278,0.9964379020473756,-0.005148195693390129,0.7139713578517997,0.7821407552300275,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,24.318654783177898,1.2494047070342678,0.32124087026674736,0.041439243003192065,0.08310617415475331,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,21.784813540310235,0.8667151961815712,-0.20637009516318233,0.00654843812478187,0.021152034650844094,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,22.928283771934336,0.9388260761790735,-0.09107018117734773,0.002576878285587238,0.012540807656524558,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,20.475389434119734,0.816868262813282,-0.29182466267364443,0.0013122360050663799,0.007921788149874274,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.497973241322267,0.9898901128056645,-0.014659713643976079,0.8219107565918614,0.8620615694138777,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.485788575419033,1.037503200145043,0.053115786412587455,0.006322760483348946,0.020605424789485405,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,22.165337714170267,0.8724043800065735,-0.19693108167405884,0.0024559615009637787,0.012279807504818894,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,25.28688897484737,1.0038833972791867,0.005591707599108244,0.7720505162001491,0.8228508080872459,Upregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.122502056196932,0.9339384303965501,-0.0986006510438823,0.009129819911104982,0.026659074140426547,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,24.9743973785335,1.25510904616313,0.32781271359791014,4.227441532177798e-5,0.0012858467993707469,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,23.497595787553568,1.060598468239976,0.08487856999315756,0.6395315214122348,0.718243093278356,Upregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.958095537650166,0.9452162443479122,-0.08128367141691287,0.01552025041803678,0.0377659426838895,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,24.6671449735766,1.2256242944410356,0.29351679989690455,8.006099144280871e-5,0.0017189565809779517,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,23.38991073964,1.0676908970314392,0.09449403853764649,0.01425466957295203,0.03515509725761819,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,22.7348999953628,0.8854599622251635,-0.17550102066579315,0.003092160136033529,0.013014118638113149,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.587601625183932,1.0380965069346357,0.053940570481948065,0.012019850356753074,0.03156291640442354,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.803554025363766,1.3212815246994458,0.401937893545508,1.509789670316696e-5,6.888415370819925e-4,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,24.758022372246,1.2126132216549146,0.2781194579753137,0.004814019712443241,0.01706989735222466,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,24.5485426565242,1.2124363544970778,0.2779090166099337,0.07129836300601956,0.1257193357352519,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.029476746366534,0.9120615438043759,-0.1327969174867457,0.2627615457902587,0.36055625644152034,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,22.8985088550048,0.8322586537401743,-0.26489612844867644,0.016861134600730052,0.0402242753546828,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,20.433706575370067,0.972514773773269,-0.040207928194666,0.045482005264313445,0.08925232215846456,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,25.037299940457633,1.1741300907182688,0.23159226435632896,0.13030354043908704,0.2030328301116583,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,22.2772711304372,0.828881368545762,-0.2707624603047723,0.01240097293419107,0.03186686451875605,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,27.253349088264866,1.3536824122121383,0.4368893075469344,0.05136073029360713,0.09815008668673614,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,20.845667219626765,0.738862443882277,-0.43662229614635395,1.239999528177793e-6,1.2481230131084379e-4,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,23.7733798686438,1.0670436322419505,0.0936191702879899,0.005562213121158063,0.019237557051234692,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,22.158699269424634,0.9028007533440173,-0.14752047249715208,4.129683333541318e-4,0.003864960042929695,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.956049228421765,1.036393541881255,0.051571930737827815,0.017916688421358146,0.04192045688330592,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.471649933646468,1.143912585004738,0.19397680911047102,0.041262139530914274,0.08310617415475331,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,22.6033729887552,1.0266778458829466,0.037983559399098435,0.16000846480487446,0.23935692481057042,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,27.011193972771935,1.2875361838946837,0.3646129772215935,6.166433611776803e-4,0.004593363812854149,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.6825608717218,1.0187403530862338,0.026786397875694583,0.06182299738632972,0.11512956145923647,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,20.116460474973,0.791272009710014,-0.3377543703522401,0.004766616531558956,0.01706989735222466,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,23.0578247972753,0.954418975819366,-0.06730536781362476,0.059836565784238294,0.11200177698075373,Downregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.6625817729804,1.095569162667878,0.13168056373329118,0.22979909191692194,0.32136654616734295,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.4972793866126,1.0646502017221846,0.0903795007467462,0.10089732745941114,0.16664038245558854,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,19.20433686231887,0.8568157517860523,-0.22294309190618236,0.13448570943975952,0.2079969658708145,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,19.1185912418606,0.8344271030297887,-0.26114207608572887,0.16925995005006544,0.2481119749729875,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,19.8210213802509,0.9668329331903567,-0.04866147848515967,0.31326621275101557,0.4157897005604389,Downregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,25.294523030630334,0.9708705834659184,-0.04264909691071546,0.18214742282573243,0.26278185506479185,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.954562846351568,1.0386167468289214,0.05466339298033458,0.5157404871547384,0.6175788524387482,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,24.0000434184496,1.0590533250410104,0.08277523317856765,0.021328372645806698,0.04896135858943047,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.90240466157117,1.1407957965926234,0.1900405711106473,0.0027626202152236487,0.012604454731957898,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.80357991509757,0.9612374961764159,-0.05703516833732357,0.1256695369146301,0.1984714044045506,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,24.353790988481233,0.9715002930411335,-0.04171366390543388,0.14918759412556387,0.22688946606596172,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,21.4310757834881,0.9942753502400181,-0.00828265415124471,0.6645014367014744,0.7394604402318237,Downregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,24.506970139269633,0.8965933344097364,-0.15747432096135716,0.004296318518125518,0.016334961032456397,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,25.564708055042733,1.4235886151608501,0.5095323003678524,1.2268032307555972e-4,0.0019717592282331494,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.883969398243533,0.8643730203059706,-0.21027405285911624,0.0012056566932494928,0.00785829808992973,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,24.728874746064367,0.9023172125770756,-0.148293388058783,0.017423628080856835,0.041296261360472375,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,25.401351878297167,1.0941339813378448,0.12978941306314776,0.03805468172094693,0.07716643793414238,Upregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,22.836745093079035,1.12864003370781,0.17458542907677482,0.1913070791534775,0.2749097790985011,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,22.316963510961,0.9809368661915505,-0.027767808354548847,0.8750077173514672,0.9021972226928969,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,23.205046164106534,0.9581068376066978,-0.061741556367066186,0.5687965881656921,0.6632931459440179,Downregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.530187616676667,1.0474402280975175,0.0668679192585931,0.10569024726329265,0.17145306778267475,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,22.297625001318668,0.8658283705217891,-0.2078470209015324,0.1263378412546433,0.1984714044045506,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,24.4118505594793,1.2501497997725701,0.32210097683970895,0.03745934472186559,0.07638358001944659,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,21.86909840411323,0.9327772139556153,-0.1003955483244563,0.1654880255884727,0.2445470823473382,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,21.515747310562766,1.0512714340138714,0.07213521539626236,0.027492859128946025,0.058683588199212273,Upregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,21.438924294262634,0.8315691923991928,-0.2660917840169612,0.1119847571537858,0.18006359630454544,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,22.2136008498238,0.8457907302437145,-0.24162734618381695,0.03328412086809078,0.06902672793666553,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,23.201213878412467,1.0232434116671354,0.033149377764871625,0.0828885752619503,0.14338545009768655,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,20.350438889289368,0.9974072037516245,-0.003745472013457423,0.9526835694795937,0.9686058575488905,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.798457259929968,0.928594705528652,-0.10687903962281915,0.09556403962594869,0.15927339937658114,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.88502210316277,1.0581802055874074,0.08158533592916119,0.00288039954983736,0.012821290679154104,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,23.529627941271798,1.21752495051444,0.2839513374941623,0.013796394014012534,0.03458680342813893,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,24.073843143713866,0.9388005894068011,-0.09110934725934038,0.009506122698445972,0.026913727483742825,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.524769667096166,1.0975478154595244,0.13428379317627095,0.011407600973253496,0.030613094488419333,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.928779198312665,1.017394241977161,0.024878834290079126,0.23942584109661474,0.3322830114078494,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,19.994562376860568,0.9888455230503527,-0.016182933393435642,0.5883716533940531,0.6774626293023008,Downregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,23.733448392661234,1.1268152589364018,0.17225100542720526,4.4671633847964145e-4,0.0038821777034540265,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,22.482879336333102,0.9174117784266164,-0.12435866493796377,0.26556213324007477,0.3630343769012258,Downregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,21.041565646723765,0.9252111277988314,-0.11214547707187719,0.3120535891186412,0.4157897005604389,Downregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,24.165255710774368,1.0502310841696536,0.07070680151555805,0.1371363236029223,0.21120151103403645,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,23.538084352090902,0.9140657231513852,-0.12963019321925273,7.920636249595093e-5,0.0017189565809779517,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.769442735972667,1.1610241018778447,0.21539792164251906,0.005586797390221583,0.019237557051234692,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,26.2140919862775,1.0135226168441689,0.01937828302766191,0.39337586422302606,0.500286377844615,Upregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,22.623372687072166,1.0061415527947322,0.008833290380773191,0.7745230287996839,0.8228508080872459,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,23.090265279797098,0.9880679692859407,-0.017317806540020856,0.39080493326647986,0.4987545477002278,Downregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,22.400349997975766,0.9250125234523003,-0.11245519693384746,0.043393023649074165,0.08654892695033918,Downregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,22.947201351414336,0.9836464299770277,-0.023788260404069977,0.8203479325969751,0.8620615694138777,Downregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,22.8669909716679,1.0968439971240365,0.13335834745478156,0.28381591081291796,0.38367706461746315,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,24.1363509991147,1.1398705608688389,0.18887000702597098,0.31601341806051403,0.4179162956235059,Upregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,22.25772333764183,0.9088915956948013,-0.13781986172188196,0.37636588940851906,0.48541890330074017,Downregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,22.2100602386838,1.0132332634743486,0.018966345232297215,0.8990839617497629,0.9244102705314463,Upregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,21.398619490928034,0.8669182314918743,-0.2060321713184259,0.15141547065667202,0.22932218584931655,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,24.0627635221294,1.1710677571012247,0.2278245515060064,0.20071182428886672,0.28617115572436075,Upregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,24.420362419832866,0.9859790309458648,-0.02037113010171959,0.8426868765085652,0.8788020283589324,Downregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.830237271205835,1.0092162261480149,0.013235307220633333,0.41046106672589244,0.5148394823194183,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,25.442634343612866,0.9665418804914853,-0.0490958487743552,0.7698363038503511,0.8228508080872459,Downregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,26.180160431799134,1.0249815170395529,0.0355978945933583,0.09111592345146534,0.15396903731381875,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,26.225865677845633,1.055844720336738,0.07839767780965463,0.024110372543629292,0.05396837625205425,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,28.553976095025767,1.3200075194112997,0.40054614790683024,0.0017211368948160314,0.00981585885324768,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.070044113405768,0.8143330432405694,-0.2963091510522944,1.49136020714306e-4,0.0020086410725133775,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.593573848828566,0.9961884766223881,-0.005509372108028135,0.45820195255971413,0.5688561655928424,Downregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,25.973922461483767,1.0577166727420504,0.08095322899159452,0.002728114931460129,0.012604454731957898,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.796021753680765,1.222179413779465,0.2894560857870766,2.2639591246222027e-5,8.26345080487104e-4,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.9894823673106,1.0793301690838228,0.110136255406875,0.003101995401413271,0.013014118638113149,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.368795927286868,1.2666739956183566,0.34104526526533196,5.367742328620263e-4,0.004215465393083545,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,29.1315440805228,1.0060926215691894,0.008763126741423075,0.5120981841532508,0.6168839512077114,Upregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,24.662792247739535,1.1008826110604595,0.138660640137533,0.07860938159588965,0.13709867640368661,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0680353065692,1.2414526246321842,0.3120292075378568,5.625995736624361e-4,0.004278100924724775,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.623408826406866,1.029024265318292,0.041277002680480575,0.017696635765925613,0.041672722932663546,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,30.160000249908702,1.0203480844121264,0.029061401204569137,0.023449917060230474,0.0528346896727415,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.107123291704035,1.0653336126287118,0.09130528577189692,0.012362557013876986,0.03186686451875605,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,22.409622164550132,1.0537980056021201,0.0755983544096671,0.41628482159844155,0.520356026998052,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,26.490919508027833,0.9705131066164241,-0.04318039846275937,0.5622791361327739,0.6577945022066105,Downregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,21.180552498331465,0.9369643044298769,-0.09393400837210326,0.046116249029117456,0.08991319898235071,Downregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,18.658165294612566,0.6392226464651175,-0.6456095737238523,5.405488699761809e-7,1.2481230131084379e-4,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.132218324769134,0.8907611021619639,-0.1668895351263824,0.02685563461974847,0.05766062727181289,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,26.007661329102834,1.2289722858648864,0.2974523823532845,0.0012663858854927452,0.007921788149874274,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,25.890722771367333,1.221859175737032,0.28907801823908635,1.3922801069935127e-4,0.0020086410725133775,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,21.7600087803012,0.8158134214207139,-0.2936888529471339,0.010425757037517155,0.028612039990178657,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,18.398550731601034,0.6581669577413136,-0.6034744948901924,0.0012581628838253243,0.007921788149874274,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,25.008631001851434,1.1938482650781936,0.2556194855726581,0.10043367066363716,0.16662858996467075,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,23.863685102265467,1.1097064465321054,0.15017808725711984,0.002806393250531055,0.01264609304251648,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.18245599682387,1.1214647304696461,0.16538424906738325,7.257057696436573e-4,0.0051937765866653905,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,24.423802064708966,0.9532931985012423,-0.0690080916987022,0.3104135124409979,0.4157897005604389,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,23.4468422600727,0.9548614785234014,-0.06663663790894235,0.6176926234948701,0.7001795266323838,Downregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.769556190813802,1.1799165902755795,0.23868487734221067,0.016262286430878826,0.03930950031305147,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,25.961904728350966,1.150391023242263,0.20212432326258914,0.00814013180538269,0.02475956757470568,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,22.2084141088284,0.9041837672936336,-0.14531207753481748,4.950686937930464e-4,0.004106819846237771,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,24.948216780476233,1.165907328626915,0.22145312143409426,9.214961828527798e-4,0.006346152957382351,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.9973175426306,1.0880229115958135,0.12170893719268822,0.008099844499790392,0.02475956757470568,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,22.1980290328719,1.1015493471862121,0.13953412631083983,0.010381770881338338,0.028612039990178657,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.291061494286634,1.016382794159351,0.023443858041209978,0.21097755986152017,0.29732358822183347,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,26.896290643774165,1.2938519307876533,0.37167252386734195,0.0020687752284324437,0.010943521135910754,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.754665037825333,1.303814819547479,0.3827389785476127,1.5105144869035893e-4,0.0020086410725133775,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.951153853234366,1.0773953119156143,0.10754769268540493,8.729929282668327e-6,4.5520345545341993e-4,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.372221168289766,1.0273325935015847,0.038903322177636306,0.024248804672155882,0.05396837625205425,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.2475055098148,1.082955341612016,0.11497375101337327,0.06892786606267459,0.12454787679641696,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1117199147677,1.009050474649864,0.012998342636274746,0.494125402108136,0.6052207106358042,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.3008751858887,1.2640103448392248,0.3380082707833516,0.013834721371255573,0.03458680342813893,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,22.190746064366,0.8875827377325877,-0.17204648552026683,0.08555108674216647,0.1459165731817325,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,21.1782160796956,0.9840932057449244,-0.023133131865610036,0.5395948190564397,0.6353293837277435,Downregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,23.872074329576865,1.029964890945904,0.0425951602031325,0.3199757037434022,0.4216286348965408,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,22.740743807338802,0.9001272492751825,-0.1517991279768952,0.20847743754291015,0.2960866330862343,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.382455560123066,0.9413164941721939,-0.08724822017675382,1.483246670081398e-4,0.0020086410725133775,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,22.367876646803502,0.900428311713467,-0.15131667544927616,0.00205956103336835,0.010943521135910754,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,23.06729450881,0.9263361327236171,-0.11039230634780095,0.007018326356901053,0.022083526898869693,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.384079335290934,1.0514427164692657,0.07237025290668997,0.06697643121398135,0.12223198696551596,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,21.877988208980234,0.9396253142077188,-0.0898425137318159,0.38420452422289975,0.49266029477048623,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,22.942307806516734,0.8955863314178911,-0.1590955851717352,0.0059862242401707315,0.01994508816846971,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.316701044452202,1.0277528035116819,0.03949330730139702,0.02568404851317831,0.056473962092229414,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.813348170484634,1.025650834996793,0.0365396740703279,0.016593023858331987,0.03984509018612615,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.901086034777933,0.9607495518690677,-0.05776769652816738,0.003236555130672252,0.01327351261455474,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,27.909488039612032,1.0669988698502126,0.09355864808140334,0.05740562406468731,0.10800542671964365,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.50742501049143,0.9878244336418988,-0.017673440953309225,0.1558391864555886,0.2340794364456372,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,24.1455385493278,1.1630081553244698,0.2178612134103724,0.3129111278449974,0.4157897005604389,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,24.939526478210265,1.2045803747008574,0.2685306595072348,0.07005648456455801,0.12519045880967647,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,28.173696116950566,1.386380839954424,0.47132362143000445,0.0022216644475437047,0.011584393190763603,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,24.9235035664126,1.2440544144863752,0.3150495898035344,0.1982255713171534,0.2837346412971019,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.781975247267432,1.3869508461509321,0.4719166591316813,1.1990734792780877e-4,0.0019717592282331494,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,19.705480221759068,1.0040119231053555,0.005776402060428594,0.517175008740252,0.6175788524387482,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,23.6548731976333,0.8020987488239184,-0.31814823268524034,0.0038216808886408606,0.014999070154343163,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.099573067452233,0.8570770948150795,-0.22250311306430962,9.33194785681232e-5,0.0018923116487424983,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,21.695794727274965,0.9826820037562316,-0.025203459425501333,0.1818061573447661,0.26278185506479185,Downregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,29.744880444626066,0.9714242947947421,-0.04182652705403723,0.10403447059438159,0.17028063572622995,Downregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.623232217938032,0.8712324524915745,-0.19887040096033393,4.765131676723138e-5,0.0013379023553876503,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.616801933017666,1.009853555634826,0.014146095078357627,0.38467995619065365,0.49266029477048623,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,22.208054932019035,1.0426986143403185,0.06032221593073452,0.07042246767851136,0.12519045880967647,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,19.6245483141361,0.9973028341348247,-0.0038964448624972206,0.8582671099819785,0.8899644748392674,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,22.5906632251769,0.8990854964067552,-0.1534697829549348,0.0048169847322716165,0.01706989735222466,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,24.428730592725632,1.1319160537765611,0.17876696763000904,0.002312968237659415,0.011729473695736901,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,21.926386648387865,1.004767863883691,0.006862227466135879,0.9678047536526572,0.9785283520310799,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,22.966200792567435,1.0014423432936639,0.0020793623001184387,0.9799212366159809,0.9826133279253654,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,25.796916021192267,0.9875707638368896,-0.018043967491177447,0.8504051004053235,0.884324392159382,Downregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,21.665846514552968,0.942040279890762,-0.08613934677301911,0.4992215843800703,0.6094176531729956,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,20.591065114808067,0.8090109867234606,-0.3057687996686689,0.006192265977615745,0.020361955692159883,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,26.8691542025348,1.0041773220880736,0.006014049277438921,0.9666973436200184,0.9785283520310799,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.9170538346994,0.876209981550381,-0.19065144533582043,4.448157642309398e-4,0.0038821777034540265,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.7173040578018,0.9596508062411847,-0.05941855545955328,0.08969253559601217,0.15226872322113694,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,21.039713919288733,0.7917423079005055,-0.336897148936647,0.009469229097633146,0.026913727483742825,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,22.379361040085033,0.8513287512022888,-0.23221174071833253,0.30040729998977966,0.4046076180674154,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,26.269378315050066,0.8821451786802249,-0.18091198862145738,0.2801536008822923,0.38013406811166056,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.773482146853834,1.1636772008184855,0.21869091618079728,0.15470548949064766,0.233336792000357,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,21.0121770164514,0.8067763346358181,-0.3097593292362989,1.5840649888208315e-4,0.0020086410725133775,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,27.695660187399035,1.4322197639846412,0.5182528809295713,0.00840778399453988,0.025362323619893025,Upregulated
Feature0167,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,22.3372806432835,0.8019299607795531,-0.3184518552750456,0.027853155173505055,0.05910698626935666,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,21.93527962217363,0.8726646991919892,-0.1965006560764593,0.11440805658121543,0.1823534526294482,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.285136866672833,0.9598359958064161,-0.05914017681383645,2.6469038718810025e-4,0.0027603426092473312,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.140693160787634,0.9910891591982214,-0.01291324560159214,0.504028565325876,0.6104367608644916,Downregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.291514034102,1.0228694036727615,0.03262195866979506,0.14846361702375627,0.22673313896933486,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.438707093650066,0.8676295539809953,-0.20484889865952247,0.015338811880569476,0.0375749418550863,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,21.733237079986733,0.8015867666083135,-0.3190694036024348,0.004404320567316057,0.016403847010922047,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,22.252768619880968,0.8509398636468836,-0.2328709153662264,0.004349848215717159,0.01636798555398725,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,20.92999464096337,0.9870020166236282,-0.018875062515785093,0.5288586649131611,0.6247036009492033,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,20.005141981386267,1.0010466106384572,0.001509150369115668,0.937757575318346,0.9587717506756198,Upregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.5456550326866,1.4724840278049784,0.558251985069981,6.619883439885149e-4,0.004832514911116159,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,24.25762104421,0.9603577768470356,-0.05835611954942881,0.001989279411050226,0.01088937650052313,Downregulated
Feature0155,[Similar to: NP-015005; ΔMass: -441.3129 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.965383720255165,1.1406822675293915,0.18989699066669533,0.2374475831502146,0.3307952971367494,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,22.25895033704043,0.9477027018490967,-0.0774935440300995,0.09540864912241748,0.15927339937658114,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,24.923316596574733,0.9270276274580581,-0.10931575991703202,0.018121949856287095,0.04213064775506236,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,24.222725506233168,0.8797609206112229,-0.18481657739992566,0.27598121150056687,0.3758699335735332,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,26.316278898461267,1.2824605897461887,0.3589144922250486,1.2424784177907517e-4,0.0019717592282331494,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,21.738216075565102,1.0212952472304766,0.03039999661719758,0.6347268124949577,0.7172609491042091,Upregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,26.162434114821632,1.3427891176895903,0.4252327502216194,0.0037539621313901917,0.014893436716928478,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.8337936011975,1.0034793482117053,0.005010926078565344,0.6697607978795947,0.7430476936962068,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,26.937916665808466,0.9964815513220846,-0.005084999368957957,0.5206635132659071,0.6190299099089775,Downregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,23.217544671826833,1.0468989933361064,0.06612225521750936,0.7744867306084532,0.8228508080872459,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,24.108635256202835,1.2155081633653666,0.2815595825539583,0.008981759595220054,0.026438243969800965,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,21.3107007310268,0.9269158962071873,-0.10948965315561368,0.25110489405010555,0.3458614578425982,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.917033442832967,0.9606937808994696,-0.05785144659241886,2.474690025272079e-4,0.0026566525271303197,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.0349272644887,0.705144884269071,-0.5040083801543239,0.004635488137063159,0.01706989735222466,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.197596559426202,0.7178719033054582,-0.478201661637359,0.0073867947200479634,0.022848983667944973,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.938223191140768,0.8303431209937723,-0.26822047329019444,0.0016300371174004147,0.009443865838907163,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.125362054021366,0.7801166176953956,-0.3582382898932086,0.06654375702696083,0.12223198696551596,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,20.317969427304867,0.7908718899755154,-0.33848407738981623,1.0435085940069187e-6,1.2481230131084379e-4,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,18.85588198535987,0.7060879660683211,-0.5020801659164786,0.0011689691727038553,0.0077577045097619495,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,21.5637946093456,0.873056472942814,-0.1958531184673886,0.0041558985240438264,0.016137265545489325,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,22.801633119129335,0.8879286282639947,-0.17148437753242637,0.026683778720702187,0.057630646349445556,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,21.14245989898127,0.7823577845478202,-0.35409956926317593,1.596250030768819e-4,0.0020086410725133775,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.202955578550668,0.8689247652245848,-0.2026968264048736,0.06675032524037698,0.12223198696551596,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,21.8974773807363,0.8602024227044587,-0.217251900341854,0.0013239152798420017,0.007921788149874274,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.65159511419827,1.0235922742449224,0.03364116351910951,0.7755087068000344,0.8228508080872459,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,21.1559492989488,0.8109139486561008,-0.3023792660598981,0.011394757310157603,0.030613094488419333,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,25.603971130468235,0.9698127942973577,-0.04422180821066402,0.014164101169295047,0.03515509725761819,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,25.451702419370932,0.8961609419030477,-0.1581702451551585,0.006010848489127857,0.01994508816846971,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,21.714504669852033,0.9468731175986884,-0.07875697951604749,0.008485393057504637,0.02538662677040322,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,23.261406152512667,0.9491403195233016,-0.07530670593857591,0.07887869053362792,0.13709867640368661,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,25.304712550202268,1.0715347378379236,0.09967862117091744,0.005025435769326288,0.017637346690423994,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.90328229717007,1.0568372005636186,0.07975315531212736,0.009876790448213229,0.02773098856613714,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.6732501470252,1.0613463869906998,0.08589557919081023,0.0034712032141385523,0.014077657479561906,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.746410490872265,1.0308275646471583,0.043803020936536645,0.011015501285689384,0.030004910218482277,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,25.095807339854865,1.0718697799232804,0.1001296452822923,1.971289281320676e-4,0.002321034153813054,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,22.884681882553068,0.9200955959546891,-0.12014433301669786,0.46333509926756133,0.5732790211276606,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,19.8498585260969,0.9949258959821654,-0.0073390199651008695,0.6565843452431543,0.7328846667087197,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,26.1004603730291,1.0719665577780395,0.10025989863117754,0.013754883120142307,0.03458680342813893,Upregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,21.256871713120866,0.7912881233276158,-0.3377249913280623,0.02975933141745994,0.06242618372053379,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,21.044622882169833,0.7507311832349055,-0.41363168520336807,2.0517090626440074e-6,1.2481230131084379e-4,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.927081129806467,0.7404433949303256,-0.43353864563215744,1.4753649344840621e-6,1.2481230131084379e-4,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,27.7706753526044,1.4158638203875868,0.5016825118196704,1.0797641565670061e-4,0.0019717592282331494,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,27.247732720547802,1.3581123318514652,0.44160281235341026,0.0031491811872838265,0.013061944697256779,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,20.504811434739832,1.0060132990414692,0.008649377046379851,0.7633659489727341,0.8228508080872459,Upregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.235425305062833,1.0239356378590543,0.03412503383418071,0.7734138524861198,0.8228508080872459,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.910134891071465,1.0588187095043624,0.08245559283476873,0.025276591032715734,0.05591488319358329,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,20.105743560235066,1.0140462551719223,0.02012346159682552,0.6058826639712285,0.6910849135921825,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.1410153720616,1.103851668970004,0.1425463217368063,0.13071976733216356,0.2030328301116583,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.389617741496433,1.009629121270818,0.013825428455172019,0.16439102585852694,0.24391351397708264,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,20.726216876243168,0.8039428154374657,-0.31483520892946204,0.04631145591419708,0.08991319898235071,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,20.424621107540467,1.0003719243647804,5.364736790212588e-4,0.9904286672760223,0.9904286672760223,Upregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.2922994852546,1.0381096126165414,0.05395878399371363,0.01177636628207781,0.031147635456220298,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,20.1144961385284,0.9941368795898476,-0.00848358926684661,0.5009710291887962,0.609514752179702,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,26.575013147248068,1.3566391906975577,0.4400370752108212,2.163879560309127e-5,8.26345080487104e-4,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,24.762378508808798,1.224137478101973,0.2917655905781073,4.705204483760791e-4,0.0039939526431923,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.151375727031734,0.8975839953910886,-0.15588114306694975,6.937179186141658e-5,0.00168804693529447,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,24.286457409492034,1.0872778271554415,0.12072063277109155,0.4720456810379627,0.5801234800634896,Upregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.4579521373332,1.1702582104346702,0.22682688691428046,4.2481642015588264e-4,0.003876449833922429,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.307620936458832,0.8699827846500533,-0.20094124190959162,5.428133519861003e-4,0.004215465393083545,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,21.810838272032534,1.045158204780373,0.06372133845627032,0.14659311020614968,0.22481716481195224,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,24.335794363931768,1.0525665570827076,0.07391146230565886,0.3468951625787929,0.45277003040870456,Upregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.815439668341533,1.029078015047878,0.04135235799112797,0.06616281190233159,0.12223198696551596,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,28.003605830377733,1.3437479557436953,0.4262625599183387,3.622033934443944e-5,0.001201856714610945,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,24.610537720242032,0.9881940015805585,-0.017133796353756156,0.8644098048791117,0.8937948407390247,Downregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,27.195462672482165,1.303488336935851,0.3823776743041665,0.002691764218950255,0.012604454731957898,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.668780909383567,1.0336822574312479,0.04779278519305363,0.08463231673549729,0.1457113000398892,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,20.0408390846854,0.9948018862889152,-0.007518851770536778,0.6499881470918395,0.7277474653022129,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,22.33873100038783,1.0039778758261586,0.005727477667601568,0.6117623754592962,0.6956176543384521,Upregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,20.3130816158032,0.8109433312072752,-0.30232699258133866,0.0027281217633199277,0.012604454731957898,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,22.1150163502614,0.8660437369607734,-0.20748820907731536,0.003025449083321851,0.013014118638113149,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,22.704067665479734,0.9385050997640288,-0.09156351031679154,0.34733043428612953,0.45277003040870456,Downregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,21.708426848423198,0.9355113064821359,-0.09617300506947442,0.5938478471200341,0.681296633564225,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,20.046508995598366,0.987799790720677,-0.017709431826272853,0.7697805121026053,0.8228508080872459,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,20.4002106878276,1.0012387712457378,0.0017860630994759308,0.9524683153371287,0.9686058575488905,Upregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,26.9410955864788,1.1635896780097208,0.21858240372493956,0.009511974918911847,0.026913727483742825,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,22.699728880447566,1.0107426948801692,0.015415776601704324,0.6779904095205164,0.7498984832575407,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,23.033311777728667,1.0494277263277914,0.06960281221474789,0.012484826373101684,0.03186686451875605,Upregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,20.837510858465734,0.8085142350342422,-0.3066549202824052,0.11288519802765357,0.18071533894777872,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.71201812109503,1.084981848959617,0.11767090752230105,2.2705252288012542e-4,0.0025113385106438116,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,20.970954117482567,0.7868356332982661,-0.3458658006941157,0.007298019841093407,0.02276732685469311,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,19.680713163433968,0.9893343187652106,-0.015469971757411863,0.3592207530852452,0.4649488470784202,Downregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,25.064584704857968,0.9769459547655731,-0.03364934123858102,0.7173824685145112,0.7821407552300275,Downregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,21.0187264198941,1.0348000712502363,0.04935205847077582,0.12669544445550765,0.1984714044045506,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.448736412949035,1.0573378051992708,0.08043637201540908,0.4087739950674999,0.5146672781144574,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.814102171301332,1.4681535344598293,0.5540028481684313,0.0030015085449933815,0.013014118638113149,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,24.511445401693567,0.8348066827323231,-0.26048594538842523,0.008860072266565837,0.026292084368264475,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,19.741058022810833,0.9680168837629345,-0.046895884258738814,0.10518581263139533,0.17139652504669328,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,24.84631810044243,1.0292475384104929,0.04158999825624675,0.1117252145762355,0.18006359630454544,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.4157355648094,1.0411712451898414,0.05820737340972859,0.011490394369625886,0.030613094488419333,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.990452279342367,1.045735443595088,0.06451791612745156,0.010179374455560266,0.02836237920824044,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,24.684339618769567,1.1661956485793947,0.22180984476219476,0.2250715858963642,0.3159658802006651,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,24.825079770936966,0.9348665206255441,-0.09716770184261689,0.595434592073939,0.681296633564225,Downregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,30.5610379393236,1.7180164042296857,0.7807438119058466,1.6509378678192143e-4,0.0020086410725133775,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,20.5573156123154,1.0071043052956328,0.010213110295910365,0.6368702880225134,0.7174618985438809,Upregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,21.0330889006201,0.9177822767129084,-0.12377614774196889,0.037329572595408846,0.07638358001944659,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.110363772102936,1.0673099628212257,0.09397921729129842,0.004242769243023444,0.01630116603898481,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,25.8361317883481,1.008666911259558,0.012449836674447724,0.7075063634724976,0.777830791167053,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,23.141694182978632,0.9184541548967816,-0.12272038460544965,0.5874393157138682,0.6774626293023008,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,24.9347004994001,1.2329700789834153,0.3021377896628803,0.18146403281742096,0.26278185506479185,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.911257123432666,0.9346005474613334,-0.09757821259635596,5.066482591107361e-4,0.0041094803238981925,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,25.94410557089917,1.4078230170522539,0.4934659785279216,0.0030589685478346848,0.013014118638113149,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,26.828544468971135,1.2160784940369804,0.2822363532083687,0.029112010834567558,0.06142129453535929,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.805674903946368,1.1350473636611857,0.18275250006545404,3.157211264994852e-4,0.003201061421453114,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.069283230913967,1.0501020695846848,0.07052956420266959,0.05012278790288056,0.09628851360290212,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,20.2000386933588,0.9929028617289777,-0.010275512840496106,0.5177510379349506,0.6175788524387482,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,26.21209259559477,1.0252029455140594,0.0359095287600971,0.7178552137042717,0.7821407552300275,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,25.413674365881267,1.2799958174322952,0.35613909602250604,0.0706554370268311,0.12519045880967647,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,22.287667406137032,0.936228775426809,-0.09506698725303496,0.005709392366683118,0.019475964615320914,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.116208624241732,1.0072758459099345,0.010458824387179799,0.8305499197016353,0.8686267068512804,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,26.138573810870266,1.1520263988752009,0.20417377675415407,0.09204004164322391,0.15481389492984665,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,18.55128408291017,0.9793173009021046,-0.03015172303495142,0.3540039914431268,0.4598272486716771,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,21.380353481004168,0.9967170068846124,-0.004744149660242255,0.9192683529458326,0.942508283216935,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.416481051520467,1.0285771339052994,0.040649986891564946,0.10217302750857267,0.1679871848676983,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,25.302410447073868,0.8908483684133927,-0.16674820382976188,0.07882149455662066,0.13709867640368661,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,22.7885861540737,1.1566384229884656,0.20993793368586516,0.048890251710323365,0.09441768187443401,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,21.600860611240467,0.9947545721360621,-0.007587469972758506,0.741097754158892,0.8050615484166534,Downregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.914901047264333,1.00961966875452,0.013811921354457746,0.5775894129272423,0.6714017061096925,Upregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.973615210334966,1.317951099718866,0.39829684265108006,1.8489320679624176e-6,1.2481230131084379e-4,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,20.0216272513046,0.76607930567508975,-0.38443434505852325,0.01838094816546537,0.04246231696452443,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,22.051379250204068,0.9942872970890568,-0.008265319359317728,0.8206893172505106,0.8620615694138777,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,24.5682518657356,0.8742391793979374,-0.1939000603275891,0.06816155965794236,0.12377596654302966,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,24.7846464920801,1.1134670061399936,0.15505880933051777,0.2108093371399271,0.29732358822183347,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.823328827164534,0.9810224110021198,-0.0276420003670998,0.16433678474636487,0.24391351397708264,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,23.991709384314934,0.922395784568335,-0.1165421751286564,0.02235364563741897,0.05067751961278214,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,23.661974831278002,0.8065852710065963,-0.310101033849446,0.004690141751407014,0.01706989735222466,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.206665230593835,0.9469108670075782,-0.0786994641019858,0.030932103922091392,0.0645155310375049,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,25.221915194440665,0.9994278270957835,-8.257072576372654e-4,0.9780748862279489,0.9826133279253654,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,24.282027306939934,0.9911398683077012,-0.012839431950621236,0.18107219339108846,0.26278185506479185,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,21.939800873107835,1.0395326420186033,0.055935060494491824,0.43017400807464634,0.5358822967482796,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,21.429909145334232,1.0457323331734223,0.06451362498803057,0.04519640104594972,0.0891712777393062,Upregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.884867714479768,1.0137133090926387,0.01964969767505932,0.0438691898356109,0.08702312114129337,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,18.2901738334145,1.007982395288537,0.011470441961126506,0.5832062341440808,0.6757786522621889,Upregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.577985861204034,1.0365592337556166,0.05180256102403164,0.0014226507847491532,0.00837528284570066,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,24.229165913917132,0.9392958910736398,-0.0903483967091581,0.002510112797135349,0.012380961769654086,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,24.418750614290865,0.954698265597568,-0.06688325651305485,0.006628625816840799,0.021223231781990277,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,22.959582771927433,1.0327554030558757,0.0464986079466617,0.8003107488632761,0.8467055748843356,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,21.729665789563366,1.0167642435378985,0.023985201213183222,0.3246550445148799,0.4262557239134215,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,20.1780974681236,0.988994803163278,-0.015965154762698528,0.5287838781289972,0.6247036009492033,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.5037403069425,0.8813059105746041,-0.18228521414809729,0.002662181875139105,0.012604454731957898,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,25.0391865595278,1.1104538205969323,0.1511493981248147,0.4714483617321614,0.5801234800634896,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,24.223592088894932,1.0726785974925146,0.10121787174874368,0.6962629149358588,0.767782368433802,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,22.269461871508234,0.8702769745470772,-0.20045346839495853,1.1750240735218273e-4,0.0019717592282331494,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.614798177812,1.033735386611513,0.04786693489873394,0.00600087231519557,0.01994508816846971,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.320172208313167,1.0380235725741753,0.05383920636411263,0.007008249982765871,0.022083526898869693,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,20.294767812924498,0.7361831519650492,-0.44186336181114483,0.0035177318079837954,0.014109583625429509,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,23.078877850794434,0.9252319390270396,-0.11211302618887485,3.3569390860161184e-4,0.003311575044313198,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,No gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.803669004105068,0.7778957469246137,-0.3623512757594722,0.0012877950490283922,0.007921788149874274,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,23.200819436435832,1.1078595157173767,0.14777494923215428,0.4089137278169662,0.5146672781144574,Upregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,21.236094019068332,0.9808595226449581,-0.02788156445258876,0.1674051776518843,0.24638262033442648,Downregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.583660968513033,1.0284181189887491,0.040426933355910334,0.02188348163509594,0.04992169248006262,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.9127932214179,1.0495424567011409,0.06976052854838032,7.514835978300933e-4,0.005274836792461232,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,25.067859196871233,1.0520053158687788,0.07314199470450107,0.0011125337800604468,0.007519904254112279,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.618789530451767,1.0348214007079213,0.04938179521562986,3.639214494617603e-4,0.0034955612908826976,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,24.420577158328534,1.06279798053827,0.08786739162548396,0.03503464891754127,0.07224659240057944,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F46,F1177_3,Area: 47,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.291037384054867,1.0333212626805808,0.04728886215973314,0.01227945949149159,0.03186686451875605,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.566127384301268,1.1008123504674148,0.1385685614336606,0.0019632835139276436,0.01088937650052313,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.594004731145233,1.085059072289574,0.11777358735117073,0.026485509647572594,0.05754292274621426,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.103801103179432,0.9576333821932541,-0.06245465074583852,0.12418370271958887,0.19707413692456494,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,25.865814408569634,1.0265314904938285,0.03777788510110572,0.08505398531370713,0.14574978703992067,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4092114122264,1.0532658116518734,0.07486957383562665,0.02624835755969652,0.05736916472628281,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.807259567111366,1.0003147408655144,4.5400364284028277e-4,0.9714962443290832,0.9795473181771144,Upregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,23.4205611952757,0.9537463244870903,-0.06832250273517732,0.0699602677557655,0.12519045880967647,Downregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,24.170614998523433,1.0548579660598723,0.07704875679420652,0.0019988718507809584,0.01088937650052313,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.307573026424432,1.015061224119682,0.02156674718387041,0.5050737035097985,0.6104367608644916,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,24.8086255276989,1.0270701580207056,0.03853473391655019,0.5521159185033222,0.6479817049958605,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,23.041615449195902,0.9207567852253831,-0.11910797123919635,0.3988442900213529,0.5054797425617841,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,19.773865904456468,0.7892315115387577,-0.34147953538808523,0.009406355227105284,0.026913727483742825,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,22.453952408312833,0.9802539583470489,-0.028772532411116224,0.2423444885428845,0.33505961484148805,Downregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,23.853567090450035,1.1165145292601892,0.15900202514626824,5.4150580298791877e-5,0.0014117829863613597,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.219694200619735,1.2267728630574928,0.29486815880153566,2.066199539534021e-4,0.0023567588497809926,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,24.8158824974359,1.0249965913013328,0.03561911195429194,0.05234192130528202,0.09950417331472884,Upregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,22.049019786161434,0.8735632169127127,-0.19501598484622076,0.002313759194775498,0.011729473695736901,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,23.939439294293933,1.0409253745124962,0.05786664339249682,0.054976077362542584,0.1039703017478137,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,19.6695044806278,0.9964379020473756,-0.005148195693390129,0.7139713578517997,0.7821407552300275,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,24.318654783177898,1.2494047070342678,0.32124087026674736,0.041439243003192065,0.08310617415475331,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,21.784813540310235,0.8667151961815712,-0.20637009516318233,0.00654843812478187,0.021152034650844094,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,22.928283771934336,0.9388260761790735,-0.09107018117734773,0.002576878285587238,0.012540807656524558,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,20.475389434119734,0.816868262813282,-0.29182466267364443,0.0013122360050663799,0.007921788149874274,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.497973241322267,0.9898901128056645,-0.014659713643976079,0.8219107565918614,0.8620615694138777,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.485788575419033,1.037503200145043,0.053115786412587455,0.006322760483348946,0.020605424789485405,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,22.165337714170267,0.8724043800065735,-0.19693108167405884,0.0024559615009637787,0.012279807504818894,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,25.28688897484737,1.0038833972791867,0.005591707599108244,0.7720505162001491,0.8228508080872459,Upregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.122502056196932,0.9339384303965501,-0.0986006510438823,0.009129819911104982,0.026659074140426547,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,24.9743973785335,1.25510904616313,0.32781271359791014,4.227441532177798e-5,0.0012858467993707469,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,23.497595787553568,1.060598468239976,0.08487856999315756,0.6395315214122348,0.718243093278356,Upregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.958095537650166,0.9452162443479122,-0.08128367141691287,0.01552025041803678,0.0377659426838895,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,24.6671449735766,1.2256242944410356,0.29351679989690455,8.006099144280871e-5,0.0017189565809779517,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,23.38991073964,1.0676908970314392,0.09449403853764649,0.01425466957295203,0.03515509725761819,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,22.7348999953628,0.8854599622251635,-0.17550102066579315,0.003092160136033529,0.013014118638113149,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.587601625183932,1.0380965069346357,0.053940570481948065,0.012019850356753074,0.03156291640442354,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.803554025363766,1.3212815246994458,0.401937893545508,1.509789670316696e-5,6.888415370819925e-4,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,24.758022372246,1.2126132216549146,0.2781194579753137,0.004814019712443241,0.01706989735222466,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,24.5485426565242,1.2124363544970778,0.2779090166099337,0.07129836300601956,0.1257193357352519,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.029476746366534,0.9120615438043759,-0.1327969174867457,0.2627615457902587,0.36055625644152034,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,22.8985088550048,0.8322586537401743,-0.26489612844867644,0.016861134600730052,0.0402242753546828,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,20.433706575370067,0.972514773773269,-0.040207928194666,0.045482005264313445,0.08925232215846456,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,25.037299940457633,1.1741300907182688,0.23159226435632896,0.13030354043908704,0.2030328301116583,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,22.2772711304372,0.828881368545762,-0.2707624603047723,0.01240097293419107,0.03186686451875605,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,27.253349088264866,1.3536824122121383,0.4368893075469344,0.05136073029360713,0.09815008668673614,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,20.845667219626765,0.738862443882277,-0.43662229614635395,1.239999528177793e-6,1.2481230131084379e-4,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,23.7733798686438,1.0670436322419505,0.0936191702879899,0.005562213121158063,0.019237557051234692,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,22.158699269424634,0.9028007533440173,-0.14752047249715208,4.129683333541318e-4,0.003864960042929695,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.956049228421765,1.036393541881255,0.051571930737827815,0.017916688421358146,0.04192045688330592,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.471649933646468,1.143912585004738,0.19397680911047102,0.041262139530914274,0.08310617415475331,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,22.6033729887552,1.0266778458829466,0.037983559399098435,0.16000846480487446,0.23935692481057042,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,27.011193972771935,1.2875361838946837,0.3646129772215935,6.166433611776803e-4,0.004593363812854149,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.6825608717218,1.0187403530862338,0.026786397875694583,0.06182299738632972,0.11512956145923647,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,20.116460474973,0.791272009710014,-0.3377543703522401,0.004766616531558956,0.01706989735222466,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,23.0578247972753,0.954418975819366,-0.06730536781362476,0.059836565784238294,0.11200177698075373,Downregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.6625817729804,1.095569162667878,0.13168056373329118,0.22979909191692194,0.32136654616734295,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.4972793866126,1.0646502017221846,0.0903795007467462,0.10089732745941114,0.16664038245558854,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,19.20433686231887,0.8568157517860523,-0.22294309190618236,0.13448570943975952,0.2079969658708145,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,19.1185912418606,0.8344271030297887,-0.26114207608572887,0.16925995005006544,0.2481119749729875,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,19.8210213802509,0.9668329331903567,-0.04866147848515967,0.31326621275101557,0.4157897005604389,Downregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,25.294523030630334,0.9708705834659184,-0.04264909691071546,0.18214742282573243,0.26278185506479185,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.954562846351568,1.0386167468289214,0.05466339298033458,0.5157404871547384,0.6175788524387482,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,24.0000434184496,1.0590533250410104,0.08277523317856765,0.021328372645806698,0.04896135858943047,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.90240466157117,1.1407957965926234,0.1900405711106473,0.0027626202152236487,0.012604454731957898,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.80357991509757,0.9612374961764159,-0.05703516833732357,0.1256695369146301,0.1984714044045506,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,24.353790988481233,0.9715002930411335,-0.04171366390543388,0.14918759412556387,0.22688946606596172,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,21.4310757834881,0.9942753502400181,-0.00828265415124471,0.6645014367014744,0.7394604402318237,Downregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,24.506970139269633,0.8965933344097364,-0.15747432096135716,0.004296318518125518,0.016334961032456397,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,25.564708055042733,1.4235886151608501,0.5095323003678524,1.2268032307555972e-4,0.0019717592282331494,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.883969398243533,0.8643730203059706,-0.21027405285911624,0.0012056566932494928,0.00785829808992973,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,24.728874746064367,0.9023172125770756,-0.148293388058783,0.017423628080856835,0.041296261360472375,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,25.401351878297167,1.0941339813378448,0.12978941306314776,0.03805468172094693,0.07716643793414238,Upregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,22.836745093079035,1.12864003370781,0.17458542907677482,0.1913070791534775,0.2749097790985011,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,22.316963510961,0.9809368661915505,-0.027767808354548847,0.8750077173514672,0.9021972226928969,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,23.205046164106534,0.9581068376066978,-0.061741556367066186,0.5687965881656921,0.6632931459440179,Downregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.530187616676667,1.0474402280975175,0.0668679192585931,0.10569024726329265,0.17145306778267475,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,22.297625001318668,0.8658283705217891,-0.2078470209015324,0.1263378412546433,0.1984714044045506,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,24.4118505594793,1.2501497997725701,0.32210097683970895,0.03745934472186559,0.07638358001944659,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,21.86909840411323,0.9327772139556153,-0.1003955483244563,0.1654880255884727,0.2445470823473382,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,21.515747310562766,1.0512714340138714,0.07213521539626236,0.027492859128946025,0.058683588199212273,Upregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,21.438924294262634,0.8315691923991928,-0.2660917840169612,0.1119847571537858,0.18006359630454544,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,22.2136008498238,0.8457907302437145,-0.24162734618381695,0.03328412086809078,0.06902672793666553,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,23.201213878412467,1.0232434116671354,0.033149377764871625,0.0828885752619503,0.14338545009768655,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,20.350438889289368,0.9974072037516245,-0.003745472013457423,0.9526835694795937,0.9686058575488905,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.798457259929968,0.928594705528652,-0.10687903962281915,0.09556403962594869,0.15927339937658114,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.88502210316277,1.0581802055874074,0.08158533592916119,0.00288039954983736,0.012821290679154104,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,23.529627941271798,1.21752495051444,0.2839513374941623,0.013796394014012534,0.03458680342813893,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,24.073843143713866,0.9388005894068011,-0.09110934725934038,0.009506122698445972,0.026913727483742825,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.524769667096166,1.0975478154595244,0.13428379317627095,0.011407600973253496,0.030613094488419333,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.928779198312665,1.017394241977161,0.024878834290079126,0.23942584109661474,0.3322830114078494,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,19.994562376860568,0.9888455230503527,-0.016182933393435642,0.5883716533940531,0.6774626293023008,Downregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,23.733448392661234,1.1268152589364018,0.17225100542720526,4.4671633847964145e-4,0.0038821777034540265,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,22.482879336333102,0.9174117784266164,-0.12435866493796377,0.26556213324007477,0.3630343769012258,Downregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,21.041565646723765,0.9252111277988314,-0.11214547707187719,0.3120535891186412,0.4157897005604389,Downregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,24.165255710774368,1.0502310841696536,0.07070680151555805,0.1371363236029223,0.21120151103403645,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,23.538084352090902,0.9140657231513852,-0.12963019321925273,7.920636249595093e-5,0.0017189565809779517,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.769442735972667,1.1610241018778447,0.21539792164251906,0.005586797390221583,0.019237557051234692,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,26.2140919862775,1.0135226168441689,0.01937828302766191,0.39337586422302606,0.500286377844615,Upregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,22.623372687072166,1.0061415527947322,0.008833290380773191,0.7745230287996839,0.8228508080872459,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,23.090265279797098,0.9880679692859407,-0.017317806540020856,0.39080493326647986,0.4987545477002278,Downregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,22.400349997975766,0.9250125234523003,-0.11245519693384746,0.043393023649074165,0.08654892695033918,Downregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,22.947201351414336,0.9836464299770277,-0.023788260404069977,0.8203479325969751,0.8620615694138777,Downregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,22.8669909716679,1.0968439971240365,0.13335834745478156,0.28381591081291796,0.38367706461746315,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,24.1363509991147,1.1398705608688389,0.18887000702597098,0.31601341806051403,0.4179162956235059,Upregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,22.25772333764183,0.9088915956948013,-0.13781986172188196,0.37636588940851906,0.48541890330074017,Downregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,22.2100602386838,1.0132332634743486,0.018966345232297215,0.8990839617497629,0.9244102705314463,Upregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,21.398619490928034,0.8669182314918743,-0.2060321713184259,0.15141547065667202,0.22932218584931655,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,24.0627635221294,1.1710677571012247,0.2278245515060064,0.20071182428886672,0.28617115572436075,Upregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,24.420362419832866,0.9859790309458648,-0.02037113010171959,0.8426868765085652,0.8788020283589324,Downregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.830237271205835,1.0092162261480149,0.013235307220633333,0.41046106672589244,0.5148394823194183,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,25.442634343612866,0.9665418804914853,-0.0490958487743552,0.7698363038503511,0.8228508080872459,Downregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,26.180160431799134,1.0249815170395529,0.0355978945933583,0.09111592345146534,0.15396903731381875,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,26.225865677845633,1.055844720336738,0.07839767780965463,0.024110372543629292,0.05396837625205425,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,28.553976095025767,1.3200075194112997,0.40054614790683024,0.0017211368948160314,0.00981585885324768,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.070044113405768,0.8143330432405694,-0.2963091510522944,1.49136020714306e-4,0.0020086410725133775,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.593573848828566,0.9961884766223881,-0.005509372108028135,0.45820195255971413,0.5688561655928424,Downregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,25.973922461483767,1.0577166727420504,0.08095322899159452,0.002728114931460129,0.012604454731957898,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.796021753680765,1.222179413779465,0.2894560857870766,2.2639591246222027e-5,8.26345080487104e-4,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.9894823673106,1.0793301690838228,0.110136255406875,0.003101995401413271,0.013014118638113149,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.368795927286868,1.2666739956183566,0.34104526526533196,5.367742328620263e-4,0.004215465393083545,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,29.1315440805228,1.0060926215691894,0.008763126741423075,0.5120981841532508,0.6168839512077114,Upregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,24.662792247739535,1.1008826110604595,0.138660640137533,0.07860938159588965,0.13709867640368661,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0680353065692,1.2414526246321842,0.3120292075378568,5.625995736624361e-4,0.004278100924724775,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.623408826406866,1.029024265318292,0.041277002680480575,0.017696635765925613,0.041672722932663546,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,30.160000249908702,1.0203480844121264,0.029061401204569137,0.023449917060230474,0.0528346896727415,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.107123291704035,1.0653336126287118,0.09130528577189692,0.012362557013876986,0.03186686451875605,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,22.409622164550132,1.0537980056021201,0.0755983544096671,0.41628482159844155,0.520356026998052,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,26.490919508027833,0.9705131066164241,-0.04318039846275937,0.5622791361327739,0.6577945022066105,Downregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,21.180552498331465,0.9369643044298769,-0.09393400837210326,0.046116249029117456,0.08991319898235071,Downregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,18.658165294612566,0.6392226464651175,-0.6456095737238523,5.405488699761809e-7,1.2481230131084379e-4,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.132218324769134,0.8907611021619639,-0.1668895351263824,0.02685563461974847,0.05766062727181289,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,26.007661329102834,1.2289722858648864,0.2974523823532845,0.0012663858854927452,0.007921788149874274,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,25.890722771367333,1.221859175737032,0.28907801823908635,1.3922801069935127e-4,0.0020086410725133775,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,21.7600087803012,0.8158134214207139,-0.2936888529471339,0.010425757037517155,0.028612039990178657,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,18.398550731601034,0.6581669577413136,-0.6034744948901924,0.0012581628838253243,0.007921788149874274,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,25.008631001851434,1.1938482650781936,0.2556194855726581,0.10043367066363716,0.16662858996467075,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,23.863685102265467,1.1097064465321054,0.15017808725711984,0.002806393250531055,0.01264609304251648,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.18245599682387,1.1214647304696461,0.16538424906738325,7.257057696436573e-4,0.0051937765866653905,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,24.423802064708966,0.9532931985012423,-0.0690080916987022,0.3104135124409979,0.4157897005604389,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,23.4468422600727,0.9548614785234014,-0.06663663790894235,0.6176926234948701,0.7001795266323838,Downregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.769556190813802,1.1799165902755795,0.23868487734221067,0.016262286430878826,0.03930950031305147,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,25.961904728350966,1.150391023242263,0.20212432326258914,0.00814013180538269,0.02475956757470568,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,22.2084141088284,0.9041837672936336,-0.14531207753481748,4.950686937930464e-4,0.004106819846237771,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,24.948216780476233,1.165907328626915,0.22145312143409426,9.214961828527798e-4,0.006346152957382351,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.9973175426306,1.0880229115958135,0.12170893719268822,0.008099844499790392,0.02475956757470568,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,22.1980290328719,1.1015493471862121,0.13953412631083983,0.010381770881338338,0.028612039990178657,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.291061494286634,1.016382794159351,0.023443858041209978,0.21097755986152017,0.29732358822183347,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,26.896290643774165,1.2938519307876533,0.37167252386734195,0.0020687752284324437,0.010943521135910754,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.754665037825333,1.303814819547479,0.3827389785476127,1.5105144869035893e-4,0.0020086410725133775,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.951153853234366,1.0773953119156143,0.10754769268540493,8.729929282668327e-6,4.5520345545341993e-4,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.372221168289766,1.0273325935015847,0.038903322177636306,0.024248804672155882,0.05396837625205425,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.2475055098148,1.082955341612016,0.11497375101337327,0.06892786606267459,0.12454787679641696,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1117199147677,1.009050474649864,0.012998342636274746,0.494125402108136,0.6052207106358042,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.3008751858887,1.2640103448392248,0.3380082707833516,0.013834721371255573,0.03458680342813893,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,22.190746064366,0.8875827377325877,-0.17204648552026683,0.08555108674216647,0.1459165731817325,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,21.1782160796956,0.9840932057449244,-0.023133131865610036,0.5395948190564397,0.6353293837277435,Downregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,23.872074329576865,1.029964890945904,0.0425951602031325,0.3199757037434022,0.4216286348965408,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,22.740743807338802,0.9001272492751825,-0.1517991279768952,0.20847743754291015,0.2960866330862343,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.382455560123066,0.9413164941721939,-0.08724822017675382,1.483246670081398e-4,0.0020086410725133775,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,22.367876646803502,0.900428311713467,-0.15131667544927616,0.00205956103336835,0.010943521135910754,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,23.06729450881,0.9263361327236171,-0.11039230634780095,0.007018326356901053,0.022083526898869693,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.384079335290934,1.0514427164692657,0.07237025290668997,0.06697643121398135,0.12223198696551596,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,21.877988208980234,0.9396253142077188,-0.0898425137318159,0.38420452422289975,0.49266029477048623,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,22.942307806516734,0.8955863314178911,-0.1590955851717352,0.0059862242401707315,0.01994508816846971,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.316701044452202,1.0277528035116819,0.03949330730139702,0.02568404851317831,0.056473962092229414,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.813348170484634,1.025650834996793,0.0365396740703279,0.016593023858331987,0.03984509018612615,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.901086034777933,0.9607495518690677,-0.05776769652816738,0.003236555130672252,0.01327351261455474,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,27.909488039612032,1.0669988698502126,0.09355864808140334,0.05740562406468731,0.10800542671964365,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.50742501049143,0.9878244336418988,-0.017673440953309225,0.1558391864555886,0.2340794364456372,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,24.1455385493278,1.1630081553244698,0.2178612134103724,0.3129111278449974,0.4157897005604389,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,24.939526478210265,1.2045803747008574,0.2685306595072348,0.07005648456455801,0.12519045880967647,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,28.173696116950566,1.386380839954424,0.47132362143000445,0.0022216644475437047,0.011584393190763603,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,24.9235035664126,1.2440544144863752,0.3150495898035344,0.1982255713171534,0.2837346412971019,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.781975247267432,1.3869508461509321,0.4719166591316813,1.1990734792780877e-4,0.0019717592282331494,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,19.705480221759068,1.0040119231053555,0.005776402060428594,0.517175008740252,0.6175788524387482,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,23.6548731976333,0.8020987488239184,-0.31814823268524034,0.0038216808886408606,0.014999070154343163,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.099573067452233,0.8570770948150795,-0.22250311306430962,9.33194785681232e-5,0.0018923116487424983,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,21.695794727274965,0.9826820037562316,-0.025203459425501333,0.1818061573447661,0.26278185506479185,Downregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,29.744880444626066,0.9714242947947421,-0.04182652705403723,0.10403447059438159,0.17028063572622995,Downregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.623232217938032,0.8712324524915745,-0.19887040096033393,4.765131676723138e-5,0.0013379023553876503,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.616801933017666,1.009853555634826,0.014146095078357627,0.38467995619065365,0.49266029477048623,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,22.208054932019035,1.0426986143403185,0.06032221593073452,0.07042246767851136,0.12519045880967647,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,19.6245483141361,0.9973028341348247,-0.0038964448624972206,0.8582671099819785,0.8899644748392674,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,22.5906632251769,0.8990854964067552,-0.1534697829549348,0.0048169847322716165,0.01706989735222466,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,24.428730592725632,1.1319160537765611,0.17876696763000904,0.002312968237659415,0.011729473695736901,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,21.926386648387865,1.004767863883691,0.006862227466135879,0.9678047536526572,0.9785283520310799,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,22.966200792567435,1.0014423432936639,0.0020793623001184387,0.9799212366159809,0.9826133279253654,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,25.796916021192267,0.9875707638368896,-0.018043967491177447,0.8504051004053235,0.884324392159382,Downregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,21.665846514552968,0.942040279890762,-0.08613934677301911,0.4992215843800703,0.6094176531729956,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,20.591065114808067,0.8090109867234606,-0.3057687996686689,0.006192265977615745,0.020361955692159883,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,26.8691542025348,1.0041773220880736,0.006014049277438921,0.9666973436200184,0.9785283520310799,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.9170538346994,0.876209981550381,-0.19065144533582043,4.448157642309398e-4,0.0038821777034540265,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.7173040578018,0.9596508062411847,-0.05941855545955328,0.08969253559601217,0.15226872322113694,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,21.039713919288733,0.7917423079005055,-0.336897148936647,0.009469229097633146,0.026913727483742825,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,22.379361040085033,0.8513287512022888,-0.23221174071833253,0.30040729998977966,0.4046076180674154,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,26.269378315050066,0.8821451786802249,-0.18091198862145738,0.2801536008822923,0.38013406811166056,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.773482146853834,1.1636772008184855,0.21869091618079728,0.15470548949064766,0.233336792000357,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,21.0121770164514,0.8067763346358181,-0.3097593292362989,1.5840649888208315e-4,0.0020086410725133775,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,27.695660187399035,1.4322197639846412,0.5182528809295713,0.00840778399453988,0.025362323619893025,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,22.3372806432835,0.8019299607795531,-0.3184518552750456,0.027853155173505055,0.05910698626935666,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,21.93527962217363,0.8726646991919892,-0.1965006560764593,0.11440805658121543,0.1823534526294482,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.285136866672833,0.9598359958064161,-0.05914017681383645,2.6469038718810025e-4,0.0027603426092473312,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.140693160787634,0.9910891591982214,-0.01291324560159214,0.504028565325876,0.6104367608644916,Downregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.291514034102,1.0228694036727615,0.03262195866979506,0.14846361702375627,0.22673313896933486,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.438707093650066,0.8676295539809953,-0.20484889865952247,0.015338811880569476,0.0375749418550863,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,21.733237079986733,0.8015867666083135,-0.3190694036024348,0.004404320567316057,0.016403847010922047,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,22.252768619880968,0.8509398636468836,-0.2328709153662264,0.004349848215717159,0.01636798555398725,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,20.92999464096337,0.9870020166236282,-0.018875062515785093,0.5288586649131611,0.6247036009492033,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,20.005141981386267,1.0010466106384572,0.001509150369115668,0.937757575318346,0.9587717506756198,Upregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.5456550326866,1.4724840278049784,0.558251985069981,6.619883439885149e-4,0.004832514911116159,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,24.25762104421,0.9603577768470356,-0.05835611954942881,0.001989279411050226,0.01088937650052313,Downregulated
Feature0155,[Similar to: NP-010746; ΔMass: 146.0345 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.965383720255165,1.1406822675293915,0.18989699066669533,0.2374475831502146,0.3307952971367494,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,22.25895033704043,0.9477027018490967,-0.0774935440300995,0.09540864912241748,0.15927339937658114,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,24.923316596574733,0.9270276274580581,-0.10931575991703202,0.018121949856287095,0.04213064775506236,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,24.222725506233168,0.8797609206112229,-0.18481657739992566,0.27598121150056687,0.3758699335735332,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,26.316278898461267,1.2824605897461887,0.3589144922250486,1.2424784177907517e-4,0.0019717592282331494,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,21.738216075565102,1.0212952472304766,0.03039999661719758,0.6347268124949577,0.7172609491042091,Upregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,26.162434114821632,1.3427891176895903,0.4252327502216194,0.0037539621313901917,0.014893436716928478,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.8337936011975,1.0034793482117053,0.005010926078565344,0.6697607978795947,0.7430476936962068,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,26.937916665808466,0.9964815513220846,-0.005084999368957957,0.5206635132659071,0.6190299099089775,Downregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,23.217544671826833,1.0468989933361064,0.06612225521750936,0.7744867306084532,0.8228508080872459,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,24.108635256202835,1.2155081633653666,0.2815595825539583,0.008981759595220054,0.026438243969800965,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,21.3107007310268,0.9269158962071873,-0.10948965315561368,0.25110489405010555,0.3458614578425982,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.917033442832967,0.9606937808994696,-0.05785144659241886,2.474690025272079e-4,0.0026566525271303197,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.0349272644887,0.705144884269071,-0.5040083801543239,0.004635488137063159,0.01706989735222466,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.197596559426202,0.7178719033054582,-0.478201661637359,0.0073867947200479634,0.022848983667944973,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.938223191140768,0.8303431209937723,-0.26822047329019444,0.0016300371174004147,0.009443865838907163,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.125362054021366,0.7801166176953956,-0.3582382898932086,0.06654375702696083,0.12223198696551596,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,20.317969427304867,0.7908718899755154,-0.33848407738981623,1.0435085940069187e-6,1.2481230131084379e-4,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,18.85588198535987,0.7060879660683211,-0.5020801659164786,0.0011689691727038553,0.0077577045097619495,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,21.5637946093456,0.873056472942814,-0.1958531184673886,0.0041558985240438264,0.016137265545489325,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,22.801633119129335,0.8879286282639947,-0.17148437753242637,0.026683778720702187,0.057630646349445556,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,21.14245989898127,0.7823577845478202,-0.35409956926317593,1.596250030768819e-4,0.0020086410725133775,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.202955578550668,0.8689247652245848,-0.2026968264048736,0.06675032524037698,0.12223198696551596,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,21.8974773807363,0.8602024227044587,-0.217251900341854,0.0013239152798420017,0.007921788149874274,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.65159511419827,1.0235922742449224,0.03364116351910951,0.7755087068000344,0.8228508080872459,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,21.1559492989488,0.8109139486561008,-0.3023792660598981,0.011394757310157603,0.030613094488419333,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,25.603971130468235,0.9698127942973577,-0.04422180821066402,0.014164101169295047,0.03515509725761819,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,25.451702419370932,0.8961609419030477,-0.1581702451551585,0.006010848489127857,0.01994508816846971,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,21.714504669852033,0.9468731175986884,-0.07875697951604749,0.008485393057504637,0.02538662677040322,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,23.261406152512667,0.9491403195233016,-0.07530670593857591,0.07887869053362792,0.13709867640368661,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,25.304712550202268,1.0715347378379236,0.09967862117091744,0.005025435769326288,0.017637346690423994,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.90328229717007,1.0568372005636186,0.07975315531212736,0.009876790448213229,0.02773098856613714,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.6732501470252,1.0613463869906998,0.08589557919081023,0.0034712032141385523,0.014077657479561906,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.746410490872265,1.0308275646471583,0.043803020936536645,0.011015501285689384,0.030004910218482277,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,25.095807339854865,1.0718697799232804,0.1001296452822923,1.971289281320676e-4,0.002321034153813054,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,22.884681882553068,0.9200955959546891,-0.12014433301669786,0.46333509926756133,0.5732790211276606,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,19.8498585260969,0.9949258959821654,-0.0073390199651008695,0.6565843452431543,0.7328846667087197,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,26.1004603730291,1.0719665577780395,0.10025989863117754,0.013754883120142307,0.03458680342813893,Upregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,21.256871713120866,0.7912881233276158,-0.3377249913280623,0.02975933141745994,0.06242618372053379,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,21.044622882169833,0.7507311832349055,-0.41363168520336807,2.0517090626440074e-6,1.2481230131084379e-4,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.927081129806467,0.7404433949303256,-0.43353864563215744,1.4753649344840621e-6,1.2481230131084379e-4,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,27.7706753526044,1.4158638203875868,0.5016825118196704,1.0797641565670061e-4,0.0019717592282331494,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,27.247732720547802,1.3581123318514652,0.44160281235341026,0.0031491811872838265,0.013061944697256779,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,20.504811434739832,1.0060132990414692,0.008649377046379851,0.7633659489727341,0.8228508080872459,Upregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.235425305062833,1.0239356378590543,0.03412503383418071,0.7734138524861198,0.8228508080872459,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.910134891071465,1.0588187095043624,0.08245559283476873,0.025276591032715734,0.05591488319358329,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,20.105743560235066,1.0140462551719223,0.02012346159682552,0.6058826639712285,0.6910849135921825,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.1410153720616,1.103851668970004,0.1425463217368063,0.13071976733216356,0.2030328301116583,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.389617741496433,1.009629121270818,0.013825428455172019,0.16439102585852694,0.24391351397708264,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,20.726216876243168,0.8039428154374657,-0.31483520892946204,0.04631145591419708,0.08991319898235071,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,20.424621107540467,1.0003719243647804,5.364736790212588e-4,0.9904286672760223,0.9904286672760223,Upregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.2922994852546,1.0381096126165414,0.05395878399371363,0.01177636628207781,0.031147635456220298,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,20.1144961385284,0.9941368795898476,-0.00848358926684661,0.5009710291887962,0.609514752179702,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,26.575013147248068,1.3566391906975577,0.4400370752108212,2.163879560309127e-5,8.26345080487104e-4,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,24.762378508808798,1.224137478101973,0.2917655905781073,4.705204483760791e-4,0.0039939526431923,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.151375727031734,0.8975839953910886,-0.15588114306694975,6.937179186141658e-5,0.00168804693529447,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,24.286457409492034,1.0872778271554415,0.12072063277109155,0.4720456810379627,0.5801234800634896,Upregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.4579521373332,1.1702582104346702,0.22682688691428046,4.2481642015588264e-4,0.003876449833922429,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.307620936458832,0.8699827846500533,-0.20094124190959162,5.428133519861003e-4,0.004215465393083545,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,21.810838272032534,1.045158204780373,0.06372133845627032,0.14659311020614968,0.22481716481195224,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,24.335794363931768,1.0525665570827076,0.07391146230565886,0.3468951625787929,0.45277003040870456,Upregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.815439668341533,1.029078015047878,0.04135235799112797,0.06616281190233159,0.12223198696551596,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,28.003605830377733,1.3437479557436953,0.4262625599183387,3.622033934443944e-5,0.001201856714610945,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,24.610537720242032,0.9881940015805585,-0.017133796353756156,0.8644098048791117,0.8937948407390247,Downregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,27.195462672482165,1.303488336935851,0.3823776743041665,0.002691764218950255,0.012604454731957898,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.668780909383567,1.0336822574312479,0.04779278519305363,0.08463231673549729,0.1457113000398892,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,20.0408390846854,0.9948018862889152,-0.007518851770536778,0.6499881470918395,0.7277474653022129,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,22.33873100038783,1.0039778758261586,0.005727477667601568,0.6117623754592962,0.6956176543384521,Upregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,20.3130816158032,0.8109433312072752,-0.30232699258133866,0.0027281217633199277,0.012604454731957898,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,22.1150163502614,0.8660437369607734,-0.20748820907731536,0.003025449083321851,0.013014118638113149,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,22.704067665479734,0.9385050997640288,-0.09156351031679154,0.34733043428612953,0.45277003040870456,Downregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,21.708426848423198,0.9355113064821359,-0.09617300506947442,0.5938478471200341,0.681296633564225,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,20.046508995598366,0.987799790720677,-0.017709431826272853,0.7697805121026053,0.8228508080872459,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,20.4002106878276,1.0012387712457378,0.0017860630994759308,0.9524683153371287,0.9686058575488905,Upregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,26.9410955864788,1.1635896780097208,0.21858240372493956,0.009511974918911847,0.026913727483742825,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,22.699728880447566,1.0107426948801692,0.015415776601704324,0.6779904095205164,0.7498984832575407,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,23.033311777728667,1.0494277263277914,0.06960281221474789,0.012484826373101684,0.03186686451875605,Upregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,20.837510858465734,0.8085142350342422,-0.3066549202824052,0.11288519802765357,0.18071533894777872,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.71201812109503,1.084981848959617,0.11767090752230105,2.2705252288012542e-4,0.0025113385106438116,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,20.970954117482567,0.7868356332982661,-0.3458658006941157,0.007298019841093407,0.02276732685469311,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,19.680713163433968,0.9893343187652106,-0.015469971757411863,0.3592207530852452,0.4649488470784202,Downregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,25.064584704857968,0.9769459547655731,-0.03364934123858102,0.7173824685145112,0.7821407552300275,Downregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,21.0187264198941,1.0348000712502363,0.04935205847077582,0.12669544445550765,0.1984714044045506,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.448736412949035,1.0573378051992708,0.08043637201540908,0.4087739950674999,0.5146672781144574,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.814102171301332,1.4681535344598293,0.5540028481684313,0.0030015085449933815,0.013014118638113149,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,24.511445401693567,0.8348066827323231,-0.26048594538842523,0.008860072266565837,0.026292084368264475,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,19.741058022810833,0.9680168837629345,-0.046895884258738814,0.10518581263139533,0.17139652504669328,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,24.84631810044243,1.0292475384104929,0.04158999825624675,0.1117252145762355,0.18006359630454544,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.4157355648094,1.0411712451898414,0.05820737340972859,0.011490394369625886,0.030613094488419333,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.990452279342367,1.045735443595088,0.06451791612745156,0.010179374455560266,0.02836237920824044,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,24.684339618769567,1.1661956485793947,0.22180984476219476,0.2250715858963642,0.3159658802006651,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,24.825079770936966,0.9348665206255441,-0.09716770184261689,0.595434592073939,0.681296633564225,Downregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,30.5610379393236,1.7180164042296857,0.7807438119058466,1.6509378678192143e-4,0.0020086410725133775,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,20.5573156123154,1.0071043052956328,0.010213110295910365,0.6368702880225134,0.7174618985438809,Upregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,21.0330889006201,0.9177822767129084,-0.12377614774196889,0.037329572595408846,0.07638358001944659,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.110363772102936,1.0673099628212257,0.09397921729129842,0.004242769243023444,0.01630116603898481,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,25.8361317883481,1.008666911259558,0.012449836674447724,0.7075063634724976,0.777830791167053,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,23.141694182978632,0.9184541548967816,-0.12272038460544965,0.5874393157138682,0.6774626293023008,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,24.9347004994001,1.2329700789834153,0.3021377896628803,0.18146403281742096,0.26278185506479185,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.911257123432666,0.9346005474613334,-0.09757821259635596,5.066482591107361e-4,0.0041094803238981925,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,25.94410557089917,1.4078230170522539,0.4934659785279216,0.0030589685478346848,0.013014118638113149,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,26.828544468971135,1.2160784940369804,0.2822363532083687,0.029112010834567558,0.06142129453535929,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.805674903946368,1.1350473636611857,0.18275250006545404,3.157211264994852e-4,0.003201061421453114,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.069283230913967,1.0501020695846848,0.07052956420266959,0.05012278790288056,0.09628851360290212,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,20.2000386933588,0.9929028617289777,-0.010275512840496106,0.5177510379349506,0.6175788524387482,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,26.21209259559477,1.0252029455140594,0.0359095287600971,0.7178552137042717,0.7821407552300275,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,25.413674365881267,1.2799958174322952,0.35613909602250604,0.0706554370268311,0.12519045880967647,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,22.287667406137032,0.936228775426809,-0.09506698725303496,0.005709392366683118,0.019475964615320914,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.116208624241732,1.0072758459099345,0.010458824387179799,0.8305499197016353,0.8686267068512804,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,26.138573810870266,1.1520263988752009,0.20417377675415407,0.09204004164322391,0.15481389492984665,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,18.55128408291017,0.9793173009021046,-0.03015172303495142,0.3540039914431268,0.4598272486716771,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,21.380353481004168,0.9967170068846124,-0.004744149660242255,0.9192683529458326,0.942508283216935,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.416481051520467,1.0285771339052994,0.040649986891564946,0.10217302750857267,0.1679871848676983,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,25.302410447073868,0.8908483684133927,-0.16674820382976188,0.07882149455662066,0.13709867640368661,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,22.7885861540737,1.1566384229884656,0.20993793368586516,0.048890251710323365,0.09441768187443401,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,21.600860611240467,0.9947545721360621,-0.007587469972758506,0.741097754158892,0.8050615484166534,Downregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.914901047264333,1.00961966875452,0.013811921354457746,0.5775894129272423,0.6714017061096925,Upregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.973615210334966,1.317951099718866,0.39829684265108006,1.8489320679624176e-6,1.2481230131084379e-4,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,20.0216272513046,0.76607930567508975,-0.38443434505852325,0.01838094816546537,0.04246231696452443,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,22.051379250204068,0.9942872970890568,-0.008265319359317728,0.8206893172505106,0.8620615694138777,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,24.5682518657356,0.8742391793979374,-0.1939000603275891,0.06816155965794236,0.12377596654302966,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,24.7846464920801,1.1134670061399936,0.15505880933051777,0.2108093371399271,0.29732358822183347,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.823328827164534,0.9810224110021198,-0.0276420003670998,0.16433678474636487,0.24391351397708264,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,23.991709384314934,0.922395784568335,-0.1165421751286564,0.02235364563741897,0.05067751961278214,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,23.661974831278002,0.8065852710065963,-0.310101033849446,0.004690141751407014,0.01706989735222466,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.206665230593835,0.9469108670075782,-0.0786994641019858,0.030932103922091392,0.0645155310375049,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,25.221915194440665,0.9994278270957835,-8.257072576372654e-4,0.9780748862279489,0.9826133279253654,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,24.282027306939934,0.9911398683077012,-0.012839431950621236,0.18107219339108846,0.26278185506479185,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,21.939800873107835,1.0395326420186033,0.055935060494491824,0.43017400807464634,0.5358822967482796,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,21.429909145334232,1.0457323331734223,0.06451362498803057,0.04519640104594972,0.0891712777393062,Upregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.884867714479768,1.0137133090926387,0.01964969767505932,0.0438691898356109,0.08702312114129337,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,18.2901738334145,1.007982395288537,0.011470441961126506,0.5832062341440808,0.6757786522621889,Upregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.577985861204034,1.0365592337556166,0.05180256102403164,0.0014226507847491532,0.00837528284570066,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,24.229165913917132,0.9392958910736398,-0.0903483967091581,0.002510112797135349,0.012380961769654086,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,24.418750614290865,0.954698265597568,-0.06688325651305485,0.006628625816840799,0.021223231781990277,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,22.959582771927433,1.0327554030558757,0.0464986079466617,0.8003107488632761,0.8467055748843356,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,21.729665789563366,1.0167642435378985,0.023985201213183222,0.3246550445148799,0.4262557239134215,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,20.1780974681236,0.988994803163278,-0.015965154762698528,0.5287838781289972,0.6247036009492033,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.5037403069425,0.8813059105746041,-0.18228521414809729,0.002662181875139105,0.012604454731957898,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,25.0391865595278,1.1104538205969323,0.1511493981248147,0.4714483617321614,0.5801234800634896,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,24.223592088894932,1.0726785974925146,0.10121787174874368,0.6962629149358588,0.767782368433802,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,22.269461871508234,0.8702769745470772,-0.20045346839495853,1.1750240735218273e-4,0.0019717592282331494,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.614798177812,1.033735386611513,0.04786693489873394,0.00600087231519557,0.01994508816846971,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.320172208313167,1.0380235725741753,0.05383920636411263,0.007008249982765871,0.022083526898869693,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,20.294767812924498,0.7361831519650492,-0.44186336181114483,0.0035177318079837954,0.014109583625429509,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,23.078877850794434,0.9252319390270396,-0.11211302618887485,3.3569390860161184e-4,0.003311575044313198,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.803669004105068,0.7778957469246137,-0.3623512757594722,0.0012877950490283922,0.007921788149874274,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,23.200819436435832,1.1078595157173767,0.14777494923215428,0.4089137278169662,0.5146672781144574,Upregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,21.236094019068332,0.9808595226449581,-0.02788156445258876,0.1674051776518843,0.24638262033442648,Downregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.583660968513033,1.0284181189887491,0.040426933355910334,0.02188348163509594,0.04992169248006262,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.9127932214179,1.0495424567011409,0.06976052854838032,7.514835978300933e-4,0.005274836792461232,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,25.067859196871233,1.0520053158687788,0.07314199470450107,0.0011125337800604468,0.007519904254112279,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.618789530451767,1.0348214007079213,0.04938179521562986,3.639214494617603e-4,0.0034955612908826976,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,24.420577158328534,1.06279798053827,0.08786739162548396,0.03503464891754127,0.07224659240057944,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,No gap,F45,F1154_2,Area: 46,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.291037384054867,1.0333212626805808,0.04728886215973314,0.01227945949149159,0.03186686451875605,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.407942392992666,23.566127384301268,1.1008123504674148,0.1385685614336606,0.0019632835139276436,0.01088937650052313,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.74444261487047,23.594004731145233,1.085059072289574,0.11777358735117073,0.026485509647572594,0.05754292274621426,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.2586582595881,26.103801103179432,0.9576333821932541,-0.06245465074583852,0.12418370271958887,0.19707413692456494,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.197292677428234,25.865814408569634,1.0265314904938285,0.03777788510110572,0.08505398531370713,0.14574978703992067,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.225359594187267,23.4092114122264,1.0532658116518734,0.07486957383562665,0.02624835755969652,0.05736916472628281,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.798510239938434,27.807259567111366,1.0003147408655144,4.5400364284028277e-4,0.9714962443290832,0.9795473181771144,Upregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.556384222891666,23.4205611952757,0.9537463244870903,-0.06832250273517732,0.0699602677557655,0.12519045880967647,Downregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.913620388919302,24.170614998523433,1.0548579660598723,0.07704875679420652,0.0019988718507809584,0.01088937650052313,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.961741097575732,23.307573026424432,1.015061224119682,0.02156674718387041,0.5050737035097985,0.6104367608644916,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.154752558976366,24.8086255276989,1.0270701580207056,0.03853473391655019,0.5521159185033222,0.6479817049958605,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.02464909184,23.041615449195902,0.9207567852253831,-0.11910797123919635,0.3988442900213529,0.5054797425617841,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.0545823568341,19.773865904456468,0.7892315115387577,-0.34147953538808523,0.009406355227105284,0.026913727483742825,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.906260379887435,22.453952408312833,0.9802539583470489,-0.028772532411116224,0.2423444885428845,0.33505961484148805,Downregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.364314091152565,23.853567090450035,1.1165145292601892,0.15900202514626824,5.4150580298791877e-5,0.0014117829863613597,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.557753566348502,25.219694200619735,1.2267728630574928,0.29486815880153566,2.066199539534021e-4,0.0023567588497809926,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.210697584788768,24.8158824974359,1.0249965913013328,0.03561911195429194,0.05234192130528202,0.09950417331472884,Upregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2403253242342,22.049019786161434,0.8735632169127127,-0.19501598484622076,0.002313759194775498,0.011729473695736901,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.998228192396265,23.939439294293933,1.0409253745124962,0.05786664339249682,0.054976077362542584,0.1039703017478137,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.739819651794633,19.6695044806278,0.9964379020473756,-0.005148195693390129,0.7139713578517997,0.7821407552300275,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.4641933444476,24.318654783177898,1.2494047070342678,0.32124087026674736,0.041439243003192065,0.08310617415475331,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1349158711952,21.784813540310235,0.8667151961815712,-0.20637009516318233,0.00654843812478187,0.021152034650844094,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.422291150294967,22.928283771934336,0.9388260761790735,-0.09107018117734773,0.002576878285587238,0.012540807656524558,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.065717896301667,20.475389434119734,0.816868262813282,-0.29182466267364443,0.0013122360050663799,0.007921788149874274,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.7379613528228,23.497973241322267,0.9898901128056645,-0.014659713643976079,0.8219107565918614,0.8620615694138777,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.5283921743242,26.485788575419033,1.037503200145043,0.053115786412587455,0.006322760483348946,0.020605424789485405,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.4071829786128,22.165337714170267,0.8724043800065735,-0.19693108167405884,0.0024559615009637787,0.012279807504818894,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1890698096832,25.28688897484737,1.0038833972791867,0.005591707599108244,0.7720505162001491,0.8228508080872459,Upregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.040995823119435,27.122502056196932,0.9339384303965501,-0.0986006510438823,0.009129819911104982,0.026659074140426547,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.898189288715802,24.9743973785335,1.25510904616313,0.32781271359791014,4.227441532177798e-5,0.0012858467993707469,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.1550346254478,23.497595787553568,1.060598468239976,0.08487856999315756,0.6395315214122348,0.718243093278356,Upregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.346681969244433,23.958095537650166,0.9452162443479122,-0.08128367141691287,0.01552025041803678,0.0377659426838895,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.126188005131233,24.6671449735766,1.2256242944410356,0.29351679989690455,8.006099144280871e-5,0.0017189565809779517,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.9070058615956,23.38991073964,1.0676908970314392,0.09449403853764649,0.01425466957295203,0.03515509725761819,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6758080153392,22.7348999953628,0.8854599622251635,-0.17550102066579315,0.003092160136033529,0.013014118638113149,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.611878517628067,26.587601625183932,1.0380965069346357,0.053940570481948065,0.012019850356753074,0.03156291640442354,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.0428689916695,27.803554025363766,1.3212815246994458,0.401937893545508,1.509789670316696e-5,6.888415370819925e-4,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.417081003337135,24.758022372246,1.2126132216549146,0.2781194579753137,0.004814019712443241,0.01706989735222466,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.247283550572032,24.5485426565242,1.2124363544970778,0.2779090166099337,0.07129836300601956,0.1257193357352519,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.249915318550066,23.029476746366534,0.9120615438043759,-0.1327969174867457,0.2627615457902587,0.36055625644152034,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.513692710912398,22.8985088550048,0.8322586537401743,-0.26489612844867644,0.016861134600730052,0.0402242753546828,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.011204278253935,20.433706575370067,0.972514773773269,-0.040207928194666,0.045482005264313445,0.08925232215846456,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.32412765704793,25.037299940457633,1.1741300907182688,0.23159226435632896,0.13030354043908704,0.2030328301116583,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.876308209848833,22.2772711304372,0.828881368545762,-0.2707624603047723,0.01240097293419107,0.03186686451875605,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.132749633445,27.253349088264866,1.3536824122121383,0.4368893075469344,0.05136073029360713,0.09815008668673614,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.213190956215534,20.845667219626765,0.738862443882277,-0.43662229614635395,1.239999528177793e-6,1.2481230131084379e-4,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2796698750677,23.7733798686438,1.0670436322419505,0.0936191702879899,0.005562213121158063,0.019237557051234692,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.544396077814234,22.158699269424634,0.9028007533440173,-0.14752047249715208,4.129683333541318e-4,0.003864960042929695,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.009472405136098,26.956049228421765,1.036393541881255,0.051571930737827815,0.017916688421358146,0.04192045688330592,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.644551715071298,22.471649933646468,1.143912585004738,0.19397680911047102,0.041262139530914274,0.08310617415475331,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.0160326624329,22.6033729887552,1.0266778458829466,0.037983559399098435,0.16000846480487446,0.23935692481057042,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9789785410655,27.011193972771935,1.2875361838946837,0.3646129772215935,6.166433611776803e-4,0.004593363812854149,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.228510038840568,24.6825608717218,1.0187403530862338,0.026786397875694583,0.06182299738632972,0.11512956145923647,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.422939555697535,20.116460474973,0.791272009710014,-0.3377543703522401,0.004766616531558956,0.01706989735222466,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.159017560899,23.0578247972753,0.954418975819366,-0.06730536781362476,0.059836565784238294,0.11200177698075373,Downregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.685669645715066,22.6625817729804,1.095569162667878,0.13168056373329118,0.22979909191692194,0.32136654616734295,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.948973423729267,25.4972793866126,1.0646502017221846,0.0903795007467462,0.10089732745941114,0.16664038245558854,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.413613221147,19.20433686231887,0.8568157517860523,-0.22294309190618236,0.13448570943975952,0.2079969658708145,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9122366380974,19.1185912418606,0.8344271030297887,-0.26114207608572887,0.16925995005006544,0.2481119749729875,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.5009787108156,19.8210213802509,0.9668329331903567,-0.04866147848515967,0.31326621275101557,0.4157897005604389,Downregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.053444672647533,25.294523030630334,0.9708705834659184,-0.04264909691071546,0.18214742282573243,0.26278185506479185,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.138271564927766,21.954562846351568,1.0386167468289214,0.05466339298033458,0.5157404871547384,0.6175788524387482,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.66178940283317,24.0000434184496,1.0590533250410104,0.08277523317856765,0.021328372645806698,0.04896135858943047,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.828976523187333,24.90240466157117,1.1407957965926234,0.1900405711106473,0.0027626202152236487,0.012604454731957898,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.803799803649532,24.80357991509757,0.9612374961764159,-0.05703516833732357,0.1256695369146301,0.1984714044045506,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.068228144579766,24.353790988481233,0.9715002930411335,-0.04171366390543388,0.14918759412556387,0.22688946606596172,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.554467561037935,21.4310757834881,0.9942753502400181,-0.00828265415124471,0.6645014367014744,0.7394604402318237,Downregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.333428878772068,24.506970139269633,0.8965933344097364,-0.15747432096135716,0.004296318518125518,0.016334961032456397,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,17.9579323568517,25.564708055042733,1.4235886151608501,0.5095323003678524,1.2268032307555972e-4,0.0019717592282331494,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.00392183828807,19.883969398243533,0.8643730203059706,-0.21027405285911624,0.0012056566932494928,0.00785829808992973,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.405965885807632,24.728874746064367,0.9023172125770756,-0.148293388058783,0.017423628080856835,0.041296261360472375,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.21594275614933,25.401351878297167,1.0941339813378448,0.12978941306314776,0.03805468172094693,0.07716643793414238,Upregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.233860585341567,22.836745093079035,1.12864003370781,0.17458542907677482,0.1913070791534775,0.2749097790985011,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.7506624331551,22.316963510961,0.9809368661915505,-0.027767808354548847,0.8750077173514672,0.9021972226928969,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.219685376707634,23.205046164106534,0.9581068376066978,-0.061741556367066186,0.5687965881656921,0.6632931459440179,Downregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.41917653977377,24.530187616676667,1.0474402280975175,0.0668679192585931,0.10569024726329265,0.17145306778267475,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.752938758383564,22.297625001318668,0.8658283705217891,-0.2078470209015324,0.1263378412546433,0.1984714044045506,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.527140318640498,24.4118505594793,1.2501497997725701,0.32210097683970895,0.03745934472186559,0.07638358001944659,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.4451464689765,21.86909840411323,0.9327772139556153,-0.1003955483244563,0.1654880255884727,0.2445470823473382,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4664053587124,21.515747310562766,1.0512714340138714,0.07213521539626236,0.027492859128946025,0.058683588199212273,Upregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.78128734231767,21.438924294262634,0.8315691923991928,-0.2660917840169612,0.1119847571537858,0.18006359630454544,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.263708096473167,22.2136008498238,0.8457907302437145,-0.24162734618381695,0.03328412086809078,0.06902672793666553,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.6741883835944,23.201213878412467,1.0232434116671354,0.033149377764871625,0.0828885752619503,0.14338545009768655,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.403340594236433,20.350438889289368,0.9974072037516245,-0.003745472013457423,0.9526835694795937,0.9686058575488905,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6284653770252,23.798457259929968,0.928594705528652,-0.10687903962281915,0.09556403962594869,0.15927339937658114,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.29688379223497,28.88502210316277,1.0581802055874074,0.08158533592916119,0.00288039954983736,0.012821290679154104,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.3257870660719,23.529627941271798,1.21752495051444,0.2839513374941623,0.013796394014012534,0.03458680342813893,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.643191339414667,24.073843143713866,0.9388005894068011,-0.09110934725934038,0.009506122698445972,0.026913727483742825,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.1673021379854,26.524769667096166,1.0975478154595244,0.13428379317627095,0.011407600973253496,0.030613094488419333,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.485478616356,25.928779198312665,1.017394241977161,0.024878834290079126,0.23942584109661474,0.3322830114078494,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.220107095375333,19.994562376860568,0.9888455230503527,-0.016182933393435642,0.5883716533940531,0.6774626293023008,Downregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.062413030387233,23.733448392661234,1.1268152589364018,0.17225100542720526,4.4671633847964145e-4,0.0038821777034540265,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.506857078826467,22.482879336333102,0.9174117784266164,-0.12435866493796377,0.26556213324007477,0.3630343769012258,Downregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.7424476581726,21.041565646723765,0.9252111277988314,-0.11214547707187719,0.3120535891186412,0.4157897005604389,Downregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.00946532151083,24.165255710774368,1.0502310841696536,0.07070680151555805,0.1371363236029223,0.21120151103403645,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7509758389579,23.538084352090902,0.9140657231513852,-0.12963019321925273,7.920636249595093e-5,0.0017189565809779517,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.056750236860434,26.769442735972667,1.1610241018778447,0.21539792164251906,0.005586797390221583,0.019237557051234692,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.864338447523732,26.2140919862775,1.0135226168441689,0.01937828302766191,0.39337586422302606,0.500286377844615,Upregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.485278164122967,22.623372687072166,1.0061415527947322,0.008833290380773191,0.7745230287996839,0.8228508080872459,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.369106172406365,23.090265279797098,0.9880679692859407,-0.017317806540020856,0.39080493326647986,0.4987545477002278,Downregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.2162667315832,22.400349997975766,0.9250125234523003,-0.11245519693384746,0.043393023649074165,0.08654892695033918,Downregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.3287090280501,22.947201351414336,0.9836464299770277,-0.023788260404069977,0.8203479325969751,0.8620615694138777,Downregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.847988439218298,22.8669909716679,1.0968439971240365,0.13335834745478156,0.28381591081291796,0.38367706461746315,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.174641952957668,24.1363509991147,1.1398705608688389,0.18887000702597098,0.31601341806051403,0.4179162956235059,Upregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.488864726080934,22.25772333764183,0.9088915956948013,-0.13781986172188196,0.37636588940851906,0.48541890330074017,Downregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.9199872717622,22.2100602386838,1.0132332634743486,0.018966345232297215,0.8990839617497629,0.9244102705314463,Upregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.6835499746075,21.398619490928034,0.8669182314918743,-0.2060321713184259,0.15141547065667202,0.22932218584931655,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.547712441244734,24.0627635221294,1.1710677571012247,0.2278245515060064,0.20071182428886672,0.28617115572436075,Upregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.767628573607734,24.420362419832866,0.9859790309458648,-0.02037113010171959,0.8426868765085652,0.8788020283589324,Downregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.585221854400533,26.830237271205835,1.0092162261480149,0.013235307220633333,0.41046106672589244,0.5148394823194183,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.323364623036635,25.442634343612866,0.9665418804914853,-0.0490958487743552,0.7698363038503511,0.8228508080872459,Downregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.542080512256565,26.180160431799134,1.0249815170395529,0.0355978945933583,0.09111592345146534,0.15396903731381875,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.838752491447302,26.225865677845633,1.055844720336738,0.07839767780965463,0.024110372543629292,0.05396837625205425,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.631676846629134,28.553976095025767,1.3200075194112997,0.40054614790683024,0.0017211368948160314,0.00981585885324768,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.329986490048935,23.070044113405768,0.8143330432405694,-0.2963091510522944,1.49136020714306e-4,0.0020086410725133775,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.706802019198832,29.593573848828566,0.9961884766223881,-0.005509372108028135,0.45820195255971413,0.5688561655928424,Downregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5565973675619,25.973922461483767,1.0577166727420504,0.08095322899159452,0.002728114931460129,0.012604454731957898,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.379417144279667,29.796021753680765,1.222179413779465,0.2894560857870766,2.2639591246222027e-5,8.26345080487104e-4,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.1527692666301,24.9894823673106,1.0793301690838228,0.110136255406875,0.003101995401413271,0.013014118638113149,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.606819135752566,27.368795927286868,1.2666739956183566,0.34104526526533196,5.367742328620263e-4,0.004215465393083545,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.9551314222807,29.1315440805228,1.0060926215691894,0.008763126741423075,0.5120981841532508,0.6168839512077114,Upregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.402744852134898,24.662792247739535,1.1008826110604595,0.138660640137533,0.07860938159588965,0.13709867640368661,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9980105477586,26.0680353065692,1.2414526246321842,0.3120292075378568,5.625995736624361e-4,0.004278100924724775,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.872479127760766,26.623408826406866,1.029024265318292,0.041277002680480575,0.017696635765925613,0.041672722932663546,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.558540571265333,30.160000249908702,1.0203480844121264,0.029061401204569137,0.023449917060230474,0.0528346896727415,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.5673811415301,25.107123291704035,1.0653336126287118,0.09130528577189692,0.012362557013876986,0.03186686451875605,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.265576557763268,22.409622164550132,1.0537980056021201,0.0755983544096671,0.41628482159844155,0.520356026998052,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.29578748337073,26.490919508027833,0.9705131066164241,-0.04318039846275937,0.5622791361327739,0.6577945022066105,Downregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.605506312451666,21.180552498331465,0.9369643044298769,-0.09393400837210326,0.046116249029117456,0.08991319898235071,Downregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.188836468469432,18.658165294612566,0.6392226464651175,-0.6456095737238523,5.405488699761809e-7,1.2481230131084379e-4,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.9690485682693,23.132218324769134,0.8907611021619639,-0.1668895351263824,0.02685563461974847,0.05766062727181289,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.162121903180267,26.007661329102834,1.2289722858648864,0.2974523823532845,0.0012663858854927452,0.007921788149874274,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.189612752017766,25.890722771367333,1.221859175737032,0.28907801823908635,1.3922801069935127e-4,0.0020086410725133775,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.672776162969733,21.7600087803012,0.8158134214207139,-0.2936888529471339,0.010425757037517155,0.028612039990178657,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.954230328944,18.398550731601034,0.6581669577413136,-0.6034744948901924,0.0012581628838253243,0.007921788149874274,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9479141808808,25.008631001851434,1.1938482650781936,0.2556194855726581,0.10043367066363716,0.16662858996467075,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.504502543750032,23.863685102265467,1.1097064465321054,0.15017808725711984,0.002806393250531055,0.01264609304251648,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.563278219812368,24.18245599682387,1.1214647304696461,0.16538424906738325,7.257057696436573e-4,0.0051937765866653905,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.620451402682633,24.423802064708966,0.9532931985012423,-0.0690080916987022,0.3104135124409979,0.4157897005604389,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.555228991257366,23.4468422600727,0.9548614785234014,-0.06663663790894235,0.6176926234948701,0.7001795266323838,Downregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.840150738786633,25.769556190813802,1.1799165902755795,0.23868487734221067,0.016262286430878826,0.03930950031305147,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.567895788320666,25.961904728350966,1.150391023242263,0.20212432326258914,0.00814013180538269,0.02475956757470568,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.561836777165034,22.2084141088284,0.9041837672936336,-0.14531207753481748,4.950686937930464e-4,0.004106819846237771,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.3981130128564,24.948216780476233,1.165907328626915,0.22145312143409426,9.214961828527798e-4,0.006346152957382351,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.894090157072235,25.9973175426306,1.0880229115958135,0.12170893719268822,0.008099844499790392,0.02475956757470568,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.15164285610477,22.1980290328719,1.1015493471862121,0.13953412631083983,0.010381770881338338,0.028612039990178657,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.835045670648267,28.291061494286634,1.016382794159351,0.023443858041209978,0.21097755986152017,0.29732358822183347,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.787765588756834,26.896290643774165,1.2938519307876533,0.37167252386734195,0.0020687752284324437,0.010943521135910754,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.8212354942801,29.754665037825333,1.303814819547479,0.3827389785476127,1.5105144869035893e-4,0.0020086410725133775,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.7995954892184,29.951153853234366,1.0773953119156143,0.10754769268540493,8.729929282668327e-6,4.5520345545341993e-4,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.64397230403607,27.372221168289766,1.0273325935015847,0.038903322177636306,0.024248804672155882,0.05396837625205425,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.313524149789068,25.2475055098148,1.082955341612016,0.11497375101337327,0.06892786606267459,0.12454787679641696,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.868546812958332,27.1117199147677,1.009050474649864,0.012998342636274746,0.494125402108136,0.6052207106358042,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.2252185950105,24.3008751858887,1.2640103448392248,0.3380082707833516,0.013834721371255573,0.03458680342813893,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.001326773269966,22.190746064366,0.8875827377325877,-0.17204648552026683,0.08555108674216647,0.1459165731817325,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.520538863658167,21.1782160796956,0.9840932057449244,-0.023133131865610036,0.5395948190564397,0.6353293837277435,Downregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.177561234784534,23.872074329576865,1.029964890945904,0.0425951602031325,0.3199757037434022,0.4216286348965408,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.263921101878132,22.740743807338802,0.9001272492751825,-0.1517991279768952,0.20847743754291015,0.2960866330862343,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.902505385890766,24.382455560123066,0.9413164941721939,-0.08724822017675382,1.483246670081398e-4,0.0020086410725133775,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.841374216941965,22.367876646803502,0.900428311713467,-0.15131667544927616,0.00205956103336835,0.010943521135910754,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.9016460590687,23.06729450881,0.9263361327236171,-0.11039230634780095,0.007018326356901053,0.022083526898869693,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.337845324658733,21.384079335290934,1.0514427164692657,0.07237025290668997,0.06697643121398135,0.12223198696551596,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.283736483225233,21.877988208980234,0.9396253142077188,-0.0898425137318159,0.38420452422289975,0.49266029477048623,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6170812368189,22.942307806516734,0.8955863314178911,-0.1590955851717352,0.0059862242401707315,0.01994508816846971,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.5790576791569,27.316701044452202,1.0277528035116819,0.03949330730139702,0.02568404851317831,0.056473962092229414,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.117755108707733,27.813348170484634,1.025650834996793,0.0365396740703279,0.016593023858331987,0.03984509018612615,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,30.0818105806586,28.901086034777933,0.9607495518690677,-0.05776769652816738,0.003236555130672252,0.01327351261455474,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.156998688789635,27.909488039612032,1.0669988698502126,0.09355864808140334,0.05740562406468731,0.10800542671964365,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.871122848929566,29.50742501049143,0.9878244336418988,-0.017673440953309225,0.1558391864555886,0.2340794364456372,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.761280511048,24.1455385493278,1.1630081553244698,0.2178612134103724,0.3129111278449974,0.4157897005604389,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.703912334952065,24.939526478210265,1.2045803747008574,0.2685306595072348,0.07005648456455801,0.12519045880967647,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.321758138172733,28.173696116950566,1.386380839954424,0.47132362143000445,0.0022216644475437047,0.011584393190763603,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.034094390238234,24.9235035664126,1.2440544144863752,0.3150495898035344,0.1982255713171534,0.2837346412971019,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.309967127957567,26.781975247267432,1.3869508461509321,0.4719166591316813,1.1990734792780877e-4,0.0019717592282331494,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.6267392530669,19.705480221759068,1.0040119231053555,0.005776402060428594,0.517175008740252,0.6175788524387482,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.491223159638867,23.6548731976333,0.8020987488239184,-0.31814823268524034,0.0038216808886408606,0.014999070154343163,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.9515697096492,23.099573067452233,0.8570770948150795,-0.22250311306430962,9.33194785681232e-5,0.0018923116487424983,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.0781439411166,21.695794727274965,0.9826820037562316,-0.025203459425501333,0.1818061573447661,0.26278185506479185,Downregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,30.6198646708862,29.744880444626066,0.9714242947947421,-0.04182652705403723,0.10403447059438159,0.17028063572622995,Downregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.966930126672267,22.623232217938032,0.8712324524915745,-0.19887040096033393,4.765131676723138e-5,0.0013379023553876503,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.3570908717408,26.616801933017666,1.009853555634826,0.014146095078357627,0.38467995619065365,0.49266029477048623,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.298632823128234,22.208054932019035,1.0426986143403185,0.06032221593073452,0.07042246767851136,0.12519045880967647,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.677622124839033,19.6245483141361,0.9973028341348247,-0.0038964448624972206,0.8582671099819785,0.8899644748392674,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1262680973742,22.5906632251769,0.8990854964067552,-0.1534697829549348,0.0048169847322716165,0.01706989735222466,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.5817511477294,24.428730592725632,1.1319160537765611,0.17876696763000904,0.002312968237659415,0.011729473695736901,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.82234069831477,21.926386648387865,1.004767863883691,0.006862227466135879,0.9678047536526572,0.9785283520310799,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9331233558923,22.966200792567435,1.0014423432936639,0.0020793623001184387,0.9799212366159809,0.9826133279253654,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.12158739994147,25.796916021192267,0.9875707638368896,-0.018043967491177447,0.8504051004053235,0.884324392159382,Downregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.998853634013734,21.665846514552968,0.942040279890762,-0.08613934677301911,0.4992215843800703,0.6094176531729956,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.452145215237465,20.591065114808067,0.8090109867234606,-0.3057687996686689,0.006192265977615745,0.020361955692159883,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.757380008008365,26.8691542025348,1.0041773220880736,0.006014049277438921,0.9666973436200184,0.9785283520310799,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.296029876742733,23.9170538346994,0.876209981550381,-0.19065144533582043,4.448157642309398e-4,0.0038821777034540265,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.588377692244666,20.7173040578018,0.9596508062411847,-0.05941855545955328,0.08969253559601217,0.15226872322113694,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.57394168448643,21.039713919288733,0.7917423079005055,-0.336897148936647,0.009469229097633146,0.026913727483742825,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.287566358448235,22.379361040085033,0.8513287512022888,-0.23221174071833253,0.30040729998977966,0.4046076180674154,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.778973971553768,26.269378315050066,0.8821451786802249,-0.18091198862145738,0.2801536008822923,0.38013406811166056,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.288964095394434,24.773482146853834,1.1636772008184855,0.21869091618079728,0.15470548949064766,0.233336792000357,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.044612508293735,21.0121770164514,0.8067763346358181,-0.3097593292362989,1.5840649888208315e-4,0.0020086410725133775,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.3375771539039,27.695660187399035,1.4322197639846412,0.5182528809295713,0.00840778399453988,0.025362323619893025,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.854403421427865,22.3372806432835,0.8019299607795531,-0.3184518552750456,0.027853155173505055,0.05910698626935666,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.135976787515034,21.93527962217363,0.8726646991919892,-0.1965006560764593,0.11440805658121543,0.1823534526294482,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.343184645236466,25.285136866672833,0.9598359958064161,-0.05914017681383645,2.6469038718810025e-4,0.0027603426092473312,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.357741114146734,24.140693160787634,0.9910891591982214,-0.01291324560159214,0.504028565325876,0.6104367608644916,Downregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.7260441492229,25.291514034102,1.0228694036727615,0.03262195866979506,0.14846361702375627,0.22673313896933486,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.709516861524133,21.438707093650066,0.8676295539809953,-0.20484889865952247,0.015338811880569476,0.0375749418550863,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.1127693037458,21.733237079986733,0.8015867666083135,-0.3190694036024348,0.004404320567316057,0.016403847010922047,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.150812261294234,22.252768619880968,0.8509398636468836,-0.2328709153662264,0.004349848215717159,0.01636798555398725,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.2056250022279,20.92999464096337,0.9870020166236282,-0.018875062515785093,0.5288586649131611,0.6247036009492033,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.984226277562833,20.005141981386267,1.0010466106384572,0.001509150369115668,0.937757575318346,0.9587717506756198,Upregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.027805077287,26.5456550326866,1.4724840278049784,0.558251985069981,6.619883439885149e-4,0.004832514911116159,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2589416455298,24.25762104421,0.9603577768470356,-0.05835611954942881,0.001989279411050226,0.01088937650052313,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.1330242206675,22.965383720255165,1.1406822675293915,0.18989699066669533,0.2374475831502146,0.3307952971367494,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.487271159626534,22.25895033704043,0.9477027018490967,-0.0774935440300995,0.09540864912241748,0.15927339937658114,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.885192909423132,24.923316596574733,0.9270276274580581,-0.10931575991703202,0.018121949856287095,0.04213064775506236,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.533304718063835,24.222725506233168,0.8797609206112229,-0.18481657739992566,0.27598121150056687,0.3758699335735332,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.5201462788572,26.316278898461267,1.2824605897461887,0.3589144922250486,1.2424784177907517e-4,0.0019717592282331494,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.28494784883633,21.738216075565102,1.0212952472304766,0.03039999661719758,0.6347268124949577,0.7172609491042091,Upregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.483650686592433,26.162434114821632,1.3427891176895903,0.4252327502216194,0.0037539621313901917,0.014893436716928478,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.744220493661132,25.8337936011975,1.0034793482117053,0.005010926078565344,0.6697607978795947,0.7430476936962068,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,Missing ions,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.033030997983367,26.937916665808466,0.9964815513220846,-0.005084999368957957,0.5206635132659071,0.6190299099089775,Downregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.177444834329734,23.217544671826833,1.0468989933361064,0.06612225521750936,0.7744867306084532,0.8228508080872459,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.834202667511068,24.108635256202835,1.2155081633653666,0.2815595825539583,0.008981759595220054,0.026438243969800965,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.990975576346532,21.3107007310268,0.9269158962071873,-0.10948965315561368,0.25110489405010555,0.3458614578425982,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.059242391155134,27.917033442832967,0.9606937808994696,-0.05785144659241886,2.474690025272079e-4,0.0026566525271303197,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.412497504333768,20.0349272644887,0.705144884269071,-0.5040083801543239,0.004635488137063159,0.01706989735222466,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.742370708521133,19.197596559426202,0.7178719033054582,-0.478201661637359,0.0073867947200479634,0.022848983667944973,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2163505203505,20.938223191140768,0.8303431209937723,-0.26822047329019444,0.0016300371174004147,0.009443865838907163,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7978891841521,20.125362054021366,0.7801166176953956,-0.3582382898932086,0.06654375702696083,0.12223198696551596,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.690595006397167,20.317969427304867,0.7908718899755154,-0.33848407738981623,1.0435085940069187e-6,1.2481230131084379e-4,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7047207876297,18.85588198535987,0.7060879660683211,-0.5020801659164786,0.0011689691727038553,0.0077577045097619495,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.699197907164532,21.5637946093456,0.873056472942814,-0.1958531184673886,0.0041558985240438264,0.016137265545489325,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.679578733382233,22.801633119129335,0.8879286282639947,-0.17148437753242637,0.026683778720702187,0.057630646349445556,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.024029563661834,21.14245989898127,0.7823577845478202,-0.35409956926317593,1.596250030768819e-4,0.0020086410725133775,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.401371012909834,21.202955578550668,0.8689247652245848,-0.2026968264048736,0.06675032524037698,0.12223198696551596,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.456191243790133,21.8974773807363,0.8602024227044587,-0.217251900341854,0.0013239152798420017,0.007921788149874274,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.0373156234092,26.65159511419827,1.0235922742449224,0.03364116351910951,0.7755087068000344,0.8228508080872459,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.089018858301568,21.1559492989488,0.8109139486561008,-0.3023792660598981,0.011394757310157603,0.030613094488419333,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.4009417910584,25.603971130468235,0.9698127942973577,-0.04422180821066402,0.014164101169295047,0.03515509725761819,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.400816448575434,25.451702419370932,0.8961609419030477,-0.1581702451551585,0.006010848489127857,0.01994508816846971,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.932855803236833,21.714504669852033,0.9468731175986884,-0.07875697951604749,0.008485393057504637,0.02538662677040322,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5078685143157,23.261406152512667,0.9491403195233016,-0.07530670593857591,0.07887869053362792,0.13709867640368661,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.615391696269732,25.304712550202268,1.0715347378379236,0.09967862117091744,0.005025435769326288,0.017637346690423994,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.510191620200033,25.90328229717007,1.0568372005636186,0.07975315531212736,0.009876790448213229,0.02773098856613714,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.189322601660834,25.6732501470252,1.0613463869906998,0.08589557919081023,0.0034712032141385523,0.014077657479561906,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.916636149877867,27.746410490872265,1.0308275646471583,0.043803020936536645,0.011015501285689384,0.030004910218482277,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.413112124171565,25.095807339854865,1.0718697799232804,0.1001296452822923,1.971289281320676e-4,0.002321034153813054,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.87206979706057,22.884681882553068,0.9200955959546891,-0.12014433301669786,0.46333509926756133,0.5732790211276606,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.951092444429367,19.8498585260969,0.9949258959821654,-0.0073390199651008695,0.6565843452431543,0.7328846667087197,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.3482039468935,26.1004603730291,1.0719665577780395,0.10025989863117754,0.013754883120142307,0.03458680342813893,Upregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.863630435559966,21.256871713120866,0.7912881233276158,-0.3377249913280623,0.02975933141745994,0.06242618372053379,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.032168307553732,21.044622882169833,0.7507311832349055,-0.41363168520336807,2.0517090626440074e-6,1.2481230131084379e-4,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.262904731259933,20.927081129806467,0.7404433949303256,-0.43353864563215744,1.4753649344840621e-6,1.2481230131084379e-4,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.613945178006098,27.7706753526044,1.4158638203875868,0.5016825118196704,1.0797641565670061e-4,0.0019717592282331494,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.062944781159565,27.247732720547802,1.3581123318514652,0.44160281235341026,0.0031491811872838265,0.013061944697256779,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.382246889058866,20.504811434739832,1.0060132990414692,0.008649377046379851,0.7633659489727341,0.8228508080872459,Upregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.7623996634916,20.235425305062833,1.0239356378590543,0.03412503383418071,0.7734138524861198,0.8228508080872459,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.748550628520334,20.910134891071465,1.0588187095043624,0.08245559283476873,0.025276591032715734,0.05591488319358329,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.827245017364934,20.105743560235066,1.0140462551719223,0.02012346159682552,0.6058826639712285,0.6910849135921825,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9638813099357,23.1410153720616,1.103851668970004,0.1425463217368063,0.13071976733216356,0.2030328301116583,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.1283951348602,27.389617741496433,1.009629121270818,0.013825428455172019,0.16439102585852694,0.24391351397708264,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.780710366775267,20.726216876243168,0.8039428154374657,-0.31483520892946204,0.04631145591419708,0.08991319898235071,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4170275175503,20.424621107540467,1.0003719243647804,5.364736790212588e-4,0.9904286672760223,0.9904286672760223,Upregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.327093753602,26.2922994852546,1.0381096126165414,0.05395878399371363,0.01177636628207781,0.031147635456220298,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.233125388957568,20.1144961385284,0.9941368795898476,-0.00848358926684661,0.5009710291887962,0.609514752179702,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.588858503773366,26.575013147248068,1.3566391906975577,0.4400370752108212,2.163879560309127e-5,8.26345080487104e-4,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.228429364978602,24.762378508808798,1.224137478101973,0.2917655905781073,4.705204483760791e-4,0.0039939526431923,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.9070926521018,24.151375727031734,0.8975839953910886,-0.15588114306694975,6.937179186141658e-5,0.00168804693529447,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.336937995903735,24.286457409492034,1.0872778271554415,0.12072063277109155,0.4720456810379627,0.5801234800634896,Upregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.7541324729329,25.4579521373332,1.1702582104346702,0.22682688691428046,4.2481642015588264e-4,0.003876449833922429,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7908990243229,23.307620936458832,0.8699827846500533,-0.20094124190959162,5.428133519861003e-4,0.004215465393083545,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.868456251191,21.810838272032534,1.045158204780373,0.06372133845627032,0.14659311020614968,0.22481716481195224,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.120432812705765,24.335794363931768,1.0525665570827076,0.07391146230565886,0.3468951625787929,0.45277003040870456,Upregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.085988905457732,25.815439668341533,1.029078015047878,0.04135235799112797,0.06616281190233159,0.12223198696551596,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.839924414902033,28.003605830377733,1.3437479557436953,0.4262625599183387,3.622033934443944e-5,0.001201856714610945,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.904560927185265,24.610537720242032,0.9881940015805585,-0.017133796353756156,0.8644098048791117,0.8937948407390247,Downregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.863602612978767,27.195462672482165,1.303488336935851,0.3823776743041665,0.002691764218950255,0.012604454731957898,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.99529426068173,20.668780909383567,1.0336822574312479,0.04779278519305363,0.08463231673549729,0.1457113000398892,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.1455579858692,20.0408390846854,0.9948018862889152,-0.007518851770536778,0.6499881470918395,0.7277474653022129,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2502223786611,22.33873100038783,1.0039778758261586,0.005727477667601568,0.6117623754592962,0.6956176543384521,Upregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.0487066532288,20.3130816158032,0.8109433312072752,-0.30232699258133866,0.0027281217633199277,0.012604454731957898,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.535680712697165,22.1150163502614,0.8660437369607734,-0.20748820907731536,0.003025449083321851,0.013014118638113149,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.1917360610915,22.704067665479734,0.9385050997640288,-0.09156351031679154,0.34733043428612953,0.45277003040870456,Downregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.204879190669335,21.708426848423198,0.9355113064821359,-0.09617300506947442,0.5938478471200341,0.681296633564225,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.294101278329766,20.046508995598366,0.987799790720677,-0.017709431826272853,0.7697805121026053,0.8228508080872459,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.374970759917467,20.4002106878276,1.0012387712457378,0.0017860630994759308,0.9524683153371287,0.9686058575488905,Upregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.153432946019766,26.9410955864788,1.1635896780097208,0.21858240372493956,0.009511974918911847,0.026913727483742825,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.458464449390632,22.699728880447566,1.0107426948801692,0.015415776601704324,0.6779904095205164,0.7498984832575407,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.948449807332565,23.033311777728667,1.0494277263277914,0.06960281221474789,0.012484826373101684,0.03186686451875605,Upregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.772596146786732,20.837510858465734,0.8085142350342422,-0.3066549202824052,0.11288519802765357,0.18071533894777872,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.776434596386334,24.71201812109503,1.084981848959617,0.11767090752230105,2.2705252288012542e-4,0.0025113385106438116,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.652267932473134,20.970954117482567,0.7868356332982661,-0.3458658006941157,0.007298019841093407,0.02276732685469311,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.892884326500965,19.680713163433968,0.9893343187652106,-0.015469971757411863,0.3592207530852452,0.4649488470784202,Downregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.656060688508035,25.064584704857968,0.9769459547655731,-0.03364934123858102,0.7173824685145112,0.7821407552300275,Downregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.311871832884066,21.0187264198941,1.0348000712502363,0.04935205847077582,0.12669544445550765,0.1984714044045506,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.2313759165343,22.448736412949035,1.0573378051992708,0.08043637201540908,0.4087739950674999,0.5146672781144574,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.26382700578173,26.814102171301332,1.4681535344598293,0.5540028481684313,0.0030015085449933815,0.013014118638113149,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.361822214297067,24.511445401693567,0.8348066827323231,-0.26048594538842523,0.008860072266565837,0.026292084368264475,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.393299284277134,19.741058022810833,0.9680168837629345,-0.046895884258738814,0.10518581263139533,0.17139652504669328,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.14027449491263,24.84631810044243,1.0292475384104929,0.04158999825624675,0.1117252145762355,0.18006359630454544,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.371172789153334,26.4157355648094,1.0411712451898414,0.05820737340972859,0.011490394369625886,0.030613094488419333,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.853754779498466,25.990452279342367,1.045735443595088,0.06451791612745156,0.010179374455560266,0.02836237920824044,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.166550954669468,24.684339618769567,1.1661956485793947,0.22180984476219476,0.2250715858963642,0.3159658802006651,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.554678366624834,24.825079770936966,0.9348665206255441,-0.09716770184261689,0.595434592073939,0.681296633564225,Downregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,17.7885600300926,30.5610379393236,1.7180164042296857,0.7807438119058466,1.6509378678192143e-4,0.0020086410725133775,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4123003984983,20.5573156123154,1.0071043052956328,0.010213110295910365,0.6368702880225134,0.7174618985438809,Upregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9172968734495,21.0330889006201,0.9177822767129084,-0.12377614774196889,0.037329572595408846,0.07638358001944659,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.526777268834433,25.110363772102936,1.0673099628212257,0.09397921729129842,0.004242769243023444,0.01630116603898481,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6141363416845,25.8361317883481,1.008666911259558,0.012449836674447724,0.7075063634724976,0.777830791167053,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1963520003667,23.141694182978632,0.9184541548967816,-0.12272038460544965,0.5874393157138682,0.6774626293023008,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.223281103430168,24.9347004994001,1.2329700789834153,0.3021377896628803,0.18146403281742096,0.26278185506479185,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5144914430735,22.911257123432666,0.9346005474613334,-0.09757821259635596,5.066482591107361e-4,0.0041094803238981925,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.4285277741955,25.94410557089917,1.4078230170522539,0.4934659785279216,0.0030589685478346848,0.013014118638113149,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.061523660293666,26.828544468971135,1.2160784940369804,0.2822363532083687,0.029112010834567558,0.06142129453535929,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.735328700917034,25.805674903946368,1.1350473636611857,0.18275250006545404,3.157211264994852e-4,0.003201061421453114,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.920898765996498,24.069283230913967,1.0501020695846848,0.07052956420266959,0.05012278790288056,0.09628851360290212,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.344425896994334,20.2000386933588,0.9929028617289777,-0.010275512840496106,0.5177510379349506,0.6175788524387482,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.5677109691208,26.21209259559477,1.0252029455140594,0.0359095287600971,0.7178552137042717,0.7821407552300275,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.8544979755182,25.413674365881267,1.2799958174322952,0.35613909602250604,0.0706554370268311,0.12519045880967647,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.8057919080478,22.287667406137032,0.936228775426809,-0.09506698725303496,0.005709392366683118,0.019475964615320914,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.949233537273432,23.116208624241732,1.0072758459099345,0.010458824387179799,0.8305499197016353,0.8686267068512804,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.689214271817967,26.138573810870266,1.1520263988752009,0.20417377675415407,0.09204004164322391,0.15481389492984665,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.943078066548534,18.55128408291017,0.9793173009021046,-0.03015172303495142,0.3540039914431268,0.4598272486716771,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.450776231692533,21.380353481004168,0.9967170068846124,-0.004744149660242255,0.9192683529458326,0.942508283216935,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.710330624422134,25.416481051520467,1.0285771339052994,0.040649986891564946,0.10217302750857267,0.1679871848676983,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.4026006492414,25.302410447073868,0.8908483684133927,-0.16674820382976188,0.07882149455662066,0.13709867640368661,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.702428780805732,22.7885861540737,1.1566384229884656,0.20993793368586516,0.048890251710323365,0.09441768187443401,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.714763838537966,21.600860611240467,0.9947545721360621,-0.007587469972758506,0.741097754158892,0.8050615484166534,Downregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.715623610091935,20.914901047264333,1.00961966875452,0.013811921354457746,0.5775894129272423,0.6714017061096925,Upregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.466324749141865,26.973615210334966,1.317951099718866,0.39829684265108006,1.8489320679624176e-6,1.2481230131084379e-4,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.135188750022433,20.0216272513046,0.76607930567508975,-0.38443434505852325,0.01838094816546537,0.04246231696452443,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.178076009583133,22.051379250204068,0.9942872970890568,-0.008265319359317728,0.8206893172505106,0.8620615694138777,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.102437461856866,24.5682518657356,0.8742391793979374,-0.1939000603275891,0.06816155965794236,0.12377596654302966,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2589859918705,24.7846464920801,1.1134670061399936,0.15505880933051777,0.2108093371399271,0.29732358822183347,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.322873501723432,25.823328827164534,0.9810224110021198,-0.0276420003670998,0.16433678474636487,0.24391351397708264,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.0102114360189,23.991709384314934,0.922395784568335,-0.1165421751286564,0.02235364563741897,0.05067751961278214,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.335986760269634,23.661974831278002,0.8065852710065963,-0.310101033849446,0.004690141751407014,0.01706989735222466,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.563826621920168,24.206665230593835,0.9469108670075782,-0.0786994641019858,0.030932103922091392,0.0645155310375049,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.23635475283143,25.221915194440665,0.9994278270957835,-8.257072576372654e-4,0.9780748862279489,0.9826133279253654,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.499092492767666,24.282027306939934,0.9911398683077012,-0.012839431950621236,0.18107219339108846,0.26278185506479185,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.105446800116166,21.939800873107835,1.0395326420186033,0.055935060494491824,0.43017400807464634,0.5358822967482796,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4927288422862,21.429909145334232,1.0457323331734223,0.06451362498803057,0.04519640104594972,0.0891712777393062,Upregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.521174649017933,26.884867714479768,1.0137133090926387,0.01964969767505932,0.0438691898356109,0.08702312114129337,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.1453306316713,18.2901738334145,1.007982395288537,0.011470441961126506,0.5832062341440808,0.6757786522621889,Upregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.640585695144335,26.577985861204034,1.0365592337556166,0.05180256102403164,0.0014226507847491532,0.00837528284570066,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7950302393238,24.229165913917132,0.9392958910736398,-0.0903483967091581,0.002510112797135349,0.012380961769654086,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.577453625105935,24.418750614290865,0.954698265597568,-0.06688325651305485,0.006628625816840799,0.021223231781990277,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2313848022398,22.959582771927433,1.0327554030558757,0.0464986079466617,0.8003107488632761,0.8467055748843356,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.3713905929201,21.729665789563366,1.0167642435378985,0.023985201213183222,0.3246550445148799,0.4262557239134215,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.402632454270133,20.1780974681236,0.988994803163278,-0.015965154762698528,0.5287838781289972,0.6247036009492033,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.399859400605,21.5037403069425,0.8813059105746041,-0.18228521414809729,0.002662181875139105,0.012604454731957898,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,No gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.548606790391165,25.0391865595278,1.1104538205969323,0.1511493981248147,0.4714483617321614,0.5801234800634896,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.582339337728765,24.223592088894932,1.0726785974925146,0.10121787174874368,0.6962629149358588,0.767782368433802,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.58893607761833,22.269461871508234,0.8702769745470772,-0.20045346839495853,1.1750240735218273e-4,0.0019717592282331494,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.778873307002566,25.614798177812,1.033735386611513,0.04786693489873394,0.00600087231519557,0.01994508816846971,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.392675539652867,25.320172208313167,1.0380235725741753,0.05383920636411263,0.007008249982765871,0.022083526898869693,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.567552665057466,20.294767812924498,0.7361831519650492,-0.44186336181114483,0.0035177318079837954,0.014109583625429509,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.94388366560697,23.078877850794434,0.9252319390270396,-0.11211302618887485,3.3569390860161184e-4,0.003311575044313198,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7435181209715,20.803669004105068,0.7778957469246137,-0.3623512757594722,0.0012877950490283922,0.007921788149874274,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9420229797029,23.200819436435832,1.1078595157173767,0.14777494923215428,0.4089137278169662,0.5146672781144574,Upregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.650494824991533,21.236094019068332,0.9808595226449581,-0.02788156445258876,0.1674051776518843,0.24638262033442648,Downregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.9043444632095,24.583660968513033,1.0284181189887491,0.040426933355910334,0.02188348163509594,0.04992169248006262,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.73681318211967,24.9127932214179,1.0495424567011409,0.06976052854838032,7.514835978300933e-4,0.005274836792461232,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.8286430864367,25.067859196871233,1.0520053158687788,0.07314199470450107,0.0011125337800604468,0.007519904254112279,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.790375337821633,24.618789530451767,1.0348214007079213,0.04938179521562986,3.639214494617603e-4,0.0034955612908826976,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.977628491503502,24.420577158328534,1.06279798053827,0.08786739162548396,0.03503464891754127,0.07224659240057944,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F40,CTRL3,Area: 41,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.5077301332603,24.291037384054867,1.0333212626805808,0.04728886215973314,0.01227945949149159,0.03186686451875605,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.407942392992666,23.566127384301268,1.1008123504674148,0.1385685614336606,0.0019632835139276436,0.01088937650052313,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.74444261487047,23.594004731145233,1.085059072289574,0.11777358735117073,0.026485509647572594,0.05754292274621426,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.2586582595881,26.103801103179432,0.9576333821932541,-0.06245465074583852,0.12418370271958887,0.19707413692456494,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.197292677428234,25.865814408569634,1.0265314904938285,0.03777788510110572,0.08505398531370713,0.14574978703992067,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.225359594187267,23.4092114122264,1.0532658116518734,0.07486957383562665,0.02624835755969652,0.05736916472628281,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.798510239938434,27.807259567111366,1.0003147408655144,4.5400364284028277e-4,0.9714962443290832,0.9795473181771144,Upregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.556384222891666,23.4205611952757,0.9537463244870903,-0.06832250273517732,0.0699602677557655,0.12519045880967647,Downregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.913620388919302,24.170614998523433,1.0548579660598723,0.07704875679420652,0.0019988718507809584,0.01088937650052313,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.961741097575732,23.307573026424432,1.015061224119682,0.02156674718387041,0.5050737035097985,0.6104367608644916,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.154752558976366,24.8086255276989,1.0270701580207056,0.03853473391655019,0.5521159185033222,0.6479817049958605,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.02464909184,23.041615449195902,0.9207567852253831,-0.11910797123919635,0.3988442900213529,0.5054797425617841,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.0545823568341,19.773865904456468,0.7892315115387577,-0.34147953538808523,0.009406355227105284,0.026913727483742825,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.906260379887435,22.453952408312833,0.9802539583470489,-0.028772532411116224,0.2423444885428845,0.33505961484148805,Downregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.364314091152565,23.853567090450035,1.1165145292601892,0.15900202514626824,5.4150580298791877e-5,0.0014117829863613597,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.557753566348502,25.219694200619735,1.2267728630574928,0.29486815880153566,2.066199539534021e-4,0.0023567588497809926,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.210697584788768,24.8158824974359,1.0249965913013328,0.03561911195429194,0.05234192130528202,0.09950417331472884,Upregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2403253242342,22.049019786161434,0.8735632169127127,-0.19501598484622076,0.002313759194775498,0.011729473695736901,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.998228192396265,23.939439294293933,1.0409253745124962,0.05786664339249682,0.054976077362542584,0.1039703017478137,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.739819651794633,19.6695044806278,0.9964379020473756,-0.005148195693390129,0.7139713578517997,0.7821407552300275,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.4641933444476,24.318654783177898,1.2494047070342678,0.32124087026674736,0.041439243003192065,0.08310617415475331,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1349158711952,21.784813540310235,0.8667151961815712,-0.20637009516318233,0.00654843812478187,0.021152034650844094,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.422291150294967,22.928283771934336,0.9388260761790735,-0.09107018117734773,0.002576878285587238,0.012540807656524558,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.065717896301667,20.475389434119734,0.816868262813282,-0.29182466267364443,0.0013122360050663799,0.007921788149874274,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.7379613528228,23.497973241322267,0.9898901128056645,-0.014659713643976079,0.8219107565918614,0.8620615694138777,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.5283921743242,26.485788575419033,1.037503200145043,0.053115786412587455,0.006322760483348946,0.020605424789485405,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.4071829786128,22.165337714170267,0.8724043800065735,-0.19693108167405884,0.0024559615009637787,0.012279807504818894,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1890698096832,25.28688897484737,1.0038833972791867,0.005591707599108244,0.7720505162001491,0.8228508080872459,Upregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.040995823119435,27.122502056196932,0.9339384303965501,-0.0986006510438823,0.009129819911104982,0.026659074140426547,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.898189288715802,24.9743973785335,1.25510904616313,0.32781271359791014,4.227441532177798e-5,0.0012858467993707469,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.1550346254478,23.497595787553568,1.060598468239976,0.08487856999315756,0.6395315214122348,0.718243093278356,Upregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.346681969244433,23.958095537650166,0.9452162443479122,-0.08128367141691287,0.01552025041803678,0.0377659426838895,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.126188005131233,24.6671449735766,1.2256242944410356,0.29351679989690455,8.006099144280871e-5,0.0017189565809779517,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.9070058615956,23.38991073964,1.0676908970314392,0.09449403853764649,0.01425466957295203,0.03515509725761819,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6758080153392,22.7348999953628,0.8854599622251635,-0.17550102066579315,0.003092160136033529,0.013014118638113149,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.611878517628067,26.587601625183932,1.0380965069346357,0.053940570481948065,0.012019850356753074,0.03156291640442354,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.0428689916695,27.803554025363766,1.3212815246994458,0.401937893545508,1.509789670316696e-5,6.888415370819925e-4,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.417081003337135,24.758022372246,1.2126132216549146,0.2781194579753137,0.004814019712443241,0.01706989735222466,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.247283550572032,24.5485426565242,1.2124363544970778,0.2779090166099337,0.07129836300601956,0.1257193357352519,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.249915318550066,23.029476746366534,0.9120615438043759,-0.1327969174867457,0.2627615457902587,0.36055625644152034,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.513692710912398,22.8985088550048,0.8322586537401743,-0.26489612844867644,0.016861134600730052,0.0402242753546828,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.011204278253935,20.433706575370067,0.972514773773269,-0.040207928194666,0.045482005264313445,0.08925232215846456,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.32412765704793,25.037299940457633,1.1741300907182688,0.23159226435632896,0.13030354043908704,0.2030328301116583,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.876308209848833,22.2772711304372,0.828881368545762,-0.2707624603047723,0.01240097293419107,0.03186686451875605,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.132749633445,27.253349088264866,1.3536824122121383,0.4368893075469344,0.05136073029360713,0.09815008668673614,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.213190956215534,20.845667219626765,0.738862443882277,-0.43662229614635395,1.239999528177793e-6,1.2481230131084379e-4,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2796698750677,23.7733798686438,1.0670436322419505,0.0936191702879899,0.005562213121158063,0.019237557051234692,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.544396077814234,22.158699269424634,0.9028007533440173,-0.14752047249715208,4.129683333541318e-4,0.003864960042929695,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.009472405136098,26.956049228421765,1.036393541881255,0.051571930737827815,0.017916688421358146,0.04192045688330592,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.644551715071298,22.471649933646468,1.143912585004738,0.19397680911047102,0.041262139530914274,0.08310617415475331,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.0160326624329,22.6033729887552,1.0266778458829466,0.037983559399098435,0.16000846480487446,0.23935692481057042,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9789785410655,27.011193972771935,1.2875361838946837,0.3646129772215935,6.166433611776803e-4,0.004593363812854149,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.228510038840568,24.6825608717218,1.0187403530862338,0.026786397875694583,0.06182299738632972,0.11512956145923647,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.422939555697535,20.116460474973,0.791272009710014,-0.3377543703522401,0.004766616531558956,0.01706989735222466,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.159017560899,23.0578247972753,0.954418975819366,-0.06730536781362476,0.059836565784238294,0.11200177698075373,Downregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.685669645715066,22.6625817729804,1.095569162667878,0.13168056373329118,0.22979909191692194,0.32136654616734295,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.948973423729267,25.4972793866126,1.0646502017221846,0.0903795007467462,0.10089732745941114,0.16664038245558854,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.413613221147,19.20433686231887,0.8568157517860523,-0.22294309190618236,0.13448570943975952,0.2079969658708145,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9122366380974,19.1185912418606,0.8344271030297887,-0.26114207608572887,0.16925995005006544,0.2481119749729875,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.5009787108156,19.8210213802509,0.9668329331903567,-0.04866147848515967,0.31326621275101557,0.4157897005604389,Downregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.053444672647533,25.294523030630334,0.9708705834659184,-0.04264909691071546,0.18214742282573243,0.26278185506479185,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.138271564927766,21.954562846351568,1.0386167468289214,0.05466339298033458,0.5157404871547384,0.6175788524387482,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.66178940283317,24.0000434184496,1.0590533250410104,0.08277523317856765,0.021328372645806698,0.04896135858943047,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.828976523187333,24.90240466157117,1.1407957965926234,0.1900405711106473,0.0027626202152236487,0.012604454731957898,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.803799803649532,24.80357991509757,0.9612374961764159,-0.05703516833732357,0.1256695369146301,0.1984714044045506,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.068228144579766,24.353790988481233,0.9715002930411335,-0.04171366390543388,0.14918759412556387,0.22688946606596172,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.554467561037935,21.4310757834881,0.9942753502400181,-0.00828265415124471,0.6645014367014744,0.7394604402318237,Downregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.333428878772068,24.506970139269633,0.8965933344097364,-0.15747432096135716,0.004296318518125518,0.016334961032456397,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,17.9579323568517,25.564708055042733,1.4235886151608501,0.5095323003678524,1.2268032307555972e-4,0.0019717592282331494,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.00392183828807,19.883969398243533,0.8643730203059706,-0.21027405285911624,0.0012056566932494928,0.00785829808992973,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.405965885807632,24.728874746064367,0.9023172125770756,-0.148293388058783,0.017423628080856835,0.041296261360472375,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.21594275614933,25.401351878297167,1.0941339813378448,0.12978941306314776,0.03805468172094693,0.07716643793414238,Upregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.233860585341567,22.836745093079035,1.12864003370781,0.17458542907677482,0.1913070791534775,0.2749097790985011,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.7506624331551,22.316963510961,0.9809368661915505,-0.027767808354548847,0.8750077173514672,0.9021972226928969,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.219685376707634,23.205046164106534,0.9581068376066978,-0.061741556367066186,0.5687965881656921,0.6632931459440179,Downregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.41917653977377,24.530187616676667,1.0474402280975175,0.0668679192585931,0.10569024726329265,0.17145306778267475,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.752938758383564,22.297625001318668,0.8658283705217891,-0.2078470209015324,0.1263378412546433,0.1984714044045506,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.527140318640498,24.4118505594793,1.2501497997725701,0.32210097683970895,0.03745934472186559,0.07638358001944659,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.4451464689765,21.86909840411323,0.9327772139556153,-0.1003955483244563,0.1654880255884727,0.2445470823473382,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4664053587124,21.515747310562766,1.0512714340138714,0.07213521539626236,0.027492859128946025,0.058683588199212273,Upregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.78128734231767,21.438924294262634,0.8315691923991928,-0.2660917840169612,0.1119847571537858,0.18006359630454544,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.263708096473167,22.2136008498238,0.8457907302437145,-0.24162734618381695,0.03328412086809078,0.06902672793666553,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.6741883835944,23.201213878412467,1.0232434116671354,0.033149377764871625,0.0828885752619503,0.14338545009768655,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.403340594236433,20.350438889289368,0.9974072037516245,-0.003745472013457423,0.9526835694795937,0.9686058575488905,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6284653770252,23.798457259929968,0.928594705528652,-0.10687903962281915,0.09556403962594869,0.15927339937658114,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.29688379223497,28.88502210316277,1.0581802055874074,0.08158533592916119,0.00288039954983736,0.012821290679154104,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.3257870660719,23.529627941271798,1.21752495051444,0.2839513374941623,0.013796394014012534,0.03458680342813893,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.643191339414667,24.073843143713866,0.9388005894068011,-0.09110934725934038,0.009506122698445972,0.026913727483742825,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.1673021379854,26.524769667096166,1.0975478154595244,0.13428379317627095,0.011407600973253496,0.030613094488419333,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.485478616356,25.928779198312665,1.017394241977161,0.024878834290079126,0.23942584109661474,0.3322830114078494,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.220107095375333,19.994562376860568,0.9888455230503527,-0.016182933393435642,0.5883716533940531,0.6774626293023008,Downregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.062413030387233,23.733448392661234,1.1268152589364018,0.17225100542720526,4.4671633847964145e-4,0.0038821777034540265,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.506857078826467,22.482879336333102,0.9174117784266164,-0.12435866493796377,0.26556213324007477,0.3630343769012258,Downregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.7424476581726,21.041565646723765,0.9252111277988314,-0.11214547707187719,0.3120535891186412,0.4157897005604389,Downregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.00946532151083,24.165255710774368,1.0502310841696536,0.07070680151555805,0.1371363236029223,0.21120151103403645,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7509758389579,23.538084352090902,0.9140657231513852,-0.12963019321925273,7.920636249595093e-5,0.0017189565809779517,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.056750236860434,26.769442735972667,1.1610241018778447,0.21539792164251906,0.005586797390221583,0.019237557051234692,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.864338447523732,26.2140919862775,1.0135226168441689,0.01937828302766191,0.39337586422302606,0.500286377844615,Upregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.485278164122967,22.623372687072166,1.0061415527947322,0.008833290380773191,0.7745230287996839,0.8228508080872459,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.369106172406365,23.090265279797098,0.9880679692859407,-0.017317806540020856,0.39080493326647986,0.4987545477002278,Downregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.2162667315832,22.400349997975766,0.9250125234523003,-0.11245519693384746,0.043393023649074165,0.08654892695033918,Downregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.3287090280501,22.947201351414336,0.9836464299770277,-0.023788260404069977,0.8203479325969751,0.8620615694138777,Downregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.847988439218298,22.8669909716679,1.0968439971240365,0.13335834745478156,0.28381591081291796,0.38367706461746315,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.174641952957668,24.1363509991147,1.1398705608688389,0.18887000702597098,0.31601341806051403,0.4179162956235059,Upregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.488864726080934,22.25772333764183,0.9088915956948013,-0.13781986172188196,0.37636588940851906,0.48541890330074017,Downregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.9199872717622,22.2100602386838,1.0132332634743486,0.018966345232297215,0.8990839617497629,0.9244102705314463,Upregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.6835499746075,21.398619490928034,0.8669182314918743,-0.2060321713184259,0.15141547065667202,0.22932218584931655,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.547712441244734,24.0627635221294,1.1710677571012247,0.2278245515060064,0.20071182428886672,0.28617115572436075,Upregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.767628573607734,24.420362419832866,0.9859790309458648,-0.02037113010171959,0.8426868765085652,0.8788020283589324,Downregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.585221854400533,26.830237271205835,1.0092162261480149,0.013235307220633333,0.41046106672589244,0.5148394823194183,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.323364623036635,25.442634343612866,0.9665418804914853,-0.0490958487743552,0.7698363038503511,0.8228508080872459,Downregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.542080512256565,26.180160431799134,1.0249815170395529,0.0355978945933583,0.09111592345146534,0.15396903731381875,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.838752491447302,26.225865677845633,1.055844720336738,0.07839767780965463,0.024110372543629292,0.05396837625205425,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.631676846629134,28.553976095025767,1.3200075194112997,0.40054614790683024,0.0017211368948160314,0.00981585885324768,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.329986490048935,23.070044113405768,0.8143330432405694,-0.2963091510522944,1.49136020714306e-4,0.0020086410725133775,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.706802019198832,29.593573848828566,0.9961884766223881,-0.005509372108028135,0.45820195255971413,0.5688561655928424,Downregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5565973675619,25.973922461483767,1.0577166727420504,0.08095322899159452,0.002728114931460129,0.012604454731957898,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.379417144279667,29.796021753680765,1.222179413779465,0.2894560857870766,2.2639591246222027e-5,8.26345080487104e-4,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.1527692666301,24.9894823673106,1.0793301690838228,0.110136255406875,0.003101995401413271,0.013014118638113149,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.606819135752566,27.368795927286868,1.2666739956183566,0.34104526526533196,5.367742328620263e-4,0.004215465393083545,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.9551314222807,29.1315440805228,1.0060926215691894,0.008763126741423075,0.5120981841532508,0.6168839512077114,Upregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.402744852134898,24.662792247739535,1.1008826110604595,0.138660640137533,0.07860938159588965,0.13709867640368661,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9980105477586,26.0680353065692,1.2414526246321842,0.3120292075378568,5.625995736624361e-4,0.004278100924724775,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.872479127760766,26.623408826406866,1.029024265318292,0.041277002680480575,0.017696635765925613,0.041672722932663546,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.558540571265333,30.160000249908702,1.0203480844121264,0.029061401204569137,0.023449917060230474,0.0528346896727415,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.5673811415301,25.107123291704035,1.0653336126287118,0.09130528577189692,0.012362557013876986,0.03186686451875605,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.265576557763268,22.409622164550132,1.0537980056021201,0.0755983544096671,0.41628482159844155,0.520356026998052,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.29578748337073,26.490919508027833,0.9705131066164241,-0.04318039846275937,0.5622791361327739,0.6577945022066105,Downregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.605506312451666,21.180552498331465,0.9369643044298769,-0.09393400837210326,0.046116249029117456,0.08991319898235071,Downregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.188836468469432,18.658165294612566,0.6392226464651175,-0.6456095737238523,5.405488699761809e-7,1.2481230131084379e-4,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.9690485682693,23.132218324769134,0.8907611021619639,-0.1668895351263824,0.02685563461974847,0.05766062727181289,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.162121903180267,26.007661329102834,1.2289722858648864,0.2974523823532845,0.0012663858854927452,0.007921788149874274,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.189612752017766,25.890722771367333,1.221859175737032,0.28907801823908635,1.3922801069935127e-4,0.0020086410725133775,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.672776162969733,21.7600087803012,0.8158134214207139,-0.2936888529471339,0.010425757037517155,0.028612039990178657,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.954230328944,18.398550731601034,0.6581669577413136,-0.6034744948901924,0.0012581628838253243,0.007921788149874274,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9479141808808,25.008631001851434,1.1938482650781936,0.2556194855726581,0.10043367066363716,0.16662858996467075,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.504502543750032,23.863685102265467,1.1097064465321054,0.15017808725711984,0.002806393250531055,0.01264609304251648,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.563278219812368,24.18245599682387,1.1214647304696461,0.16538424906738325,7.257057696436573e-4,0.0051937765866653905,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.620451402682633,24.423802064708966,0.9532931985012423,-0.0690080916987022,0.3104135124409979,0.4157897005604389,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.555228991257366,23.4468422600727,0.9548614785234014,-0.06663663790894235,0.6176926234948701,0.7001795266323838,Downregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.840150738786633,25.769556190813802,1.1799165902755795,0.23868487734221067,0.016262286430878826,0.03930950031305147,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.567895788320666,25.961904728350966,1.150391023242263,0.20212432326258914,0.00814013180538269,0.02475956757470568,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.561836777165034,22.2084141088284,0.9041837672936336,-0.14531207753481748,4.950686937930464e-4,0.004106819846237771,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.3981130128564,24.948216780476233,1.165907328626915,0.22145312143409426,9.214961828527798e-4,0.006346152957382351,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.894090157072235,25.9973175426306,1.0880229115958135,0.12170893719268822,0.008099844499790392,0.02475956757470568,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.15164285610477,22.1980290328719,1.1015493471862121,0.13953412631083983,0.010381770881338338,0.028612039990178657,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.835045670648267,28.291061494286634,1.016382794159351,0.023443858041209978,0.21097755986152017,0.29732358822183347,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.787765588756834,26.896290643774165,1.2938519307876533,0.37167252386734195,0.0020687752284324437,0.010943521135910754,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.8212354942801,29.754665037825333,1.303814819547479,0.3827389785476127,1.5105144869035893e-4,0.0020086410725133775,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.7995954892184,29.951153853234366,1.0773953119156143,0.10754769268540493,8.729929282668327e-6,4.5520345545341993e-4,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.64397230403607,27.372221168289766,1.0273325935015847,0.038903322177636306,0.024248804672155882,0.05396837625205425,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.313524149789068,25.2475055098148,1.082955341612016,0.11497375101337327,0.06892786606267459,0.12454787679641696,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.868546812958332,27.1117199147677,1.009050474649864,0.012998342636274746,0.494125402108136,0.6052207106358042,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.2252185950105,24.3008751858887,1.2640103448392248,0.3380082707833516,0.013834721371255573,0.03458680342813893,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.001326773269966,22.190746064366,0.8875827377325877,-0.17204648552026683,0.08555108674216647,0.1459165731817325,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.520538863658167,21.1782160796956,0.9840932057449244,-0.023133131865610036,0.5395948190564397,0.6353293837277435,Downregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.177561234784534,23.872074329576865,1.029964890945904,0.0425951602031325,0.3199757037434022,0.4216286348965408,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.263921101878132,22.740743807338802,0.9001272492751825,-0.1517991279768952,0.20847743754291015,0.2960866330862343,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.902505385890766,24.382455560123066,0.9413164941721939,-0.08724822017675382,1.483246670081398e-4,0.0020086410725133775,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.841374216941965,22.367876646803502,0.900428311713467,-0.15131667544927616,0.00205956103336835,0.010943521135910754,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.9016460590687,23.06729450881,0.9263361327236171,-0.11039230634780095,0.007018326356901053,0.022083526898869693,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.337845324658733,21.384079335290934,1.0514427164692657,0.07237025290668997,0.06697643121398135,0.12223198696551596,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.283736483225233,21.877988208980234,0.9396253142077188,-0.0898425137318159,0.38420452422289975,0.49266029477048623,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6170812368189,22.942307806516734,0.8955863314178911,-0.1590955851717352,0.0059862242401707315,0.01994508816846971,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.5790576791569,27.316701044452202,1.0277528035116819,0.03949330730139702,0.02568404851317831,0.056473962092229414,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.117755108707733,27.813348170484634,1.025650834996793,0.0365396740703279,0.016593023858331987,0.03984509018612615,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,30.0818105806586,28.901086034777933,0.9607495518690677,-0.05776769652816738,0.003236555130672252,0.01327351261455474,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.156998688789635,27.909488039612032,1.0669988698502126,0.09355864808140334,0.05740562406468731,0.10800542671964365,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.871122848929566,29.50742501049143,0.9878244336418988,-0.017673440953309225,0.1558391864555886,0.2340794364456372,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.761280511048,24.1455385493278,1.1630081553244698,0.2178612134103724,0.3129111278449974,0.4157897005604389,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.703912334952065,24.939526478210265,1.2045803747008574,0.2685306595072348,0.07005648456455801,0.12519045880967647,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.321758138172733,28.173696116950566,1.386380839954424,0.47132362143000445,0.0022216644475437047,0.011584393190763603,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.034094390238234,24.9235035664126,1.2440544144863752,0.3150495898035344,0.1982255713171534,0.2837346412971019,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.309967127957567,26.781975247267432,1.3869508461509321,0.4719166591316813,1.1990734792780877e-4,0.0019717592282331494,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.6267392530669,19.705480221759068,1.0040119231053555,0.005776402060428594,0.517175008740252,0.6175788524387482,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.491223159638867,23.6548731976333,0.8020987488239184,-0.31814823268524034,0.0038216808886408606,0.014999070154343163,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.9515697096492,23.099573067452233,0.8570770948150795,-0.22250311306430962,9.33194785681232e-5,0.0018923116487424983,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.0781439411166,21.695794727274965,0.9826820037562316,-0.025203459425501333,0.1818061573447661,0.26278185506479185,Downregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,30.6198646708862,29.744880444626066,0.9714242947947421,-0.04182652705403723,0.10403447059438159,0.17028063572622995,Downregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.966930126672267,22.623232217938032,0.8712324524915745,-0.19887040096033393,4.765131676723138e-5,0.0013379023553876503,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.3570908717408,26.616801933017666,1.009853555634826,0.014146095078357627,0.38467995619065365,0.49266029477048623,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.298632823128234,22.208054932019035,1.0426986143403185,0.06032221593073452,0.07042246767851136,0.12519045880967647,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.677622124839033,19.6245483141361,0.9973028341348247,-0.0038964448624972206,0.8582671099819785,0.8899644748392674,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1262680973742,22.5906632251769,0.8990854964067552,-0.1534697829549348,0.0048169847322716165,0.01706989735222466,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.5817511477294,24.428730592725632,1.1319160537765611,0.17876696763000904,0.002312968237659415,0.011729473695736901,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.82234069831477,21.926386648387865,1.004767863883691,0.006862227466135879,0.9678047536526572,0.9785283520310799,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9331233558923,22.966200792567435,1.0014423432936639,0.0020793623001184387,0.9799212366159809,0.9826133279253654,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.12158739994147,25.796916021192267,0.9875707638368896,-0.018043967491177447,0.8504051004053235,0.884324392159382,Downregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.998853634013734,21.665846514552968,0.942040279890762,-0.08613934677301911,0.4992215843800703,0.6094176531729956,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.452145215237465,20.591065114808067,0.8090109867234606,-0.3057687996686689,0.006192265977615745,0.020361955692159883,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.757380008008365,26.8691542025348,1.0041773220880736,0.006014049277438921,0.9666973436200184,0.9785283520310799,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.296029876742733,23.9170538346994,0.876209981550381,-0.19065144533582043,4.448157642309398e-4,0.0038821777034540265,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.588377692244666,20.7173040578018,0.9596508062411847,-0.05941855545955328,0.08969253559601217,0.15226872322113694,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.57394168448643,21.039713919288733,0.7917423079005055,-0.336897148936647,0.009469229097633146,0.026913727483742825,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.287566358448235,22.379361040085033,0.8513287512022888,-0.23221174071833253,0.30040729998977966,0.4046076180674154,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.778973971553768,26.269378315050066,0.8821451786802249,-0.18091198862145738,0.2801536008822923,0.38013406811166056,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.288964095394434,24.773482146853834,1.1636772008184855,0.21869091618079728,0.15470548949064766,0.233336792000357,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.044612508293735,21.0121770164514,0.8067763346358181,-0.3097593292362989,1.5840649888208315e-4,0.0020086410725133775,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.3375771539039,27.695660187399035,1.4322197639846412,0.5182528809295713,0.00840778399453988,0.025362323619893025,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.854403421427865,22.3372806432835,0.8019299607795531,-0.3184518552750456,0.027853155173505055,0.05910698626935666,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.135976787515034,21.93527962217363,0.8726646991919892,-0.1965006560764593,0.11440805658121543,0.1823534526294482,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.343184645236466,25.285136866672833,0.9598359958064161,-0.05914017681383645,2.6469038718810025e-4,0.0027603426092473312,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.357741114146734,24.140693160787634,0.9910891591982214,-0.01291324560159214,0.504028565325876,0.6104367608644916,Downregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.7260441492229,25.291514034102,1.0228694036727615,0.03262195866979506,0.14846361702375627,0.22673313896933486,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.709516861524133,21.438707093650066,0.8676295539809953,-0.20484889865952247,0.015338811880569476,0.0375749418550863,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.1127693037458,21.733237079986733,0.8015867666083135,-0.3190694036024348,0.004404320567316057,0.016403847010922047,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.150812261294234,22.252768619880968,0.8509398636468836,-0.2328709153662264,0.004349848215717159,0.01636798555398725,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.2056250022279,20.92999464096337,0.9870020166236282,-0.018875062515785093,0.5288586649131611,0.6247036009492033,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.984226277562833,20.005141981386267,1.0010466106384572,0.001509150369115668,0.937757575318346,0.9587717506756198,Upregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.027805077287,26.5456550326866,1.4724840278049784,0.558251985069981,6.619883439885149e-4,0.004832514911116159,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2589416455298,24.25762104421,0.9603577768470356,-0.05835611954942881,0.001989279411050226,0.01088937650052313,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.1330242206675,22.965383720255165,1.1406822675293915,0.18989699066669533,0.2374475831502146,0.3307952971367494,Upregulated
Feature0154,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.487271159626534,22.25895033704043,0.9477027018490967,-0.0774935440300995,0.09540864912241748,0.15927339937658114,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.885192909423132,24.923316596574733,0.9270276274580581,-0.10931575991703202,0.018121949856287095,0.04213064775506236,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.533304718063835,24.222725506233168,0.8797609206112229,-0.18481657739992566,0.27598121150056687,0.3758699335735332,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.5201462788572,26.316278898461267,1.2824605897461887,0.3589144922250486,1.2424784177907517e-4,0.0019717592282331494,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.28494784883633,21.738216075565102,1.0212952472304766,0.03039999661719758,0.6347268124949577,0.7172609491042091,Upregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.483650686592433,26.162434114821632,1.3427891176895903,0.4252327502216194,0.0037539621313901917,0.014893436716928478,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.744220493661132,25.8337936011975,1.0034793482117053,0.005010926078565344,0.6697607978795947,0.7430476936962068,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.033030997983367,26.937916665808466,0.9964815513220846,-0.005084999368957957,0.5206635132659071,0.6190299099089775,Downregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.177444834329734,23.217544671826833,1.0468989933361064,0.06612225521750936,0.7744867306084532,0.8228508080872459,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.834202667511068,24.108635256202835,1.2155081633653666,0.2815595825539583,0.008981759595220054,0.026438243969800965,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.990975576346532,21.3107007310268,0.9269158962071873,-0.10948965315561368,0.25110489405010555,0.3458614578425982,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.059242391155134,27.917033442832967,0.9606937808994696,-0.05785144659241886,2.474690025272079e-4,0.0026566525271303197,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.412497504333768,20.0349272644887,0.705144884269071,-0.5040083801543239,0.004635488137063159,0.01706989735222466,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.742370708521133,19.197596559426202,0.7178719033054582,-0.478201661637359,0.0073867947200479634,0.022848983667944973,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2163505203505,20.938223191140768,0.8303431209937723,-0.26822047329019444,0.0016300371174004147,0.009443865838907163,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7978891841521,20.125362054021366,0.7801166176953956,-0.3582382898932086,0.06654375702696083,0.12223198696551596,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.690595006397167,20.317969427304867,0.7908718899755154,-0.33848407738981623,1.0435085940069187e-6,1.2481230131084379e-4,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7047207876297,18.85588198535987,0.7060879660683211,-0.5020801659164786,0.0011689691727038553,0.0077577045097619495,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.699197907164532,21.5637946093456,0.873056472942814,-0.1958531184673886,0.0041558985240438264,0.016137265545489325,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.679578733382233,22.801633119129335,0.8879286282639947,-0.17148437753242637,0.026683778720702187,0.057630646349445556,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.024029563661834,21.14245989898127,0.7823577845478202,-0.35409956926317593,1.596250030768819e-4,0.0020086410725133775,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.401371012909834,21.202955578550668,0.8689247652245848,-0.2026968264048736,0.06675032524037698,0.12223198696551596,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.456191243790133,21.8974773807363,0.8602024227044587,-0.217251900341854,0.0013239152798420017,0.007921788149874274,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.0373156234092,26.65159511419827,1.0235922742449224,0.03364116351910951,0.7755087068000344,0.8228508080872459,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.089018858301568,21.1559492989488,0.8109139486561008,-0.3023792660598981,0.011394757310157603,0.030613094488419333,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.4009417910584,25.603971130468235,0.9698127942973577,-0.04422180821066402,0.014164101169295047,0.03515509725761819,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.400816448575434,25.451702419370932,0.8961609419030477,-0.1581702451551585,0.006010848489127857,0.01994508816846971,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.932855803236833,21.714504669852033,0.9468731175986884,-0.07875697951604749,0.008485393057504637,0.02538662677040322,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5078685143157,23.261406152512667,0.9491403195233016,-0.07530670593857591,0.07887869053362792,0.13709867640368661,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.615391696269732,25.304712550202268,1.0715347378379236,0.09967862117091744,0.005025435769326288,0.017637346690423994,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.510191620200033,25.90328229717007,1.0568372005636186,0.07975315531212736,0.009876790448213229,0.02773098856613714,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.189322601660834,25.6732501470252,1.0613463869906998,0.08589557919081023,0.0034712032141385523,0.014077657479561906,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.916636149877867,27.746410490872265,1.0308275646471583,0.043803020936536645,0.011015501285689384,0.030004910218482277,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.413112124171565,25.095807339854865,1.0718697799232804,0.1001296452822923,1.971289281320676e-4,0.002321034153813054,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.87206979706057,22.884681882553068,0.9200955959546891,-0.12014433301669786,0.46333509926756133,0.5732790211276606,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.951092444429367,19.8498585260969,0.9949258959821654,-0.0073390199651008695,0.6565843452431543,0.7328846667087197,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.3482039468935,26.1004603730291,1.0719665577780395,0.10025989863117754,0.013754883120142307,0.03458680342813893,Upregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.863630435559966,21.256871713120866,0.7912881233276158,-0.3377249913280623,0.02975933141745994,0.06242618372053379,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.032168307553732,21.044622882169833,0.7507311832349055,-0.41363168520336807,2.0517090626440074e-6,1.2481230131084379e-4,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.262904731259933,20.927081129806467,0.7404433949303256,-0.43353864563215744,1.4753649344840621e-6,1.2481230131084379e-4,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.613945178006098,27.7706753526044,1.4158638203875868,0.5016825118196704,1.0797641565670061e-4,0.0019717592282331494,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.062944781159565,27.247732720547802,1.3581123318514652,0.44160281235341026,0.0031491811872838265,0.013061944697256779,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.382246889058866,20.504811434739832,1.0060132990414692,0.008649377046379851,0.7633659489727341,0.8228508080872459,Upregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.7623996634916,20.235425305062833,1.0239356378590543,0.03412503383418071,0.7734138524861198,0.8228508080872459,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.748550628520334,20.910134891071465,1.0588187095043624,0.08245559283476873,0.025276591032715734,0.05591488319358329,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.827245017364934,20.105743560235066,1.0140462551719223,0.02012346159682552,0.6058826639712285,0.6910849135921825,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9638813099357,23.1410153720616,1.103851668970004,0.1425463217368063,0.13071976733216356,0.2030328301116583,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.1283951348602,27.389617741496433,1.009629121270818,0.013825428455172019,0.16439102585852694,0.24391351397708264,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.780710366775267,20.726216876243168,0.8039428154374657,-0.31483520892946204,0.04631145591419708,0.08991319898235071,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4170275175503,20.424621107540467,1.0003719243647804,5.364736790212588e-4,0.9904286672760223,0.9904286672760223,Upregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.327093753602,26.2922994852546,1.0381096126165414,0.05395878399371363,0.01177636628207781,0.031147635456220298,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.233125388957568,20.1144961385284,0.9941368795898476,-0.00848358926684661,0.5009710291887962,0.609514752179702,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.588858503773366,26.575013147248068,1.3566391906975577,0.4400370752108212,2.163879560309127e-5,8.26345080487104e-4,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.228429364978602,24.762378508808798,1.224137478101973,0.2917655905781073,4.705204483760791e-4,0.0039939526431923,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.9070926521018,24.151375727031734,0.8975839953910886,-0.15588114306694975,6.937179186141658e-5,0.00168804693529447,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.336937995903735,24.286457409492034,1.0872778271554415,0.12072063277109155,0.4720456810379627,0.5801234800634896,Upregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.7541324729329,25.4579521373332,1.1702582104346702,0.22682688691428046,4.2481642015588264e-4,0.003876449833922429,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7908990243229,23.307620936458832,0.8699827846500533,-0.20094124190959162,5.428133519861003e-4,0.004215465393083545,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.868456251191,21.810838272032534,1.045158204780373,0.06372133845627032,0.14659311020614968,0.22481716481195224,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.120432812705765,24.335794363931768,1.0525665570827076,0.07391146230565886,0.3468951625787929,0.45277003040870456,Upregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.085988905457732,25.815439668341533,1.029078015047878,0.04135235799112797,0.06616281190233159,0.12223198696551596,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.839924414902033,28.003605830377733,1.3437479557436953,0.4262625599183387,3.622033934443944e-5,0.001201856714610945,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.904560927185265,24.610537720242032,0.9881940015805585,-0.017133796353756156,0.8644098048791117,0.8937948407390247,Downregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.863602612978767,27.195462672482165,1.303488336935851,0.3823776743041665,0.002691764218950255,0.012604454731957898,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.99529426068173,20.668780909383567,1.0336822574312479,0.04779278519305363,0.08463231673549729,0.1457113000398892,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.1455579858692,20.0408390846854,0.9948018862889152,-0.007518851770536778,0.6499881470918395,0.7277474653022129,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2502223786611,22.33873100038783,1.0039778758261586,0.005727477667601568,0.6117623754592962,0.6956176543384521,Upregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.0487066532288,20.3130816158032,0.8109433312072752,-0.30232699258133866,0.0027281217633199277,0.012604454731957898,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.535680712697165,22.1150163502614,0.8660437369607734,-0.20748820907731536,0.003025449083321851,0.013014118638113149,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.1917360610915,22.704067665479734,0.9385050997640288,-0.09156351031679154,0.34733043428612953,0.45277003040870456,Downregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.204879190669335,21.708426848423198,0.9355113064821359,-0.09617300506947442,0.5938478471200341,0.681296633564225,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.294101278329766,20.046508995598366,0.987799790720677,-0.017709431826272853,0.7697805121026053,0.8228508080872459,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.374970759917467,20.4002106878276,1.0012387712457378,0.0017860630994759308,0.9524683153371287,0.9686058575488905,Upregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.153432946019766,26.9410955864788,1.1635896780097208,0.21858240372493956,0.009511974918911847,0.026913727483742825,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.458464449390632,22.699728880447566,1.0107426948801692,0.015415776601704324,0.6779904095205164,0.7498984832575407,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.948449807332565,23.033311777728667,1.0494277263277914,0.06960281221474789,0.012484826373101684,0.03186686451875605,Upregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.772596146786732,20.837510858465734,0.8085142350342422,-0.3066549202824052,0.11288519802765357,0.18071533894777872,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.776434596386334,24.71201812109503,1.084981848959617,0.11767090752230105,2.2705252288012542e-4,0.0025113385106438116,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.652267932473134,20.970954117482567,0.7868356332982661,-0.3458658006941157,0.007298019841093407,0.02276732685469311,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.892884326500965,19.680713163433968,0.9893343187652106,-0.015469971757411863,0.3592207530852452,0.4649488470784202,Downregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.656060688508035,25.064584704857968,0.9769459547655731,-0.03364934123858102,0.7173824685145112,0.7821407552300275,Downregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.311871832884066,21.0187264198941,1.0348000712502363,0.04935205847077582,0.12669544445550765,0.1984714044045506,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.2313759165343,22.448736412949035,1.0573378051992708,0.08043637201540908,0.4087739950674999,0.5146672781144574,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.26382700578173,26.814102171301332,1.4681535344598293,0.5540028481684313,0.0030015085449933815,0.013014118638113149,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.361822214297067,24.511445401693567,0.8348066827323231,-0.26048594538842523,0.008860072266565837,0.026292084368264475,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.393299284277134,19.741058022810833,0.9680168837629345,-0.046895884258738814,0.10518581263139533,0.17139652504669328,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.14027449491263,24.84631810044243,1.0292475384104929,0.04158999825624675,0.1117252145762355,0.18006359630454544,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.371172789153334,26.4157355648094,1.0411712451898414,0.05820737340972859,0.011490394369625886,0.030613094488419333,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.853754779498466,25.990452279342367,1.045735443595088,0.06451791612745156,0.010179374455560266,0.02836237920824044,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.166550954669468,24.684339618769567,1.1661956485793947,0.22180984476219476,0.2250715858963642,0.3159658802006651,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.554678366624834,24.825079770936966,0.9348665206255441,-0.09716770184261689,0.595434592073939,0.681296633564225,Downregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,17.7885600300926,30.5610379393236,1.7180164042296857,0.7807438119058466,1.6509378678192143e-4,0.0020086410725133775,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4123003984983,20.5573156123154,1.0071043052956328,0.010213110295910365,0.6368702880225134,0.7174618985438809,Upregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9172968734495,21.0330889006201,0.9177822767129084,-0.12377614774196889,0.037329572595408846,0.07638358001944659,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.526777268834433,25.110363772102936,1.0673099628212257,0.09397921729129842,0.004242769243023444,0.01630116603898481,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6141363416845,25.8361317883481,1.008666911259558,0.012449836674447724,0.7075063634724976,0.777830791167053,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1963520003667,23.141694182978632,0.9184541548967816,-0.12272038460544965,0.5874393157138682,0.6774626293023008,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.223281103430168,24.9347004994001,1.2329700789834153,0.3021377896628803,0.18146403281742096,0.26278185506479185,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5144914430735,22.911257123432666,0.9346005474613334,-0.09757821259635596,5.066482591107361e-4,0.0041094803238981925,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.4285277741955,25.94410557089917,1.4078230170522539,0.4934659785279216,0.0030589685478346848,0.013014118638113149,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.061523660293666,26.828544468971135,1.2160784940369804,0.2822363532083687,0.029112010834567558,0.06142129453535929,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.735328700917034,25.805674903946368,1.1350473636611857,0.18275250006545404,3.157211264994852e-4,0.003201061421453114,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.920898765996498,24.069283230913967,1.0501020695846848,0.07052956420266959,0.05012278790288056,0.09628851360290212,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.344425896994334,20.2000386933588,0.9929028617289777,-0.010275512840496106,0.5177510379349506,0.6175788524387482,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.5677109691208,26.21209259559477,1.0252029455140594,0.0359095287600971,0.7178552137042717,0.7821407552300275,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.8544979755182,25.413674365881267,1.2799958174322952,0.35613909602250604,0.0706554370268311,0.12519045880967647,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.8057919080478,22.287667406137032,0.936228775426809,-0.09506698725303496,0.005709392366683118,0.019475964615320914,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.949233537273432,23.116208624241732,1.0072758459099345,0.010458824387179799,0.8305499197016353,0.8686267068512804,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.689214271817967,26.138573810870266,1.1520263988752009,0.20417377675415407,0.09204004164322391,0.15481389492984665,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.943078066548534,18.55128408291017,0.9793173009021046,-0.03015172303495142,0.3540039914431268,0.4598272486716771,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.450776231692533,21.380353481004168,0.9967170068846124,-0.004744149660242255,0.9192683529458326,0.942508283216935,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.710330624422134,25.416481051520467,1.0285771339052994,0.040649986891564946,0.10217302750857267,0.1679871848676983,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.4026006492414,25.302410447073868,0.8908483684133927,-0.16674820382976188,0.07882149455662066,0.13709867640368661,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.702428780805732,22.7885861540737,1.1566384229884656,0.20993793368586516,0.048890251710323365,0.09441768187443401,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.714763838537966,21.600860611240467,0.9947545721360621,-0.007587469972758506,0.741097754158892,0.8050615484166534,Downregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.715623610091935,20.914901047264333,1.00961966875452,0.013811921354457746,0.5775894129272423,0.6714017061096925,Upregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.466324749141865,26.973615210334966,1.317951099718866,0.39829684265108006,1.8489320679624176e-6,1.2481230131084379e-4,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.135188750022433,20.0216272513046,0.76607930567508975,-0.38443434505852325,0.01838094816546537,0.04246231696452443,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.178076009583133,22.051379250204068,0.9942872970890568,-0.008265319359317728,0.8206893172505106,0.8620615694138777,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.102437461856866,24.5682518657356,0.8742391793979374,-0.1939000603275891,0.06816155965794236,0.12377596654302966,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2589859918705,24.7846464920801,1.1134670061399936,0.15505880933051777,0.2108093371399271,0.29732358822183347,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.322873501723432,25.823328827164534,0.9810224110021198,-0.0276420003670998,0.16433678474636487,0.24391351397708264,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.0102114360189,23.991709384314934,0.922395784568335,-0.1165421751286564,0.02235364563741897,0.05067751961278214,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.335986760269634,23.661974831278002,0.8065852710065963,-0.310101033849446,0.004690141751407014,0.01706989735222466,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.563826621920168,24.206665230593835,0.9469108670075782,-0.0786994641019858,0.030932103922091392,0.0645155310375049,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Missing ions,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.23635475283143,25.221915194440665,0.9994278270957835,-8.257072576372654e-4,0.9780748862279489,0.9826133279253654,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.499092492767666,24.282027306939934,0.9911398683077012,-0.012839431950621236,0.18107219339108846,0.26278185506479185,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.105446800116166,21.939800873107835,1.0395326420186033,0.055935060494491824,0.43017400807464634,0.5358822967482796,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4927288422862,21.429909145334232,1.0457323331734223,0.06451362498803057,0.04519640104594972,0.0891712777393062,Upregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.521174649017933,26.884867714479768,1.0137133090926387,0.01964969767505932,0.0438691898356109,0.08702312114129337,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.1453306316713,18.2901738334145,1.007982395288537,0.011470441961126506,0.5832062341440808,0.6757786522621889,Upregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.640585695144335,26.577985861204034,1.0365592337556166,0.05180256102403164,0.0014226507847491532,0.00837528284570066,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7950302393238,24.229165913917132,0.9392958910736398,-0.0903483967091581,0.002510112797135349,0.012380961769654086,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.577453625105935,24.418750614290865,0.954698265597568,-0.06688325651305485,0.006628625816840799,0.021223231781990277,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2313848022398,22.959582771927433,1.0327554030558757,0.0464986079466617,0.8003107488632761,0.8467055748843356,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.3713905929201,21.729665789563366,1.0167642435378985,0.023985201213183222,0.3246550445148799,0.4262557239134215,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.402632454270133,20.1780974681236,0.988994803163278,-0.015965154762698528,0.5287838781289972,0.6247036009492033,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.399859400605,21.5037403069425,0.8813059105746041,-0.18228521414809729,0.002662181875139105,0.012604454731957898,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.548606790391165,25.0391865595278,1.1104538205969323,0.1511493981248147,0.4714483617321614,0.5801234800634896,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.582339337728765,24.223592088894932,1.0726785974925146,0.10121787174874368,0.6962629149358588,0.767782368433802,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.58893607761833,22.269461871508234,0.8702769745470772,-0.20045346839495853,1.1750240735218273e-4,0.0019717592282331494,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.778873307002566,25.614798177812,1.033735386611513,0.04786693489873394,0.00600087231519557,0.01994508816846971,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.392675539652867,25.320172208313167,1.0380235725741753,0.05383920636411263,0.007008249982765871,0.022083526898869693,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.567552665057466,20.294767812924498,0.7361831519650492,-0.44186336181114483,0.0035177318079837954,0.014109583625429509,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.94388366560697,23.078877850794434,0.9252319390270396,-0.11211302618887485,3.3569390860161184e-4,0.003311575044313198,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7435181209715,20.803669004105068,0.7778957469246137,-0.3623512757594722,0.0012877950490283922,0.007921788149874274,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9420229797029,23.200819436435832,1.1078595157173767,0.14777494923215428,0.4089137278169662,0.5146672781144574,Upregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.650494824991533,21.236094019068332,0.9808595226449581,-0.02788156445258876,0.1674051776518843,0.24638262033442648,Downregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.9043444632095,24.583660968513033,1.0284181189887491,0.040426933355910334,0.02188348163509594,0.04992169248006262,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,No gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.73681318211967,24.9127932214179,1.0495424567011409,0.06976052854838032,7.514835978300933e-4,0.005274836792461232,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.8286430864367,25.067859196871233,1.0520053158687788,0.07314199470450107,0.0011125337800604468,0.007519904254112279,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.790375337821633,24.618789530451767,1.0348214007079213,0.04938179521562986,3.639214494617603e-4,0.0034955612908826976,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.977628491503502,24.420577158328534,1.06279798053827,0.08786739162548396,0.03503464891754127,0.07224659240057944,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F39,CTRL2,Area: 40,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.5077301332603,24.291037384054867,1.0333212626805808,0.04728886215973314,0.01227945949149159,0.03186686451875605,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.566127384301268,1.1008123504674148,0.1385685614336606,0.0019632835139276436,0.01088937650052313,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.594004731145233,1.085059072289574,0.11777358735117073,0.026485509647572594,0.05754292274621426,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.103801103179432,0.9576333821932541,-0.06245465074583852,0.12418370271958887,0.19707413692456494,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,25.865814408569634,1.0265314904938285,0.03777788510110572,0.08505398531370713,0.14574978703992067,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4092114122264,1.0532658116518734,0.07486957383562665,0.02624835755969652,0.05736916472628281,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.807259567111366,1.0003147408655144,4.5400364284028277e-4,0.9714962443290832,0.9795473181771144,Upregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,23.4205611952757,0.9537463244870903,-0.06832250273517732,0.0699602677557655,0.12519045880967647,Downregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,24.170614998523433,1.0548579660598723,0.07704875679420652,0.0019988718507809584,0.01088937650052313,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.307573026424432,1.015061224119682,0.02156674718387041,0.5050737035097985,0.6104367608644916,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,24.8086255276989,1.0270701580207056,0.03853473391655019,0.5521159185033222,0.6479817049958605,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,23.041615449195902,0.9207567852253831,-0.11910797123919635,0.3988442900213529,0.5054797425617841,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,19.773865904456468,0.7892315115387577,-0.34147953538808523,0.009406355227105284,0.026913727483742825,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,22.453952408312833,0.9802539583470489,-0.028772532411116224,0.2423444885428845,0.33505961484148805,Downregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,23.853567090450035,1.1165145292601892,0.15900202514626824,5.4150580298791877e-5,0.0014117829863613597,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.219694200619735,1.2267728630574928,0.29486815880153566,2.066199539534021e-4,0.0023567588497809926,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,24.8158824974359,1.0249965913013328,0.03561911195429194,0.05234192130528202,0.09950417331472884,Upregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,22.049019786161434,0.8735632169127127,-0.19501598484622076,0.002313759194775498,0.011729473695736901,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,23.939439294293933,1.0409253745124962,0.05786664339249682,0.054976077362542584,0.1039703017478137,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,19.6695044806278,0.9964379020473756,-0.005148195693390129,0.7139713578517997,0.7821407552300275,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,24.318654783177898,1.2494047070342678,0.32124087026674736,0.041439243003192065,0.08310617415475331,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,21.784813540310235,0.8667151961815712,-0.20637009516318233,0.00654843812478187,0.021152034650844094,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,22.928283771934336,0.9388260761790735,-0.09107018117734773,0.002576878285587238,0.012540807656524558,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,20.475389434119734,0.816868262813282,-0.29182466267364443,0.0013122360050663799,0.007921788149874274,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.497973241322267,0.9898901128056645,-0.014659713643976079,0.8219107565918614,0.8620615694138777,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.485788575419033,1.037503200145043,0.053115786412587455,0.006322760483348946,0.020605424789485405,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,22.165337714170267,0.8724043800065735,-0.19693108167405884,0.0024559615009637787,0.012279807504818894,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,25.28688897484737,1.0038833972791867,0.005591707599108244,0.7720505162001491,0.8228508080872459,Upregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.122502056196932,0.9339384303965501,-0.0986006510438823,0.009129819911104982,0.026659074140426547,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,24.9743973785335,1.25510904616313,0.32781271359791014,4.227441532177798e-5,0.0012858467993707469,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,23.497595787553568,1.060598468239976,0.08487856999315756,0.6395315214122348,0.718243093278356,Upregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.958095537650166,0.9452162443479122,-0.08128367141691287,0.01552025041803678,0.0377659426838895,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,24.6671449735766,1.2256242944410356,0.29351679989690455,8.006099144280871e-5,0.0017189565809779517,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,23.38991073964,1.0676908970314392,0.09449403853764649,0.01425466957295203,0.03515509725761819,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,22.7348999953628,0.8854599622251635,-0.17550102066579315,0.003092160136033529,0.013014118638113149,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.587601625183932,1.0380965069346357,0.053940570481948065,0.012019850356753074,0.03156291640442354,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.803554025363766,1.3212815246994458,0.401937893545508,1.509789670316696e-5,6.888415370819925e-4,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,24.758022372246,1.2126132216549146,0.2781194579753137,0.004814019712443241,0.01706989735222466,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,24.5485426565242,1.2124363544970778,0.2779090166099337,0.07129836300601956,0.1257193357352519,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.029476746366534,0.9120615438043759,-0.1327969174867457,0.2627615457902587,0.36055625644152034,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,22.8985088550048,0.8322586537401743,-0.26489612844867644,0.016861134600730052,0.0402242753546828,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,20.433706575370067,0.972514773773269,-0.040207928194666,0.045482005264313445,0.08925232215846456,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,25.037299940457633,1.1741300907182688,0.23159226435632896,0.13030354043908704,0.2030328301116583,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,22.2772711304372,0.828881368545762,-0.2707624603047723,0.01240097293419107,0.03186686451875605,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,27.253349088264866,1.3536824122121383,0.4368893075469344,0.05136073029360713,0.09815008668673614,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,20.845667219626765,0.738862443882277,-0.43662229614635395,1.239999528177793e-6,1.2481230131084379e-4,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,23.7733798686438,1.0670436322419505,0.0936191702879899,0.005562213121158063,0.019237557051234692,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,22.158699269424634,0.9028007533440173,-0.14752047249715208,4.129683333541318e-4,0.003864960042929695,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.956049228421765,1.036393541881255,0.051571930737827815,0.017916688421358146,0.04192045688330592,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.471649933646468,1.143912585004738,0.19397680911047102,0.041262139530914274,0.08310617415475331,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,22.6033729887552,1.0266778458829466,0.037983559399098435,0.16000846480487446,0.23935692481057042,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,27.011193972771935,1.2875361838946837,0.3646129772215935,6.166433611776803e-4,0.004593363812854149,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.6825608717218,1.0187403530862338,0.026786397875694583,0.06182299738632972,0.11512956145923647,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,20.116460474973,0.791272009710014,-0.3377543703522401,0.004766616531558956,0.01706989735222466,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,23.0578247972753,0.954418975819366,-0.06730536781362476,0.059836565784238294,0.11200177698075373,Downregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.6625817729804,1.095569162667878,0.13168056373329118,0.22979909191692194,0.32136654616734295,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.4972793866126,1.0646502017221846,0.0903795007467462,0.10089732745941114,0.16664038245558854,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,19.20433686231887,0.8568157517860523,-0.22294309190618236,0.13448570943975952,0.2079969658708145,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,19.1185912418606,0.8344271030297887,-0.26114207608572887,0.16925995005006544,0.2481119749729875,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,19.8210213802509,0.9668329331903567,-0.04866147848515967,0.31326621275101557,0.4157897005604389,Downregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,25.294523030630334,0.9708705834659184,-0.04264909691071546,0.18214742282573243,0.26278185506479185,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.954562846351568,1.0386167468289214,0.05466339298033458,0.5157404871547384,0.6175788524387482,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,24.0000434184496,1.0590533250410104,0.08277523317856765,0.021328372645806698,0.04896135858943047,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.90240466157117,1.1407957965926234,0.1900405711106473,0.0027626202152236487,0.012604454731957898,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.80357991509757,0.9612374961764159,-0.05703516833732357,0.1256695369146301,0.1984714044045506,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,24.353790988481233,0.9715002930411335,-0.04171366390543388,0.14918759412556387,0.22688946606596172,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,21.4310757834881,0.9942753502400181,-0.00828265415124471,0.6645014367014744,0.7394604402318237,Downregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,24.506970139269633,0.8965933344097364,-0.15747432096135716,0.004296318518125518,0.016334961032456397,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,25.564708055042733,1.4235886151608501,0.5095323003678524,1.2268032307555972e-4,0.0019717592282331494,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.883969398243533,0.8643730203059706,-0.21027405285911624,0.0012056566932494928,0.00785829808992973,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,24.728874746064367,0.9023172125770756,-0.148293388058783,0.017423628080856835,0.041296261360472375,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,25.401351878297167,1.0941339813378448,0.12978941306314776,0.03805468172094693,0.07716643793414238,Upregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,22.836745093079035,1.12864003370781,0.17458542907677482,0.1913070791534775,0.2749097790985011,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,22.316963510961,0.9809368661915505,-0.027767808354548847,0.8750077173514672,0.9021972226928969,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,23.205046164106534,0.9581068376066978,-0.061741556367066186,0.5687965881656921,0.6632931459440179,Downregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.530187616676667,1.0474402280975175,0.0668679192585931,0.10569024726329265,0.17145306778267475,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,22.297625001318668,0.8658283705217891,-0.2078470209015324,0.1263378412546433,0.1984714044045506,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,24.4118505594793,1.2501497997725701,0.32210097683970895,0.03745934472186559,0.07638358001944659,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,21.86909840411323,0.9327772139556153,-0.1003955483244563,0.1654880255884727,0.2445470823473382,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,21.515747310562766,1.0512714340138714,0.07213521539626236,0.027492859128946025,0.058683588199212273,Upregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,21.438924294262634,0.8315691923991928,-0.2660917840169612,0.1119847571537858,0.18006359630454544,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,22.2136008498238,0.8457907302437145,-0.24162734618381695,0.03328412086809078,0.06902672793666553,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,23.201213878412467,1.0232434116671354,0.033149377764871625,0.0828885752619503,0.14338545009768655,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,20.350438889289368,0.9974072037516245,-0.003745472013457423,0.9526835694795937,0.9686058575488905,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.798457259929968,0.928594705528652,-0.10687903962281915,0.09556403962594869,0.15927339937658114,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.88502210316277,1.0581802055874074,0.08158533592916119,0.00288039954983736,0.012821290679154104,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,23.529627941271798,1.21752495051444,0.2839513374941623,0.013796394014012534,0.03458680342813893,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,24.073843143713866,0.9388005894068011,-0.09110934725934038,0.009506122698445972,0.026913727483742825,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.524769667096166,1.0975478154595244,0.13428379317627095,0.011407600973253496,0.030613094488419333,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.928779198312665,1.017394241977161,0.024878834290079126,0.23942584109661474,0.3322830114078494,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,19.994562376860568,0.9888455230503527,-0.016182933393435642,0.5883716533940531,0.6774626293023008,Downregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,23.733448392661234,1.1268152589364018,0.17225100542720526,4.4671633847964145e-4,0.0038821777034540265,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,22.482879336333102,0.9174117784266164,-0.12435866493796377,0.26556213324007477,0.3630343769012258,Downregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,21.041565646723765,0.9252111277988314,-0.11214547707187719,0.3120535891186412,0.4157897005604389,Downregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,24.165255710774368,1.0502310841696536,0.07070680151555805,0.1371363236029223,0.21120151103403645,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,23.538084352090902,0.9140657231513852,-0.12963019321925273,7.920636249595093e-5,0.0017189565809779517,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.769442735972667,1.1610241018778447,0.21539792164251906,0.005586797390221583,0.019237557051234692,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,26.2140919862775,1.0135226168441689,0.01937828302766191,0.39337586422302606,0.500286377844615,Upregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,22.623372687072166,1.0061415527947322,0.008833290380773191,0.7745230287996839,0.8228508080872459,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,23.090265279797098,0.9880679692859407,-0.017317806540020856,0.39080493326647986,0.4987545477002278,Downregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,22.400349997975766,0.9250125234523003,-0.11245519693384746,0.043393023649074165,0.08654892695033918,Downregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,22.947201351414336,0.9836464299770277,-0.023788260404069977,0.8203479325969751,0.8620615694138777,Downregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,22.8669909716679,1.0968439971240365,0.13335834745478156,0.28381591081291796,0.38367706461746315,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,24.1363509991147,1.1398705608688389,0.18887000702597098,0.31601341806051403,0.4179162956235059,Upregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,22.25772333764183,0.9088915956948013,-0.13781986172188196,0.37636588940851906,0.48541890330074017,Downregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,22.2100602386838,1.0132332634743486,0.018966345232297215,0.8990839617497629,0.9244102705314463,Upregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,21.398619490928034,0.8669182314918743,-0.2060321713184259,0.15141547065667202,0.22932218584931655,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,24.0627635221294,1.1710677571012247,0.2278245515060064,0.20071182428886672,0.28617115572436075,Upregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,24.420362419832866,0.9859790309458648,-0.02037113010171959,0.8426868765085652,0.8788020283589324,Downregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.830237271205835,1.0092162261480149,0.013235307220633333,0.41046106672589244,0.5148394823194183,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,25.442634343612866,0.9665418804914853,-0.0490958487743552,0.7698363038503511,0.8228508080872459,Downregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,26.180160431799134,1.0249815170395529,0.0355978945933583,0.09111592345146534,0.15396903731381875,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,26.225865677845633,1.055844720336738,0.07839767780965463,0.024110372543629292,0.05396837625205425,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,28.553976095025767,1.3200075194112997,0.40054614790683024,0.0017211368948160314,0.00981585885324768,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.070044113405768,0.8143330432405694,-0.2963091510522944,1.49136020714306e-4,0.0020086410725133775,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.593573848828566,0.9961884766223881,-0.005509372108028135,0.45820195255971413,0.5688561655928424,Downregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,25.973922461483767,1.0577166727420504,0.08095322899159452,0.002728114931460129,0.012604454731957898,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.796021753680765,1.222179413779465,0.2894560857870766,2.2639591246222027e-5,8.26345080487104e-4,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.9894823673106,1.0793301690838228,0.110136255406875,0.003101995401413271,0.013014118638113149,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.368795927286868,1.2666739956183566,0.34104526526533196,5.367742328620263e-4,0.004215465393083545,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,29.1315440805228,1.0060926215691894,0.008763126741423075,0.5120981841532508,0.6168839512077114,Upregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,24.662792247739535,1.1008826110604595,0.138660640137533,0.07860938159588965,0.13709867640368661,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0680353065692,1.2414526246321842,0.3120292075378568,5.625995736624361e-4,0.004278100924724775,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.623408826406866,1.029024265318292,0.041277002680480575,0.017696635765925613,0.041672722932663546,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,30.160000249908702,1.0203480844121264,0.029061401204569137,0.023449917060230474,0.0528346896727415,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.107123291704035,1.0653336126287118,0.09130528577189692,0.012362557013876986,0.03186686451875605,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,22.409622164550132,1.0537980056021201,0.0755983544096671,0.41628482159844155,0.520356026998052,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,26.490919508027833,0.9705131066164241,-0.04318039846275937,0.5622791361327739,0.6577945022066105,Downregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,21.180552498331465,0.9369643044298769,-0.09393400837210326,0.046116249029117456,0.08991319898235071,Downregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,18.658165294612566,0.6392226464651175,-0.6456095737238523,5.405488699761809e-7,1.2481230131084379e-4,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.132218324769134,0.8907611021619639,-0.1668895351263824,0.02685563461974847,0.05766062727181289,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,26.007661329102834,1.2289722858648864,0.2974523823532845,0.0012663858854927452,0.007921788149874274,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,25.890722771367333,1.221859175737032,0.28907801823908635,1.3922801069935127e-4,0.0020086410725133775,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,21.7600087803012,0.8158134214207139,-0.2936888529471339,0.010425757037517155,0.028612039990178657,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,18.398550731601034,0.6581669577413136,-0.6034744948901924,0.0012581628838253243,0.007921788149874274,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,25.008631001851434,1.1938482650781936,0.2556194855726581,0.10043367066363716,0.16662858996467075,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,23.863685102265467,1.1097064465321054,0.15017808725711984,0.002806393250531055,0.01264609304251648,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.18245599682387,1.1214647304696461,0.16538424906738325,7.257057696436573e-4,0.0051937765866653905,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,24.423802064708966,0.9532931985012423,-0.0690080916987022,0.3104135124409979,0.4157897005604389,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,23.4468422600727,0.9548614785234014,-0.06663663790894235,0.6176926234948701,0.7001795266323838,Downregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.769556190813802,1.1799165902755795,0.23868487734221067,0.016262286430878826,0.03930950031305147,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,25.961904728350966,1.150391023242263,0.20212432326258914,0.00814013180538269,0.02475956757470568,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,22.2084141088284,0.9041837672936336,-0.14531207753481748,4.950686937930464e-4,0.004106819846237771,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,24.948216780476233,1.165907328626915,0.22145312143409426,9.214961828527798e-4,0.006346152957382351,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.9973175426306,1.0880229115958135,0.12170893719268822,0.008099844499790392,0.02475956757470568,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,22.1980290328719,1.1015493471862121,0.13953412631083983,0.010381770881338338,0.028612039990178657,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.291061494286634,1.016382794159351,0.023443858041209978,0.21097755986152017,0.29732358822183347,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,26.896290643774165,1.2938519307876533,0.37167252386734195,0.0020687752284324437,0.010943521135910754,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.754665037825333,1.303814819547479,0.3827389785476127,1.5105144869035893e-4,0.0020086410725133775,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.951153853234366,1.0773953119156143,0.10754769268540493,8.729929282668327e-6,4.5520345545341993e-4,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.372221168289766,1.0273325935015847,0.038903322177636306,0.024248804672155882,0.05396837625205425,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.2475055098148,1.082955341612016,0.11497375101337327,0.06892786606267459,0.12454787679641696,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1117199147677,1.009050474649864,0.012998342636274746,0.494125402108136,0.6052207106358042,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.3008751858887,1.2640103448392248,0.3380082707833516,0.013834721371255573,0.03458680342813893,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,22.190746064366,0.8875827377325877,-0.17204648552026683,0.08555108674216647,0.1459165731817325,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,21.1782160796956,0.9840932057449244,-0.023133131865610036,0.5395948190564397,0.6353293837277435,Downregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,23.872074329576865,1.029964890945904,0.0425951602031325,0.3199757037434022,0.4216286348965408,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,22.740743807338802,0.9001272492751825,-0.1517991279768952,0.20847743754291015,0.2960866330862343,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.382455560123066,0.9413164941721939,-0.08724822017675382,1.483246670081398e-4,0.0020086410725133775,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,22.367876646803502,0.900428311713467,-0.15131667544927616,0.00205956103336835,0.010943521135910754,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,23.06729450881,0.9263361327236171,-0.11039230634780095,0.007018326356901053,0.022083526898869693,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.384079335290934,1.0514427164692657,0.07237025290668997,0.06697643121398135,0.12223198696551596,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,21.877988208980234,0.9396253142077188,-0.0898425137318159,0.38420452422289975,0.49266029477048623,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,22.942307806516734,0.8955863314178911,-0.1590955851717352,0.0059862242401707315,0.01994508816846971,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.316701044452202,1.0277528035116819,0.03949330730139702,0.02568404851317831,0.056473962092229414,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.813348170484634,1.025650834996793,0.0365396740703279,0.016593023858331987,0.03984509018612615,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.901086034777933,0.9607495518690677,-0.05776769652816738,0.003236555130672252,0.01327351261455474,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,27.909488039612032,1.0669988698502126,0.09355864808140334,0.05740562406468731,0.10800542671964365,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.50742501049143,0.9878244336418988,-0.017673440953309225,0.1558391864555886,0.2340794364456372,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,24.1455385493278,1.1630081553244698,0.2178612134103724,0.3129111278449974,0.4157897005604389,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,24.939526478210265,1.2045803747008574,0.2685306595072348,0.07005648456455801,0.12519045880967647,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,28.173696116950566,1.386380839954424,0.47132362143000445,0.0022216644475437047,0.011584393190763603,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,24.9235035664126,1.2440544144863752,0.3150495898035344,0.1982255713171534,0.2837346412971019,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.781975247267432,1.3869508461509321,0.4719166591316813,1.1990734792780877e-4,0.0019717592282331494,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,19.705480221759068,1.0040119231053555,0.005776402060428594,0.517175008740252,0.6175788524387482,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,23.6548731976333,0.8020987488239184,-0.31814823268524034,0.0038216808886408606,0.014999070154343163,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.099573067452233,0.8570770948150795,-0.22250311306430962,9.33194785681232e-5,0.0018923116487424983,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,21.695794727274965,0.9826820037562316,-0.025203459425501333,0.1818061573447661,0.26278185506479185,Downregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,29.744880444626066,0.9714242947947421,-0.04182652705403723,0.10403447059438159,0.17028063572622995,Downregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.623232217938032,0.8712324524915745,-0.19887040096033393,4.765131676723138e-5,0.0013379023553876503,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.616801933017666,1.009853555634826,0.014146095078357627,0.38467995619065365,0.49266029477048623,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,22.208054932019035,1.0426986143403185,0.06032221593073452,0.07042246767851136,0.12519045880967647,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,19.6245483141361,0.9973028341348247,-0.0038964448624972206,0.8582671099819785,0.8899644748392674,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,22.5906632251769,0.8990854964067552,-0.1534697829549348,0.0048169847322716165,0.01706989735222466,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,24.428730592725632,1.1319160537765611,0.17876696763000904,0.002312968237659415,0.011729473695736901,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,21.926386648387865,1.004767863883691,0.006862227466135879,0.9678047536526572,0.9785283520310799,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,22.966200792567435,1.0014423432936639,0.0020793623001184387,0.9799212366159809,0.9826133279253654,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,25.796916021192267,0.9875707638368896,-0.018043967491177447,0.8504051004053235,0.884324392159382,Downregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,21.665846514552968,0.942040279890762,-0.08613934677301911,0.4992215843800703,0.6094176531729956,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,20.591065114808067,0.8090109867234606,-0.3057687996686689,0.006192265977615745,0.020361955692159883,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,26.8691542025348,1.0041773220880736,0.006014049277438921,0.9666973436200184,0.9785283520310799,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.9170538346994,0.876209981550381,-0.19065144533582043,4.448157642309398e-4,0.0038821777034540265,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.7173040578018,0.9596508062411847,-0.05941855545955328,0.08969253559601217,0.15226872322113694,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,21.039713919288733,0.7917423079005055,-0.336897148936647,0.009469229097633146,0.026913727483742825,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,22.379361040085033,0.8513287512022888,-0.23221174071833253,0.30040729998977966,0.4046076180674154,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,26.269378315050066,0.8821451786802249,-0.18091198862145738,0.2801536008822923,0.38013406811166056,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.773482146853834,1.1636772008184855,0.21869091618079728,0.15470548949064766,0.233336792000357,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,21.0121770164514,0.8067763346358181,-0.3097593292362989,1.5840649888208315e-4,0.0020086410725133775,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,27.695660187399035,1.4322197639846412,0.5182528809295713,0.00840778399453988,0.025362323619893025,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,22.3372806432835,0.8019299607795531,-0.3184518552750456,0.027853155173505055,0.05910698626935666,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,21.93527962217363,0.8726646991919892,-0.1965006560764593,0.11440805658121543,0.1823534526294482,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.285136866672833,0.9598359958064161,-0.05914017681383645,2.6469038718810025e-4,0.0027603426092473312,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.140693160787634,0.9910891591982214,-0.01291324560159214,0.504028565325876,0.6104367608644916,Downregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.291514034102,1.0228694036727615,0.03262195866979506,0.14846361702375627,0.22673313896933486,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.438707093650066,0.8676295539809953,-0.20484889865952247,0.015338811880569476,0.0375749418550863,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,21.733237079986733,0.8015867666083135,-0.3190694036024348,0.004404320567316057,0.016403847010922047,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,22.252768619880968,0.8509398636468836,-0.2328709153662264,0.004349848215717159,0.01636798555398725,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,20.92999464096337,0.9870020166236282,-0.018875062515785093,0.5288586649131611,0.6247036009492033,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,20.005141981386267,1.0010466106384572,0.001509150369115668,0.937757575318346,0.9587717506756198,Upregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.5456550326866,1.4724840278049784,0.558251985069981,6.619883439885149e-4,0.004832514911116159,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,24.25762104421,0.9603577768470356,-0.05835611954942881,0.001989279411050226,0.01088937650052313,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.965383720255165,1.1406822675293915,0.18989699066669533,0.2374475831502146,0.3307952971367494,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,22.25895033704043,0.9477027018490967,-0.0774935440300995,0.09540864912241748,0.15927339937658114,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,24.923316596574733,0.9270276274580581,-0.10931575991703202,0.018121949856287095,0.04213064775506236,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,24.222725506233168,0.8797609206112229,-0.18481657739992566,0.27598121150056687,0.3758699335735332,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,26.316278898461267,1.2824605897461887,0.3589144922250486,1.2424784177907517e-4,0.0019717592282331494,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,21.738216075565102,1.0212952472304766,0.03039999661719758,0.6347268124949577,0.7172609491042091,Upregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,26.162434114821632,1.3427891176895903,0.4252327502216194,0.0037539621313901917,0.014893436716928478,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.8337936011975,1.0034793482117053,0.005010926078565344,0.6697607978795947,0.7430476936962068,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,26.937916665808466,0.9964815513220846,-0.005084999368957957,0.5206635132659071,0.6190299099089775,Downregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,23.217544671826833,1.0468989933361064,0.06612225521750936,0.7744867306084532,0.8228508080872459,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,24.108635256202835,1.2155081633653666,0.2815595825539583,0.008981759595220054,0.026438243969800965,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,21.3107007310268,0.9269158962071873,-0.10948965315561368,0.25110489405010555,0.3458614578425982,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.917033442832967,0.9606937808994696,-0.05785144659241886,2.474690025272079e-4,0.0026566525271303197,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.0349272644887,0.705144884269071,-0.5040083801543239,0.004635488137063159,0.01706989735222466,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.197596559426202,0.7178719033054582,-0.478201661637359,0.0073867947200479634,0.022848983667944973,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.938223191140768,0.8303431209937723,-0.26822047329019444,0.0016300371174004147,0.009443865838907163,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.125362054021366,0.7801166176953956,-0.3582382898932086,0.06654375702696083,0.12223198696551596,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,20.317969427304867,0.7908718899755154,-0.33848407738981623,1.0435085940069187e-6,1.2481230131084379e-4,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,18.85588198535987,0.7060879660683211,-0.5020801659164786,0.0011689691727038553,0.0077577045097619495,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,21.5637946093456,0.873056472942814,-0.1958531184673886,0.0041558985240438264,0.016137265545489325,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,22.801633119129335,0.8879286282639947,-0.17148437753242637,0.026683778720702187,0.057630646349445556,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,21.14245989898127,0.7823577845478202,-0.35409956926317593,1.596250030768819e-4,0.0020086410725133775,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.202955578550668,0.8689247652245848,-0.2026968264048736,0.06675032524037698,0.12223198696551596,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,21.8974773807363,0.8602024227044587,-0.217251900341854,0.0013239152798420017,0.007921788149874274,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.65159511419827,1.0235922742449224,0.03364116351910951,0.7755087068000344,0.8228508080872459,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,21.1559492989488,0.8109139486561008,-0.3023792660598981,0.011394757310157603,0.030613094488419333,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,25.603971130468235,0.9698127942973577,-0.04422180821066402,0.014164101169295047,0.03515509725761819,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,25.451702419370932,0.8961609419030477,-0.1581702451551585,0.006010848489127857,0.01994508816846971,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,21.714504669852033,0.9468731175986884,-0.07875697951604749,0.008485393057504637,0.02538662677040322,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,23.261406152512667,0.9491403195233016,-0.07530670593857591,0.07887869053362792,0.13709867640368661,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,25.304712550202268,1.0715347378379236,0.09967862117091744,0.005025435769326288,0.017637346690423994,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.90328229717007,1.0568372005636186,0.07975315531212736,0.009876790448213229,0.02773098856613714,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.6732501470252,1.0613463869906998,0.08589557919081023,0.0034712032141385523,0.014077657479561906,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.746410490872265,1.0308275646471583,0.043803020936536645,0.011015501285689384,0.030004910218482277,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,25.095807339854865,1.0718697799232804,0.1001296452822923,1.971289281320676e-4,0.002321034153813054,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,22.884681882553068,0.9200955959546891,-0.12014433301669786,0.46333509926756133,0.5732790211276606,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,19.8498585260969,0.9949258959821654,-0.0073390199651008695,0.6565843452431543,0.7328846667087197,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,26.1004603730291,1.0719665577780395,0.10025989863117754,0.013754883120142307,0.03458680342813893,Upregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,21.256871713120866,0.7912881233276158,-0.3377249913280623,0.02975933141745994,0.06242618372053379,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,21.044622882169833,0.7507311832349055,-0.41363168520336807,2.0517090626440074e-6,1.2481230131084379e-4,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.927081129806467,0.7404433949303256,-0.43353864563215744,1.4753649344840621e-6,1.2481230131084379e-4,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,27.7706753526044,1.4158638203875868,0.5016825118196704,1.0797641565670061e-4,0.0019717592282331494,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,27.247732720547802,1.3581123318514652,0.44160281235341026,0.0031491811872838265,0.013061944697256779,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,20.504811434739832,1.0060132990414692,0.008649377046379851,0.7633659489727341,0.8228508080872459,Upregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.235425305062833,1.0239356378590543,0.03412503383418071,0.7734138524861198,0.8228508080872459,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.910134891071465,1.0588187095043624,0.08245559283476873,0.025276591032715734,0.05591488319358329,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,20.105743560235066,1.0140462551719223,0.02012346159682552,0.6058826639712285,0.6910849135921825,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.1410153720616,1.103851668970004,0.1425463217368063,0.13071976733216356,0.2030328301116583,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.389617741496433,1.009629121270818,0.013825428455172019,0.16439102585852694,0.24391351397708264,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,20.726216876243168,0.8039428154374657,-0.31483520892946204,0.04631145591419708,0.08991319898235071,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,20.424621107540467,1.0003719243647804,5.364736790212588e-4,0.9904286672760223,0.9904286672760223,Upregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.2922994852546,1.0381096126165414,0.05395878399371363,0.01177636628207781,0.031147635456220298,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,20.1144961385284,0.9941368795898476,-0.00848358926684661,0.5009710291887962,0.609514752179702,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,26.575013147248068,1.3566391906975577,0.4400370752108212,2.163879560309127e-5,8.26345080487104e-4,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,24.762378508808798,1.224137478101973,0.2917655905781073,4.705204483760791e-4,0.0039939526431923,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.151375727031734,0.8975839953910886,-0.15588114306694975,6.937179186141658e-5,0.00168804693529447,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,24.286457409492034,1.0872778271554415,0.12072063277109155,0.4720456810379627,0.5801234800634896,Upregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.4579521373332,1.1702582104346702,0.22682688691428046,4.2481642015588264e-4,0.003876449833922429,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.307620936458832,0.8699827846500533,-0.20094124190959162,5.428133519861003e-4,0.004215465393083545,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,21.810838272032534,1.045158204780373,0.06372133845627032,0.14659311020614968,0.22481716481195224,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,24.335794363931768,1.0525665570827076,0.07391146230565886,0.3468951625787929,0.45277003040870456,Upregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.815439668341533,1.029078015047878,0.04135235799112797,0.06616281190233159,0.12223198696551596,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,28.003605830377733,1.3437479557436953,0.4262625599183387,3.622033934443944e-5,0.001201856714610945,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,24.610537720242032,0.9881940015805585,-0.017133796353756156,0.8644098048791117,0.8937948407390247,Downregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,27.195462672482165,1.303488336935851,0.3823776743041665,0.002691764218950255,0.012604454731957898,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.668780909383567,1.0336822574312479,0.04779278519305363,0.08463231673549729,0.1457113000398892,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,20.0408390846854,0.9948018862889152,-0.007518851770536778,0.6499881470918395,0.7277474653022129,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,22.33873100038783,1.0039778758261586,0.005727477667601568,0.6117623754592962,0.6956176543384521,Upregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,20.3130816158032,0.8109433312072752,-0.30232699258133866,0.0027281217633199277,0.012604454731957898,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,22.1150163502614,0.8660437369607734,-0.20748820907731536,0.003025449083321851,0.013014118638113149,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,22.704067665479734,0.9385050997640288,-0.09156351031679154,0.34733043428612953,0.45277003040870456,Downregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,21.708426848423198,0.9355113064821359,-0.09617300506947442,0.5938478471200341,0.681296633564225,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,20.046508995598366,0.987799790720677,-0.017709431826272853,0.7697805121026053,0.8228508080872459,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,20.4002106878276,1.0012387712457378,0.0017860630994759308,0.9524683153371287,0.9686058575488905,Upregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,26.9410955864788,1.1635896780097208,0.21858240372493956,0.009511974918911847,0.026913727483742825,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,22.699728880447566,1.0107426948801692,0.015415776601704324,0.6779904095205164,0.7498984832575407,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,23.033311777728667,1.0494277263277914,0.06960281221474789,0.012484826373101684,0.03186686451875605,Upregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,20.837510858465734,0.8085142350342422,-0.3066549202824052,0.11288519802765357,0.18071533894777872,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.71201812109503,1.084981848959617,0.11767090752230105,2.2705252288012542e-4,0.0025113385106438116,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,20.970954117482567,0.7868356332982661,-0.3458658006941157,0.007298019841093407,0.02276732685469311,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,19.680713163433968,0.9893343187652106,-0.015469971757411863,0.3592207530852452,0.4649488470784202,Downregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,25.064584704857968,0.9769459547655731,-0.03364934123858102,0.7173824685145112,0.7821407552300275,Downregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,21.0187264198941,1.0348000712502363,0.04935205847077582,0.12669544445550765,0.1984714044045506,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.448736412949035,1.0573378051992708,0.08043637201540908,0.4087739950674999,0.5146672781144574,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.814102171301332,1.4681535344598293,0.5540028481684313,0.0030015085449933815,0.013014118638113149,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,24.511445401693567,0.8348066827323231,-0.26048594538842523,0.008860072266565837,0.026292084368264475,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,19.741058022810833,0.9680168837629345,-0.046895884258738814,0.10518581263139533,0.17139652504669328,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,24.84631810044243,1.0292475384104929,0.04158999825624675,0.1117252145762355,0.18006359630454544,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.4157355648094,1.0411712451898414,0.05820737340972859,0.011490394369625886,0.030613094488419333,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.990452279342367,1.045735443595088,0.06451791612745156,0.010179374455560266,0.02836237920824044,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,24.684339618769567,1.1661956485793947,0.22180984476219476,0.2250715858963642,0.3159658802006651,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,24.825079770936966,0.9348665206255441,-0.09716770184261689,0.595434592073939,0.681296633564225,Downregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,30.5610379393236,1.7180164042296857,0.7807438119058466,1.6509378678192143e-4,0.0020086410725133775,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,20.5573156123154,1.0071043052956328,0.010213110295910365,0.6368702880225134,0.7174618985438809,Upregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,21.0330889006201,0.9177822767129084,-0.12377614774196889,0.037329572595408846,0.07638358001944659,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.110363772102936,1.0673099628212257,0.09397921729129842,0.004242769243023444,0.01630116603898481,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,25.8361317883481,1.008666911259558,0.012449836674447724,0.7075063634724976,0.777830791167053,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,23.141694182978632,0.9184541548967816,-0.12272038460544965,0.5874393157138682,0.6774626293023008,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,24.9347004994001,1.2329700789834153,0.3021377896628803,0.18146403281742096,0.26278185506479185,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.911257123432666,0.9346005474613334,-0.09757821259635596,5.066482591107361e-4,0.0041094803238981925,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,25.94410557089917,1.4078230170522539,0.4934659785279216,0.0030589685478346848,0.013014118638113149,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,26.828544468971135,1.2160784940369804,0.2822363532083687,0.029112010834567558,0.06142129453535929,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.805674903946368,1.1350473636611857,0.18275250006545404,3.157211264994852e-4,0.003201061421453114,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.069283230913967,1.0501020695846848,0.07052956420266959,0.05012278790288056,0.09628851360290212,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,20.2000386933588,0.9929028617289777,-0.010275512840496106,0.5177510379349506,0.6175788524387482,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,26.21209259559477,1.0252029455140594,0.0359095287600971,0.7178552137042717,0.7821407552300275,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,25.413674365881267,1.2799958174322952,0.35613909602250604,0.0706554370268311,0.12519045880967647,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,22.287667406137032,0.936228775426809,-0.09506698725303496,0.005709392366683118,0.019475964615320914,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.116208624241732,1.0072758459099345,0.010458824387179799,0.8305499197016353,0.8686267068512804,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,26.138573810870266,1.1520263988752009,0.20417377675415407,0.09204004164322391,0.15481389492984665,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,18.55128408291017,0.9793173009021046,-0.03015172303495142,0.3540039914431268,0.4598272486716771,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,21.380353481004168,0.9967170068846124,-0.004744149660242255,0.9192683529458326,0.942508283216935,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.416481051520467,1.0285771339052994,0.040649986891564946,0.10217302750857267,0.1679871848676983,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,25.302410447073868,0.8908483684133927,-0.16674820382976188,0.07882149455662066,0.13709867640368661,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,22.7885861540737,1.1566384229884656,0.20993793368586516,0.048890251710323365,0.09441768187443401,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,21.600860611240467,0.9947545721360621,-0.007587469972758506,0.741097754158892,0.8050615484166534,Downregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.914901047264333,1.00961966875452,0.013811921354457746,0.5775894129272423,0.6714017061096925,Upregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.973615210334966,1.317951099718866,0.39829684265108006,1.8489320679624176e-6,1.2481230131084379e-4,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,20.0216272513046,0.76607930567508975,-0.38443434505852325,0.01838094816546537,0.04246231696452443,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,22.051379250204068,0.9942872970890568,-0.008265319359317728,0.8206893172505106,0.8620615694138777,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,24.5682518657356,0.8742391793979374,-0.1939000603275891,0.06816155965794236,0.12377596654302966,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,24.7846464920801,1.1134670061399936,0.15505880933051777,0.2108093371399271,0.29732358822183347,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.823328827164534,0.9810224110021198,-0.0276420003670998,0.16433678474636487,0.24391351397708264,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,23.991709384314934,0.922395784568335,-0.1165421751286564,0.02235364563741897,0.05067751961278214,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,23.661974831278002,0.8065852710065963,-0.310101033849446,0.004690141751407014,0.01706989735222466,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.206665230593835,0.9469108670075782,-0.0786994641019858,0.030932103922091392,0.0645155310375049,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,25.221915194440665,0.9994278270957835,-8.257072576372654e-4,0.9780748862279489,0.9826133279253654,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,24.282027306939934,0.9911398683077012,-0.012839431950621236,0.18107219339108846,0.26278185506479185,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,21.939800873107835,1.0395326420186033,0.055935060494491824,0.43017400807464634,0.5358822967482796,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,21.429909145334232,1.0457323331734223,0.06451362498803057,0.04519640104594972,0.0891712777393062,Upregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.884867714479768,1.0137133090926387,0.01964969767505932,0.0438691898356109,0.08702312114129337,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,18.2901738334145,1.007982395288537,0.011470441961126506,0.5832062341440808,0.6757786522621889,Upregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.577985861204034,1.0365592337556166,0.05180256102403164,0.0014226507847491532,0.00837528284570066,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,24.229165913917132,0.9392958910736398,-0.0903483967091581,0.002510112797135349,0.012380961769654086,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,24.418750614290865,0.954698265597568,-0.06688325651305485,0.006628625816840799,0.021223231781990277,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,22.959582771927433,1.0327554030558757,0.0464986079466617,0.8003107488632761,0.8467055748843356,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,21.729665789563366,1.0167642435378985,0.023985201213183222,0.3246550445148799,0.4262557239134215,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,20.1780974681236,0.988994803163278,-0.015965154762698528,0.5287838781289972,0.6247036009492033,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.5037403069425,0.8813059105746041,-0.18228521414809729,0.002662181875139105,0.012604454731957898,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,25.0391865595278,1.1104538205969323,0.1511493981248147,0.4714483617321614,0.5801234800634896,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,24.223592088894932,1.0726785974925146,0.10121787174874368,0.6962629149358588,0.767782368433802,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,22.269461871508234,0.8702769745470772,-0.20045346839495853,1.1750240735218273e-4,0.0019717592282331494,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.614798177812,1.033735386611513,0.04786693489873394,0.00600087231519557,0.01994508816846971,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.320172208313167,1.0380235725741753,0.05383920636411263,0.007008249982765871,0.022083526898869693,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,20.294767812924498,0.7361831519650492,-0.44186336181114483,0.0035177318079837954,0.014109583625429509,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,23.078877850794434,0.9252319390270396,-0.11211302618887485,3.3569390860161184e-4,0.003311575044313198,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.803669004105068,0.7778957469246137,-0.3623512757594722,0.0012877950490283922,0.007921788149874274,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,23.200819436435832,1.1078595157173767,0.14777494923215428,0.4089137278169662,0.5146672781144574,Upregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,21.236094019068332,0.9808595226449581,-0.02788156445258876,0.1674051776518843,0.24638262033442648,Downregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.583660968513033,1.0284181189887491,0.040426933355910334,0.02188348163509594,0.04992169248006262,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.9127932214179,1.0495424567011409,0.06976052854838032,7.514835978300933e-4,0.005274836792461232,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,25.067859196871233,1.0520053158687788,0.07314199470450107,0.0011125337800604468,0.007519904254112279,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.618789530451767,1.0348214007079213,0.04938179521562986,3.639214494617603e-4,0.0034955612908826976,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,24.420577158328534,1.06279798053827,0.08786739162548396,0.03503464891754127,0.07224659240057944,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,NA,F18,F1246_1,Area: 19,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.291037384054867,1.0333212626805808,0.04728886215973314,0.01227945949149159,0.03186686451875605,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.566127384301268,1.1008123504674148,0.1385685614336606,0.0019632835139276436,0.01088937650052313,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.594004731145233,1.085059072289574,0.11777358735117073,0.026485509647572594,0.05754292274621426,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.103801103179432,0.9576333821932541,-0.06245465074583852,0.12418370271958887,0.19707413692456494,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,25.865814408569634,1.0265314904938285,0.03777788510110572,0.08505398531370713,0.14574978703992067,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4092114122264,1.0532658116518734,0.07486957383562665,0.02624835755969652,0.05736916472628281,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.807259567111366,1.0003147408655144,4.5400364284028277e-4,0.9714962443290832,0.9795473181771144,Upregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,23.4205611952757,0.9537463244870903,-0.06832250273517732,0.0699602677557655,0.12519045880967647,Downregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,24.170614998523433,1.0548579660598723,0.07704875679420652,0.0019988718507809584,0.01088937650052313,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.307573026424432,1.015061224119682,0.02156674718387041,0.5050737035097985,0.6104367608644916,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,24.8086255276989,1.0270701580207056,0.03853473391655019,0.5521159185033222,0.6479817049958605,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,23.041615449195902,0.9207567852253831,-0.11910797123919635,0.3988442900213529,0.5054797425617841,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,19.773865904456468,0.7892315115387577,-0.34147953538808523,0.009406355227105284,0.026913727483742825,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,22.453952408312833,0.9802539583470489,-0.028772532411116224,0.2423444885428845,0.33505961484148805,Downregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,23.853567090450035,1.1165145292601892,0.15900202514626824,5.4150580298791877e-5,0.0014117829863613597,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.219694200619735,1.2267728630574928,0.29486815880153566,2.066199539534021e-4,0.0023567588497809926,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,24.8158824974359,1.0249965913013328,0.03561911195429194,0.05234192130528202,0.09950417331472884,Upregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,22.049019786161434,0.8735632169127127,-0.19501598484622076,0.002313759194775498,0.011729473695736901,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,23.939439294293933,1.0409253745124962,0.05786664339249682,0.054976077362542584,0.1039703017478137,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,19.6695044806278,0.9964379020473756,-0.005148195693390129,0.7139713578517997,0.7821407552300275,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,24.318654783177898,1.2494047070342678,0.32124087026674736,0.041439243003192065,0.08310617415475331,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,21.784813540310235,0.8667151961815712,-0.20637009516318233,0.00654843812478187,0.021152034650844094,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,22.928283771934336,0.9388260761790735,-0.09107018117734773,0.002576878285587238,0.012540807656524558,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,20.475389434119734,0.816868262813282,-0.29182466267364443,0.0013122360050663799,0.007921788149874274,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.497973241322267,0.9898901128056645,-0.014659713643976079,0.8219107565918614,0.8620615694138777,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.485788575419033,1.037503200145043,0.053115786412587455,0.006322760483348946,0.020605424789485405,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,22.165337714170267,0.8724043800065735,-0.19693108167405884,0.0024559615009637787,0.012279807504818894,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,25.28688897484737,1.0038833972791867,0.005591707599108244,0.7720505162001491,0.8228508080872459,Upregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.122502056196932,0.9339384303965501,-0.0986006510438823,0.009129819911104982,0.026659074140426547,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,24.9743973785335,1.25510904616313,0.32781271359791014,4.227441532177798e-5,0.0012858467993707469,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,23.497595787553568,1.060598468239976,0.08487856999315756,0.6395315214122348,0.718243093278356,Upregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.958095537650166,0.9452162443479122,-0.08128367141691287,0.01552025041803678,0.0377659426838895,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,24.6671449735766,1.2256242944410356,0.29351679989690455,8.006099144280871e-5,0.0017189565809779517,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,23.38991073964,1.0676908970314392,0.09449403853764649,0.01425466957295203,0.03515509725761819,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,22.7348999953628,0.8854599622251635,-0.17550102066579315,0.003092160136033529,0.013014118638113149,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.587601625183932,1.0380965069346357,0.053940570481948065,0.012019850356753074,0.03156291640442354,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.803554025363766,1.3212815246994458,0.401937893545508,1.509789670316696e-5,6.888415370819925e-4,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,24.758022372246,1.2126132216549146,0.2781194579753137,0.004814019712443241,0.01706989735222466,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,24.5485426565242,1.2124363544970778,0.2779090166099337,0.07129836300601956,0.1257193357352519,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.029476746366534,0.9120615438043759,-0.1327969174867457,0.2627615457902587,0.36055625644152034,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,22.8985088550048,0.8322586537401743,-0.26489612844867644,0.016861134600730052,0.0402242753546828,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,20.433706575370067,0.972514773773269,-0.040207928194666,0.045482005264313445,0.08925232215846456,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,25.037299940457633,1.1741300907182688,0.23159226435632896,0.13030354043908704,0.2030328301116583,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,22.2772711304372,0.828881368545762,-0.2707624603047723,0.01240097293419107,0.03186686451875605,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,27.253349088264866,1.3536824122121383,0.4368893075469344,0.05136073029360713,0.09815008668673614,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,20.845667219626765,0.738862443882277,-0.43662229614635395,1.239999528177793e-6,1.2481230131084379e-4,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,23.7733798686438,1.0670436322419505,0.0936191702879899,0.005562213121158063,0.019237557051234692,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,22.158699269424634,0.9028007533440173,-0.14752047249715208,4.129683333541318e-4,0.003864960042929695,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.956049228421765,1.036393541881255,0.051571930737827815,0.017916688421358146,0.04192045688330592,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.471649933646468,1.143912585004738,0.19397680911047102,0.041262139530914274,0.08310617415475331,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,22.6033729887552,1.0266778458829466,0.037983559399098435,0.16000846480487446,0.23935692481057042,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,27.011193972771935,1.2875361838946837,0.3646129772215935,6.166433611776803e-4,0.004593363812854149,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.6825608717218,1.0187403530862338,0.026786397875694583,0.06182299738632972,0.11512956145923647,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,20.116460474973,0.791272009710014,-0.3377543703522401,0.004766616531558956,0.01706989735222466,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,23.0578247972753,0.954418975819366,-0.06730536781362476,0.059836565784238294,0.11200177698075373,Downregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.6625817729804,1.095569162667878,0.13168056373329118,0.22979909191692194,0.32136654616734295,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.4972793866126,1.0646502017221846,0.0903795007467462,0.10089732745941114,0.16664038245558854,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,19.20433686231887,0.8568157517860523,-0.22294309190618236,0.13448570943975952,0.2079969658708145,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,19.1185912418606,0.8344271030297887,-0.26114207608572887,0.16925995005006544,0.2481119749729875,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,19.8210213802509,0.9668329331903567,-0.04866147848515967,0.31326621275101557,0.4157897005604389,Downregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,25.294523030630334,0.9708705834659184,-0.04264909691071546,0.18214742282573243,0.26278185506479185,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.954562846351568,1.0386167468289214,0.05466339298033458,0.5157404871547384,0.6175788524387482,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,24.0000434184496,1.0590533250410104,0.08277523317856765,0.021328372645806698,0.04896135858943047,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.90240466157117,1.1407957965926234,0.1900405711106473,0.0027626202152236487,0.012604454731957898,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.80357991509757,0.9612374961764159,-0.05703516833732357,0.1256695369146301,0.1984714044045506,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,24.353790988481233,0.9715002930411335,-0.04171366390543388,0.14918759412556387,0.22688946606596172,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,21.4310757834881,0.9942753502400181,-0.00828265415124471,0.6645014367014744,0.7394604402318237,Downregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,24.506970139269633,0.8965933344097364,-0.15747432096135716,0.004296318518125518,0.016334961032456397,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,25.564708055042733,1.4235886151608501,0.5095323003678524,1.2268032307555972e-4,0.0019717592282331494,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.883969398243533,0.8643730203059706,-0.21027405285911624,0.0012056566932494928,0.00785829808992973,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,24.728874746064367,0.9023172125770756,-0.148293388058783,0.017423628080856835,0.041296261360472375,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,25.401351878297167,1.0941339813378448,0.12978941306314776,0.03805468172094693,0.07716643793414238,Upregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,22.836745093079035,1.12864003370781,0.17458542907677482,0.1913070791534775,0.2749097790985011,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,22.316963510961,0.9809368661915505,-0.027767808354548847,0.8750077173514672,0.9021972226928969,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,23.205046164106534,0.9581068376066978,-0.061741556367066186,0.5687965881656921,0.6632931459440179,Downregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.530187616676667,1.0474402280975175,0.0668679192585931,0.10569024726329265,0.17145306778267475,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,22.297625001318668,0.8658283705217891,-0.2078470209015324,0.1263378412546433,0.1984714044045506,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,24.4118505594793,1.2501497997725701,0.32210097683970895,0.03745934472186559,0.07638358001944659,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,21.86909840411323,0.9327772139556153,-0.1003955483244563,0.1654880255884727,0.2445470823473382,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,21.515747310562766,1.0512714340138714,0.07213521539626236,0.027492859128946025,0.058683588199212273,Upregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,21.438924294262634,0.8315691923991928,-0.2660917840169612,0.1119847571537858,0.18006359630454544,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,22.2136008498238,0.8457907302437145,-0.24162734618381695,0.03328412086809078,0.06902672793666553,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,23.201213878412467,1.0232434116671354,0.033149377764871625,0.0828885752619503,0.14338545009768655,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,20.350438889289368,0.9974072037516245,-0.003745472013457423,0.9526835694795937,0.9686058575488905,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.798457259929968,0.928594705528652,-0.10687903962281915,0.09556403962594869,0.15927339937658114,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.88502210316277,1.0581802055874074,0.08158533592916119,0.00288039954983736,0.012821290679154104,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,23.529627941271798,1.21752495051444,0.2839513374941623,0.013796394014012534,0.03458680342813893,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,24.073843143713866,0.9388005894068011,-0.09110934725934038,0.009506122698445972,0.026913727483742825,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.524769667096166,1.0975478154595244,0.13428379317627095,0.011407600973253496,0.030613094488419333,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.928779198312665,1.017394241977161,0.024878834290079126,0.23942584109661474,0.3322830114078494,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,19.994562376860568,0.9888455230503527,-0.016182933393435642,0.5883716533940531,0.6774626293023008,Downregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,23.733448392661234,1.1268152589364018,0.17225100542720526,4.4671633847964145e-4,0.0038821777034540265,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,22.482879336333102,0.9174117784266164,-0.12435866493796377,0.26556213324007477,0.3630343769012258,Downregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,21.041565646723765,0.9252111277988314,-0.11214547707187719,0.3120535891186412,0.4157897005604389,Downregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,24.165255710774368,1.0502310841696536,0.07070680151555805,0.1371363236029223,0.21120151103403645,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,23.538084352090902,0.9140657231513852,-0.12963019321925273,7.920636249595093e-5,0.0017189565809779517,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.769442735972667,1.1610241018778447,0.21539792164251906,0.005586797390221583,0.019237557051234692,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,26.2140919862775,1.0135226168441689,0.01937828302766191,0.39337586422302606,0.500286377844615,Upregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,22.623372687072166,1.0061415527947322,0.008833290380773191,0.7745230287996839,0.8228508080872459,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,23.090265279797098,0.9880679692859407,-0.017317806540020856,0.39080493326647986,0.4987545477002278,Downregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,22.400349997975766,0.9250125234523003,-0.11245519693384746,0.043393023649074165,0.08654892695033918,Downregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,22.947201351414336,0.9836464299770277,-0.023788260404069977,0.8203479325969751,0.8620615694138777,Downregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,22.8669909716679,1.0968439971240365,0.13335834745478156,0.28381591081291796,0.38367706461746315,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,24.1363509991147,1.1398705608688389,0.18887000702597098,0.31601341806051403,0.4179162956235059,Upregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,22.25772333764183,0.9088915956948013,-0.13781986172188196,0.37636588940851906,0.48541890330074017,Downregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,22.2100602386838,1.0132332634743486,0.018966345232297215,0.8990839617497629,0.9244102705314463,Upregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,21.398619490928034,0.8669182314918743,-0.2060321713184259,0.15141547065667202,0.22932218584931655,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,24.0627635221294,1.1710677571012247,0.2278245515060064,0.20071182428886672,0.28617115572436075,Upregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,24.420362419832866,0.9859790309458648,-0.02037113010171959,0.8426868765085652,0.8788020283589324,Downregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.830237271205835,1.0092162261480149,0.013235307220633333,0.41046106672589244,0.5148394823194183,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,25.442634343612866,0.9665418804914853,-0.0490958487743552,0.7698363038503511,0.8228508080872459,Downregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,26.180160431799134,1.0249815170395529,0.0355978945933583,0.09111592345146534,0.15396903731381875,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,26.225865677845633,1.055844720336738,0.07839767780965463,0.024110372543629292,0.05396837625205425,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,28.553976095025767,1.3200075194112997,0.40054614790683024,0.0017211368948160314,0.00981585885324768,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.070044113405768,0.8143330432405694,-0.2963091510522944,1.49136020714306e-4,0.0020086410725133775,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.593573848828566,0.9961884766223881,-0.005509372108028135,0.45820195255971413,0.5688561655928424,Downregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,25.973922461483767,1.0577166727420504,0.08095322899159452,0.002728114931460129,0.012604454731957898,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.796021753680765,1.222179413779465,0.2894560857870766,2.2639591246222027e-5,8.26345080487104e-4,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.9894823673106,1.0793301690838228,0.110136255406875,0.003101995401413271,0.013014118638113149,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.368795927286868,1.2666739956183566,0.34104526526533196,5.367742328620263e-4,0.004215465393083545,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,29.1315440805228,1.0060926215691894,0.008763126741423075,0.5120981841532508,0.6168839512077114,Upregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,24.662792247739535,1.1008826110604595,0.138660640137533,0.07860938159588965,0.13709867640368661,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0680353065692,1.2414526246321842,0.3120292075378568,5.625995736624361e-4,0.004278100924724775,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.623408826406866,1.029024265318292,0.041277002680480575,0.017696635765925613,0.041672722932663546,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,30.160000249908702,1.0203480844121264,0.029061401204569137,0.023449917060230474,0.0528346896727415,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.107123291704035,1.0653336126287118,0.09130528577189692,0.012362557013876986,0.03186686451875605,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,22.409622164550132,1.0537980056021201,0.0755983544096671,0.41628482159844155,0.520356026998052,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,26.490919508027833,0.9705131066164241,-0.04318039846275937,0.5622791361327739,0.6577945022066105,Downregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,21.180552498331465,0.9369643044298769,-0.09393400837210326,0.046116249029117456,0.08991319898235071,Downregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,18.658165294612566,0.6392226464651175,-0.6456095737238523,5.405488699761809e-7,1.2481230131084379e-4,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.132218324769134,0.8907611021619639,-0.1668895351263824,0.02685563461974847,0.05766062727181289,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,26.007661329102834,1.2289722858648864,0.2974523823532845,0.0012663858854927452,0.007921788149874274,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,25.890722771367333,1.221859175737032,0.28907801823908635,1.3922801069935127e-4,0.0020086410725133775,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,21.7600087803012,0.8158134214207139,-0.2936888529471339,0.010425757037517155,0.028612039990178657,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,18.398550731601034,0.6581669577413136,-0.6034744948901924,0.0012581628838253243,0.007921788149874274,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,25.008631001851434,1.1938482650781936,0.2556194855726581,0.10043367066363716,0.16662858996467075,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,23.863685102265467,1.1097064465321054,0.15017808725711984,0.002806393250531055,0.01264609304251648,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.18245599682387,1.1214647304696461,0.16538424906738325,7.257057696436573e-4,0.0051937765866653905,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,24.423802064708966,0.9532931985012423,-0.0690080916987022,0.3104135124409979,0.4157897005604389,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,23.4468422600727,0.9548614785234014,-0.06663663790894235,0.6176926234948701,0.7001795266323838,Downregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.769556190813802,1.1799165902755795,0.23868487734221067,0.016262286430878826,0.03930950031305147,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,25.961904728350966,1.150391023242263,0.20212432326258914,0.00814013180538269,0.02475956757470568,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,22.2084141088284,0.9041837672936336,-0.14531207753481748,4.950686937930464e-4,0.004106819846237771,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,24.948216780476233,1.165907328626915,0.22145312143409426,9.214961828527798e-4,0.006346152957382351,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.9973175426306,1.0880229115958135,0.12170893719268822,0.008099844499790392,0.02475956757470568,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,22.1980290328719,1.1015493471862121,0.13953412631083983,0.010381770881338338,0.028612039990178657,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.291061494286634,1.016382794159351,0.023443858041209978,0.21097755986152017,0.29732358822183347,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,26.896290643774165,1.2938519307876533,0.37167252386734195,0.0020687752284324437,0.010943521135910754,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.754665037825333,1.303814819547479,0.3827389785476127,1.5105144869035893e-4,0.0020086410725133775,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.951153853234366,1.0773953119156143,0.10754769268540493,8.729929282668327e-6,4.5520345545341993e-4,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.372221168289766,1.0273325935015847,0.038903322177636306,0.024248804672155882,0.05396837625205425,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.2475055098148,1.082955341612016,0.11497375101337327,0.06892786606267459,0.12454787679641696,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1117199147677,1.009050474649864,0.012998342636274746,0.494125402108136,0.6052207106358042,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.3008751858887,1.2640103448392248,0.3380082707833516,0.013834721371255573,0.03458680342813893,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,22.190746064366,0.8875827377325877,-0.17204648552026683,0.08555108674216647,0.1459165731817325,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,21.1782160796956,0.9840932057449244,-0.023133131865610036,0.5395948190564397,0.6353293837277435,Downregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,23.872074329576865,1.029964890945904,0.0425951602031325,0.3199757037434022,0.4216286348965408,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,22.740743807338802,0.9001272492751825,-0.1517991279768952,0.20847743754291015,0.2960866330862343,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.382455560123066,0.9413164941721939,-0.08724822017675382,1.483246670081398e-4,0.0020086410725133775,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,22.367876646803502,0.900428311713467,-0.15131667544927616,0.00205956103336835,0.010943521135910754,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,23.06729450881,0.9263361327236171,-0.11039230634780095,0.007018326356901053,0.022083526898869693,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.384079335290934,1.0514427164692657,0.07237025290668997,0.06697643121398135,0.12223198696551596,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,21.877988208980234,0.9396253142077188,-0.0898425137318159,0.38420452422289975,0.49266029477048623,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,22.942307806516734,0.8955863314178911,-0.1590955851717352,0.0059862242401707315,0.01994508816846971,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.316701044452202,1.0277528035116819,0.03949330730139702,0.02568404851317831,0.056473962092229414,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.813348170484634,1.025650834996793,0.0365396740703279,0.016593023858331987,0.03984509018612615,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.901086034777933,0.9607495518690677,-0.05776769652816738,0.003236555130672252,0.01327351261455474,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,27.909488039612032,1.0669988698502126,0.09355864808140334,0.05740562406468731,0.10800542671964365,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.50742501049143,0.9878244336418988,-0.017673440953309225,0.1558391864555886,0.2340794364456372,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,24.1455385493278,1.1630081553244698,0.2178612134103724,0.3129111278449974,0.4157897005604389,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,24.939526478210265,1.2045803747008574,0.2685306595072348,0.07005648456455801,0.12519045880967647,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,28.173696116950566,1.386380839954424,0.47132362143000445,0.0022216644475437047,0.011584393190763603,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,24.9235035664126,1.2440544144863752,0.3150495898035344,0.1982255713171534,0.2837346412971019,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.781975247267432,1.3869508461509321,0.4719166591316813,1.1990734792780877e-4,0.0019717592282331494,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,19.705480221759068,1.0040119231053555,0.005776402060428594,0.517175008740252,0.6175788524387482,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,23.6548731976333,0.8020987488239184,-0.31814823268524034,0.0038216808886408606,0.014999070154343163,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.099573067452233,0.8570770948150795,-0.22250311306430962,9.33194785681232e-5,0.0018923116487424983,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,21.695794727274965,0.9826820037562316,-0.025203459425501333,0.1818061573447661,0.26278185506479185,Downregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,29.744880444626066,0.9714242947947421,-0.04182652705403723,0.10403447059438159,0.17028063572622995,Downregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.623232217938032,0.8712324524915745,-0.19887040096033393,4.765131676723138e-5,0.0013379023553876503,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.616801933017666,1.009853555634826,0.014146095078357627,0.38467995619065365,0.49266029477048623,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,22.208054932019035,1.0426986143403185,0.06032221593073452,0.07042246767851136,0.12519045880967647,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,19.6245483141361,0.9973028341348247,-0.0038964448624972206,0.8582671099819785,0.8899644748392674,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,22.5906632251769,0.8990854964067552,-0.1534697829549348,0.0048169847322716165,0.01706989735222466,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,24.428730592725632,1.1319160537765611,0.17876696763000904,0.002312968237659415,0.011729473695736901,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,21.926386648387865,1.004767863883691,0.006862227466135879,0.9678047536526572,0.9785283520310799,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,22.966200792567435,1.0014423432936639,0.0020793623001184387,0.9799212366159809,0.9826133279253654,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,25.796916021192267,0.9875707638368896,-0.018043967491177447,0.8504051004053235,0.884324392159382,Downregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,21.665846514552968,0.942040279890762,-0.08613934677301911,0.4992215843800703,0.6094176531729956,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,20.591065114808067,0.8090109867234606,-0.3057687996686689,0.006192265977615745,0.020361955692159883,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,26.8691542025348,1.0041773220880736,0.006014049277438921,0.9666973436200184,0.9785283520310799,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.9170538346994,0.876209981550381,-0.19065144533582043,4.448157642309398e-4,0.0038821777034540265,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.7173040578018,0.9596508062411847,-0.05941855545955328,0.08969253559601217,0.15226872322113694,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,21.039713919288733,0.7917423079005055,-0.336897148936647,0.009469229097633146,0.026913727483742825,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,22.379361040085033,0.8513287512022888,-0.23221174071833253,0.30040729998977966,0.4046076180674154,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,26.269378315050066,0.8821451786802249,-0.18091198862145738,0.2801536008822923,0.38013406811166056,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.773482146853834,1.1636772008184855,0.21869091618079728,0.15470548949064766,0.233336792000357,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,21.0121770164514,0.8067763346358181,-0.3097593292362989,1.5840649888208315e-4,0.0020086410725133775,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,27.695660187399035,1.4322197639846412,0.5182528809295713,0.00840778399453988,0.025362323619893025,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,22.3372806432835,0.8019299607795531,-0.3184518552750456,0.027853155173505055,0.05910698626935666,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,21.93527962217363,0.8726646991919892,-0.1965006560764593,0.11440805658121543,0.1823534526294482,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.285136866672833,0.9598359958064161,-0.05914017681383645,2.6469038718810025e-4,0.0027603426092473312,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.140693160787634,0.9910891591982214,-0.01291324560159214,0.504028565325876,0.6104367608644916,Downregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.291514034102,1.0228694036727615,0.03262195866979506,0.14846361702375627,0.22673313896933486,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.438707093650066,0.8676295539809953,-0.20484889865952247,0.015338811880569476,0.0375749418550863,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,21.733237079986733,0.8015867666083135,-0.3190694036024348,0.004404320567316057,0.016403847010922047,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,22.252768619880968,0.8509398636468836,-0.2328709153662264,0.004349848215717159,0.01636798555398725,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,20.92999464096337,0.9870020166236282,-0.018875062515785093,0.5288586649131611,0.6247036009492033,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,20.005141981386267,1.0010466106384572,0.001509150369115668,0.937757575318346,0.9587717506756198,Upregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.5456550326866,1.4724840278049784,0.558251985069981,6.619883439885149e-4,0.004832514911116159,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,24.25762104421,0.9603577768470356,-0.05835611954942881,0.001989279411050226,0.01088937650052313,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.965383720255165,1.1406822675293915,0.18989699066669533,0.2374475831502146,0.3307952971367494,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,22.25895033704043,0.9477027018490967,-0.0774935440300995,0.09540864912241748,0.15927339937658114,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,24.923316596574733,0.9270276274580581,-0.10931575991703202,0.018121949856287095,0.04213064775506236,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,24.222725506233168,0.8797609206112229,-0.18481657739992566,0.27598121150056687,0.3758699335735332,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,26.316278898461267,1.2824605897461887,0.3589144922250486,1.2424784177907517e-4,0.0019717592282331494,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,21.738216075565102,1.0212952472304766,0.03039999661719758,0.6347268124949577,0.7172609491042091,Upregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,26.162434114821632,1.3427891176895903,0.4252327502216194,0.0037539621313901917,0.014893436716928478,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.8337936011975,1.0034793482117053,0.005010926078565344,0.6697607978795947,0.7430476936962068,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,26.937916665808466,0.9964815513220846,-0.005084999368957957,0.5206635132659071,0.6190299099089775,Downregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,23.217544671826833,1.0468989933361064,0.06612225521750936,0.7744867306084532,0.8228508080872459,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,24.108635256202835,1.2155081633653666,0.2815595825539583,0.008981759595220054,0.026438243969800965,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,21.3107007310268,0.9269158962071873,-0.10948965315561368,0.25110489405010555,0.3458614578425982,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.917033442832967,0.9606937808994696,-0.05785144659241886,2.474690025272079e-4,0.0026566525271303197,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.0349272644887,0.705144884269071,-0.5040083801543239,0.004635488137063159,0.01706989735222466,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.197596559426202,0.7178719033054582,-0.478201661637359,0.0073867947200479634,0.022848983667944973,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.938223191140768,0.8303431209937723,-0.26822047329019444,0.0016300371174004147,0.009443865838907163,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.125362054021366,0.7801166176953956,-0.3582382898932086,0.06654375702696083,0.12223198696551596,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,20.317969427304867,0.7908718899755154,-0.33848407738981623,1.0435085940069187e-6,1.2481230131084379e-4,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,18.85588198535987,0.7060879660683211,-0.5020801659164786,0.0011689691727038553,0.0077577045097619495,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,21.5637946093456,0.873056472942814,-0.1958531184673886,0.0041558985240438264,0.016137265545489325,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,22.801633119129335,0.8879286282639947,-0.17148437753242637,0.026683778720702187,0.057630646349445556,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,21.14245989898127,0.7823577845478202,-0.35409956926317593,1.596250030768819e-4,0.0020086410725133775,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.202955578550668,0.8689247652245848,-0.2026968264048736,0.06675032524037698,0.12223198696551596,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,21.8974773807363,0.8602024227044587,-0.217251900341854,0.0013239152798420017,0.007921788149874274,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.65159511419827,1.0235922742449224,0.03364116351910951,0.7755087068000344,0.8228508080872459,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,21.1559492989488,0.8109139486561008,-0.3023792660598981,0.011394757310157603,0.030613094488419333,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,25.603971130468235,0.9698127942973577,-0.04422180821066402,0.014164101169295047,0.03515509725761819,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,25.451702419370932,0.8961609419030477,-0.1581702451551585,0.006010848489127857,0.01994508816846971,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,21.714504669852033,0.9468731175986884,-0.07875697951604749,0.008485393057504637,0.02538662677040322,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,23.261406152512667,0.9491403195233016,-0.07530670593857591,0.07887869053362792,0.13709867640368661,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,25.304712550202268,1.0715347378379236,0.09967862117091744,0.005025435769326288,0.017637346690423994,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.90328229717007,1.0568372005636186,0.07975315531212736,0.009876790448213229,0.02773098856613714,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.6732501470252,1.0613463869906998,0.08589557919081023,0.0034712032141385523,0.014077657479561906,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.746410490872265,1.0308275646471583,0.043803020936536645,0.011015501285689384,0.030004910218482277,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,25.095807339854865,1.0718697799232804,0.1001296452822923,1.971289281320676e-4,0.002321034153813054,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,22.884681882553068,0.9200955959546891,-0.12014433301669786,0.46333509926756133,0.5732790211276606,Downregulated
Feature0119,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,19.8498585260969,0.9949258959821654,-0.0073390199651008695,0.6565843452431543,0.7328846667087197,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,26.1004603730291,1.0719665577780395,0.10025989863117754,0.013754883120142307,0.03458680342813893,Upregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,21.256871713120866,0.7912881233276158,-0.3377249913280623,0.02975933141745994,0.06242618372053379,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,21.044622882169833,0.7507311832349055,-0.41363168520336807,2.0517090626440074e-6,1.2481230131084379e-4,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.927081129806467,0.7404433949303256,-0.43353864563215744,1.4753649344840621e-6,1.2481230131084379e-4,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,27.7706753526044,1.4158638203875868,0.5016825118196704,1.0797641565670061e-4,0.0019717592282331494,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,27.247732720547802,1.3581123318514652,0.44160281235341026,0.0031491811872838265,0.013061944697256779,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,20.504811434739832,1.0060132990414692,0.008649377046379851,0.7633659489727341,0.8228508080872459,Upregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.235425305062833,1.0239356378590543,0.03412503383418071,0.7734138524861198,0.8228508080872459,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.910134891071465,1.0588187095043624,0.08245559283476873,0.025276591032715734,0.05591488319358329,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,20.105743560235066,1.0140462551719223,0.02012346159682552,0.6058826639712285,0.6910849135921825,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.1410153720616,1.103851668970004,0.1425463217368063,0.13071976733216356,0.2030328301116583,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.389617741496433,1.009629121270818,0.013825428455172019,0.16439102585852694,0.24391351397708264,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,20.726216876243168,0.8039428154374657,-0.31483520892946204,0.04631145591419708,0.08991319898235071,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,20.424621107540467,1.0003719243647804,5.364736790212588e-4,0.9904286672760223,0.9904286672760223,Upregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.2922994852546,1.0381096126165414,0.05395878399371363,0.01177636628207781,0.031147635456220298,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,20.1144961385284,0.9941368795898476,-0.00848358926684661,0.5009710291887962,0.609514752179702,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,26.575013147248068,1.3566391906975577,0.4400370752108212,2.163879560309127e-5,8.26345080487104e-4,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,24.762378508808798,1.224137478101973,0.2917655905781073,4.705204483760791e-4,0.0039939526431923,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.151375727031734,0.8975839953910886,-0.15588114306694975,6.937179186141658e-5,0.00168804693529447,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,24.286457409492034,1.0872778271554415,0.12072063277109155,0.4720456810379627,0.5801234800634896,Upregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.4579521373332,1.1702582104346702,0.22682688691428046,4.2481642015588264e-4,0.003876449833922429,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.307620936458832,0.8699827846500533,-0.20094124190959162,5.428133519861003e-4,0.004215465393083545,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,21.810838272032534,1.045158204780373,0.06372133845627032,0.14659311020614968,0.22481716481195224,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,24.335794363931768,1.0525665570827076,0.07391146230565886,0.3468951625787929,0.45277003040870456,Upregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.815439668341533,1.029078015047878,0.04135235799112797,0.06616281190233159,0.12223198696551596,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,28.003605830377733,1.3437479557436953,0.4262625599183387,3.622033934443944e-5,0.001201856714610945,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,24.610537720242032,0.9881940015805585,-0.017133796353756156,0.8644098048791117,0.8937948407390247,Downregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,27.195462672482165,1.303488336935851,0.3823776743041665,0.002691764218950255,0.012604454731957898,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.668780909383567,1.0336822574312479,0.04779278519305363,0.08463231673549729,0.1457113000398892,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,20.0408390846854,0.9948018862889152,-0.007518851770536778,0.6499881470918395,0.7277474653022129,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,22.33873100038783,1.0039778758261586,0.005727477667601568,0.6117623754592962,0.6956176543384521,Upregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,20.3130816158032,0.8109433312072752,-0.30232699258133866,0.0027281217633199277,0.012604454731957898,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,22.1150163502614,0.8660437369607734,-0.20748820907731536,0.003025449083321851,0.013014118638113149,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,22.704067665479734,0.9385050997640288,-0.09156351031679154,0.34733043428612953,0.45277003040870456,Downregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,21.708426848423198,0.9355113064821359,-0.09617300506947442,0.5938478471200341,0.681296633564225,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,20.046508995598366,0.987799790720677,-0.017709431826272853,0.7697805121026053,0.8228508080872459,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,20.4002106878276,1.0012387712457378,0.0017860630994759308,0.9524683153371287,0.9686058575488905,Upregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,26.9410955864788,1.1635896780097208,0.21858240372493956,0.009511974918911847,0.026913727483742825,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,22.699728880447566,1.0107426948801692,0.015415776601704324,0.6779904095205164,0.7498984832575407,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,23.033311777728667,1.0494277263277914,0.06960281221474789,0.012484826373101684,0.03186686451875605,Upregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,20.837510858465734,0.8085142350342422,-0.3066549202824052,0.11288519802765357,0.18071533894777872,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.71201812109503,1.084981848959617,0.11767090752230105,2.2705252288012542e-4,0.0025113385106438116,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,20.970954117482567,0.7868356332982661,-0.3458658006941157,0.007298019841093407,0.02276732685469311,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,19.680713163433968,0.9893343187652106,-0.015469971757411863,0.3592207530852452,0.4649488470784202,Downregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,25.064584704857968,0.9769459547655731,-0.03364934123858102,0.7173824685145112,0.7821407552300275,Downregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,21.0187264198941,1.0348000712502363,0.04935205847077582,0.12669544445550765,0.1984714044045506,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.448736412949035,1.0573378051992708,0.08043637201540908,0.4087739950674999,0.5146672781144574,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.814102171301332,1.4681535344598293,0.5540028481684313,0.0030015085449933815,0.013014118638113149,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,24.511445401693567,0.8348066827323231,-0.26048594538842523,0.008860072266565837,0.026292084368264475,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,19.741058022810833,0.9680168837629345,-0.046895884258738814,0.10518581263139533,0.17139652504669328,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,24.84631810044243,1.0292475384104929,0.04158999825624675,0.1117252145762355,0.18006359630454544,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.4157355648094,1.0411712451898414,0.05820737340972859,0.011490394369625886,0.030613094488419333,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.990452279342367,1.045735443595088,0.06451791612745156,0.010179374455560266,0.02836237920824044,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,24.684339618769567,1.1661956485793947,0.22180984476219476,0.2250715858963642,0.3159658802006651,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,24.825079770936966,0.9348665206255441,-0.09716770184261689,0.595434592073939,0.681296633564225,Downregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,30.5610379393236,1.7180164042296857,0.7807438119058466,1.6509378678192143e-4,0.0020086410725133775,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,20.5573156123154,1.0071043052956328,0.010213110295910365,0.6368702880225134,0.7174618985438809,Upregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,21.0330889006201,0.9177822767129084,-0.12377614774196889,0.037329572595408846,0.07638358001944659,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.110363772102936,1.0673099628212257,0.09397921729129842,0.004242769243023444,0.01630116603898481,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,25.8361317883481,1.008666911259558,0.012449836674447724,0.7075063634724976,0.777830791167053,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,23.141694182978632,0.9184541548967816,-0.12272038460544965,0.5874393157138682,0.6774626293023008,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,24.9347004994001,1.2329700789834153,0.3021377896628803,0.18146403281742096,0.26278185506479185,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.911257123432666,0.9346005474613334,-0.09757821259635596,5.066482591107361e-4,0.0041094803238981925,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,25.94410557089917,1.4078230170522539,0.4934659785279216,0.0030589685478346848,0.013014118638113149,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,26.828544468971135,1.2160784940369804,0.2822363532083687,0.029112010834567558,0.06142129453535929,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.805674903946368,1.1350473636611857,0.18275250006545404,3.157211264994852e-4,0.003201061421453114,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.069283230913967,1.0501020695846848,0.07052956420266959,0.05012278790288056,0.09628851360290212,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,20.2000386933588,0.9929028617289777,-0.010275512840496106,0.5177510379349506,0.6175788524387482,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,26.21209259559477,1.0252029455140594,0.0359095287600971,0.7178552137042717,0.7821407552300275,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,25.413674365881267,1.2799958174322952,0.35613909602250604,0.0706554370268311,0.12519045880967647,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,22.287667406137032,0.936228775426809,-0.09506698725303496,0.005709392366683118,0.019475964615320914,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.116208624241732,1.0072758459099345,0.010458824387179799,0.8305499197016353,0.8686267068512804,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Missing ions,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,26.138573810870266,1.1520263988752009,0.20417377675415407,0.09204004164322391,0.15481389492984665,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,18.55128408291017,0.9793173009021046,-0.03015172303495142,0.3540039914431268,0.4598272486716771,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,21.380353481004168,0.9967170068846124,-0.004744149660242255,0.9192683529458326,0.942508283216935,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.416481051520467,1.0285771339052994,0.040649986891564946,0.10217302750857267,0.1679871848676983,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,25.302410447073868,0.8908483684133927,-0.16674820382976188,0.07882149455662066,0.13709867640368661,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,22.7885861540737,1.1566384229884656,0.20993793368586516,0.048890251710323365,0.09441768187443401,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,21.600860611240467,0.9947545721360621,-0.007587469972758506,0.741097754158892,0.8050615484166534,Downregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.914901047264333,1.00961966875452,0.013811921354457746,0.5775894129272423,0.6714017061096925,Upregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.973615210334966,1.317951099718866,0.39829684265108006,1.8489320679624176e-6,1.2481230131084379e-4,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,20.0216272513046,0.76607930567508975,-0.38443434505852325,0.01838094816546537,0.04246231696452443,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,22.051379250204068,0.9942872970890568,-0.008265319359317728,0.8206893172505106,0.8620615694138777,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,24.5682518657356,0.8742391793979374,-0.1939000603275891,0.06816155965794236,0.12377596654302966,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,24.7846464920801,1.1134670061399936,0.15505880933051777,0.2108093371399271,0.29732358822183347,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.823328827164534,0.9810224110021198,-0.0276420003670998,0.16433678474636487,0.24391351397708264,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,23.991709384314934,0.922395784568335,-0.1165421751286564,0.02235364563741897,0.05067751961278214,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,23.661974831278002,0.8065852710065963,-0.310101033849446,0.004690141751407014,0.01706989735222466,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.206665230593835,0.9469108670075782,-0.0786994641019858,0.030932103922091392,0.0645155310375049,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,25.221915194440665,0.9994278270957835,-8.257072576372654e-4,0.9780748862279489,0.9826133279253654,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,24.282027306939934,0.9911398683077012,-0.012839431950621236,0.18107219339108846,0.26278185506479185,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,21.939800873107835,1.0395326420186033,0.055935060494491824,0.43017400807464634,0.5358822967482796,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,21.429909145334232,1.0457323331734223,0.06451362498803057,0.04519640104594972,0.0891712777393062,Upregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.884867714479768,1.0137133090926387,0.01964969767505932,0.0438691898356109,0.08702312114129337,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,18.2901738334145,1.007982395288537,0.011470441961126506,0.5832062341440808,0.6757786522621889,Upregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.577985861204034,1.0365592337556166,0.05180256102403164,0.0014226507847491532,0.00837528284570066,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,24.229165913917132,0.9392958910736398,-0.0903483967091581,0.002510112797135349,0.012380961769654086,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,24.418750614290865,0.954698265597568,-0.06688325651305485,0.006628625816840799,0.021223231781990277,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,22.959582771927433,1.0327554030558757,0.0464986079466617,0.8003107488632761,0.8467055748843356,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,21.729665789563366,1.0167642435378985,0.023985201213183222,0.3246550445148799,0.4262557239134215,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,20.1780974681236,0.988994803163278,-0.015965154762698528,0.5287838781289972,0.6247036009492033,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.5037403069425,0.8813059105746041,-0.18228521414809729,0.002662181875139105,0.012604454731957898,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,25.0391865595278,1.1104538205969323,0.1511493981248147,0.4714483617321614,0.5801234800634896,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,24.223592088894932,1.0726785974925146,0.10121787174874368,0.6962629149358588,0.767782368433802,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,22.269461871508234,0.8702769745470772,-0.20045346839495853,1.1750240735218273e-4,0.0019717592282331494,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.614798177812,1.033735386611513,0.04786693489873394,0.00600087231519557,0.01994508816846971,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.320172208313167,1.0380235725741753,0.05383920636411263,0.007008249982765871,0.022083526898869693,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,20.294767812924498,0.7361831519650492,-0.44186336181114483,0.0035177318079837954,0.014109583625429509,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,23.078877850794434,0.9252319390270396,-0.11211302618887485,3.3569390860161184e-4,0.003311575044313198,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.803669004105068,0.7778957469246137,-0.3623512757594722,0.0012877950490283922,0.007921788149874274,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,23.200819436435832,1.1078595157173767,0.14777494923215428,0.4089137278169662,0.5146672781144574,Upregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,21.236094019068332,0.9808595226449581,-0.02788156445258876,0.1674051776518843,0.24638262033442648,Downregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.583660968513033,1.0284181189887491,0.040426933355910334,0.02188348163509594,0.04992169248006262,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.9127932214179,1.0495424567011409,0.06976052854838032,7.514835978300933e-4,0.005274836792461232,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,25.067859196871233,1.0520053158687788,0.07314199470450107,0.0011125337800604468,0.007519904254112279,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,No gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.618789530451767,1.0348214007079213,0.04938179521562986,3.639214494617603e-4,0.0034955612908826976,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,24.420577158328534,1.06279798053827,0.08786739162548396,0.03503464891754127,0.07224659240057944,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F13,F1177_1,Area: 14,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.291037384054867,1.0333212626805808,0.04728886215973314,0.01227945949149159,0.03186686451875605,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.407942392992666,23.566127384301268,1.1008123504674148,0.1385685614336606,0.0019632835139276436,0.01088937650052313,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.74444261487047,23.594004731145233,1.085059072289574,0.11777358735117073,0.026485509647572594,0.05754292274621426,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.2586582595881,26.103801103179432,0.9576333821932541,-0.06245465074583852,0.12418370271958887,0.19707413692456494,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.197292677428234,25.865814408569634,1.0265314904938285,0.03777788510110572,0.08505398531370713,0.14574978703992067,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.225359594187267,23.4092114122264,1.0532658116518734,0.07486957383562665,0.02624835755969652,0.05736916472628281,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.798510239938434,27.807259567111366,1.0003147408655144,4.5400364284028277e-4,0.9714962443290832,0.9795473181771144,Upregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.556384222891666,23.4205611952757,0.9537463244870903,-0.06832250273517732,0.0699602677557655,0.12519045880967647,Downregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.913620388919302,24.170614998523433,1.0548579660598723,0.07704875679420652,0.0019988718507809584,0.01088937650052313,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.961741097575732,23.307573026424432,1.015061224119682,0.02156674718387041,0.5050737035097985,0.6104367608644916,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.154752558976366,24.8086255276989,1.0270701580207056,0.03853473391655019,0.5521159185033222,0.6479817049958605,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.02464909184,23.041615449195902,0.9207567852253831,-0.11910797123919635,0.3988442900213529,0.5054797425617841,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0545823568341,19.773865904456468,0.7892315115387577,-0.34147953538808523,0.009406355227105284,0.026913727483742825,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.906260379887435,22.453952408312833,0.9802539583470489,-0.028772532411116224,0.2423444885428845,0.33505961484148805,Downregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.364314091152565,23.853567090450035,1.1165145292601892,0.15900202514626824,5.4150580298791877e-5,0.0014117829863613597,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.557753566348502,25.219694200619735,1.2267728630574928,0.29486815880153566,2.066199539534021e-4,0.0023567588497809926,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.210697584788768,24.8158824974359,1.0249965913013328,0.03561911195429194,0.05234192130528202,0.09950417331472884,Upregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2403253242342,22.049019786161434,0.8735632169127127,-0.19501598484622076,0.002313759194775498,0.011729473695736901,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998228192396265,23.939439294293933,1.0409253745124962,0.05786664339249682,0.054976077362542584,0.1039703017478137,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.739819651794633,19.6695044806278,0.9964379020473756,-0.005148195693390129,0.7139713578517997,0.7821407552300275,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.4641933444476,24.318654783177898,1.2494047070342678,0.32124087026674736,0.041439243003192065,0.08310617415475331,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1349158711952,21.784813540310235,0.8667151961815712,-0.20637009516318233,0.00654843812478187,0.021152034650844094,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.422291150294967,22.928283771934336,0.9388260761790735,-0.09107018117734773,0.002576878285587238,0.012540807656524558,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.065717896301667,20.475389434119734,0.816868262813282,-0.29182466267364443,0.0013122360050663799,0.007921788149874274,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.7379613528228,23.497973241322267,0.9898901128056645,-0.014659713643976079,0.8219107565918614,0.8620615694138777,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5283921743242,26.485788575419033,1.037503200145043,0.053115786412587455,0.006322760483348946,0.020605424789485405,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.4071829786128,22.165337714170267,0.8724043800065735,-0.19693108167405884,0.0024559615009637787,0.012279807504818894,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1890698096832,25.28688897484737,1.0038833972791867,0.005591707599108244,0.7720505162001491,0.8228508080872459,Upregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.040995823119435,27.122502056196932,0.9339384303965501,-0.0986006510438823,0.009129819911104982,0.026659074140426547,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.898189288715802,24.9743973785335,1.25510904616313,0.32781271359791014,4.227441532177798e-5,0.0012858467993707469,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.1550346254478,23.497595787553568,1.060598468239976,0.08487856999315756,0.6395315214122348,0.718243093278356,Upregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.346681969244433,23.958095537650166,0.9452162443479122,-0.08128367141691287,0.01552025041803678,0.0377659426838895,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.126188005131233,24.6671449735766,1.2256242944410356,0.29351679989690455,8.006099144280871e-5,0.0017189565809779517,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9070058615956,23.38991073964,1.0676908970314392,0.09449403853764649,0.01425466957295203,0.03515509725761819,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6758080153392,22.7348999953628,0.8854599622251635,-0.17550102066579315,0.003092160136033529,0.013014118638113149,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.611878517628067,26.587601625183932,1.0380965069346357,0.053940570481948065,0.012019850356753074,0.03156291640442354,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.0428689916695,27.803554025363766,1.3212815246994458,0.401937893545508,1.509789670316696e-5,6.888415370819925e-4,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.417081003337135,24.758022372246,1.2126132216549146,0.2781194579753137,0.004814019712443241,0.01706989735222466,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.247283550572032,24.5485426565242,1.2124363544970778,0.2779090166099337,0.07129836300601956,0.1257193357352519,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.249915318550066,23.029476746366534,0.9120615438043759,-0.1327969174867457,0.2627615457902587,0.36055625644152034,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.513692710912398,22.8985088550048,0.8322586537401743,-0.26489612844867644,0.016861134600730052,0.0402242753546828,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.011204278253935,20.433706575370067,0.972514773773269,-0.040207928194666,0.045482005264313445,0.08925232215846456,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.32412765704793,25.037299940457633,1.1741300907182688,0.23159226435632896,0.13030354043908704,0.2030328301116583,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.876308209848833,22.2772711304372,0.828881368545762,-0.2707624603047723,0.01240097293419107,0.03186686451875605,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.132749633445,27.253349088264866,1.3536824122121383,0.4368893075469344,0.05136073029360713,0.09815008668673614,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.213190956215534,20.845667219626765,0.738862443882277,-0.43662229614635395,1.239999528177793e-6,1.2481230131084379e-4,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2796698750677,23.7733798686438,1.0670436322419505,0.0936191702879899,0.005562213121158063,0.019237557051234692,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.544396077814234,22.158699269424634,0.9028007533440173,-0.14752047249715208,4.129683333541318e-4,0.003864960042929695,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.009472405136098,26.956049228421765,1.036393541881255,0.051571930737827815,0.017916688421358146,0.04192045688330592,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.644551715071298,22.471649933646468,1.143912585004738,0.19397680911047102,0.041262139530914274,0.08310617415475331,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0160326624329,22.6033729887552,1.0266778458829466,0.037983559399098435,0.16000846480487446,0.23935692481057042,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9789785410655,27.011193972771935,1.2875361838946837,0.3646129772215935,6.166433611776803e-4,0.004593363812854149,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.228510038840568,24.6825608717218,1.0187403530862338,0.026786397875694583,0.06182299738632972,0.11512956145923647,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.422939555697535,20.116460474973,0.791272009710014,-0.3377543703522401,0.004766616531558956,0.01706989735222466,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.159017560899,23.0578247972753,0.954418975819366,-0.06730536781362476,0.059836565784238294,0.11200177698075373,Downregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.685669645715066,22.6625817729804,1.095569162667878,0.13168056373329118,0.22979909191692194,0.32136654616734295,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.948973423729267,25.4972793866126,1.0646502017221846,0.0903795007467462,0.10089732745941114,0.16664038245558854,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.413613221147,19.20433686231887,0.8568157517860523,-0.22294309190618236,0.13448570943975952,0.2079969658708145,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9122366380974,19.1185912418606,0.8344271030297887,-0.26114207608572887,0.16925995005006544,0.2481119749729875,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5009787108156,19.8210213802509,0.9668329331903567,-0.04866147848515967,0.31326621275101557,0.4157897005604389,Downregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.053444672647533,25.294523030630334,0.9708705834659184,-0.04264909691071546,0.18214742282573243,0.26278185506479185,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.138271564927766,21.954562846351568,1.0386167468289214,0.05466339298033458,0.5157404871547384,0.6175788524387482,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.66178940283317,24.0000434184496,1.0590533250410104,0.08277523317856765,0.021328372645806698,0.04896135858943047,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.828976523187333,24.90240466157117,1.1407957965926234,0.1900405711106473,0.0027626202152236487,0.012604454731957898,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.803799803649532,24.80357991509757,0.9612374961764159,-0.05703516833732357,0.1256695369146301,0.1984714044045506,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.068228144579766,24.353790988481233,0.9715002930411335,-0.04171366390543388,0.14918759412556387,0.22688946606596172,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.554467561037935,21.4310757834881,0.9942753502400181,-0.00828265415124471,0.6645014367014744,0.7394604402318237,Downregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.333428878772068,24.506970139269633,0.8965933344097364,-0.15747432096135716,0.004296318518125518,0.016334961032456397,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.9579323568517,25.564708055042733,1.4235886151608501,0.5095323003678524,1.2268032307555972e-4,0.0019717592282331494,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00392183828807,19.883969398243533,0.8643730203059706,-0.21027405285911624,0.0012056566932494928,0.00785829808992973,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.405965885807632,24.728874746064367,0.9023172125770756,-0.148293388058783,0.017423628080856835,0.041296261360472375,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.21594275614933,25.401351878297167,1.0941339813378448,0.12978941306314776,0.03805468172094693,0.07716643793414238,Upregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233860585341567,22.836745093079035,1.12864003370781,0.17458542907677482,0.1913070791534775,0.2749097790985011,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7506624331551,22.316963510961,0.9809368661915505,-0.027767808354548847,0.8750077173514672,0.9021972226928969,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.219685376707634,23.205046164106534,0.9581068376066978,-0.061741556367066186,0.5687965881656921,0.6632931459440179,Downregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.41917653977377,24.530187616676667,1.0474402280975175,0.0668679192585931,0.10569024726329265,0.17145306778267475,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.752938758383564,22.297625001318668,0.8658283705217891,-0.2078470209015324,0.1263378412546433,0.1984714044045506,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.527140318640498,24.4118505594793,1.2501497997725701,0.32210097683970895,0.03745934472186559,0.07638358001944659,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.4451464689765,21.86909840411323,0.9327772139556153,-0.1003955483244563,0.1654880255884727,0.2445470823473382,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4664053587124,21.515747310562766,1.0512714340138714,0.07213521539626236,0.027492859128946025,0.058683588199212273,Upregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.78128734231767,21.438924294262634,0.8315691923991928,-0.2660917840169612,0.1119847571537858,0.18006359630454544,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.263708096473167,22.2136008498238,0.8457907302437145,-0.24162734618381695,0.03328412086809078,0.06902672793666553,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.6741883835944,23.201213878412467,1.0232434116671354,0.033149377764871625,0.0828885752619503,0.14338545009768655,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.403340594236433,20.350438889289368,0.9974072037516245,-0.003745472013457423,0.9526835694795937,0.9686058575488905,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6284653770252,23.798457259929968,0.928594705528652,-0.10687903962281915,0.09556403962594869,0.15927339937658114,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29688379223497,28.88502210316277,1.0581802055874074,0.08158533592916119,0.00288039954983736,0.012821290679154104,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3257870660719,23.529627941271798,1.21752495051444,0.2839513374941623,0.013796394014012534,0.03458680342813893,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.643191339414667,24.073843143713866,0.9388005894068011,-0.09110934725934038,0.009506122698445972,0.026913727483742825,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1673021379854,26.524769667096166,1.0975478154595244,0.13428379317627095,0.011407600973253496,0.030613094488419333,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.485478616356,25.928779198312665,1.017394241977161,0.024878834290079126,0.23942584109661474,0.3322830114078494,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.220107095375333,19.994562376860568,0.9888455230503527,-0.016182933393435642,0.5883716533940531,0.6774626293023008,Downregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.062413030387233,23.733448392661234,1.1268152589364018,0.17225100542720526,4.4671633847964145e-4,0.0038821777034540265,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.506857078826467,22.482879336333102,0.9174117784266164,-0.12435866493796377,0.26556213324007477,0.3630343769012258,Downregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.7424476581726,21.041565646723765,0.9252111277988314,-0.11214547707187719,0.3120535891186412,0.4157897005604389,Downregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.00946532151083,24.165255710774368,1.0502310841696536,0.07070680151555805,0.1371363236029223,0.21120151103403645,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7509758389579,23.538084352090902,0.9140657231513852,-0.12963019321925273,7.920636249595093e-5,0.0017189565809779517,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.056750236860434,26.769442735972667,1.1610241018778447,0.21539792164251906,0.005586797390221583,0.019237557051234692,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.864338447523732,26.2140919862775,1.0135226168441689,0.01937828302766191,0.39337586422302606,0.500286377844615,Upregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.485278164122967,22.623372687072166,1.0061415527947322,0.008833290380773191,0.7745230287996839,0.8228508080872459,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.369106172406365,23.090265279797098,0.9880679692859407,-0.017317806540020856,0.39080493326647986,0.4987545477002278,Downregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.2162667315832,22.400349997975766,0.9250125234523003,-0.11245519693384746,0.043393023649074165,0.08654892695033918,Downregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.3287090280501,22.947201351414336,0.9836464299770277,-0.023788260404069977,0.8203479325969751,0.8620615694138777,Downregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.847988439218298,22.8669909716679,1.0968439971240365,0.13335834745478156,0.28381591081291796,0.38367706461746315,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.174641952957668,24.1363509991147,1.1398705608688389,0.18887000702597098,0.31601341806051403,0.4179162956235059,Upregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.488864726080934,22.25772333764183,0.9088915956948013,-0.13781986172188196,0.37636588940851906,0.48541890330074017,Downregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.9199872717622,22.2100602386838,1.0132332634743486,0.018966345232297215,0.8990839617497629,0.9244102705314463,Upregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.6835499746075,21.398619490928034,0.8669182314918743,-0.2060321713184259,0.15141547065667202,0.22932218584931655,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.547712441244734,24.0627635221294,1.1710677571012247,0.2278245515060064,0.20071182428886672,0.28617115572436075,Upregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.767628573607734,24.420362419832866,0.9859790309458648,-0.02037113010171959,0.8426868765085652,0.8788020283589324,Downregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.585221854400533,26.830237271205835,1.0092162261480149,0.013235307220633333,0.41046106672589244,0.5148394823194183,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.323364623036635,25.442634343612866,0.9665418804914853,-0.0490958487743552,0.7698363038503511,0.8228508080872459,Downregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.542080512256565,26.180160431799134,1.0249815170395529,0.0355978945933583,0.09111592345146534,0.15396903731381875,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.838752491447302,26.225865677845633,1.055844720336738,0.07839767780965463,0.024110372543629292,0.05396837625205425,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.631676846629134,28.553976095025767,1.3200075194112997,0.40054614790683024,0.0017211368948160314,0.00981585885324768,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.329986490048935,23.070044113405768,0.8143330432405694,-0.2963091510522944,1.49136020714306e-4,0.0020086410725133775,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.706802019198832,29.593573848828566,0.9961884766223881,-0.005509372108028135,0.45820195255971413,0.5688561655928424,Downregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5565973675619,25.973922461483767,1.0577166727420504,0.08095322899159452,0.002728114931460129,0.012604454731957898,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.379417144279667,29.796021753680765,1.222179413779465,0.2894560857870766,2.2639591246222027e-5,8.26345080487104e-4,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.1527692666301,24.9894823673106,1.0793301690838228,0.110136255406875,0.003101995401413271,0.013014118638113149,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.606819135752566,27.368795927286868,1.2666739956183566,0.34104526526533196,5.367742328620263e-4,0.004215465393083545,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.9551314222807,29.1315440805228,1.0060926215691894,0.008763126741423075,0.5120981841532508,0.6168839512077114,Upregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.402744852134898,24.662792247739535,1.1008826110604595,0.138660640137533,0.07860938159588965,0.13709867640368661,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9980105477586,26.0680353065692,1.2414526246321842,0.3120292075378568,5.625995736624361e-4,0.004278100924724775,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.872479127760766,26.623408826406866,1.029024265318292,0.041277002680480575,0.017696635765925613,0.041672722932663546,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.558540571265333,30.160000249908702,1.0203480844121264,0.029061401204569137,0.023449917060230474,0.0528346896727415,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5673811415301,25.107123291704035,1.0653336126287118,0.09130528577189692,0.012362557013876986,0.03186686451875605,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.265576557763268,22.409622164550132,1.0537980056021201,0.0755983544096671,0.41628482159844155,0.520356026998052,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.29578748337073,26.490919508027833,0.9705131066164241,-0.04318039846275937,0.5622791361327739,0.6577945022066105,Downregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.605506312451666,21.180552498331465,0.9369643044298769,-0.09393400837210326,0.046116249029117456,0.08991319898235071,Downregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.188836468469432,18.658165294612566,0.6392226464651175,-0.6456095737238523,5.405488699761809e-7,1.2481230131084379e-4,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.9690485682693,23.132218324769134,0.8907611021619639,-0.1668895351263824,0.02685563461974847,0.05766062727181289,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.162121903180267,26.007661329102834,1.2289722858648864,0.2974523823532845,0.0012663858854927452,0.007921788149874274,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.189612752017766,25.890722771367333,1.221859175737032,0.28907801823908635,1.3922801069935127e-4,0.0020086410725133775,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.672776162969733,21.7600087803012,0.8158134214207139,-0.2936888529471339,0.010425757037517155,0.028612039990178657,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.954230328944,18.398550731601034,0.6581669577413136,-0.6034744948901924,0.0012581628838253243,0.007921788149874274,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9479141808808,25.008631001851434,1.1938482650781936,0.2556194855726581,0.10043367066363716,0.16662858996467075,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.504502543750032,23.863685102265467,1.1097064465321054,0.15017808725711984,0.002806393250531055,0.01264609304251648,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.563278219812368,24.18245599682387,1.1214647304696461,0.16538424906738325,7.257057696436573e-4,0.0051937765866653905,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.620451402682633,24.423802064708966,0.9532931985012423,-0.0690080916987022,0.3104135124409979,0.4157897005604389,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.555228991257366,23.4468422600727,0.9548614785234014,-0.06663663790894235,0.6176926234948701,0.7001795266323838,Downregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.840150738786633,25.769556190813802,1.1799165902755795,0.23868487734221067,0.016262286430878826,0.03930950031305147,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.567895788320666,25.961904728350966,1.150391023242263,0.20212432326258914,0.00814013180538269,0.02475956757470568,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.561836777165034,22.2084141088284,0.9041837672936336,-0.14531207753481748,4.950686937930464e-4,0.004106819846237771,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3981130128564,24.948216780476233,1.165907328626915,0.22145312143409426,9.214961828527798e-4,0.006346152957382351,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.894090157072235,25.9973175426306,1.0880229115958135,0.12170893719268822,0.008099844499790392,0.02475956757470568,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.15164285610477,22.1980290328719,1.1015493471862121,0.13953412631083983,0.010381770881338338,0.028612039990178657,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.835045670648267,28.291061494286634,1.016382794159351,0.023443858041209978,0.21097755986152017,0.29732358822183347,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.787765588756834,26.896290643774165,1.2938519307876533,0.37167252386734195,0.0020687752284324437,0.010943521135910754,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.8212354942801,29.754665037825333,1.303814819547479,0.3827389785476127,1.5105144869035893e-4,0.0020086410725133775,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.7995954892184,29.951153853234366,1.0773953119156143,0.10754769268540493,8.729929282668327e-6,4.5520345545341993e-4,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.64397230403607,27.372221168289766,1.0273325935015847,0.038903322177636306,0.024248804672155882,0.05396837625205425,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.313524149789068,25.2475055098148,1.082955341612016,0.11497375101337327,0.06892786606267459,0.12454787679641696,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.868546812958332,27.1117199147677,1.009050474649864,0.012998342636274746,0.494125402108136,0.6052207106358042,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.2252185950105,24.3008751858887,1.2640103448392248,0.3380082707833516,0.013834721371255573,0.03458680342813893,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.001326773269966,22.190746064366,0.8875827377325877,-0.17204648552026683,0.08555108674216647,0.1459165731817325,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.520538863658167,21.1782160796956,0.9840932057449244,-0.023133131865610036,0.5395948190564397,0.6353293837277435,Downregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.177561234784534,23.872074329576865,1.029964890945904,0.0425951602031325,0.3199757037434022,0.4216286348965408,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.263921101878132,22.740743807338802,0.9001272492751825,-0.1517991279768952,0.20847743754291015,0.2960866330862343,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.902505385890766,24.382455560123066,0.9413164941721939,-0.08724822017675382,1.483246670081398e-4,0.0020086410725133775,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.841374216941965,22.367876646803502,0.900428311713467,-0.15131667544927616,0.00205956103336835,0.010943521135910754,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.9016460590687,23.06729450881,0.9263361327236171,-0.11039230634780095,0.007018326356901053,0.022083526898869693,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.337845324658733,21.384079335290934,1.0514427164692657,0.07237025290668997,0.06697643121398135,0.12223198696551596,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.283736483225233,21.877988208980234,0.9396253142077188,-0.0898425137318159,0.38420452422289975,0.49266029477048623,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6170812368189,22.942307806516734,0.8955863314178911,-0.1590955851717352,0.0059862242401707315,0.01994508816846971,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.5790576791569,27.316701044452202,1.0277528035116819,0.03949330730139702,0.02568404851317831,0.056473962092229414,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.117755108707733,27.813348170484634,1.025650834996793,0.0365396740703279,0.016593023858331987,0.03984509018612615,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.0818105806586,28.901086034777933,0.9607495518690677,-0.05776769652816738,0.003236555130672252,0.01327351261455474,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.156998688789635,27.909488039612032,1.0669988698502126,0.09355864808140334,0.05740562406468731,0.10800542671964365,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.871122848929566,29.50742501049143,0.9878244336418988,-0.017673440953309225,0.1558391864555886,0.2340794364456372,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.761280511048,24.1455385493278,1.1630081553244698,0.2178612134103724,0.3129111278449974,0.4157897005604389,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.703912334952065,24.939526478210265,1.2045803747008574,0.2685306595072348,0.07005648456455801,0.12519045880967647,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.321758138172733,28.173696116950566,1.386380839954424,0.47132362143000445,0.0022216644475437047,0.011584393190763603,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.034094390238234,24.9235035664126,1.2440544144863752,0.3150495898035344,0.1982255713171534,0.2837346412971019,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.309967127957567,26.781975247267432,1.3869508461509321,0.4719166591316813,1.1990734792780877e-4,0.0019717592282331494,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.6267392530669,19.705480221759068,1.0040119231053555,0.005776402060428594,0.517175008740252,0.6175788524387482,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.491223159638867,23.6548731976333,0.8020987488239184,-0.31814823268524034,0.0038216808886408606,0.014999070154343163,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9515697096492,23.099573067452233,0.8570770948150795,-0.22250311306430962,9.33194785681232e-5,0.0018923116487424983,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.0781439411166,21.695794727274965,0.9826820037562316,-0.025203459425501333,0.1818061573447661,0.26278185506479185,Downregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,30.6198646708862,29.744880444626066,0.9714242947947421,-0.04182652705403723,0.10403447059438159,0.17028063572622995,Downregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.966930126672267,22.623232217938032,0.8712324524915745,-0.19887040096033393,4.765131676723138e-5,0.0013379023553876503,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.3570908717408,26.616801933017666,1.009853555634826,0.014146095078357627,0.38467995619065365,0.49266029477048623,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.298632823128234,22.208054932019035,1.0426986143403185,0.06032221593073452,0.07042246767851136,0.12519045880967647,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.677622124839033,19.6245483141361,0.9973028341348247,-0.0038964448624972206,0.8582671099819785,0.8899644748392674,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1262680973742,22.5906632251769,0.8990854964067552,-0.1534697829549348,0.0048169847322716165,0.01706989735222466,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.5817511477294,24.428730592725632,1.1319160537765611,0.17876696763000904,0.002312968237659415,0.011729473695736901,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.82234069831477,21.926386648387865,1.004767863883691,0.006862227466135879,0.9678047536526572,0.9785283520310799,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9331233558923,22.966200792567435,1.0014423432936639,0.0020793623001184387,0.9799212366159809,0.9826133279253654,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.12158739994147,25.796916021192267,0.9875707638368896,-0.018043967491177447,0.8504051004053235,0.884324392159382,Downregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.998853634013734,21.665846514552968,0.942040279890762,-0.08613934677301911,0.4992215843800703,0.6094176531729956,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.452145215237465,20.591065114808067,0.8090109867234606,-0.3057687996686689,0.006192265977615745,0.020361955692159883,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.757380008008365,26.8691542025348,1.0041773220880736,0.006014049277438921,0.9666973436200184,0.9785283520310799,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.296029876742733,23.9170538346994,0.876209981550381,-0.19065144533582043,4.448157642309398e-4,0.0038821777034540265,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.588377692244666,20.7173040578018,0.9596508062411847,-0.05941855545955328,0.08969253559601217,0.15226872322113694,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.57394168448643,21.039713919288733,0.7917423079005055,-0.336897148936647,0.009469229097633146,0.026913727483742825,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.287566358448235,22.379361040085033,0.8513287512022888,-0.23221174071833253,0.30040729998977966,0.4046076180674154,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.778973971553768,26.269378315050066,0.8821451786802249,-0.18091198862145738,0.2801536008822923,0.38013406811166056,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.288964095394434,24.773482146853834,1.1636772008184855,0.21869091618079728,0.15470548949064766,0.233336792000357,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.044612508293735,21.0121770164514,0.8067763346358181,-0.3097593292362989,1.5840649888208315e-4,0.0020086410725133775,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.3375771539039,27.695660187399035,1.4322197639846412,0.5182528809295713,0.00840778399453988,0.025362323619893025,Upregulated
Feature0167,[Similar to: NP-017684; ΔMass: -96.2336 Da],C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.854403421427865,22.3372806432835,0.8019299607795531,-0.3184518552750456,0.027853155173505055,0.05910698626935666,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.135976787515034,21.93527962217363,0.8726646991919892,-0.1965006560764593,0.11440805658121543,0.1823534526294482,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.343184645236466,25.285136866672833,0.9598359958064161,-0.05914017681383645,2.6469038718810025e-4,0.0027603426092473312,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.357741114146734,24.140693160787634,0.9910891591982214,-0.01291324560159214,0.504028565325876,0.6104367608644916,Downregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.7260441492229,25.291514034102,1.0228694036727615,0.03262195866979506,0.14846361702375627,0.22673313896933486,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.709516861524133,21.438707093650066,0.8676295539809953,-0.20484889865952247,0.015338811880569476,0.0375749418550863,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1127693037458,21.733237079986733,0.8015867666083135,-0.3190694036024348,0.004404320567316057,0.016403847010922047,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.150812261294234,22.252768619880968,0.8509398636468836,-0.2328709153662264,0.004349848215717159,0.01636798555398725,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2056250022279,20.92999464096337,0.9870020166236282,-0.018875062515785093,0.5288586649131611,0.6247036009492033,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.984226277562833,20.005141981386267,1.0010466106384572,0.001509150369115668,0.937757575318346,0.9587717506756198,Upregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.027805077287,26.5456550326866,1.4724840278049784,0.558251985069981,6.619883439885149e-4,0.004832514911116159,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2589416455298,24.25762104421,0.9603577768470356,-0.05835611954942881,0.001989279411050226,0.01088937650052313,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1330242206675,22.965383720255165,1.1406822675293915,0.18989699066669533,0.2374475831502146,0.3307952971367494,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.487271159626534,22.25895033704043,0.9477027018490967,-0.0774935440300995,0.09540864912241748,0.15927339937658114,Downregulated
Feature0153,[Similar to: Muramic acid; ΔMass: 162.0529 Da],C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.885192909423132,24.923316596574733,0.9270276274580581,-0.10931575991703202,0.018121949856287095,0.04213064775506236,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.533304718063835,24.222725506233168,0.8797609206112229,-0.18481657739992566,0.27598121150056687,0.3758699335735332,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.5201462788572,26.316278898461267,1.2824605897461887,0.3589144922250486,1.2424784177907517e-4,0.0019717592282331494,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.28494784883633,21.738216075565102,1.0212952472304766,0.03039999661719758,0.6347268124949577,0.7172609491042091,Upregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.483650686592433,26.162434114821632,1.3427891176895903,0.4252327502216194,0.0037539621313901917,0.014893436716928478,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.744220493661132,25.8337936011975,1.0034793482117053,0.005010926078565344,0.6697607978795947,0.7430476936962068,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.033030997983367,26.937916665808466,0.9964815513220846,-0.005084999368957957,0.5206635132659071,0.6190299099089775,Downregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.177444834329734,23.217544671826833,1.0468989933361064,0.06612225521750936,0.7744867306084532,0.8228508080872459,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.834202667511068,24.108635256202835,1.2155081633653666,0.2815595825539583,0.008981759595220054,0.026438243969800965,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.990975576346532,21.3107007310268,0.9269158962071873,-0.10948965315561368,0.25110489405010555,0.3458614578425982,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.059242391155134,27.917033442832967,0.9606937808994696,-0.05785144659241886,2.474690025272079e-4,0.0026566525271303197,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.412497504333768,20.0349272644887,0.705144884269071,-0.5040083801543239,0.004635488137063159,0.01706989735222466,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.742370708521133,19.197596559426202,0.7178719033054582,-0.478201661637359,0.0073867947200479634,0.022848983667944973,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.2163505203505,20.938223191140768,0.8303431209937723,-0.26822047329019444,0.0016300371174004147,0.009443865838907163,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7978891841521,20.125362054021366,0.7801166176953956,-0.3582382898932086,0.06654375702696083,0.12223198696551596,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.690595006397167,20.317969427304867,0.7908718899755154,-0.33848407738981623,1.0435085940069187e-6,1.2481230131084379e-4,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7047207876297,18.85588198535987,0.7060879660683211,-0.5020801659164786,0.0011689691727038553,0.0077577045097619495,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.699197907164532,21.5637946093456,0.873056472942814,-0.1958531184673886,0.0041558985240438264,0.016137265545489325,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.679578733382233,22.801633119129335,0.8879286282639947,-0.17148437753242637,0.026683778720702187,0.057630646349445556,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.024029563661834,21.14245989898127,0.7823577845478202,-0.35409956926317593,1.596250030768819e-4,0.0020086410725133775,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.401371012909834,21.202955578550668,0.8689247652245848,-0.2026968264048736,0.06675032524037698,0.12223198696551596,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.456191243790133,21.8974773807363,0.8602024227044587,-0.217251900341854,0.0013239152798420017,0.007921788149874274,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0373156234092,26.65159511419827,1.0235922742449224,0.03364116351910951,0.7755087068000344,0.8228508080872459,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.089018858301568,21.1559492989488,0.8109139486561008,-0.3023792660598981,0.011394757310157603,0.030613094488419333,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.4009417910584,25.603971130468235,0.9698127942973577,-0.04422180821066402,0.014164101169295047,0.03515509725761819,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.400816448575434,25.451702419370932,0.8961609419030477,-0.1581702451551585,0.006010848489127857,0.01994508816846971,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.932855803236833,21.714504669852033,0.9468731175986884,-0.07875697951604749,0.008485393057504637,0.02538662677040322,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5078685143157,23.261406152512667,0.9491403195233016,-0.07530670593857591,0.07887869053362792,0.13709867640368661,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.615391696269732,25.304712550202268,1.0715347378379236,0.09967862117091744,0.005025435769326288,0.017637346690423994,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.510191620200033,25.90328229717007,1.0568372005636186,0.07975315531212736,0.009876790448213229,0.02773098856613714,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.189322601660834,25.6732501470252,1.0613463869906998,0.08589557919081023,0.0034712032141385523,0.014077657479561906,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.916636149877867,27.746410490872265,1.0308275646471583,0.043803020936536645,0.011015501285689384,0.030004910218482277,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.413112124171565,25.095807339854865,1.0718697799232804,0.1001296452822923,1.971289281320676e-4,0.002321034153813054,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.87206979706057,22.884681882553068,0.9200955959546891,-0.12014433301669786,0.46333509926756133,0.5732790211276606,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.951092444429367,19.8498585260969,0.9949258959821654,-0.0073390199651008695,0.6565843452431543,0.7328846667087197,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.3482039468935,26.1004603730291,1.0719665577780395,0.10025989863117754,0.013754883120142307,0.03458680342813893,Upregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.863630435559966,21.256871713120866,0.7912881233276158,-0.3377249913280623,0.02975933141745994,0.06242618372053379,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.032168307553732,21.044622882169833,0.7507311832349055,-0.41363168520336807,2.0517090626440074e-6,1.2481230131084379e-4,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.262904731259933,20.927081129806467,0.7404433949303256,-0.43353864563215744,1.4753649344840621e-6,1.2481230131084379e-4,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.613945178006098,27.7706753526044,1.4158638203875868,0.5016825118196704,1.0797641565670061e-4,0.0019717592282331494,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.062944781159565,27.247732720547802,1.3581123318514652,0.44160281235341026,0.0031491811872838265,0.013061944697256779,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.382246889058866,20.504811434739832,1.0060132990414692,0.008649377046379851,0.7633659489727341,0.8228508080872459,Upregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.7623996634916,20.235425305062833,1.0239356378590543,0.03412503383418071,0.7734138524861198,0.8228508080872459,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.748550628520334,20.910134891071465,1.0588187095043624,0.08245559283476873,0.025276591032715734,0.05591488319358329,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.827245017364934,20.105743560235066,1.0140462551719223,0.02012346159682552,0.6058826639712285,0.6910849135921825,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9638813099357,23.1410153720616,1.103851668970004,0.1425463217368063,0.13071976733216356,0.2030328301116583,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.1283951348602,27.389617741496433,1.009629121270818,0.013825428455172019,0.16439102585852694,0.24391351397708264,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.780710366775267,20.726216876243168,0.8039428154374657,-0.31483520892946204,0.04631145591419708,0.08991319898235071,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4170275175503,20.424621107540467,1.0003719243647804,5.364736790212588e-4,0.9904286672760223,0.9904286672760223,Upregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.327093753602,26.2922994852546,1.0381096126165414,0.05395878399371363,0.01177636628207781,0.031147635456220298,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.233125388957568,20.1144961385284,0.9941368795898476,-0.00848358926684661,0.5009710291887962,0.609514752179702,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.588858503773366,26.575013147248068,1.3566391906975577,0.4400370752108212,2.163879560309127e-5,8.26345080487104e-4,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.228429364978602,24.762378508808798,1.224137478101973,0.2917655905781073,4.705204483760791e-4,0.0039939526431923,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.9070926521018,24.151375727031734,0.8975839953910886,-0.15588114306694975,6.937179186141658e-5,0.00168804693529447,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.336937995903735,24.286457409492034,1.0872778271554415,0.12072063277109155,0.4720456810379627,0.5801234800634896,Upregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.7541324729329,25.4579521373332,1.1702582104346702,0.22682688691428046,4.2481642015588264e-4,0.003876449833922429,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7908990243229,23.307620936458832,0.8699827846500533,-0.20094124190959162,5.428133519861003e-4,0.004215465393083545,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.868456251191,21.810838272032534,1.045158204780373,0.06372133845627032,0.14659311020614968,0.22481716481195224,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.120432812705765,24.335794363931768,1.0525665570827076,0.07391146230565886,0.3468951625787929,0.45277003040870456,Upregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.085988905457732,25.815439668341533,1.029078015047878,0.04135235799112797,0.06616281190233159,0.12223198696551596,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.839924414902033,28.003605830377733,1.3437479557436953,0.4262625599183387,3.622033934443944e-5,0.001201856714610945,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.904560927185265,24.610537720242032,0.9881940015805585,-0.017133796353756156,0.8644098048791117,0.8937948407390247,Downregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.863602612978767,27.195462672482165,1.303488336935851,0.3823776743041665,0.002691764218950255,0.012604454731957898,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.99529426068173,20.668780909383567,1.0336822574312479,0.04779278519305363,0.08463231673549729,0.1457113000398892,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.1455579858692,20.0408390846854,0.9948018862889152,-0.007518851770536778,0.6499881470918395,0.7277474653022129,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2502223786611,22.33873100038783,1.0039778758261586,0.005727477667601568,0.6117623754592962,0.6956176543384521,Upregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.0487066532288,20.3130816158032,0.8109433312072752,-0.30232699258133866,0.0027281217633199277,0.012604454731957898,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.535680712697165,22.1150163502614,0.8660437369607734,-0.20748820907731536,0.003025449083321851,0.013014118638113149,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.1917360610915,22.704067665479734,0.9385050997640288,-0.09156351031679154,0.34733043428612953,0.45277003040870456,Downregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.204879190669335,21.708426848423198,0.9355113064821359,-0.09617300506947442,0.5938478471200341,0.681296633564225,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.294101278329766,20.046508995598366,0.987799790720677,-0.017709431826272853,0.7697805121026053,0.8228508080872459,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.374970759917467,20.4002106878276,1.0012387712457378,0.0017860630994759308,0.9524683153371287,0.9686058575488905,Upregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.153432946019766,26.9410955864788,1.1635896780097208,0.21858240372493956,0.009511974918911847,0.026913727483742825,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.458464449390632,22.699728880447566,1.0107426948801692,0.015415776601704324,0.6779904095205164,0.7498984832575407,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.948449807332565,23.033311777728667,1.0494277263277914,0.06960281221474789,0.012484826373101684,0.03186686451875605,Upregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.772596146786732,20.837510858465734,0.8085142350342422,-0.3066549202824052,0.11288519802765357,0.18071533894777872,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.776434596386334,24.71201812109503,1.084981848959617,0.11767090752230105,2.2705252288012542e-4,0.0025113385106438116,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.652267932473134,20.970954117482567,0.7868356332982661,-0.3458658006941157,0.007298019841093407,0.02276732685469311,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.892884326500965,19.680713163433968,0.9893343187652106,-0.015469971757411863,0.3592207530852452,0.4649488470784202,Downregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.656060688508035,25.064584704857968,0.9769459547655731,-0.03364934123858102,0.7173824685145112,0.7821407552300275,Downregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.311871832884066,21.0187264198941,1.0348000712502363,0.04935205847077582,0.12669544445550765,0.1984714044045506,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.2313759165343,22.448736412949035,1.0573378051992708,0.08043637201540908,0.4087739950674999,0.5146672781144574,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.26382700578173,26.814102171301332,1.4681535344598293,0.5540028481684313,0.0030015085449933815,0.013014118638113149,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.361822214297067,24.511445401693567,0.8348066827323231,-0.26048594538842523,0.008860072266565837,0.026292084368264475,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.393299284277134,19.741058022810833,0.9680168837629345,-0.046895884258738814,0.10518581263139533,0.17139652504669328,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.14027449491263,24.84631810044243,1.0292475384104929,0.04158999825624675,0.1117252145762355,0.18006359630454544,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.371172789153334,26.4157355648094,1.0411712451898414,0.05820737340972859,0.011490394369625886,0.030613094488419333,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.853754779498466,25.990452279342367,1.045735443595088,0.06451791612745156,0.010179374455560266,0.02836237920824044,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.166550954669468,24.684339618769567,1.1661956485793947,0.22180984476219476,0.2250715858963642,0.3159658802006651,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.554678366624834,24.825079770936966,0.9348665206255441,-0.09716770184261689,0.595434592073939,0.681296633564225,Downregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,17.7885600300926,30.5610379393236,1.7180164042296857,0.7807438119058466,1.6509378678192143e-4,0.0020086410725133775,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4123003984983,20.5573156123154,1.0071043052956328,0.010213110295910365,0.6368702880225134,0.7174618985438809,Upregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.9172968734495,21.0330889006201,0.9177822767129084,-0.12377614774196889,0.037329572595408846,0.07638358001944659,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.526777268834433,25.110363772102936,1.0673099628212257,0.09397921729129842,0.004242769243023444,0.01630116603898481,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.6141363416845,25.8361317883481,1.008666911259558,0.012449836674447724,0.7075063634724976,0.777830791167053,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.1963520003667,23.141694182978632,0.9184541548967816,-0.12272038460544965,0.5874393157138682,0.6774626293023008,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.223281103430168,24.9347004994001,1.2329700789834153,0.3021377896628803,0.18146403281742096,0.26278185506479185,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.5144914430735,22.911257123432666,0.9346005474613334,-0.09757821259635596,5.066482591107361e-4,0.0041094803238981925,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.4285277741955,25.94410557089917,1.4078230170522539,0.4934659785279216,0.0030589685478346848,0.013014118638113149,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.061523660293666,26.828544468971135,1.2160784940369804,0.2822363532083687,0.029112010834567558,0.06142129453535929,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.735328700917034,25.805674903946368,1.1350473636611857,0.18275250006545404,3.157211264994852e-4,0.003201061421453114,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.920898765996498,24.069283230913967,1.0501020695846848,0.07052956420266959,0.05012278790288056,0.09628851360290212,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.344425896994334,20.2000386933588,0.9929028617289777,-0.010275512840496106,0.5177510379349506,0.6175788524387482,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.5677109691208,26.21209259559477,1.0252029455140594,0.0359095287600971,0.7178552137042717,0.7821407552300275,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.8544979755182,25.413674365881267,1.2799958174322952,0.35613909602250604,0.0706554370268311,0.12519045880967647,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8057919080478,22.287667406137032,0.936228775426809,-0.09506698725303496,0.005709392366683118,0.019475964615320914,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.949233537273432,23.116208624241732,1.0072758459099345,0.010458824387179799,0.8305499197016353,0.8686267068512804,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.689214271817967,26.138573810870266,1.1520263988752009,0.20417377675415407,0.09204004164322391,0.15481389492984665,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.943078066548534,18.55128408291017,0.9793173009021046,-0.03015172303495142,0.3540039914431268,0.4598272486716771,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.450776231692533,21.380353481004168,0.9967170068846124,-0.004744149660242255,0.9192683529458326,0.942508283216935,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.710330624422134,25.416481051520467,1.0285771339052994,0.040649986891564946,0.10217302750857267,0.1679871848676983,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.4026006492414,25.302410447073868,0.8908483684133927,-0.16674820382976188,0.07882149455662066,0.13709867640368661,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,19.702428780805732,22.7885861540737,1.1566384229884656,0.20993793368586516,0.048890251710323365,0.09441768187443401,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.714763838537966,21.600860611240467,0.9947545721360621,-0.007587469972758506,0.741097754158892,0.8050615484166534,Downregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.715623610091935,20.914901047264333,1.00961966875452,0.013811921354457746,0.5775894129272423,0.6714017061096925,Upregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.466324749141865,26.973615210334966,1.317951099718866,0.39829684265108006,1.8489320679624176e-6,1.2481230131084379e-4,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.135188750022433,20.0216272513046,0.76607930567508975,-0.38443434505852325,0.01838094816546537,0.04246231696452443,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.178076009583133,22.051379250204068,0.9942872970890568,-0.008265319359317728,0.8206893172505106,0.8620615694138777,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,28.102437461856866,24.5682518657356,0.8742391793979374,-0.1939000603275891,0.06816155965794236,0.12377596654302966,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2589859918705,24.7846464920801,1.1134670061399936,0.15505880933051777,0.2108093371399271,0.29732358822183347,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.322873501723432,25.823328827164534,0.9810224110021198,-0.0276420003670998,0.16433678474636487,0.24391351397708264,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.0102114360189,23.991709384314934,0.922395784568335,-0.1165421751286564,0.02235364563741897,0.05067751961278214,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,29.335986760269634,23.661974831278002,0.8065852710065963,-0.310101033849446,0.004690141751407014,0.01706989735222466,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.563826621920168,24.206665230593835,0.9469108670075782,-0.0786994641019858,0.030932103922091392,0.0645155310375049,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.23635475283143,25.221915194440665,0.9994278270957835,-8.257072576372654e-4,0.9780748862279489,0.9826133279253654,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.499092492767666,24.282027306939934,0.9911398683077012,-0.012839431950621236,0.18107219339108846,0.26278185506479185,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.105446800116166,21.939800873107835,1.0395326420186033,0.055935060494491824,0.43017400807464634,0.5358822967482796,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.4927288422862,21.429909145334232,1.0457323331734223,0.06451362498803057,0.04519640104594972,0.0891712777393062,Upregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.521174649017933,26.884867714479768,1.0137133090926387,0.01964969767505932,0.0438691898356109,0.08702312114129337,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,18.1453306316713,18.2901738334145,1.007982395288537,0.011470441961126506,0.5832062341440808,0.6757786522621889,Upregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,No gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.640585695144335,26.577985861204034,1.0365592337556166,0.05180256102403164,0.0014226507847491532,0.00837528284570066,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.7950302393238,24.229165913917132,0.9392958910736398,-0.0903483967091581,0.002510112797135349,0.012380961769654086,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.577453625105935,24.418750614290865,0.954698265597568,-0.06688325651305485,0.006628625816840799,0.021223231781990277,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.2313848022398,22.959582771927433,1.0327554030558757,0.0464986079466617,0.8003107488632761,0.8467055748843356,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.3713905929201,21.729665789563366,1.0167642435378985,0.023985201213183222,0.3246550445148799,0.4262557239134215,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.402632454270133,20.1780974681236,0.988994803163278,-0.015965154762698528,0.5287838781289972,0.6247036009492033,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.399859400605,21.5037403069425,0.8813059105746041,-0.18228521414809729,0.002662181875139105,0.012604454731957898,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.548606790391165,25.0391865595278,1.1104538205969323,0.1511493981248147,0.4714483617321614,0.5801234800634896,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.582339337728765,24.223592088894932,1.0726785974925146,0.10121787174874368,0.6962629149358588,0.767782368433802,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,25.58893607761833,22.269461871508234,0.8702769745470772,-0.20045346839495853,1.1750240735218273e-4,0.0019717592282331494,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.778873307002566,25.614798177812,1.033735386611513,0.04786693489873394,0.00600087231519557,0.01994508816846971,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.392675539652867,25.320172208313167,1.0380235725741753,0.05383920636411263,0.007008249982765871,0.022083526898869693,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,27.567552665057466,20.294767812924498,0.7361831519650492,-0.44186336181114483,0.0035177318079837954,0.014109583625429509,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,24.94388366560697,23.078877850794434,0.9252319390270396,-0.11211302618887485,3.3569390860161184e-4,0.003311575044313198,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,26.7435181209715,20.803669004105068,0.7778957469246137,-0.3623512757594722,0.0012877950490283922,0.007921788149874274,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,20.9420229797029,23.200819436435832,1.1078595157173767,0.14777494923215428,0.4089137278169662,0.5146672781144574,Upregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,21.650494824991533,21.236094019068332,0.9808595226449581,-0.02788156445258876,0.1674051776518843,0.24638262033442648,Downregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.9043444632095,24.583660968513033,1.0284181189887491,0.040426933355910334,0.02188348163509594,0.04992169248006262,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.73681318211967,24.9127932214179,1.0495424567011409,0.06976052854838032,7.514835978300933e-4,0.005274836792461232,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.8286430864367,25.067859196871233,1.0520053158687788,0.07314199470450107,0.0011125337800604468,0.007519904254112279,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.790375337821633,24.618789530451767,1.0348214007079213,0.04938179521562986,3.639214494617603e-4,0.0034955612908826976,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,22.977628491503502,24.420577158328534,1.06279798053827,0.08786739162548396,0.03503464891754127,0.07224659240057944,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F9,F1154_1,Area: 10,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Sample,23.5077301332603,24.291037384054867,1.0333212626805808,0.04728886215973314,0.01227945949149159,0.03186686451875605,Upregulated
Feature0365,δ-Valerolactam,C5 H9 N O,99.06838,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,δ-Valerolactam,5,9,1,1,0,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.407942392992666,23.566127384301268,1.1008123504674148,0.1385685614336606,0.0019632835139276436,0.01088937650052313,Upregulated
Feature0364,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,α-Eleostearic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.74444261487047,23.594004731145233,1.085059072289574,0.11777358735117073,0.026485509647572594,0.05754292274621426,Upregulated
Feature0363,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06331,Metabolic pathways;Microbial metabolism in diverse environments;Other,Υ-Aminobutyric acid (GABA),4,9,1,2,0,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.2586582595881,26.103801103179432,0.9576333821932541,-0.06245465074583852,0.12418370271958887,0.19707413692456494,Downregulated
Feature0362,Valylproline,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Valylproline,10,18,2,3,0,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.197292677428234,25.865814408569634,1.0265314904938285,0.03777788510110572,0.08505398531370713,0.14574978703992067,Upregulated
Feature0361,Valyllysine,C11 H23 N3 O3,245.17392,NA,Valyllysine,11,23,3,3,0,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.225359594187267,23.4092114122264,1.0532658116518734,0.07486957383562665,0.02624835755969652,0.05736916472628281,Upregulated
Feature0360,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.798510239938434,27.807259567111366,1.0003147408655144,4.5400364284028277e-4,0.9714962443290832,0.9795473181771144,Upregulated
Feature0359,Val-Leu,C11 H22 N2 O3,230.16304,NA,Val-Leu,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.556384222891666,23.4205611952757,0.9537463244870903,-0.06832250273517732,0.0699602677557655,0.12519045880967647,Downregulated
Feature0358,val-his,C11 H18 N4 O3,254.13787,NA,val-his,11,18,4,3,0,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909091,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.913620388919302,24.170614998523433,1.0548579660598723,0.07704875679420652,0.0019988718507809584,0.01088937650052313,Upregulated
Feature0357,val-arg,C11 H23 N5 O3,273.18012,NA,val-arg,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.961741097575732,23.307573026424432,1.015061224119682,0.02156674718387041,0.5050737035097985,0.6104367608644916,Upregulated
Feature0356,Uracil,C4 H4 N2 O2,112.02722,Metabolic pathways;Other,Uracil,4,4,2,2,0,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.154752558976366,24.8086255276989,1.0270701580207056,0.03853473391655019,0.5521159185033222,0.6479817049958605,Upregulated
Feature0355,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,Tris(hydroxymethyl)aminomethane,4,11,1,3,0,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.02464909184,23.041615449195902,0.9207567852253831,-0.11910797123919635,0.3988442900213529,0.5054797425617841,Downregulated
Feature0354,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of various plant secondary metabolites;Other",Trigonelline,7,7,1,2,0,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.0545823568341,19.773865904456468,0.7892315115387577,-0.34147953538808523,0.009406355227105284,0.026913727483742825,Downregulated
Feature0353,Tolycaine,C15 H22 N2 O3,278.16307,NA,Tolycaine,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.906260379887435,22.453952408312833,0.9802539583470489,-0.028772532411116224,0.2423444885428845,0.33505961484148805,Downregulated
Feature0352,Tn Antigen,C11 H20 N2 O8,308.12198,NA,Tn Antigen,11,20,2,8,0,0,0,1.8181818181818181,0.7272727272727273,0.18181818181818166,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.364314091152565,23.853567090450035,1.1165145292601892,0.15900202514626824,5.4150580298791877e-5,0.0014117829863613597,Upregulated
Feature0351,Tiglic acid,C5 H8 O2,100.05241,NA,Tiglic acid,5,8,0,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.557753566348502,25.219694200619735,1.2267728630574928,0.29486815880153566,2.066199539534021e-4,0.0023567588497809926,Upregulated
Feature0350,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Thymine,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.210697584788768,24.8158824974359,1.0249965913013328,0.03561911195429194,0.05234192130528202,0.09950417331472884,Upregulated
Feature0349,Tetrolic Acid,C4 H4 O2,84.02115,Metabolic pathways;Other,Tetrolic Acid,4,4,0,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2403253242342,22.049019786161434,0.8735632169127127,-0.19501598484622076,0.002313759194775498,0.011729473695736901,Downregulated
Feature0348,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,2,3,0,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.998228192396265,23.939439294293933,1.0409253745124962,0.05786664339249682,0.054976077362542584,0.1039703017478137,Upregulated
Feature0347,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Stavudine,10,12,2,4,0,0,0,1.2,0.4,0.20000000000000018,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.739819651794633,19.6695044806278,0.9964379020473756,-0.005148195693390129,0.7139713578517997,0.7821407552300275,Downregulated
Feature0346,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Sorbic acid,6,8,0,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.4641933444476,24.318654783177898,1.2494047070342678,0.32124087026674736,0.041439243003192065,0.08310617415475331,Upregulated
Feature0345,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,Pyrone,5,4,0,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1349158711952,21.784813540310235,0.8667151961815712,-0.20637009516318233,0.00654843812478187,0.021152034650844094,Downregulated
Feature0344,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Cyanoamino acid metabolism;Other,pyroglutamine,5,8,2,2,0,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.422291150294967,22.928283771934336,0.9388260761790735,-0.09107018117734773,0.002576878285587238,0.012540807656524558,Downregulated
Feature0343,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Pyrogallol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.065717896301667,20.475389434119734,0.816868262813282,-0.29182466267364443,0.0013122360050663799,0.007921788149874274,Downregulated
Feature0342,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Pyridoxine,8,11,1,3,0,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.7379613528228,23.497973241322267,0.9898901128056645,-0.014659713643976079,0.8219107565918614,0.8620615694138777,Downregulated
Feature0341,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,PYRIDOXAMINE,8,12,2,2,0,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.5283921743242,26.485788575419033,1.037503200145043,0.053115786412587455,0.006322760483348946,0.020605424789485405,Upregulated
Feature0340,propionyl adenylate,C13 H17 N5 O5,323.12166,NA,propionyl adenylate,13,17,5,5,0,0,0,1.3076923076923077,0.38461538461538464,0.6153846153846154,42.76153846153846,8,3,-0.6666666666666666,0.09090909090909091,-2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.4071829786128,22.165337714170267,0.8724043800065735,-0.19693108167405884,0.0024559615009637787,0.012279807504818894,Downregulated
Feature0339,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",C10 H15 N O8,277.07983,NA,"Propane, 1,3-diacetoxy-2-acetoxymethyl-2-nitro-",10,15,1,8,0,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1890698096832,25.28688897484737,1.0038833972791867,0.005591707599108244,0.7720505162001491,0.8228508080872459,Upregulated
Feature0338,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,Proline,5,9,1,2,0,0,0,1.8,0.4,-0.40000000000000036,71.7,2,0,-0.5,0,-1,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.040995823119435,27.122502056196932,0.9339384303965501,-0.0986006510438823,0.009129819911104982,0.026659074140426547,Downregulated
Feature0337,pro-his,C11 H16 N4 O3,252.12226,NA,pro-his,11,16,4,3,0,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818166,55.11818181818182,6,3,-0.25,0.09090909090909091,-1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.898189288715802,24.9743973785335,1.25510904616313,0.32781271359791014,4.227441532177798e-5,0.0012858467993707469,Upregulated
Feature0336,Piptamine(antibiotic),C23 H41 N,331.32396,NA,Piptamine(antibiotic),23,41,1,0,0,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.1550346254478,23.497595787553568,1.060598468239976,0.08487856999315756,0.6395315214122348,0.718243093278356,Upregulated
Feature0335,Pipecolic acid,C6 H11 N O2,129.07898,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak2,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.346681969244433,23.958095537650166,0.9452162443479122,-0.08128367141691287,0.01552025041803678,0.0377659426838895,Downregulated
Feature0334,Pipecolic acid,C6 H11 N O2,129.07895,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Pipecolic acid-peak1,6,11,1,2,0,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.126188005131233,24.6671449735766,1.2256242944410356,0.29351679989690455,8.006099144280871e-5,0.0017189565809779517,Upregulated
Feature0333,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Pinolenic acid,18,30,0,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666667,4,2,0.125,0.17647058823529413,2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.9070058615956,23.38991073964,1.0676908970314392,0.09449403853764649,0.01425466957295203,0.03515509725761819,Upregulated
Feature0332,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Phloroglucinol,6,6,0,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6758080153392,22.7348999953628,0.8854599622251635,-0.17550102066579315,0.003092160136033529,0.013014118638113149,Downregulated
Feature0331,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Phenacetin,10,13,1,2,0,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.611878517628067,26.587601625183932,1.0380965069346357,0.053940570481948065,0.012019850356753074,0.03156291640442354,Upregulated
Feature0330,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,"pentane-1,2,3,4,5-pentol",5,12,0,5,0,0,0,2.4,1,-0.40000000000000036,71.7,0,-5,-Inf,-1,-5,Carbohydrate,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.0428689916695,27.803554025363766,1.3212815246994458,0.401937893545508,1.509789670316696e-5,6.888415370819925e-4,Upregulated
Feature0329,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Penicillic acid,8,10,0,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.417081003337135,24.758022372246,1.2126132216549146,0.2781194579753137,0.004814019712443241,0.01706989735222466,Upregulated
Feature0328,"Octahydro-1,6,7,8-indolizinetetrol",C8 H15 N O4,189.10014,NA,"Octahydro-1,6,7,8-indolizinetetrol",8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.247283550572032,24.5485426565242,1.2124363544970778,0.2779090166099337,0.07129836300601956,0.1257193357352519,Upregulated
Feature0327,O-Ethylthreonine,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,O-Ethylthreonine,6,13,1,3,0,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.249915318550066,23.029476746366534,0.9120615438043759,-0.1327969174867457,0.2627615457902587,0.36055625644152034,Downregulated
Feature0326,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10047,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,N~2~-Acetyl-L-ornithine,7,14,2,3,0,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.513692710912398,22.8985088550048,0.8322586537401743,-0.26489612844867644,0.016861134600730052,0.0402242753546828,Downregulated
Feature0325,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NP-021733,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.011204278253935,20.433706575370067,0.972514773773269,-0.040207928194666,0.045482005264313445,0.08925232215846456,Downregulated
Feature0324,NP-019988,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019988,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.32412765704793,25.037299940457633,1.1741300907182688,0.23159226435632896,0.13030354043908704,0.2030328301116583,Upregulated
Feature0323,NP-019811,C6 H7 N O2,125.04764,"Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",NP-019811,6,7,1,2,0,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.876308209848833,22.2772711304372,0.828881368545762,-0.2707624603047723,0.01240097293419107,0.03186686451875605,Downregulated
Feature0322,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,NP-019445,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.132749633445,27.253349088264866,1.3536824122121383,0.4368893075469344,0.05136073029360713,0.09815008668673614,Upregulated
Feature0321,NP-016455,C11 H18 N2 O4,242.12665,NA,NP-016455,11,18,2,4,0,0,0,1.6363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.213190956215534,20.845667219626765,0.738862443882277,-0.43662229614635395,1.239999528177793e-6,1.2481230131084379e-4,Downregulated
Feature0320,NP-014287,C18 H32 O3,296.23516,Metabolic pathways;Other,NP-014287,18,32,0,3,0,0,0,1.7777777777777777,0.16666666666666666,-1.4444444444444446,101.46666666666667,3,0,0,0.09090909090909091,0,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2796698750677,23.7733798686438,1.0670436322419505,0.0936191702879899,0.005562213121158063,0.019237557051234692,Upregulated
Feature0319,NP-013538,C12 H16 O8,288.08457,NA,NP-013538,12,16,0,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.544396077814234,22.158699269424634,0.9028007533440173,-0.14752047249715208,4.129683333541318e-4,0.003864960042929695,Downregulated
Feature0318,NP-011220,C11 H18 N2 O2,210.13681,NA,NP-011220,11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.009472405136098,26.956049228421765,1.036393541881255,0.051571930737827815,0.017916688421358146,0.04192045688330592,Upregulated
Feature0317,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Other,NP-007065,8,10,0,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.644551715071298,22.471649933646468,1.143912585004738,0.19397680911047102,0.041262139530914274,0.08310617415475331,Upregulated
Feature0316,NP-003553,C20 H34 O4,338.24574,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NP-003553,20,34,0,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.0160326624329,22.6033729887552,1.0266778458829466,0.037983559399098435,0.16000846480487446,0.23935692481057042,Upregulated
Feature0315,Nonylbenzene,C15 H24,204.18777,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Nonylbenzene,15,24,0,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9789785410655,27.011193972771935,1.2875361838946837,0.3646129772215935,6.166433611776803e-4,0.004593363812854149,Upregulated
Feature0314,Nicotinic acid,C6 H5 N O2,123.03198,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Degradation of aromatic compounds;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",Nicotinic acid,6,5,1,2,0,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.228510038840568,24.6825608717218,1.0187403530862338,0.026786397875694583,0.06182299738632972,0.11512956145923647,Upregulated
Feature0313,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Nicotinamide,6,6,2,1,0,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.422939555697535,20.116460474973,0.791272009710014,-0.3377543703522401,0.004766616531558956,0.01706989735222466,Downregulated
Feature0312,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Ne-Acetyllysine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.159017560899,23.0578247972753,0.954418975819366,-0.06730536781362476,0.059836565784238294,0.11200177698075373,Downregulated
Feature0311,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,N8-Acetylspermidine,9,21,3,1,0,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666665,1,0,-0.6,-0.45454545454545453,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.685669645715066,22.6625817729804,1.095569162667878,0.13168056373329118,0.22979909191692194,0.32136654616734295,Upregulated
Feature0310,"N3,N4-Dimethyl-L-arginine",C8 H18 N4 O2,202.14285,NA,"N3,N4-Dimethyl-L-arginine",8,18,4,2,0,0,0,2.25,0.25,-0.25,67.425,2,0,-2,-1,-4,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.948973423729267,25.4972793866126,1.0646502017221846,0.0903795007467462,0.10089732745941114,0.16664038245558854,Upregulated
Feature0309,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13244,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak2,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.413613221147,19.20433686231887,0.8568157517860523,-0.22294309190618236,0.13448570943975952,0.2079969658708145,Downregulated
Feature0308,N-Methyl-Nâ€²-piperazinoacetohydrazide,C7 H16 N4 O,172.13243,NA,N-Methyl-Nâ€²-piperazinoacetohydrazide-peak1,7,16,4,1,0,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9122366380974,19.1185912418606,0.8344271030297887,-0.26114207608572887,0.16925995005006544,0.2481119749729875,Downregulated
Feature0307,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,N-Caffeoylputrescine,13,18,2,3,0,0,0,1.3846153846153846,0.23076923076923078,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.5009787108156,19.8210213802509,0.9668329331903567,-0.04866147848515967,0.31326621275101557,0.4157897005604389,Downregulated
Feature0306,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,C11 H19 N3 O2,225.14773,NA,N-Allyl-N'-(4-piperidinylmethyl)ethanediamide,11,19,3,2,0,0,0,1.7272727272727273,0.18181818181818182,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.053444672647533,25.294523030630334,0.9708705834659184,-0.04264909691071546,0.18214742282573243,0.26278185506479185,Downregulated
Feature0305,N-Acetylvaline,C7 H13 N O3,159.08956,"Metabolic pathways;Tropane, piperidine and pyridine alkaloid biosynthesis;Other",N-Acetylvaline,7,13,1,3,0,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.138271564927766,21.954562846351568,1.0386167468289214,0.05466339298033458,0.5157404871547384,0.6175788524387482,Upregulated
Feature0304,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08006,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.66178940283317,24.0000434184496,1.0590533250410104,0.08277523317856765,0.021328372645806698,0.04896135858943047,Upregulated
Feature0303,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,N-Acetyl-D-galactosamine,8,15,1,6,0,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.828976523187333,24.90240466157117,1.1407957965926234,0.1900405711106473,0.0027626202152236487,0.012604454731957898,Upregulated
Feature0302,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",C8 H15 N O7,237.08488,NA,"N-Acetyl-3,4,5,6-tetrahydroxynorleucine",8,15,1,7,0,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.803799803649532,24.80357991509757,0.9612374961764159,-0.05703516833732357,0.1256695369146301,0.1984714044045506,Downregulated
Feature0301,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",C8 H13 N O6,219.0743,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,"N-[5-(1,2-Dihydroxyethyl)-4-hydroxy-2-oxotetrahydro-3-furanyl]acetamide",8,13,1,6,0,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.068228144579766,24.353790988481233,0.9715002930411335,-0.04171366390543388,0.14918759412556387,0.22688946606596172,Downregulated
Feature0300,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",C23 H18 Cl N3 O3,419.10311,NA,"N-[3-Chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide",24,18,3,3,1,0,0,0.75,0.125,-0.125,63.8625,17.5,14.5,0.6388888888888888,0.6666666666666666,11.5,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.554467561037935,21.4310757834881,0.9942753502400181,-0.00828265415124471,0.6645014367014744,0.7394604402318237,Downregulated
Feature0299,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08993,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,9,15,1,6,0,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.333428878772068,24.506970139269633,0.8965933344097364,-0.15747432096135716,0.004296318518125518,0.016334961032456397,Downregulated
Feature0298,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",C14 H14 N6,266.12669,Metabolic pathways;Biosynthesis of cofactors;Other,"N,N-dimethyl-N'-(3-phenyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)iminoformamide",14,14,6,0,0,0,0,1,0,0.2857142857142856,52.15714285714286,11,11,0.625,0.625,5,Unsaturated HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,17.9579323568517,25.564708055042733,1.4235886151608501,0.5095323003678524,1.2268032307555972e-4,0.0019717592282331494,Upregulated
Feature0297,"N,N'-1,4-Butanediyldiacetamide",C8 H16 N2 O2,172.1212,NA,"N,N'-1,4-Butanediyldiacetamide",8,16,2,2,0,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.00392183828807,19.883969398243533,0.8643730203059706,-0.21027405285911624,0.0012056566932494928,0.00785829808992973,Downregulated
Feature0296,muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,muramic acid,9,17,1,7,0,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.405965885807632,24.728874746064367,0.9023172125770756,-0.148293388058783,0.017423628080856835,0.041296261360472375,Downregulated
Feature0295,MFCD09839908,C11 H16 N2 O3,224.11608,NA,MFCD09839908,11,16,2,3,0,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.21594275614933,25.401351878297167,1.0941339813378448,0.12978941306314776,0.03805468172094693,0.07716643793414238,Upregulated
Feature0294,MFCD00634809,C16 H20 N2 O3,288.14736,NA,MFCD00634809,16,20,2,3,0,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.233860585341567,22.836745093079035,1.12864003370781,0.17458542907677482,0.1913070791534775,0.2749097790985011,Upregulated
Feature0293,MFCD00063043,C11 H14 N2 O3,222.10044,NA,MFCD00063043-peak2,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.7506624331551,22.316963510961,0.9809368661915505,-0.027767808354548847,0.8750077173514672,0.9021972226928969,Downregulated
Feature0292,MFCD00063043,C11 H14 N2 O3,222.10045,NA,MFCD00063043-peak1,11,14,2,3,0,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818166,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.219685376707634,23.205046164106534,0.9581068376066978,-0.061741556367066186,0.5687965881656921,0.6632931459440179,Downregulated
Feature0291,MFCD00025556,C8 H14 N2 O5,218.09029,NA,MFCD00025556,8,14,2,5,0,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.41917653977377,24.530187616676667,1.0474402280975175,0.0668679192585931,0.10569024726329265,0.17145306778267475,Upregulated
Feature0290,MFCD00025555,C9 H18 N2 O3,202.1317,NA,MFCD00025555,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.752938758383564,22.297625001318668,0.8658283705217891,-0.2078470209015324,0.1263378412546433,0.1984714044045506,Downregulated
Feature0289,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Mevalonolactone,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.527140318640498,24.4118505594793,1.2501497997725701,0.32210097683970895,0.03745934472186559,0.07638358001944659,Upregulated
Feature0288,Methylhippuric acid,C10 H11 N O3,193.07402,Other,Methylhippuric acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.4451464689765,21.86909840411323,0.9327772139556153,-0.1003955483244563,0.1654880255884727,0.2445470823473382,Downregulated
Feature0287,Methyl piperonyl ketone,C10 H10 O3,178.06304,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Methyl piperonyl ketone,10,10,0,3,0,0,0,1,0.3,-0.40000000000000036,71.7,6,3,0.42857142857142855,0.5294117647058824,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4664053587124,21.515747310562766,1.0512714340138714,0.07213521539626236,0.027492859128946025,0.058683588199212273,Upregulated
Feature0286,methyl N-acetylneuraminate,C12 H21 N O9,323.12172,NA,methyl N-acetylneuraminate-peak2,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.78128734231767,21.438924294262634,0.8315691923991928,-0.2660917840169612,0.1119847571537858,0.18006359630454544,Downregulated
Feature0285,methyl N-acetylneuraminate,C12 H21 N O9,323.12167,NA,methyl N-acetylneuraminate-peak1,12,21,1,9,0,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.263708096473167,22.2136008498238,0.8457907302437145,-0.24162734618381695,0.03328412086809078,0.06902672793666553,Downregulated
Feature0284,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,C9 H19 N5 O3,245.14919,Metabolic pathways;Other,Methyl glycyl-N~5~-(diaminomethylene)-L-ornithinate,9,19,5,3,0,0,0,2.111111111111111,0.3333333333333333,0.22222222222222232,53.96666666666666,3,0,-5,-1.4,-5,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.6741883835944,23.201213878412467,1.0232434116671354,0.033149377764871625,0.0828885752619503,0.14338545009768655,Upregulated
Feature0283,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,"Methyl 4-hydroxy-2-methoxy-3,6-dimethylbenzoate",11,14,0,4,0,0,0,1.2727272727272727,0.36363636363636365,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.403340594236433,20.350438889289368,0.9974072037516245,-0.003745472013457423,0.9526835694795937,0.9686058575488905,Downregulated
Feature0282,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",C11 H21 N O7,279.13182,NA,"Methyl 4,6-dideoxy-4-[(2,4-dihydroxybutanoyl)amino]hexopyranoside",11,21,1,7,0,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6284653770252,23.798457259929968,0.928594705528652,-0.10687903962281915,0.09556403962594869,0.15927339937658114,Downregulated
Feature0281,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",C11 H15 N O7,273.08486,NA,"Methyl (5-acetamido-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)acetate",11,15,1,7,0,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818166,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.29688379223497,28.88502210316277,1.0581802055874074,0.08158533592916119,0.00288039954983736,0.012821290679154104,Upregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,methoxyresorcinol,7,8,0,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.45454545454545453,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.3257870660719,23.529627941271798,1.21752495051444,0.2839513374941623,0.013796394014012534,0.03458680342813893,Upregulated
Feature0279,Methionine sulfoxide,C5 H11 N O3 S,165.04599,Metabolic pathways;Other,Methionine sulfoxide,5,11,1,3,0,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.643191339414667,24.073843143713866,0.9388005894068011,-0.09110934725934038,0.009506122698445972,0.026913727483742825,Downregulated
Feature0278,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Other,Methionine,5,11,1,2,0,1,0,2.2,0.4,-0.40000000000000036,71.7,1,-1,-3,-1,-3,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.1673021379854,26.524769667096166,1.0975478154595244,0.13428379317627095,0.011407600973253496,0.030613094488419333,Upregulated
Feature0277,methallylamine,C4 H9 N,71.07352,NA,methallylamine,4,9,1,0,0,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.485478616356,25.928779198312665,1.017394241977161,0.024878834290079126,0.23942584109661474,0.3322830114078494,Upregulated
Feature0276,Mephedrone,C11 H15 N O,177.11537,NA,Mephedrone,11,15,1,1,0,0,0,1.3636363636363635,0.09090909090909091,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.220107095375333,19.994562376860568,0.9888455230503527,-0.016182933393435642,0.5883716533940531,0.6774626293023008,Downregulated
Feature0275,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Meconin,10,10,0,4,0,0,0,1,0.4,-0.20000000000000018,66,6,2,0.3333333333333333,0.5,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.062413030387233,23.733448392661234,1.1268152589364018,0.17225100542720526,4.4671633847964145e-4,0.0038821777034540265,Upregulated
Feature0274,mebutamate,C10 H20 N2 O4,232.14229,Metabolic pathways;Biosynthesis of cofactors;Other,mebutamate,10,20,2,4,0,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.506857078826467,22.482879336333102,0.9174117784266164,-0.12435866493796377,0.26556213324007477,0.3630343769012258,Downregulated
Feature0273,lys-leu,C12 H25 N3 O3,259.18959,NA,lys-leu,12,25,3,3,0,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.7424476581726,21.041565646723765,0.9252111277988314,-0.11214547707187719,0.3120535891186412,0.4157897005604389,Downregulated
Feature0272,Linoleamide,C18 H33 N O,279.25625,NA,Linoleamide,18,33,1,1,0,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909091,1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.00946532151083,24.165255710774368,1.0502310841696536,0.07070680151555805,0.1371363236029223,0.21120151103403645,Upregulated
Feature0271,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Cyanoamino acid metabolism,Linamarin,10,17,1,6,0,0,0,1.7,0.6,-0.20000000000000018,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7509758389579,23.538084352090902,0.9140657231513852,-0.12963019321925273,7.920636249595093e-5,0.0017189565809779517,Downregulated
Feature0270,Levulinic acid,C5 H8 O3,116.04733,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,Levulinic acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.056750236860434,26.769442735972667,1.1610241018778447,0.21539792164251906,0.005586797390221583,0.019237557051234692,Upregulated
Feature0269,Leucylproline,C11 H20 N2 O3,228.1474,NA,Leucylproline,11,20,2,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.864338447523732,26.2140919862775,1.0135226168441689,0.01937828302766191,0.39337586422302606,0.500286377844615,Upregulated
Feature0268,leu-phe,C15 H22 N2 O3,278.16304,NA,leu-phe,15,22,2,3,0,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.485278164122967,22.623372687072166,1.0061415527947322,0.008833290380773191,0.7745230287996839,0.8228508080872459,Upregulated
Feature0267,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak2,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.369106172406365,23.090265279797098,0.9880679692859407,-0.017317806540020856,0.39080493326647986,0.4987545477002278,Downregulated
Feature0266,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,Leu-Leu-peak1,12,24,2,3,0,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.2162667315832,22.400349997975766,0.9250125234523003,-0.11245519693384746,0.043393023649074165,0.08654892695033918,Downregulated
Feature0265,Leu-Glu,C11 H20 N2 O5,260.13722,NA,Leu-Glu,11,20,2,5,0,0,0,1.8181818181818181,0.45454545454545453,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.23076923076923078,-4,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.3287090280501,22.947201351414336,0.9836464299770277,-0.023788260404069977,0.8203479325969751,0.8620615694138777,Downregulated
Feature0264,Leu-arg,C12 H25 N5 O3,287.19577,NA,Leu-arg-peak2,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.847988439218298,22.8669909716679,1.0968439971240365,0.13335834745478156,0.28381591081291796,0.38367706461746315,Upregulated
Feature0263,Leu-arg,C12 H25 N5 O3,287.19573,NA,Leu-arg-peak1,12,25,5,3,0,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.174641952957668,24.1363509991147,1.1398705608688389,0.18887000702597098,0.31601341806051403,0.4179162956235059,Upregulated
Feature0262,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak3,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.488864726080934,22.25772333764183,0.9088915956948013,-0.13781986172188196,0.37636588940851906,0.48541890330074017,Downregulated
Feature0261,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak2,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.9199872717622,22.2100602386838,1.0132332634743486,0.018966345232297215,0.8990839617497629,0.9244102705314463,Upregulated
Feature0260,Leu-ala,C9 H18 N2 O3,202.1317,NA,Leu-ala-peak1,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.6835499746075,21.398619490928034,0.8669182314918743,-0.2060321713184259,0.15141547065667202,0.22932218584931655,Downregulated
Feature0259,Lauryldimethylamine oxide,C14 H31 N O,229.24056,NA,Lauryldimethylamine oxide,14,31,1,1,0,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.22857142857141,0,-1,-0.16666666666666666,-0.12,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.547712441244734,24.0627635221294,1.1710677571012247,0.2278245515060064,0.20071182428886672,0.28617115572436075,Upregulated
Feature0258,Lauramide,C12 H25 N O,199.19362,NA,Lauramide,12,25,1,1,0,0,0,2.0833333333333335,0.08333333333333333,-1.666666666666667,107.80000000000001,1,0,-0.1,-0.047619047619047616,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.767628573607734,24.420362419832866,0.9859790309458648,-0.02037113010171959,0.8426868765085652,0.8788020283589324,Downregulated
Feature0257,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Lactamide,3,7,1,2,0,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.585221854400533,26.830237271205835,1.0092162261480149,0.013235307220633333,0.41046106672589244,0.5148394823194183,Upregulated
Feature0256,L-Tyrosine,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Cyanoamino acid metabolism;Other",L-Tyrosine,9,11,1,3,0,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.323364623036635,25.442634343612866,0.9665418804914853,-0.0490958487743552,0.7698363038503511,0.8228508080872459,Downregulated
Feature0255,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;D-Amino acid metabolism;Other,L-Threonine,4,9,1,3,0,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.542080512256565,26.180160431799134,1.0249815170395529,0.0355978945933583,0.09111592345146534,0.15396903731381875,Upregulated
Feature0254,L-Serine,C3 H7 N O3,105.04253,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Serine,3,7,1,3,0,0,0,2.3333333333333335,1,0.6666666666666665,41.3,1,-2,3,-3,-3,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.838752491447302,26.225865677845633,1.055844720336738,0.07839767780965463,0.024110372543629292,0.05396837625205425,Upregulated
Feature0253,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,L-Saccharopine,11,20,2,6,0,0,0,1.8181818181818181,0.5454545454545454,-0.18181818181818166,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.631676846629134,28.553976095025767,1.3200075194112997,0.40054614790683024,0.0017211368948160314,0.00981585885324768,Upregulated
Feature0252,L-Pyroglutamic acid,C5 H7 N O3,129.04256,Metabolic pathways;Biosynthesis of secondary metabolites;D-Amino acid metabolism;Other,L-Pyroglutamic acid,5,7,1,3,0,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.329986490048935,23.070044113405768,0.8143330432405694,-0.2963091510522944,1.49136020714306e-4,0.0020086410725133775,Downregulated
Feature0251,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other",L-Phenylalanine,9,11,1,2,0,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.706802019198832,29.593573848828566,0.9961884766223881,-0.005509372108028135,0.45820195255971413,0.5688561655928424,Downregulated
Feature0250,L-Lysine,C6 H14 N2 O2,146.10554,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Tropane, piperidine and pyridine alkaloid biosynthesis;D-Amino acid metabolism;Other",L-Lysine,6,14,2,2,0,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5565973675619,25.973922461483767,1.0577166727420504,0.08095322899159452,0.002728114931460129,0.012604454731957898,Upregulated
Feature0249,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,L-Iditol,6,14,0,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.379417144279667,29.796021753680765,1.222179413779465,0.2894560857870766,2.2639591246222027e-5,8.26345080487104e-4,Upregulated
Feature0248,L-Histidine,C6 H9 N3 O2,155.06951,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Histidine,6,9,3,2,0,0,0,1.5,0.3333333333333333,0.6666666666666665,41.3,4,2,-1,0,-1,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.1527692666301,24.9894823673106,1.0793301690838228,0.110136255406875,0.003101995401413271,0.013014118638113149,Upregulated
Feature0247,L-Glutamine,C5 H10 N2 O3,146.06915,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,L-Glutamine,5,10,2,3,0,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.606819135752566,27.368795927286868,1.2666739956183566,0.34104526526533196,5.367742328620263e-4,0.004215465393083545,Upregulated
Feature0246,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Glutamic acid,5,9,1,4,0,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.9551314222807,29.1315440805228,1.0060926215691894,0.008763126741423075,0.5120981841532508,0.6168839512077114,Upregulated
Feature0245,L-Ergothioneine,C9 H15 N3 O2 S,229.0885,NA,L-Ergothioneine,9,15,3,2,0,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.402744852134898,24.662792247739535,1.1008826110604595,0.138660640137533,0.07860938159588965,0.13709867640368661,Upregulated
Feature0244,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of cofactors;Other,L-Cystathionine,7,14,2,4,0,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9980105477586,26.0680353065692,1.2414526246321842,0.3120292075378568,5.625995736624361e-4,0.004278100924724775,Upregulated
Feature0243,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-Aspartic acid,4,7,1,4,0,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.872479127760766,26.623408826406866,1.029024265318292,0.041277002680480575,0.017696635765925613,0.041672722932663546,Upregulated
Feature0242,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,L-alpha-Glycerylphosphorylcholine,8,20,1,6,0,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.558540571265333,30.160000249908702,1.0203480844121264,0.029061401204569137,0.023449917060230474,0.0528346896727415,Upregulated
Feature0241,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,L-Alanyl-L-proline,8,14,2,3,0,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.5673811415301,25.107123291704035,1.0653336126287118,0.09130528577189692,0.012362557013876986,0.03186686451875605,Upregulated
Feature0240,L-(+)-Valine,C5 H11 N O2,117.07894,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,L-(+)-Valine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.265576557763268,22.409622164550132,1.0537980056021201,0.0755983544096671,0.41628482159844155,0.520356026998052,Upregulated
Feature0239,Isoleucine,C6 H13 N O2,131.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",Isoleucine,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.29578748337073,26.490919508027833,0.9705131066164241,-0.04318039846275937,0.5622791361327739,0.6577945022066105,Downregulated
Feature0238,Isoamylamine,C5 H13 N,87.10481,NA,Isoamylamine,5,13,1,0,0,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.605506312451666,21.180552498331465,0.9369643044298769,-0.09393400837210326,0.046116249029117456,0.08991319898235071,Downregulated
Feature0237,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04715,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;Other,Inosine-5'-monophosphate (IMP),10,13,4,8,0,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.188836468469432,18.658165294612566,0.6392226464651175,-0.6456095737238523,5.405488699761809e-7,1.2481230131084379e-4,Downregulated
Feature0236,Inosine,C10 H12 N4 O5,268.08078,Metabolic pathways;ABC transporters;Other,Inosine,10,12,4,5,0,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.9690485682693,23.132218324769134,0.8907611021619639,-0.1668895351263824,0.02685563461974847,0.05766062727181289,Downregulated
Feature0235,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Indole-3-acetic acid,10,9,1,2,0,0,0,0.9,0.2,-0.20000000000000018,66,7,5,0.5714285714285714,0.625,4,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.162121903180267,26.007661329102834,1.2289722858648864,0.2974523823532845,0.0012663858854927452,0.007921788149874274,Upregulated
Feature0234,Imidazoleacetic acid,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Imidazoleacetic acid,5,6,2,2,0,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.189612752017766,25.890722771367333,1.221859175737032,0.28907801823908635,1.3922801069935127e-4,0.0020086410725133775,Upregulated
Feature0233,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Hypoxanthine,5,4,4,1,0,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.672776162969733,21.7600087803012,0.8158134214207139,-0.2936888529471339,0.010425757037517155,0.028612039990178657,Downregulated
Feature0232,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Hordenine,10,15,1,1,0,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.954230328944,18.398550731601034,0.6581669577413136,-0.6034744948901924,0.0012581628838253243,0.007921788149874274,Downregulated
Feature0231,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",C4 H8 N6 O2,172.07118,NA,"Hexahydro[1,2,4]triazino[5,6-e][1,2,4]triazine-3,6(2H,4H)-dione",4,8,6,2,0,0,0,2,0.5,3.5,-39.45,4,2,1,1,-4,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9479141808808,25.008631001851434,1.1938482650781936,0.2556194855726581,0.10043367066363716,0.16662858996467075,Upregulated
Feature0230,HC blue 2,C12 H19 N3 O5,285.13251,NA,HC blue 2,12,19,3,5,0,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.504502543750032,23.863685102265467,1.1097064465321054,0.15017808725711984,0.002806393250531055,0.01264609304251648,Upregulated
Feature0229,H-arg-glu-OH,C11 H21 N5 O5,303.15427,NA,H-arg-glu-OH,11,21,5,5,0,0,0,1.9090909090909092,0.45454545454545453,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.563278219812368,24.18245599682387,1.1214647304696461,0.16538424906738325,7.257057696436573e-4,0.0051937765866653905,Upregulated
Feature0228,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Guanine,5,5,5,1,0,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.620451402682633,24.423802064708966,0.9532931985012423,-0.0690080916987022,0.3104135124409979,0.4157897005604389,Downregulated
Feature0227,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Other,Glycyl-L-leucine,8,16,2,3,0,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.555228991257366,23.4468422600727,0.9548614785234014,-0.06663663790894235,0.6176926234948701,0.7001795266323838,Downregulated
Feature0226,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05586,Metabolic pathways;Other,Glycerylphosphorylethanolamine,5,14,1,6,0,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.840150738786633,25.769556190813802,1.1799165902755795,0.23868487734221067,0.016262286430878826,0.03930950031305147,Upregulated
Feature0225,Glycerol 3-phosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Glycerol 3-phosphate,3,9,0,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.567895788320666,25.961904728350966,1.150391023242263,0.20212432326258914,0.00814013180538269,0.02475956757470568,Upregulated
Feature0224,Glutaric acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Glutaric acid,5,8,0,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.561836777165034,22.2084141088284,0.9041837672936336,-0.14531207753481748,4.950686937930464e-4,0.004106819846237771,Downregulated
Feature0223,Glucosamine,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Glucosamine,6,13,1,5,0,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.3981130128564,24.948216780476233,1.165907328626915,0.22145312143409426,9.214961828527798e-4,0.006346152957382351,Upregulated
Feature0222,Furan,C4 H4 O,68.02622,Other,Furan,4,4,0,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.894090157072235,25.9973175426306,1.0880229115958135,0.12170893719268822,0.008099844499790392,0.02475956757470568,Upregulated
Feature0221,DL-α-AMINOSUBERIC ACID,C8 H15 N O4,189.10013,NA,DL-α-AMINOSUBERIC ACID,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.15164285610477,22.1980290328719,1.1015493471862121,0.13953412631083983,0.010381770881338338,0.028612039990178657,Upregulated
Feature0220,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Protein digestion and absorption;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Biosynthesis of various plant secondary metabolites;Other",DL-Tryptophan,11,12,2,2,0,0,0,1.0909090909090908,0.18181818181818182,-0.18181818181818166,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.835045670648267,28.291061494286634,1.016382794159351,0.023443858041209978,0.21097755986152017,0.29732358822183347,Upregulated
Feature0219,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,DL-Stachydrine,7,13,1,2,0,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.787765588756834,26.896290643774165,1.2938519307876533,0.37167252386734195,0.0020687752284324437,0.010943521135910754,Upregulated
Feature0218,DL-Carnitine,C7 H15 N O3,161.10522,Other,DL-Carnitine,7,15,1,3,0,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.8212354942801,29.754665037825333,1.303814819547479,0.3827389785476127,1.5105144869035893e-4,0.0020086410725133775,Upregulated
Feature0217,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,DL-Carbidopa,10,14,2,4,0,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.7995954892184,29.951153853234366,1.0773953119156143,0.10754769268540493,8.729929282668327e-6,4.5520345545341993e-4,Upregulated
Feature0216,DL-Arginine,C6 H14 N4 O2,174.1118,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Other,DL-Arginine,6,14,4,2,0,0,0,2.3333333333333335,0.3333333333333333,0.3333333333333335,50.8,2,0,-Inf,-3,-4,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.64397230403607,27.372221168289766,1.0273325935015847,0.038903322177636306,0.024248804672155882,0.05396837625205425,Upregulated
Feature0215,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;D-Amino acid metabolism;Other,"DL-2,6-Diaminopimelic acid",7,14,2,4,0,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.313524149789068,25.2475055098148,1.082955341612016,0.11497375101337327,0.06892786606267459,0.12454787679641696,Upregulated
Feature0214,Dipropylene glycol dimethyl ether,C8 H18 O3,162.12559,NA,Dipropylene glycol dimethyl ether,8,18,0,3,0,0,0,2.25,0.375,-1.5,103.05,0,-3,-0.6,-0.23076923076923078,-3,Protein,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.868546812958332,27.1117199147677,1.009050474649864,0.012998342636274746,0.494125402108136,0.6052207106358042,Upregulated
Feature0213,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",C11 H18 N6 O4 S,330.10982,NA,"Diethyl 1-[4,6-diamino-2-(methylsulfanyl)-5-pyrimidinyl]-1,2-hydrazinedicarboxylate",11,18,6,4,0,1,0,1.6363636363636365,0.36363636363636365,0.9090909090909092,34.39090909090909,6,2,-Inf,-1.5,-5,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.2252185950105,24.3008751858887,1.2640103448392248,0.3380082707833516,0.013834721371255573,0.03458680342813893,Upregulated
Feature0212,Diacetylene glycol,C6 H6 O2,110.03673,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Diacetylene glycol,6,6,0,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.001326773269966,22.190746064366,0.8875827377325877,-0.17204648552026683,0.08555108674216647,0.1459165731817325,Downregulated
Feature0211,Di(2-Tetrahydrofurylmethyl)amine,C10 H19 N O2,185.14155,NA,Di(2-Tetrahydrofurylmethyl)amine,10,19,1,2,0,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.520538863658167,21.1782160796956,0.9840932057449244,-0.023133131865610036,0.5395948190564397,0.6353293837277435,Downregulated
Feature0210,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,D-PANTOTHENIC ACID,9,17,1,5,0,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.177561234784534,23.872074329576865,1.029964890945904,0.0425951602031325,0.3199757037434022,0.4216286348965408,Upregulated
Feature0209,D-lysopine,C9 H18 N2 O4,218.12664,Other,D-lysopine,9,18,2,4,0,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.263921101878132,22.740743807338802,0.9001272492751825,-0.1517991279768952,0.20847743754291015,0.2960866330862343,Downregulated
Feature0208,D-Glucose 6-phosphate,C6 H13 O9 P,260.02972,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;Biosynthesis of phenylpropanoids;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer;Other",D-Glucose 6-phosphate,6,13,0,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.902505385890766,24.382455560123066,0.9413164941721939,-0.08724822017675382,1.483246670081398e-4,0.0020086410725133775,Downregulated
Feature0207,D-Glucono-delta-lactone,C6 H10 O6,178.04775,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Glucono-delta-lactone,6,10,0,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.841374216941965,22.367876646803502,0.900428311713467,-0.15131667544927616,0.00205956103336835,0.010943521135910754,Downregulated
Feature0206,D-Gluconic acid,C6 H12 O7,196.05832,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,D-Gluconic acid,6,12,0,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.9016460590687,23.06729450881,0.9263361327236171,-0.11039230634780095,0.007018326356901053,0.022083526898869693,Downregulated
Feature0205,Cytonic acid A,C32 H36 O10,580.23109,NA,Cytonic acid A,32,36,0,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.22727272727272727,0.37037037037037035,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.337845324658733,21.384079335290934,1.0514427164692657,0.07237025290668997,0.06697643121398135,0.12223198696551596,Upregulated
Feature0204,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,Cytidine 5'-diphosphocholine,14,26,4,11,0,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.283736483225233,21.877988208980234,0.9396253142077188,-0.0898425137318159,0.38420452422289975,0.49266029477048623,Downregulated
Feature0203,Cytarabine,C9 H13 N3 O5,243.0855,Metabolic pathways;ABC transporters;Cyanoamino acid metabolism;Other,Cytarabine,9,13,3,5,0,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6170812368189,22.942307806516734,0.8955863314178911,-0.1590955851717352,0.0059862242401707315,0.01994508816846971,Downregulated
Feature0202,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12118,NA,Cyclo(phenylalanyl-prolyl),14,16,2,2,0,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.45454545454545453,4,Phenol,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.5790576791569,27.316701044452202,1.0277528035116819,0.03949330730139702,0.02568404851317831,0.056473962092229414,Upregulated
Feature0201,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,0,1.6363636363636365,0.18181818181818182,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.117755108707733,27.813348170484634,1.025650834996793,0.0365396740703279,0.016593023858331987,0.03984509018612615,Upregulated
Feature0200,Citric acid,C6 H8 O7,192.02696,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Biosynthesis of phenylpropanoids;Central carbon metabolism in cancer;Other,Citric acid,6,8,0,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,30.0818105806586,28.901086034777933,0.9607495518690677,-0.05776769652816738,0.003236555130672252,0.01327351261455474,Downregulated
Feature0199,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,Choline O-Sulfate,5,13,1,4,0,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.156998688789635,27.909488039612032,1.0669988698502126,0.09355864808140334,0.05740562406468731,0.10800542671964365,Upregulated
Feature0198,Choline,C5 H13 N O,103.09967,NA,Choline,5,13,1,1,0,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.871122848929566,29.50742501049143,0.9878244336418988,-0.017673440953309225,0.1558391864555886,0.2340794364456372,Downregulated
Feature0197,Cetrimonium,C19 H41 N,283.3239,NA,Cetrimonium,19,41,1,0,0,0,0,2.1578947368421053,0,-2,117.3,0,0,-0.05555555555555555,-0.05555555555555555,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.761280511048,24.1455385493278,1.1630081553244698,0.2178612134103724,0.3129111278449974,0.4157897005604389,Upregulated
Feature0196,Cantharidin,C10 H12 O4,196.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,Cantharidin,10,12,0,4,0,0,0,1.2,0.4,-0.40000000000000036,71.7,5,1,0.16666666666666666,0.375,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.703912334952065,24.939526478210265,1.2045803747008574,0.2685306595072348,0.07005648456455801,0.12519045880967647,Upregulated
Feature0195,Caffeic acid,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Caffeic acid,9,8,0,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.321758138172733,28.173696116950566,1.386380839954424,0.47132362143000445,0.0022216644475437047,0.011584393190763603,Upregulated
Feature0194,C16 phytosphingosine,C16 H35 N O3,289.26171,NA,C16 phytosphingosine,16,35,1,3,0,0,0,2.1875,0.1875,-1.625,106.6125,0,-3,-0.3333333333333333,-0.18518518518518517,-4,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.034094390238234,24.9235035664126,1.2440544144863752,0.3150495898035344,0.1982255713171534,0.2837346412971019,Upregulated
Feature0193,Butyl glyoxylate,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Degradation of aromatic compounds;Other,Butyl glyoxylate,6,10,0,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.309967127957567,26.781975247267432,1.3869508461509321,0.4719166591316813,1.1990734792780877e-4,0.0019717592282331494,Upregulated
Feature0192,Buphedrine,C11 H17 N O,179.13104,NA,Buphedrine,11,17,1,1,0,0,0,1.5454545454545454,0.09090909090909091,-1.0909090909090908,91.39090909090909,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.6267392530669,19.705480221759068,1.0040119231053555,0.005776402060428594,0.517175008740252,0.6175788524387482,Upregulated
Feature0191,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.491223159638867,23.6548731976333,0.8020987488239184,-0.31814823268524034,0.0038216808886408606,0.014999070154343163,Downregulated
Feature0190,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10571,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,0,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.9515697096492,23.099573067452233,0.8570770948150795,-0.22250311306430962,9.33194785681232e-5,0.0018923116487424983,Downregulated
Feature0189,Bis(triaminomethyl) carbonate,C3 H12 N6 O3,180.0979,NA,Bis(triaminomethyl) carbonate,3,12,6,3,0,0,0,4,1,4,-53.7,1,-2,1.3333333333333333,1.4444444444444444,-8,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.0781439411166,21.695794727274965,0.9826820037562316,-0.025203459425501333,0.1818061573447661,0.26278185506479185,Downregulated
Feature0188,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;D-Amino acid metabolism;Cyanoamino acid metabolism;Other,Betaine,5,11,1,2,0,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,30.6198646708862,29.744880444626066,0.9714242947947421,-0.04182652705403723,0.10403447059438159,0.17028063572622995,Downregulated
Feature0187,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",C18 H30 O15,486.15857,Metabolic pathways;ABC transporters;Other,"beta-D-Galactopyranosyl-(1->4)-3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranose",18,30,0,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.966930126672267,22.623232217938032,0.8712324524915745,-0.19887040096033393,4.765131676723138e-5,0.0013379023553876503,Downregulated
Feature0186,benzylidenemethylamine,C8 H9 N,119.07346,NA,benzylidenemethylamine,8,9,1,0,0,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.3570908717408,26.616801933017666,1.009853555634826,0.014146095078357627,0.38467995619065365,0.49266029477048623,Upregulated
Feature0185,Beauvericin,C45 H57 N3 O9,783.4096,NA,Beauvericin,45,57,3,9,0,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.298632823128234,22.208054932019035,1.0426986143403185,0.06032221593073452,0.07042246767851136,0.12519045880967647,Upregulated
Feature0184,Azobenzene,C12 H10 N2,182.08444,Biosynthesis of secondary metabolites;Other,Azobenzene,12,10,2,0,0,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.677622124839033,19.6245483141361,0.9973028341348247,-0.0038964448624972206,0.8582671099819785,0.8899644748392674,Downregulated
Feature0183,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Cyanoamino acid metabolism;Other,Asparagine,4,8,2,3,0,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1262680973742,22.5906632251769,0.8990854964067552,-0.1534697829549348,0.0048169847322716165,0.01706989735222466,Downregulated
Feature0182,arg-val,C11 H23 N5 O3,273.18012,NA,arg-val,11,23,5,3,0,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818166,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.5817511477294,24.428730592725632,1.1319160537765611,0.17876696763000904,0.002312968237659415,0.011729473695736901,Upregulated
Feature0181,ARG-PHE,C15 H23 N5 O3,321.18019,NA,ARG-PHE,15,23,5,3,0,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.82234069831477,21.926386648387865,1.004767863883691,0.006862227466135879,0.9678047536526572,0.9785283520310799,Upregulated
Feature0180,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Other,Anhydroecgonine,9,13,1,2,0,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9331233558923,22.966200792567435,1.0014423432936639,0.0020793623001184387,0.9799212366159809,0.9826133279253654,Upregulated
Feature0179,AMIDINOPROLINE,C6 H11 N3 O2,157.08515,NA,AMIDINOPROLINE,6,11,3,2,0,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.12158739994147,25.796916021192267,0.9875707638368896,-0.018043967491177447,0.8504051004053235,0.884324392159382,Downregulated
Feature0178,Ala-Leu,C9 H18 N2 O3,202.1317,NA,Ala-Leu,9,18,2,3,0,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.998853634013734,21.665846514552968,0.942040279890762,-0.08613934677301911,0.4992215843800703,0.6094176531729956,Downregulated
Feature0177,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Biosynthesis of various plant secondary metabolites;Other,Agmatine,5,14,4,0,0,0,0,2.8,0,-0.40000000000000036,71.7,1,1,-3,-3,-3,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.452145215237465,20.591065114808067,0.8090109867234606,-0.3057687996686689,0.006192265977615745,0.020361955692159883,Downregulated
Feature0176,Adenosine,C10 H13 N5 O4,267.09676,Metabolic pathways;ABC transporters;Other,Adenosine,10,13,5,4,0,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.757380008008365,26.8691542025348,1.0041773220880736,0.006014049277438921,0.9666973436200184,0.9785283520310799,Upregulated
Feature0175,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Adenine,5,5,5,0,0,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.296029876742733,23.9170538346994,0.876209981550381,-0.19065144533582043,4.448157642309398e-4,0.0038821777034540265,Downregulated
Feature0174,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,Acetyl-L-carnitine,9,17,1,4,0,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.588377692244666,20.7173040578018,0.9596508062411847,-0.05941855545955328,0.08969253559601217,0.15226872322113694,Downregulated
Feature0173,[Similar to: Valylproline; ΔMass: 243.0478 Da],C17 H31 N O13,457.17959,NA,[Similar to: Valylproline; ΔMass: 243.0478 Da],17,31,1,13,0,0,0,1.8235294117647058,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.57394168448643,21.039713919288733,0.7917423079005055,-0.336897148936647,0.009469229097633146,0.026913727483742825,Downregulated
Feature0172,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],C24 H32 O7 P2,494.16122,NA,[Similar to: Trimethoprim impurity C; ΔMass: 188.0284 Da],24,32,0,7,0,0,2,1.3333333333333333,0.2916666666666667,-1.166666666666667,93.55000000000001,10,3,0.06666666666666667,0.24324324324324326,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.287566358448235,22.379361040085033,0.8513287512022888,-0.23221174071833253,0.30040729998977966,0.4046076180674154,Downregulated
Feature0171,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],C7 H10 N6 O5,258.07153,NA,[Similar to: Trimethoprim impurity C; ΔMass: -48.0613 Da],7,10,6,5,0,0,0,1.4285714285714286,0.7142857142857143,2.571428571428571,-12.98571428571428,6,1,1.25,1.6666666666666667,-5,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.778973971553768,26.269378315050066,0.8821451786802249,-0.18091198862145738,0.2801536008822923,0.38013406811166056,Downregulated
Feature0170,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],C5 H13 O6 P,200.04505,NA,[Similar to: Triethyl phosphate; ΔMass: 17.9743 Da],5,13,0,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.288964095394434,24.773482146853834,1.1636772008184855,0.21869091618079728,0.15470548949064766,0.233336792000357,Upregulated
Feature0169,[Similar to: RPH; ΔMass: -155.0695 Da],C11 H19 N5 O2,253.15388,NA,[Similar to: RPH; ΔMass: -155.0695 Da],11,19,5,2,0,0,0,1.7272727272727273,0.18181818181818182,0,60.3,5,3,-0.5,-0.2,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.044612508293735,21.0121770164514,0.8067763346358181,-0.3097593292362989,1.5840649888208315e-4,0.0020086410725133775,Downregulated
Feature0168,[Similar to: NP-020414; ΔMass: -0.0036 Da],C25 H48 N2 O12,568.32251,NA,[Similar to: NP-020414; ΔMass: -0.0036 Da],25,48,2,12,0,0,0,1.92,0.48,-0.7199999999999998,80.82,3,-9,-1,-0.29411764705882354,-11,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.3375771539039,27.695660187399035,1.4322197639846412,0.5182528809295713,0.00840778399453988,0.025362323619893025,Upregulated
Feature0167,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,C25 H40 N4 O18,684.2324,NA,[Similar to: NP-017684; ΔMass: -96.2336 Da],25,40,4,18,0,0,0,1.6,0.72,0.31999999999999984,51.18,8,-10,-4.666666666666667,-0.4166666666666667,-14,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.854403421427865,22.3372806432835,0.8019299607795531,-0.3184518552750456,0.027853155173505055,0.05910698626935666,Downregulated
Feature0166,[Similar to: NP-017684; ΔMass: -74.2515 Da],C30 H44 O15 P2,706.21453,NA,[Similar to: NP-017684; ΔMass: -74.2515 Da],30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.135976787515034,21.93527962217363,0.8726646991919892,-0.1965006560764593,0.11440805658121543,0.1823534526294482,Downregulated
Feature0165,[Similar to: NP-016755; ΔMass: -960.7865 Da],C5 H8 N6 O4,216.06096,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak3,5,8,6,4,0,0,0,1.6,0.8,3.6,-42.30000000000001,5,1,1,1,-5,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.343184645236466,25.285136866672833,0.9598359958064161,-0.05914017681383645,2.6469038718810025e-4,0.0027603426092473312,Downregulated
Feature0164,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak2,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.357741114146734,24.140693160787634,0.9910891591982214,-0.01291324560159214,0.504028565325876,0.6104367608644916,Downregulated
Feature0163,[Similar to: NP-016755; ΔMass: -960.7865 Da],C6 H4 N10,216.06097,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da]-peak1,6,4,10,0,0,0,0,0.6666666666666666,0,4.333333333333333,-63.19999999999999,10,10,-0,-0,0,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.7260441492229,25.291514034102,1.0228694036727615,0.03262195866979506,0.14846361702375627,0.22673313896933486,Upregulated
Feature0162,[Similar to: NP-016129; ΔMass: -205.0627 Da],C6 H15 N O7,213.08483,NA,[Similar to: NP-016129; ΔMass: -205.0627 Da],6,15,1,7,0,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.709516861524133,21.438707093650066,0.8676295539809953,-0.20484889865952247,0.015338811880569476,0.0375749418550863,Downregulated
Feature0161,[Similar to: NP-015005; ΔMass: -441.3129 Da],C28 H47 N O14 P2,683.24858,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da] ak2,28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.1127693037458,21.733237079986733,0.8015867666083135,-0.3190694036024348,0.004404320567316057,0.016403847010922047,Downregulated
Feature0160,[Similar to: NP-015005; ΔMass: -441.3129 Da],C25 H41 N5 O17,683.24859,NA,[Similar to: NP-015005; ΔMass: -441.3129 Da]-peak1,25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.150812261294234,22.252768619880968,0.8509398636468836,-0.2328709153662264,0.004349848215717159,0.01636798555398725,Downregulated
Feature0159,[Similar to: NP-010746; ΔMass: 146.0345 Da],C25 H29 N4 O9 P,560.16598,NA,[Similar to: NP-010746; ΔMass: 146.0345 Da],25,29,4,9,0,0,1,1.16,0.36,-0.16000000000000014,64.86,14,5,0,0.2903225806451613,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.2056250022279,20.92999464096337,0.9870020166236282,-0.018875062515785093,0.5288586649131611,0.6247036009492033,Downregulated
Feature0158,[Similar to: NP-004022; ΔMass: 150.0295 Da],C27 H24 N6 O8,560.16601,NA,[Similar to: NP-004022; ΔMass: 150.0295 Da],27,24,6,8,0,0,0,0.8888888888888888,0.2962962962962963,0.37037037037037024,49.74444444444445,19,11,0.38461538461538464,0.5294117647058824,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.984226277562833,20.005141981386267,1.0010466106384572,0.001509150369115668,0.937757575318346,0.9587717506756198,Upregulated
Feature0157,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],C7 H11 N7 O4,257.08751,NA,[Similar to: N1-phenethyl-3-(2-thienyl)acrylamide; ΔMass: 0.0001 Da],7,11,7,4,0,0,0,1.5714285714285714,0.5714285714285714,2.571428571428571,-12.98571428571428,6,2,1.25,1.5,-5,Amino Sugar,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.027805077287,26.5456550326866,1.4724840278049784,0.558251985069981,6.619883439885149e-4,0.004832514911116159,Upregulated
Feature0156,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],C16 H23 N5 O9,429.1483,NA,[Similar to: N-Acetylneuraminic acid; ΔMass: 120.0423 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2589416455298,24.25762104421,0.9603577768470356,-0.05835611954942881,0.001989279411050226,0.01088937650052313,Downregulated
Feature0155,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0423 Da],C17 H19 N9 O5,429.14957,NA,[Similar to: NP-016755; ΔMass: -960.7865 Da,17,19,9,5,0,0,0,1.1176470588235294,0.29411764705882354,1.0588235294117645,30.123529411764707,13,8,-0.3333333333333333,0.2727272727272727,-1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.1330242206675,22.965383720255165,1.1406822675293915,0.18989699066669533,0.2374475831502146,0.3307952971367494,Upregulated
Feature0154,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],C16 H23 N5 O9,429.14955,NA,[Similar to: N(6)-OH-Me-Adenosine; ΔMass: 132.0422 Da],16,23,5,9,0,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.23076923076923078,-6,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.487271159626534,22.25895033704043,0.9477027018490967,-0.0774935440300995,0.09540864912241748,0.15927339937658114,Downregulated
Feature0153,[Similar to: N-Acetylneuraminic acid; ΔMass: 1,C15 H27 N O12,413.15341,NA,[Similar to: Muramic acid; ΔMass: 162.0529 Da],15,27,1,12,0,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.885192909423132,24.923316596574733,0.9270276274580581,-0.10931575991703202,0.018121949856287095,0.04213064775506236,Downregulated
Feature0152,[Similar to: Maltotriose; ΔMass: -251.0528 Da],C9 H19 N O7,253.11619,NA,[Similar to: Maltotriose; ΔMass: -251.0528 Da],9,19,1,7,0,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.533304718063835,24.222725506233168,0.8797609206112229,-0.18481657739992566,0.27598121150056687,0.3758699335735332,Downregulated
Feature0151,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],C6 H15 N O4 S,197.07222,NA,[Similar to: Irgarol 1051; ΔMass: -56.0639 Da],6,15,1,4,0,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.5201462788572,26.316278898461267,1.2824605897461887,0.3589144922250486,1.2424784177907517e-4,0.0019717592282331494,Upregulated
Feature0150,[Similar to: HQH; ΔMass: 27.9858 Da],C12 H34 N8 O2 P2 S2,448.17272,NA,[Similar to: HQH; ΔMass: 27.9858 Da],12,34,8,2,0,2,2,2.8333333333333335,0.16666666666666666,-1,88.8,1,-1,6.5,12,-13,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.28494784883633,21.738216075565102,1.0212952472304766,0.03039999661719758,0.6347268124949577,0.7172609491042091,Upregulated
Feature0149,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],C4 H11 O6 P,186.02936,NA,[Similar to: Dimethyl phosphate; ΔMass: 60.0212 Da],4,11,0,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.483650686592433,26.162434114821632,1.3427891176895903,0.4252327502216194,0.0037539621313901917,0.014893436716928478,Upregulated
Feature0148,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],C3 H5 Cl N2 O4 S,199.96577,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -142.1228 Da],4,5,2,4,1,1,0,1.25,1,2.75,-18.075000000000003,3.5,-0.5,1.1666666666666667,1.5,-3.5,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.744220493661132,25.8337936011975,1.0034793482117053,0.005010926078565344,0.6697607978795947,0.7430476936962068,Upregulated
Feature0147,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],C3 H7 Cl N2 O5 S,217.97633,NA,[Similar to: diethyl 2-({2-[2-(methoxycarbonyl)-3-thienyl]hydrazino}methylene)malonate; ΔMass: -124.1122 Da],4,7,2,5,1,1,0,1.75,1.25,2.75,-18.075000000000003,2.5,-2.5,1.375,2,-5.5,Carbohydrate,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.033030997983367,26.937916665808466,0.9964815513220846,-0.005084999368957957,0.5206635132659071,0.6190299099089775,Downregulated
Feature0146,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],C8 H19 N O6,225.12125,NA,[Similar to: D-(+)-Glucose; ΔMass: 45.0579 Da],8,19,1,6,0,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.177444834329734,23.217544671826833,1.0468989933361064,0.06612225521750936,0.7744867306084532,0.8228508080872459,Upregulated
Feature0145,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],C7 H17 N O6,211.10558,NA,[Similar to: D-(+)-Glucose; ΔMass: 31.0422 Da],7,17,1,6,0,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.834202667511068,24.108635256202835,1.2155081633653666,0.2815595825539583,0.008981759595220054,0.026438243969800965,Upregulated
Feature0144,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],C5 H14 N O4 P,183.0661,NA,[Similar to: Cytidine 5'-diphosphocholine; ΔMass: -305.0412 Da],5,14,1,4,0,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.990975576346532,21.3107007310268,0.9269158962071873,-0.10948965315561368,0.25110489405010555,0.3458614578425982,Downregulated
Feature0143,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],C6 H11 N O7,209.05353,NA,[Similar to: Butyryl trihexyl citrate; ΔMass: -305.2970 Da],6,11,1,7,0,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.059242391155134,27.917033442832967,0.9606937808994696,-0.05785144659241886,2.474690025272079e-4,0.0026566525271303197,Downregulated
Feature0142,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],C16 H29 N O12,427.16893,NA,[Similar to: AB-CHMINACA metabolite M7; ΔMass: 39.9895 Da],16,29,1,12,0,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.412497504333768,20.0349272644887,0.705144884269071,-0.5040083801543239,0.004635488137063159,0.01706989735222466,Downregulated
Feature0141,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",C30 H44 O15 P2,706.21457,NA,"[Similar to: [(2R,3S,4S,5R,6R)-6-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2E)-2-methylbut-2-enoate; ΔMass: -42.0492 Da]",30,44,0,15,0,0,2,1.4666666666666666,0.5,-0.7999999999999998,83.1,10,-5,-0.5384615384615384,0.024390243902439025,-7,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.742370708521133,19.197596559426202,0.7178719033054582,-0.478201661637359,0.0073867947200479634,0.022848983667944973,Downregulated
Feature0140,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",C11 H14 N10 O6,382.10881,NA,"[Similar to: 6-(2-hydroxy-3-methyl-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)-5,7-dimethoxy-2H-chromen-2-one; ΔMass: -88.0700 Da]",11,14,10,6,0,0,0,1.2727272727272727,0.5454545454545454,2.5454545454545454,-12.24545454545455,10,4,1.2,1.5,-6,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.2163505203505,20.938223191140768,0.8303431209937723,-0.26822047329019444,0.0016300371174004147,0.009443865838907163,Downregulated
Feature0139,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10286,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak4",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7978891841521,20.125362054021366,0.7801166176953956,-0.3582382898932086,0.06654375702696083,0.12223198696551596,Downregulated
Feature0138,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak3",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.690595006397167,20.317969427304867,0.7908718899755154,-0.33848407738981623,1.0435085940069187e-6,1.2481230131084379e-4,Downregulated
Feature0137,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak2",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7047207876297,18.85588198535987,0.7060879660683211,-0.5020801659164786,0.0011689691727038553,0.0077577045097619495,Downregulated
Feature0136,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]",C8 H14 N6 O5,274.10288,NA,"[Similar to: 5-O-[(4-Acetylphenyl)carbamoyl]-1,4:3,6-dianhydro-2-deoxy-2-(5-phenyl-1H-tetrazol-1-yl)-D-glucitol; ΔMass: -161.0514 Da]-peak1",8,14,6,5,0,0,0,1.75,0.625,1.75,10.424999999999997,5,0,2,7,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.699197907164532,21.5637946093456,0.873056472942814,-0.1958531184673886,0.0041558985240438264,0.016137265545489325,Downregulated
Feature0135,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",C6 H11 N8 O4 P,290.06273,NA,"[Similar to: 5-[4-Bromo-3-(trifluoromethyl)anilino]-3,3-dimethyl-5-oxopentanoic acid; ΔMass: -90.9560 Da]",6,11,8,4,0,0,1,1.8333333333333333,0.6666666666666666,2.666666666666667,-15.700000000000017,6,2,1,1,-7,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.679578733382233,22.801633119129335,0.8879286282639947,-0.17148437753242637,0.026683778720702187,0.057630646349445556,Downregulated
Feature0134,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],C17 H31 N O13 S,489.15177,NA,[Similar to: 4-[4-chloro-2-nitro-5-(1H-pyrrol-1-yl)phenyl]morpholine; ΔMass: 182.0794 Da],17,31,1,13,0,1,0,1.8235294117647058,0.7647058823529411,0,60.3,3,-10,-6,-0.6470588235294118,-12,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.024029563661834,21.14245989898127,0.7823577845478202,-0.35409956926317593,1.596250030768819e-4,0.0020086410725133775,Downregulated
Feature0133,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24864,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak2",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.401371012909834,21.202955578550668,0.8689247652245848,-0.2026968264048736,0.06675032524037698,0.12223198696551596,Downregulated
Feature0132,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]",C25 H41 N5 O17,683.24858,NA,"[Similar to: 4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0Âa,Âl.0Âl,â·.0ÂaÂa,Âaâ¶]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one; ΔMass: -155.1501 Da]-peak1",25,41,5,17,0,0,0,1.64,0.68,0.31999999999999984,51.18,8,-9,-4.666666666666667,-0.4782608695652174,-14,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.456191243790133,21.8974773807363,0.8602024227044587,-0.217251900341854,0.0013239152798420017,0.007921788149874274,Downregulated
Feature0131,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",C19 H36 N6 O2,380.29029,NA,"[Similar to: 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol; ΔMass: 22.1487 Da]",19,36,6,2,0,0,0,1.894736842105263,0.10526315789473684,-0.7368421052631575,81.29999999999998,5,3,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.0373156234092,26.65159511419827,1.0235922742449224,0.03364116351910951,0.7755087068000344,0.8228508080872459,Upregulated
Feature0130,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",C28 H47 N O14 P2,683.24861,NA,"[Similar to: 4-[(1R,4R,6S,9S,13R,14R)-6-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-9,13-dimethyl-17-oxotetracyclo[11.3.1.0Âa,Âaâ°.0â´,âa]heptadecan-14-yl]-2,5-dihydrofuran-2-one; ΔMass: -157.1657 Da]",28,47,1,14,0,0,2,1.6785714285714286,0.5,-0.9285714285714288,86.76428571428572,7,-7,-0.9090909090909091,-0.16666666666666666,-10,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.089018858301568,21.1559492989488,0.8109139486561008,-0.3023792660598981,0.011394757310157603,0.030613094488419333,Downregulated
Feature0129,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",C21 H31 N O12,489.18466,NA,"[Similar to: 3-{[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]carbonyl}-2-pyrazinecarboxylic acid; ΔMass: 136.0723 Da]",21,31,1,12,0,0,0,1.4761904761904763,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.4009417910584,25.603971130468235,0.9698127942973577,-0.04422180821066402,0.014164101169295047,0.03515509725761819,Downregulated
Feature0128,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],C19 H29 N5 O8,455.20029,NA,[Similar to: 3-[1-(dimethylamino)-1H-pyrrol-2-yl]-2-(2-furylcarbonyl)acrylonitrile; ΔMass: 200.0995 Da],19,29,5,8,0,0,0,1.5263157894736843,0.42105263157894735,0.10526315789473673,57.3,8,0,-0.8333333333333334,-0.1,-5,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.400816448575434,25.451702419370932,0.8961609419030477,-0.1581702451551585,0.006010848489127857,0.01994508816846971,Downregulated
Feature0127,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",C22 H37 N O10 P2,537.19062,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: 137.0676 Da]",22,37,1,10,0,0,2,1.6818181818181819,0.45454545454545453,-1.0909090909090908,91.39090909090909,6,-4,-0.7777777777777778,-0.14285714285714285,-7,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.932855803236833,21.714504669852033,0.9468731175986884,-0.07875697951604749,0.008485393057504637,0.02538662677040322,Downregulated
Feature0126,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",C12 H25 N O12,375.1377,NA,"[Similar to: 3,5-Di(acetyloxy)-2-[(acetyloxy)methyl]-6-(2H-1,2,3,4-tetraazol-5-yl)tetrahydro-2H-pyran-4-yl acetate; ΔMass: -24.9853 Da]",12,25,1,12,0,0,0,2.0833333333333335,1,0.16666666666666652,55.550000000000004,1,-11,12,-1.2,-12,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5078685143157,23.261406152512667,0.9491403195233016,-0.07530670593857591,0.07887869053362792,0.13709867640368661,Downregulated
Feature0125,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",C16 H5 O13 P3,497.89405,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 87.8796 Da]",16,5,0,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.615391696269732,25.304712550202268,1.0715347378379236,0.09967862117091744,0.005025435769326288,0.017637346690423994,Upregulated
Feature0124,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",C6 H5 N6 O9 P3 S,429.90653,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: 19.8921 Da]",6,5,6,9,0,1,3,0.8333333333333334,1.5,3,-25.200000000000003,9,0,0.7692307692307693,0.6470588235294118,-10,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.510191620200033,25.90328229717007,1.0568372005636186,0.07975315531212736,0.009876790448213229,0.02773098856613714,Upregulated
Feature0123,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",C5 H4 N2 O13 P2,361.91916,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -48.0953 Da]",5,4,2,13,0,0,2,0.8,2.6,3.6,-42.30000000000001,6,-7,0.9166666666666666,0.8181818181818182,-11,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.189322601660834,25.6732501470252,1.0613463869906998,0.08589557919081023,0.0034712032141385523,0.014077657479561906,Upregulated
Feature0122,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",C3 H3 N2 O6 P S,225.94422,Metabolic pathways;Microbial metabolism in diverse environments;Other,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -184.0702 Da]",3,3,2,6,0,1,1,1,2,4,-53.7,4,-2,0.8571428571428571,0.75,-6,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.916636149877867,27.746410490872265,1.0308275646471583,0.043803020936536645,0.011015501285689384,0.030004910218482277,Upregulated
Feature0121,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",C11 H4 O4 P2 S,293.93168,NA,"[Similar to: 2-(4-chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate; ΔMass: -116.0828 Da]",11,4,0,4,0,1,2,0.36363636363636365,0.36363636363636365,-0.3636363636363633,70.66363636363636,11,7,1,1,4,Condensed HC,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.413112124171565,25.095807339854865,1.0718697799232804,0.1001296452822923,1.971289281320676e-4,0.002321034153813054,Upregulated
Feature0120,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],C11 H23 N O7,281.14743,NA,[Similar to: 2'-O-Methyladenosine; ΔMass: 0.0350 Da],11,23,1,7,0,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.87206979706057,22.884681882553068,0.9200955959546891,-0.12014433301669786,0.46333509926756133,0.5732790211276606,Downregulated
Feature0119,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",C18 H16 N6 O5,396.11855,NA,"[Similar to: 1-(3,4-dimethoxyphenethyl)-6-oxo-2-(3,4,5-trimethoxyphenyl)piperidine-3-carboxylic acid; ΔMass: -77.0864 Da]",18,16,6,5,0,0,0,0.8888888888888888,0.2777777777777778,0.6666666666666665,41.3,14,9,0.42857142857142855,0.5789473684210527,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.951092444429367,19.8498585260969,0.9949258959821654,-0.0073390199651008695,0.6565843452431543,0.7328846667087197,Downregulated
Feature0118,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],C16 H27 N O14,457.14331,NA,[Similar to: (3S)-N-Phenyl-3-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1-pyrrolidinecarboxamide; ΔMass: 83.0079 Da],16,27,1,14,0,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.3482039468935,26.1004603730291,1.0719665577780395,0.10025989863117754,0.013754883120142307,0.03458680342813893,Upregulated
Feature0117,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",C25 H43 N5 O18,701.25923,NA,"[Similar to: (3beta,9xi,12beta,17xi)-20-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ΔMass: -407.3437 Da]",25,43,5,18,0,0,0,1.72,0.72,0.31999999999999984,51.18,7,-11,-8,-0.6363636363636364,-16,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.863630435559966,21.256871713120866,0.7912881233276158,-0.3377249913280623,0.02975933141745994,0.06242618372053379,Downregulated
Feature0116,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",C22 H30 N6 O16,634.17239,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0930 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.032168307553732,21.044622882169833,0.7507311832349055,-0.41363168520336807,2.0517090626440074e-6,1.2481230131084379e-4,Downregulated
Feature0115,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",C22 H30 N6 O16,634.17235,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: 306.0929 Da]",22,30,6,16,0,0,0,1.3636363636363635,0.7272727272727273,0.9090909090909092,34.39090909090909,11,-5,-Inf,-0.375,-11,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.262904731259933,20.927081129806467,0.7404433949303256,-0.43353864563215744,1.4753649344840621e-6,1.2481230131084379e-4,Downregulated
Feature0114,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C11 H19 O3 P3,292.05592,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak2",11,19,0,3,0,0,3,1.7272727272727273,0.2727272727272727,-2.545454545454546,132.84545454545457,4,1,-0.4,-0.07692307692307693,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.613945178006098,27.7706753526044,1.4158638203875868,0.5016825118196704,1.0797641565670061e-4,0.0019717592282331494,Upregulated
Feature0113,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]",C10 H8 N6 O5,292.05593,NA,"[Similar to: (2S,4R,5S,6S,7R)-5,6,12,14-tetrahydroxy-4-(hydroxymethyl)-13-methoxy-3,8-dioxatricyclo[8.4.0.0Â?,â·]tetradeca-1(14),10,12-trien-9-one; ΔMass: -36.0235 Da]-peak1",10,8,6,5,0,0,0,0.8,0.5,2,3.299999999999997,10,5,1,1,-1,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.062944781159565,27.247732720547802,1.3581123318514652,0.44160281235341026,0.0031491811872838265,0.013061944697256779,Upregulated
Feature0112,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",C30 H30 N6 O8,602.21306,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 200.0452 Da]",30,30,6,8,0,0,0,1,0.26666666666666666,0.1333333333333333,56.5,19,11,0.3125,0.45,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.382246889058866,20.504811434739832,1.0060132990414692,0.008649377046379851,0.7633659489727341,0.8228508080872459,Upregulated
Feature0111,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",C29 H28 N6 O8,588.19719,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 186.0293 Da]",29,28,6,8,0,0,0,0.9655172413793104,0.27586206896551724,0.2068965517241379,54.40344827586207,19,11,0.3333333333333333,0.47368421052631576,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.7623996634916,20.235425305062833,1.0239356378590543,0.03412503383418071,0.7734138524861198,0.8228508080872459,Upregulated
Feature0110,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",C30 H32 O10,552.19968,NA,"[Similar to: (2R,3R,3aR,5R)-5,7-dimethoxy-2-(7-methoxy-2H-1,3-benzodioxol-5-yl)-3-methyl-3a-(prop-2-en-1-yl)-2,3,3a,4,5,6-hexahydro-1-benzofuran-6-one; ΔMass: 150.0318 Da]",30,32,0,10,0,0,0,1.0666666666666667,0.3333333333333333,-0.40000000000000036,71.7,15,5,0.25,0.4,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.748550628520334,20.910134891071465,1.0588187095043624,0.08245559283476873,0.025276591032715734,0.05591488319358329,Upregulated
Feature0109,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",C11 H17 N O2,195.12596,NA,"9-Hydroxy-10-azatricyclo[7.2.1.0~1,6~]dodecan-11-one",11,17,1,2,0,0,0,1.5454545454545454,0.18181818181818182,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.827245017364934,20.105743560235066,1.0140462551719223,0.02012346159682552,0.6058826639712285,0.6910849135921825,Upregulated
Feature0108,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.2038,Metabolic pathways;Biosynthesis of secondary metabolites;Other,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,18,28,0,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9638813099357,23.1410153720616,1.103851668970004,0.1425463217368063,0.13071976733216356,0.2030328301116583,Upregulated
Feature0107,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.0917,Metabolic pathways;ABC transporters;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,0,1.3,0.5,1.2000000000000002,26.099999999999994,7,2,-Inf,-0.2,-3,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.1283951348602,27.389617741496433,1.009629121270818,0.013825428455172019,0.16439102585852694,0.24391351397708264,Upregulated
Feature0106,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",11,14,4,2,0,0,0,1.2727272727272727,0.18181818181818182,0.18181818181818166,55.11818181818182,7,5,0.2,0.3333333333333333,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.780710366775267,20.726216876243168,0.8039428154374657,-0.31483520892946204,0.04631145591419708,0.08991319898235071,Downregulated
Feature0105,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04229,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other","6-Methoxy-1,2,4-benzenetriol",7,8,0,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4170275175503,20.424621107540467,1.0003719243647804,5.364736790212588e-4,0.9904286672760223,0.9904286672760223,Upregulated
Feature0104,6-hydroxypropylthymine,C8 H12 N2 O3,184.08482,NA,6-hydroxypropylthymine,8,12,2,3,0,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.327093753602,26.2922994852546,1.0381096126165414,0.05395878399371363,0.01177636628207781,0.031147635456220298,Upregulated
Feature0103,6-Hydroxy-3-coumaranone,C8 H6 O3,150.03205,Metabolic pathways;Microbial metabolism in diverse environments;Other,6-Hydroxy-3-coumaranone,8,6,0,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.233125388957568,20.1144961385284,0.9941368795898476,-0.00848358926684661,0.5009710291887962,0.609514752179702,Downregulated
Feature0102,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",C31 H32 Cl N,453.2239,NA,"6-chloro-2-(3-ethyl-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-4-phenylquinoline",32,32,1,0,1,0,0,1,0,-0.90625,86.128125,17.5,17.5,0.532258064516129,0.532258064516129,16.5,Unsaturated HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.588858503773366,26.575013147248068,1.3566391906975577,0.4400370752108212,2.163879560309127e-5,8.26345080487104e-4,Upregulated
Feature0101,6-Aminocaproic acid,C6 H13 N O2,131.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;2-Oxocarboxylic acid metabolism;ABC transporters;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Tropane, piperidine and pyridine alkaloid biosynthesis;Cyanoamino acid metabolism;Other",6-Aminocaproic acid,6,13,1,2,0,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.228429364978602,24.762378508808798,1.224137478101973,0.2917655905781073,4.705204483760791e-4,0.0039939526431923,Upregulated
Feature0100,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13224,Metabolic pathways;Other,6-(alpha-D-glucosaminyl)-1D-myo-inositol,12,23,1,10,0,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.9070926521018,24.151375727031734,0.8975839953910886,-0.15588114306694975,6.937179186141658e-5,0.00168804693529447,Downregulated
Feature0099,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",C14 H31 N O2,245.23548,NA,"6,6-Diethoxy-N,N-diethyl-1-hexanamine",14,31,1,2,0,0,0,2.2142857142857144,0.14285714285714285,-1.7142857142857144,109.15714285714286,0,-2,-0.2727272727272727,-0.16666666666666666,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.336937995903735,24.286457409492034,1.0872778271554415,0.12072063277109155,0.4720456810379627,0.5801234800634896,Upregulated
Feature0098,5-Methylhexan-3-one,C8 H15 N O4,189.10013,NA,5-Methylhexan-3-one,8,15,1,4,0,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.7541324729329,25.4579521373332,1.1702582104346702,0.22682688691428046,4.2481642015588264e-4,0.003876449833922429,Upregulated
Feature0097,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04224,Microbial metabolism in diverse environments;Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,0,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7908990243229,23.307620936458832,0.8699827846500533,-0.20094124190959162,5.428133519861003e-4,0.004215465393083545,Downregulated
Feature0096,5-Aminolevulinic acid,C5 H9 N O3,131.05822,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of cofactors;ABC transporters;D-Amino acid metabolism;Other,5-Aminolevulinic acid,5,9,1,3,0,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.868456251191,21.810838272032534,1.045158204780373,0.06372133845627032,0.14659311020614968,0.22481716481195224,Upregulated
Feature0095,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",C10 H23 N O4 S2,285.10595,NA,"5-Amino-6,6-bis(ethylsulfanyl)-1,2,3,4-hexanetetrol",10,23,1,4,0,2,0,2.3,0.4,-0.7999999999999998,83.1,0,-4,-2.3333333333333335,-1,-7,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.120432812705765,24.335794363931768,1.0525665570827076,0.07391146230565886,0.3468951625787929,0.45277003040870456,Upregulated
Feature0094,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",C9 H15 N O7,249.08483,NA,"5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid",9,15,1,7,0,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.085988905457732,25.815439668341533,1.029078015047878,0.04135235799112797,0.06616281190233159,0.12223198696551596,Upregulated
Feature0093,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Degradation of aromatic compounds;Other,4-Phenylbutyric acid,10,12,0,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.839924414902033,28.003605830377733,1.3437479557436953,0.4262625599183387,3.622033934443944e-5,0.001201856714610945,Upregulated
Feature0092,4-Penten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",4-Penten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.904560927185265,24.610537720242032,0.9881940015805585,-0.017133796353756156,0.8644098048791117,0.8937948407390247,Downregulated
Feature0091,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,4-Methoxycinnamaldehyde,10,10,0,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.863602612978767,27.195462672482165,1.303488336935851,0.3823776743041665,0.002691764218950255,0.012604454731957898,Upregulated
Feature0090,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,0,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.99529426068173,20.668780909383567,1.0336822574312479,0.04779278519305363,0.08463231673549729,0.1457113000398892,Upregulated
Feature0089,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",C29 H33 N O10,555.21068,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"4-Hydroxy-N-(2-hydroxy-8-methyl-4-oxo-7-{[(2R,3R,4R,5R)-3,4,5-trihydroxy-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4H-chromen-3-yl)-3-(3-methyl-2-buten-1-yl)benzamide",29,33,1,10,0,0,0,1.1379310344827587,0.3448275862068966,-0.3448275862068968,70.12758620689655,14,4,0.16666666666666666,0.34782608695652173,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.1455579858692,20.0408390846854,0.9948018862889152,-0.007518851770536778,0.6499881470918395,0.7277474653022129,Downregulated
Feature0088,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03788,NA,4-Hydroxy-3-nitrosobenzamide,7,6,2,3,0,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2502223786611,22.33873100038783,1.0039778758261586,0.005727477667601568,0.6117623754592962,0.6956176543384521,Upregulated
Feature0087,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,4-Guanidinobutyric acid,5,11,3,2,0,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.0487066532288,20.3130816158032,0.8109433312072752,-0.30232699258133866,0.0027281217633199277,0.012604454731957898,Downregulated
Feature0086,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,4-guanidinobutanal,5,11,3,1,0,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.535680712697165,22.1150163502614,0.8660437369607734,-0.20748820907731536,0.003025449083321851,0.013014118638113149,Downregulated
Feature0085,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak2",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.1917360610915,22.704067665479734,0.9385050997640288,-0.09156351031679154,0.34733043428612953,0.45277003040870456,Downregulated
Feature0084,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy",C10 H20 N2 O3,216.14739,NA,"4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy-peak1",10,20,2,3,0,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.23076923076923078,-3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.204879190669335,21.708426848423198,0.9355113064821359,-0.09617300506947442,0.5938478471200341,0.681296633564225,Downregulated
Feature0083,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.294101278329766,20.046508995598366,0.987799790720677,-0.017709431826272853,0.7697805121026053,0.8228508080872459,Downregulated
Feature0082,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,0,7,0,0,0,1.1818181818181819,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.374970759917467,20.4002106878276,1.0012387712457378,0.0017860630994759308,0.9524683153371287,0.9686058575488905,Upregulated
Feature0081,"4,5-Dideoxypentonic acid",C5 H10 O4,134.05785,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,"4,5-Dideoxypentonic acid",5,10,0,4,0,0,0,2,0.8,-0.40000000000000036,71.7,1,-3,-3,-0.3333333333333333,-3,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.153432946019766,26.9410955864788,1.1635896780097208,0.21858240372493956,0.009511974918911847,0.026913727483742825,Upregulated
Feature0080,3696,C10 H14 O2,166.09939,Metabolic pathways;Biosynthesis of secondary metabolites;Other,3696,10,14,0,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.458464449390632,22.699728880447566,1.0107426948801692,0.015415776601704324,0.6779904095205164,0.7498984832575407,Upregulated
Feature0079,3603307,C9 H19 N O3,189.13649,NA,3603307,9,19,1,3,0,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666665,1,-2,-0.6,-0.23076923076923078,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.948449807332565,23.033311777728667,1.0494277263277914,0.06960281221474789,0.012484826373101684,0.03186686451875605,Upregulated
Feature0078,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",C12 H16 N2 O3,236.11609,NA,"3-{[(E)-(6,6-Dimethyl-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene)methyl](methyl)amino}propanenitrile",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.772596146786732,20.837510858465734,0.8085142350342422,-0.3066549202824052,0.11288519802765357,0.18071533894777872,Downregulated
Feature0077,3-oxovaleric acid,C5 H8 O3,116.04729,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of cofactors;Other,3-oxovaleric acid,5,8,0,3,0,0,0,1.6,0.6,-0.40000000000000036,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.776434596386334,24.71201812109503,1.084981848959617,0.11767090752230105,2.2705252288012542e-4,0.0025113385106438116,Upregulated
Feature0076,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,C14 H27 N O11,385.1585,NA,3-O-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-D-galactitol,14,27,1,11,0,0,0,1.9285714285714286,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.652267932473134,20.970954117482567,0.7868356332982661,-0.3458658006941157,0.007298019841093407,0.02276732685469311,Downregulated
Feature0075,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,2,3,0,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.892884326500965,19.680713163433968,0.9893343187652106,-0.015469971757411863,0.3592207530852452,0.4649488470784202,Downregulated
Feature0074,3-Methyl-2-buten-1-amine,C5 H11 N,85.08916,"Protein digestion and absorption;Tropane, piperidine and pyridine alkaloid biosynthesis",3-Methyl-2-buten-1-amine,5,11,1,0,0,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.656060688508035,25.064584704857968,0.9769459547655731,-0.03364934123858102,0.7173824685145112,0.7821407552300275,Downregulated
Feature0073,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",C29 H30 O10,538.18406,NA,"3-Methoxy-4-(methoxycarbonyl)-5-methylphenyl 4-[(2,4-dimethoxy-6-methylbenzoyl)oxy]-2-methoxy-6-methylbenzoate",29,30,0,10,0,0,0,1.0344827586206897,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.311871832884066,21.0187264198941,1.0348000712502363,0.04935205847077582,0.12669544445550765,0.1984714044045506,Upregulated
Feature0072,3-hydroxy-cis-5-octenoylcarnitine,C15 H27 N O5,301.18898,NA,3-hydroxy-cis-5-octenoylcarnitine,15,27,1,5,0,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.043478260869565216,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.2313759165343,22.448736412949035,1.0573378051992708,0.08043637201540908,0.4087739950674999,0.5146672781144574,Upregulated
Feature0071,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",C9 H17 N O6,235.10555,NA,"3-Hydroxy-4,5,6-trimethoxytetrahydro-2H-pyran-2-carboxamide",9,17,1,6,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.26382700578173,26.814102171301332,1.4681535344598293,0.5540028481684313,0.0030015085449933815,0.013014118638113149,Upregulated
Feature0070,3-hydroxy-3-methylpentanedioic acid,C6 H10 O5,162.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,3-hydroxy-3-methylpentanedioic acid,6,10,0,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.361822214297067,24.511445401693567,0.8348066827323231,-0.26048594538842523,0.008860072266565837,0.026292084368264475,Downregulated
Feature0069,3-Carboxytyrosine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,3-Carboxytyrosine,10,11,1,5,0,0,0,1.1,0.5,0.20000000000000018,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.393299284277134,19.741058022810833,0.9680168837629345,-0.046895884258738814,0.10518581263139533,0.17139652504669328,Downregulated
Feature0068,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11609,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,2,3,0,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.14027449491263,24.84631810044243,1.0292475384104929,0.04158999825624675,0.1117252145762355,0.18006359630454544,Upregulated
Feature0067,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.371172789153334,26.4157355648094,1.0411712451898414,0.05820737340972859,0.011490394369625886,0.030613094488419333,Upregulated
Feature0066,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",9,14,2,3,0,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909091,-1,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.853754779498466,25.990452279342367,1.045735443595088,0.06451791612745156,0.010179374455560266,0.02836237920824044,Upregulated
Feature0065,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak2",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.166550954669468,24.684339618769567,1.1661956485793947,0.22180984476219476,0.2250715858963642,0.3159658802006651,Upregulated
Feature0064,"3,4-Methylenedioxy-N-propylamphetamine",C13 H19 N O2,221.14159,NA,"3,4-Methylenedioxy-N-propylamphetamine-peak1",13,19,1,2,0,0,0,1.4615384615384615,0.15384615384615385,-0.9230769230769234,86.6076923076923,5,3,0.2,0.2727272727272727,2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.554678366624834,24.825079770936966,0.9348665206255441,-0.09716770184261689,0.595434592073939,0.681296633564225,Downregulated
Feature0063,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,"3',4'-Dimethoxyacetophenone",10,12,0,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,17.7885600300926,30.5610379393236,1.7180164042296857,0.7807438119058466,1.6509378678192143e-4,0.0020086410725133775,Upregulated
Feature0062,2050867,C12 H23 N O4,245.16269,NA,2050867,12,23,1,4,0,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4123003984983,20.5573156123154,1.0071043052956328,0.010213110295910365,0.6368702880225134,0.7174618985438809,Upregulated
Feature0061,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,C9 H19 O11 P,334.06664,NA,2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate,9,19,0,11,0,0,1,2.111111111111111,1.2222222222222223,-0.22222222222222232,66.63333333333333,1,-10,3.6666666666666665,-2.2,-11,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.9172968734495,21.0330889006201,0.9177822767129084,-0.12377614774196889,0.037329572595408846,0.07638358001944659,Downregulated
Feature0060,2-Methylhippuric Acid,C10 H11 N O3,193.0739,Other,2-Methylhippuric Acid,10,11,1,3,0,0,0,1.1,0.3,-0.20000000000000018,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.526777268834433,25.110363772102936,1.0673099628212257,0.09397921729129842,0.004242769243023444,0.01630116603898481,Upregulated
Feature0059,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",C8 H14 N6 O2,226.11807,NA,"2-Hydrazino-4-methoxy-6-(4-morpholinyl)-1,3,5-triazine",8,14,6,2,0,0,0,1.75,0.25,1,31.799999999999997,5,3,-Inf,-2,-3,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.6141363416845,25.8361317883481,1.008666911259558,0.012449836674447724,0.7075063634724976,0.777830791167053,Upregulated
Feature0058,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak2",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.1963520003667,23.141694182978632,0.9184541548967816,-0.12272038460544965,0.5874393157138682,0.6774626293023008,Downregulated
Feature0057,"2-Hexyl-3,5-dipentylpyridine",C21 H37 N,303.29265,NA,"2-Hexyl-3,5-dipentylpyridine-peak1",21,37,1,0,0,0,0,1.7619047619047619,0,-1.6190476190476186,106.44285714285712,4,4,0.15,0.15,3,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.223281103430168,24.9347004994001,1.2329700789834153,0.3021377896628803,0.18146403281742096,0.26278185506479185,Upregulated
Feature0056,2-Acetamido-2-deoxyhexitol,C8 H17 N O6,223.10559,NA,2-Acetamido-2-deoxyhexitol,8,17,1,6,0,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.5144914430735,22.911257123432666,0.9346005474613334,-0.09757821259635596,5.066482591107361e-4,0.0041094803238981925,Downregulated
Feature0055,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",C13 H21 N3 O3,267.15832,NA,"2-[9-(Hydroxyimino)-3,6-diazatricyclo[4.3.1.1~3,8~]undec-1-yl]ethyl acetate",13,21,3,3,0,0,0,1.6153846153846154,0.23076923076923078,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.058823529411764705,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.4285277741955,25.94410557089917,1.4078230170522539,0.4934659785279216,0.0030589685478346848,0.013014118638113149,Upregulated
Feature0054,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",C15 H24 O3,252.17254,Other,"2-[(2R,4aR,8R,8aR)-8-hydroxy-4a,8-dimethyl-decahydronaphthalen-2-yl]prop-2-enoic acid",15,24,0,3,0,0,0,1.6,0.2,-1.2000000000000002,94.5,4,1,0.08333333333333333,0.18518518518518517,1,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.061523660293666,26.828544468971135,1.2160784940369804,0.2822363532083687,0.029112010834567558,0.06142129453535929,Upregulated
Feature0053,"2,4-Pentadienoic acid",C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,"2,4-Pentadienoic acid",5,6,0,2,0,0,0,1.2,0.4,-0.40000000000000036,71.7,3,1,0.3333333333333333,0.5,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.735328700917034,25.805674903946368,1.1350473636611857,0.18275250006545404,3.157211264994852e-4,0.003201061421453114,Upregulated
Feature0052,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12157,Metabolic pathways;Other,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,2,5,0,0,0,1.8,0.5,-0.20000000000000018,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.920898765996498,24.069283230913967,1.0501020695846848,0.07052956420266959,0.05012278790288056,0.09628851360290212,Upregulated
Feature0051,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,"2,3,9-Trimethoxy-6a,12a-dihydrochromeno[3,4-b]chromen-12(6H)-one",19,18,0,6,0,0,0,0.9473684210526315,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.344425896994334,20.2000386933588,0.9929028617289777,-0.010275512840496106,0.5177510379349506,0.6175788524387482,Downregulated
Feature0050,2'-Deoxyadenosine,C10 H13 N5 O3,251.10189,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak2,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Missing ions,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.5677109691208,26.21209259559477,1.0252029455140594,0.0359095287600971,0.7178552137042717,0.7821407552300275,Upregulated
Feature0049,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,2'-Deoxyadenosine-peak1,10,13,5,3,0,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.8544979755182,25.413674365881267,1.2799958174322952,0.35613909602250604,0.0706554370268311,0.12519045880967647,Upregulated
Feature0048,1728928,C10 H19 N3 O4,245.13751,NA,1728928,10,19,3,4,0,0,0,1.9,0.4,-0.20000000000000018,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.8057919080478,22.287667406137032,0.936228775426809,-0.09506698725303496,0.005709392366683118,0.019475964615320914,Downregulated
Feature0047,13(S)-HOTrE,C18 H30 O3,294.21947,Metabolic pathways;Biosynthesis of secondary metabolites;Other,13(S)-HOTrE,18,30,0,3,0,0,0,1.6666666666666667,0.16666666666666666,-1.333333333333333,98.29999999999998,4,1,0.06666666666666667,0.15151515151515152,1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.949233537273432,23.116208624241732,1.0072758459099345,0.010458824387179799,0.8305499197016353,0.8686267068512804,Upregulated
Feature0046,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",C9 H15 N3 O2,197.1165,NA,"1-Methyl-5-(1-piperidinyl)-2,4-imidazolidinedione",9,15,3,2,0,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.689214271817967,26.138573810870266,1.1520263988752009,0.20417377675415407,0.09204004164322391,0.15481389492984665,Upregulated
Feature0045,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,C13 H22 N4 O4,298.16415,NA,1-Butyl-N-(2-hydroxyethyl)-4-nitro-2-propyl-1H-imidazole-5-carboxamide,13,22,4,4,0,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.943078066548534,18.55128408291017,0.9793173009021046,-0.03015172303495142,0.3540039914431268,0.4598272486716771,Downregulated
Feature0044,1-Amino-1-deoxyhexitol,C6 H15 N O5,181.09505,NA,1-Amino-1-deoxyhexitol,6,15,1,5,0,0,0,2.5,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.450776231692533,21.380353481004168,0.9967170068846124,-0.004744149660242255,0.9192683529458326,0.942508283216935,Downregulated
Feature0043,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",C7 H10 N6 O2,210.0867,NA,"1-[1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanol",7,10,6,2,0,0,0,1.4285714285714286,0.2857142857142857,1.7142857142857144,11.442857142857136,6,4,2,-Inf,-2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.710330624422134,25.416481051520467,1.0285771339052994,0.040649986891564946,0.10217302750857267,0.1679871848676983,Upregulated
Feature0042,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,10,19,1,7,0,0,0,1.9,0.7,-0.20000000000000018,66,2,-5,-3,-0.45454545454545453,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.4026006492414,25.302410447073868,0.8908483684133927,-0.16674820382976188,0.07882149455662066,0.13709867640368661,Downregulated
Feature0041,1-(Dimethylamino)-2-propanyl acetate,C7 H15 N O2,145.1103,NA,1-(Dimethylamino)-2-propanyl acetate,7,15,1,2,0,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,19.702428780805732,22.7885861540737,1.1566384229884656,0.20993793368586516,0.048890251710323365,0.09441768187443401,Upregulated
Feature0040,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",10,13,1,3,0,0,0,1.3,0.3,-0.40000000000000036,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.714763838537966,21.600860611240467,0.9947545721360621,-0.007587469972758506,0.741097754158892,0.8050615484166534,Downregulated
Feature0039,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",21,24,0,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.715623610091935,20.914901047264333,1.00961966875452,0.013811921354457746,0.5775894129272423,0.6714017061096925,Upregulated
Feature0038,"1-(2-Furyl)-1,2-ethanediol",C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,"1-(2-Furyl)-1,2-ethanediol",6,8,0,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.466324749141865,26.973615210334966,1.317951099718866,0.39829684265108006,1.8489320679624176e-6,1.2481230131084379e-4,Upregulated
Feature0037,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,2,9,0,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.135188750022433,20.0216272513046,0.76607930567508975,-0.38443434505852325,0.01838094816546537,0.04246231696452443,Downregulated
Feature0036,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",C6 H14 O5 S,198.05629,NA,"1,2-Dideoxy-5-O-(methylsulfonyl)pentitol",6,14,0,5,0,1,0,2.3333333333333335,0.8333333333333334,-0.33333333333333304,69.79999999999998,0,-5,-Inf,-1.4,-6,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.178076009583133,22.051379250204068,0.9942872970890568,-0.008265319359317728,0.8206893172505106,0.8620615694138777,Downregulated
Feature0035,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",C12 H23 N O7,293.14748,NA,"1,2-di-O-methyl-4-[(2R)-2,4-dihydrobutyramido]-4,6-dideoxy-alpha-D-mannopyranoside",12,23,1,7,0,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,28.102437461856866,24.5682518657356,0.8742391793979374,-0.1939000603275891,0.06816155965794236,0.12377596654302966,Downregulated
Feature0034,.alpha.-Glucoheptitol,C7 H16 O7,212.08956,NA,.alpha.-Glucoheptitol,7,16,0,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2589859918705,24.7846464920801,1.1134670061399936,0.15505880933051777,0.2108093371399271,0.29732358822183347,Upregulated
Feature0033,(S)-malyl alpha-D-glucosaminide,C10 H17 N O9,295.09039,NA,(S)-malyl alpha-D-glucosaminide,10,17,1,9,0,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.322873501723432,25.823328827164534,0.9810224110021198,-0.0276420003670998,0.16433678474636487,0.24391351397708264,Downregulated
Feature0032,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",C14 H23 N O11,381.12721,NA,"(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2-dihydroxy-3-(lactoyloxy)propyl]-alpha-L-threo-hex-2-ulopyranosonic acid",14,23,1,11,0,0,0,1.6428571428571428,0.7857142857142857,0.1428571428571428,56.22857142857143,4,-7,-4,-0.3333333333333333,-8,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.0102114360189,23.991709384314934,0.922395784568335,-0.1165421751286564,0.02235364563741897,0.05067751961278214,Downregulated
Feature0031,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",C4 H6 N6 O4,202.04538,NA,"(2Z,4Z)-6-Amino-2,4-diimino-5-nitro-1,3(2H,4H)-pyrimidinediol",4,6,6,4,0,0,0,1.5,1,5,-82.2,5,1,0.8333333333333334,0.75,-5,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,29.335986760269634,23.661974831278002,0.8065852710065963,-0.310101033849446,0.004690141751407014,0.01706989735222466,Downregulated
Feature0030,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,1,7,0,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.563826621920168,24.206665230593835,0.9469108670075782,-0.0786994641019858,0.030932103922091392,0.0645155310375049,Downregulated
Feature0029,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,1,8,0,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.23635475283143,25.221915194440665,0.9994278270957835,-8.257072576372654e-4,0.9780748862279489,0.9826133279253654,Downregulated
Feature0028,(2E)-2-Pentenedioate,C5 H4 O4,128.01091,NA,(2E)-2-Pentenedioate,5,4,0,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.499092492767666,24.282027306939934,0.9911398683077012,-0.012839431950621236,0.18107219339108846,0.26278185506479185,Downregulated
Feature0027,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.25075,Metabolic pathways;Biosynthesis of secondary metabolites;Other,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,0,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.058823529411764705,0.13513513513513514,1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.105446800116166,21.939800873107835,1.0395326420186033,0.055935060494491824,0.43017400807464634,0.5358822967482796,Upregulated
Feature0026,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,(+)-Piperitol,20,20,0,6,0,0,0,1,0.3,-0.40000000000000036,71.7,11,5,0.35714285714285715,0.47058823529411764,5,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.4927288422862,21.429909145334232,1.0457323331734223,0.06451362498803057,0.04519640104594972,0.0891712777393062,Upregulated
Feature0025,NA,C4 H2 O8 S2,241.91814,NA,Feature0025,4,2,0,8,0,2,0,0.5,2,4.5,-67.95,4,-4,1,1,-6,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.521174649017933,26.884867714479768,1.0137133090926387,0.01964969767505932,0.0438691898356109,0.08702312114129337,Upregulated
Feature0024,NA,C11 H20 N4 O3,256.15356,NA,Feature0024,11,20,4,3,0,0,0,1.8181818181818181,0.2727272727272727,-0.18181818181818166,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,18.1453306316713,18.2901738334145,1.007982395288537,0.011470441961126506,0.5832062341440808,0.6757786522621889,Upregulated
Feature0023,NA,C2 H3 P S,89.96937,NA,Feature0023,2,3,0,0,0,1,1,1.5,0,-3,145.8,2,2,NA,NA,0,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.640585695144335,26.577985861204034,1.0365592337556166,0.05180256102403164,0.0014226507847491532,0.00837528284570066,Upregulated
Feature0022,NA,C16 H29 N O13,443.16395,NA,Feature0022,16,29,1,13,0,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.7950302393238,24.229165913917132,0.9392958910736398,-0.0903483967091581,0.002510112797135349,0.012380961769654086,Downregulated
Feature0021,NA,C18 H25 N5 O10,471.15896,NA,Feature0021,18,25,5,10,0,0,0,1.3888888888888888,0.5555555555555556,0.5555555555555554,44.46666666666667,9,-1,-2,-0.125,-6,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.577453625105935,24.418750614290865,0.954698265597568,-0.06688325651305485,0.006628625816840799,0.021223231781990277,Downregulated
Feature0020,NA,C14 H26 N6 O10,438.1713,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Feature0020,14,26,6,10,0,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,5,-5,5.5,-2,-11,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.2313848022398,22.959582771927433,1.0327554030558757,0.0464986079466617,0.8003107488632761,0.8467055748843356,Upregulated
Feature0019,NA,C20 H32 N6 O3,404.25385,NA,Feature0019,20,32,6,3,0,0,0,1.6,0.15,-0.40000000000000036,71.7,8,5,-0.09090909090909091,0.04,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.3713905929201,21.729665789563366,1.0167642435378985,0.023985201213183222,0.3246550445148799,0.4262557239134215,Upregulated
Feature0018,NA,C30 H30 N6 O9,618.20799,NA,Feature0018,30,30,6,9,0,0,0,1,0.3,0.20000000000000018,54.599999999999994,19,10,0.26666666666666666,0.4358974358974359,4,Phenol,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.402632454270133,20.1780974681236,0.988994803163278,-0.015965154762698528,0.5287838781289972,0.6247036009492033,Downregulated
Feature0017,NA,C11 H21 N O8 S,327.09887,Other,Feature0017,11,21,1,8,0,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.399859400605,21.5037403069425,0.8813059105746041,-0.18228521414809729,0.002662181875139105,0.012604454731957898,Downregulated
Feature0016,NA,C35 H63 N O3,545.48105,NA,Feature0016,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.548606790391165,25.0391865595278,1.1104538205969323,0.1511493981248147,0.4714483617321614,0.5801234800634896,Upregulated
Feature0015,NA,C35 H63 N O3,545.48106,NA,Feature0015,35,63,1,3,0,0,0,1.8,0.08571428571428572,-1.5428571428571427,104.27142857142857,5,2,0.03225806451612903,0.07692307692307693,1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.582339337728765,24.223592088894932,1.0726785974925146,0.10121787174874368,0.6962629149358588,0.767782368433802,Upregulated
Feature0014,NA,C18 H34 N2 O12,470.2113,NA,Feature0014,18,34,2,12,0,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,25.58893607761833,22.269461871508234,0.8702769745470772,-0.20045346839495853,1.1750240735218273e-4,0.0019717592282331494,Downregulated
Feature0013,NA,C3 H2 N4 O18 S2,445.88051,NA,Feature0013,3,2,4,18,0,2,0,0.6666666666666666,6,16.666666666666664,-414.69999999999993,5,-13,0.9047619047619048,0.8333333333333334,-19,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.778873307002566,25.614798177812,1.033735386611513,0.04786693489873394,0.00600087231519557,0.01994508816846971,Upregulated
Feature0012,NA,C6 H5 O13 P3,377.89309,NA,Feature0012,6,5,0,13,0,0,3,0.8333333333333334,2.1666666666666665,1,31.799999999999997,6,-7,1,1,-10,Other,No gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.392675539652867,25.320172208313167,1.0380235725741753,0.05383920636411263,0.007008249982765871,0.022083526898869693,Upregulated
Feature0011,NA,C16 H28 N2 O13,456.15919,NA,Feature0011,16,28,2,13,0,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,27.567552665057466,20.294767812924498,0.7361831519650492,-0.44186336181114483,0.0035177318079837954,0.014109583625429509,Downregulated
Feature0010,NA,C10 H17 N7 O8,363.11421,NA,Feature0010,10,17,7,8,0,0,0,1.7,0.8,2,3.299999999999997,6,-2,1.8,5,-9,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,24.94388366560697,23.078877850794434,0.9252319390270396,-0.11211302618887485,3.3569390860161184e-4,0.003311575044313198,Downregulated
Feature0009,NA,C22 H39 N O17,589.22211,NA,Feature0009,22,39,1,17,0,0,0,1.7727272727272727,0.7727272727272727,-0.09090909090909083,62.890909090909084,4,-13,-3.5,-0.44,-14,Carbohydrate,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,26.7435181209715,20.803669004105068,0.7778957469246137,-0.3623512757594722,0.0012877950490283922,0.007921788149874274,Downregulated
Feature0008,NA,C39 H74 N2 O6,666.55504,NA,Feature0008,39,74,2,6,0,0,0,1.8974358974358974,0.15384615384615385,-1.4358974358974361,101.22307692307692,4,-2,-0.12903225806451613,-0.029411764705882353,-4,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,20.9420229797029,23.200819436435832,1.1078595157173767,0.14777494923215428,0.4089137278169662,0.5146672781144574,Upregulated
Feature0007,NA,C11 H18 N3 O6 P S,351.06551,NA,Feature0007,11,18,3,6,0,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,21.650494824991533,21.236094019068332,0.9808595226449581,-0.02788156445258876,0.1674051776518843,0.24638262033442648,Downregulated
Feature0006,NA,C9 H9 N2 O6 P3 S4,461.85452,NA,Feature0006,9,9,2,6,0,4,3,1,0.6666666666666666,0.22222222222222232,53.96666666666666,8,2,1.1666666666666667,1.3333333333333333,-7,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.9043444632095,24.583660968513033,1.0284181189887491,0.040426933355910334,0.02188348163509594,0.04992169248006262,Upregulated
Feature0005,NA,C4 H N4 O7 P3,309.90566,NA,Feature0005,4,1,4,7,0,0,3,0.25,1.75,2.5,-10.950000000000003,8,1,0.6,0.38461538461538464,-6,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.73681318211967,24.9127932214179,1.0495424567011409,0.06976052854838032,7.514835978300933e-4,0.005274836792461232,Upregulated
Feature0004,NA,C9 H8 O17 P2 S2,513.86803,NA,Feature0004,9,8,0,17,0,2,2,0.8888888888888888,1.8888888888888888,2.2222222222222223,-3.0333333333333385,7,-10,1.1666666666666667,1.5714285714285714,-14,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.8286430864367,25.067859196871233,1.0520053158687788,0.07314199470450107,0.0011125337800604468,0.007519904254112279,Upregulated
Feature0003,NA,C3 H5 N2 P S,131.99089,NA,Feature0003,3,5,2,0,0,1,1,1.6666666666666667,0,-0.666666666666667,79.30000000000001,3,3,1,1,-1,Lipid,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.790375337821633,24.618789530451767,1.0348214007079213,0.04938179521562986,3.639214494617603e-4,0.0034955612908826976,Upregulated
Feature0002,NA,C H3 N O5,109.00137,NA,Feature0002,1,3,1,5,0,0,0,3,5,10,-224.7,1,-4,1,1,-5,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,22.977628491503502,24.420577158328534,1.06279798053827,0.08786739162548396,0.03503464891754127,0.07224659240057944,Upregulated
Feature0001,NA,C6 H N6 O5 P3 S2,393.86699,NA,Feature0001,6,1,6,5,0,2,3,0.16666666666666666,0.8333333333333334,2.666666666666667,-15.700000000000017,11,6,0.5,0.3333333333333333,-5,Other,Full gap,F1,CTRL1,Area: 2,0,0.00 - 21.00,Orbitrap Exploris Slot #139,3.1-3.1.231.6/3.1.279.9,F55,Control,23.5077301332603,24.291037384054867,1.0333212626805808,0.04728886215973314,0.01227945949149159,0.03186686451875605,Upregulated
